nrci20171231

0001437749-18-004585.txt : 20180314 0001437749-18-004585.hdr.sgml : 20180314 20180314095139 ACCESSION NUMBER: 0001437749-18-004585 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 87 CONFORMED PERIOD OF REPORT: 20171231 FILED AS OF DATE: 20180314 DATE AS OF CHANGE: 20180314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATIONAL RESEARCH CORP CENTRAL INDEX KEY: 0000070487 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 470634000 STATE OF INCORPORATION: WI FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35929 FILM NUMBER: 18688498 BUSINESS ADDRESS: STREET 1: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 BUSINESS PHONE: 4024752525 MAIL ADDRESS: STREET 1: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 10-K 1 nrci20171231_10k.htm FORM 10-K nrci20171231_10k.htm

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

[X]	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2017

[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________

Commission file number: 001-35929

National Research Corporation

(Exact name of registrant as specified in its charter)

Wisconsin

(State or other jurisdiction

of incorporation or organization)

47-0634000

(I.R.S. Employer

Identification No.)

1245 Q Street

Lincoln, Nebraska

(Address of principal executive offices)

68508

(Zip code)

Registrant’s telephone number, including area code: (402) 475-2525

Securities registered pursuant to Section 12(b) of the Act:

Title of Class	Name of Each Exchange on Which Registered
Class A Common Stock, $.001 par value	The NASDAQ Stock Market
Class B Common Stock, $.001 par value	The NASDAQ Stock Market

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☒	Smaller reporting company ☐
Non-accelerated filer ☐ (Do not check if a smaller reporting company)		Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(s) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act.) Yes ☐ No ☒

Aggregate market value of the class A common stock and the class B common stock held by non-affiliates of the registrant at June 30, 2017: $458,611,975.

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class A Common Stock, $0.001 par value, outstanding as of February 28, 2018: 20,970,575 shares

Class B Common Stock, $0.001 par value, outstanding as of February 28, 2018: 3,540,857 shares

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Proxy Statement for the 2018 Annual Meeting of Shareholders are incorporated by reference into Part III.

Table of Contents

TABLE OF CONTENTS

		Page
PART I

Item 1.	Business	1
Item 1A.	Risk Factors	8
Item 1B.	Unresolved Staff Comments	13
Item 2.	Properties	13
Item 3.	Legal Proceedings	14
Item 4.	Mine Safety Disclosures	14

PART II

Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	15
Item 6.	Selected Financial Data	17
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	18
Item 7A.	Quantitative and Qualitative Disclosure About Market Risk	28
Item 8.	Financial Statements and Supplementary Data	29
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	57
Item 9A.	Controls and Procedures	57
Item 9B.	Other Information	57

PART III

Item 10.	Directors, Executive Officers and Corporate Governance	60
Item 11.	Executive Compensation	60
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters	60
Item 13.	Certain Relationships and Related Transactions, and Director Independence	61
Item 14.	Principal Accountant Fees and Services	61

PART IV

Item 15.	Exhibits	62
Item 16.	Form 10-K Summary	64
Signatures		66

Table of Contents

PART I

Item 1.

Business

Special Note Regarding Forward-Looking Statements

Certain matters discussed in this Annual Report on Form 10-K are “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can generally be identified as such because the context of the statement includes phrases such as National Research Corporation, doing business as NRC Health (“NRC Health,” the “Company,” “we,” “our,” “us” or similar terms), “believes,” “expects,” or other words of similar import. Similarly, statements that describe the Company’s future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which could cause actual results or outcomes to differ materially from those currently anticipated. Factors that could affect actual results or outcomes include, without limitation, the following factors:

●

The possibility of non-renewal of the Company’s client service contracts and retention of key clients;

●

The Company’s ability to compete in its markets, which are highly competitive, and the possibility of increased price pressure and expenses;

●

The effects of an economic downturn;

●

The impact of consolidation in the healthcare industry;

●

The impact of federal healthcare reform legislation or other regulatory changes;

●

The Company’s ability to attract and retain key managers and other personnel;

●

The possibility that the Company’s intellectual property and other proprietary information technology could be copied or independently developed by its competitors;

●

The possibility that the Company could be subject to security breaches or computer viruses; and

●

The factors set forth under the caption “Risk Factors” in Part I, Item 1A of this Annual Report on Form 10-K.

Shareholders, potential investors and other readers are urged to consider these and other factors in evaluating the forward-looking statements, and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included are only made as of the date of this Annual Report on Form 10-K and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances, except as required by the federal securities laws.

General

The Company is a leading provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers and other healthcare organizations. The Company’s solutions enable its clients to understand the voice of the customer with greater clarity, immediacy and depth. NRC Health’s heritage, proprietary methods, and holistic approach enable our partners to better understand the people they care for and design experiences that inspire loyalty and trust, while also facilitating regulatory compliance and the shift to population-based health management. The Company’s ability to measure what matters most and systematically capture, analyze and deliver insights based on self-reported information from patients, families and consumers is critical in today’s healthcare market. NRC Health believes that access to and analysis of its extensive consumer-driven information is becoming more valuable as healthcare providers increasingly need to more deeply understand and engage patients and consumers in an effort towards effective population-based health management.

Table of Contents

NRC Health’s expertise includes the efficient capture, interpretation, transmittal and benchmarking of critical data elements from millions of healthcare consumers. Using its portfolio of solutions through internet-based business intelligence tools, the Company’s clients gain insights into what people think and feel about their organizations in real-time, allowing them to build on their strengths and resolve service issues with greater speed and personalization. The Company’s clients are also able to access networking groups, on-line education and an extensive library of performance improvement material that can be tailored to each of their unique needs.

The Company’s portfolio of subscription-based solutions provide actionable information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. NRC Health partners with clients across the continuum of healthcare services. The Company’s clients range from integrated health systems and post-acute providers, such as home health, long term care and hospice, to numerous payer organizations. The Company believes this cross-continuum positioning is a unique and an increasingly important capability as evolving payment models drive healthcare providers and payers towards a more collaborative and integrated service model.

NRC Health has achieved a market leadership position through its more than 36 years of industry innovation and experience, as well as its long-term, recurring revenue relationships (solutions that are used or required by a client each year) with many of the healthcare industry’s largest organizations. Since its founding in 1981, the Company has focused on meeting the evolving information needs of the healthcare industry through internal product development, as well as select acquisitions. The Company is a Wisconsin corporation headquartered in Lincoln, Nebraska.

Industry and Market Opportunity

According to the Centers for Medicare and Medicaid Services (“CMS”), health expenditures in the United States were approximately $3.3 trillion in 2016, or $10,348 per person. In total, health spending accounted for 17.9% of the nation’s Gross Domestic Product in 2016. Addressing this growing expenditure burden continues to be a major policy priority at both federal and state levels. In addition, increased co-pays and deductibles in healthcare plans have focused even more consumer attention on health spending and affordability. In the public sector, Medicare provides health coverage for individuals aged 65 and older, while Medicaid provides coverage for low income families and other individuals in need. Both programs are administered by the CMS. With the aging of the U.S. population, Medicare enrollment has increased significantly. In addition, longer life spans and greater prevalence of chronic illnesses among both the Medicare and Medicaid populations have placed tremendous demands on the health care system.

Driven by escalating costs and a growing recognition of the challenges of chronic care and unnecessary hospitalizations, Medicare reimbursement for healthcare providers is shifting from a volume-based approach (fees paid for each element of service rendered, independent of outcome) to a more value-based model, where reimbursement is based on the value (or quality) of the healthcare service delivered. The establishment of standardized quality-focused datasets and the requirement that providers capture and transmit this data to CMS has enabled this shift.

An increasing percentage of Medicare reimbursement and reimbursement from commercial payers will be determined under value payment models, based on factors such as patient readmission rates and provider adherence to certain quality-related protocols. At the same time, many hospitals and other providers are creating new models of care delivery to improve patient experience, reduce cost and provide better clinical outcomes. These new models are based on sharing financial risk and managing the health and behaviors of large populations of patients and consumers. Certain of these new models are known as accountable care organizations, or ACOs, and medical homes, in which multiple provider organizations are coordinated in providing care and bearing shared financial risk in serving a defined patient population. This transformation towards value-based payment models and increased engagement of healthcare consumers is resulting in a greater need for providers to deliver more customer-centric healthcare.

Table of Contents

NRC Health believes that its current portfolio of solutions is aligned to address this evolving market opportunity. The Company provides tools and solutions to capture, interpret and improve the data required by CMS as well as enhanced capabilities that capture insights about patient health risks, behaviors and perceptions. The information and analytics provided through these solutions enable payers and providers to better understand what matters most to people at key moments in their relationship with a health organization. NRC Health’s solutions enable its clients to design experiences to improve the wellbeing of the people and communities they care for. In addition, the Company’s portfolio of experience solutions helps providers address and impact the types of behaviors that could result in reduced hospital re-admission rates, and a direct and measurable impact on providers’ revenue.

Finally, the Company believes that its ability to offer these insights across the entire care continuum is particularly relevant as new reimbursement models reward collaboration amongst different types of providers. Bundled payments, medical home, ACOs and other models of reimbursement for population-based health management all require effective coordination of care both within and outside of the traditional acute care settings.

NRC Health’s Solutions

NRC Health’s portfolio of solutions are designed to help healthcare companies understand the totality of how their organizations are experienced by the people they serve. NRC Health’s solutions address specific needs around market insight, experience, transparency, and governance for healthcare providers, payers and other healthcare organizations. While each distinct solution provides discernible value on a stand-alone basis, the Company believes that in combination, its solutions provide value through a comprehensive view of healthcare consumers both within healthcare settings and outside of those settings—creating a differentiated solution set to address the emerging needs for population-based health management.

NRC Health’s Market Insights Solutions – NRC Health’s Market Insights solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators; and enhanced segmentation tools to evaluate the needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. NRC Health’s Market Insights is the largest U.S. healthcare consumer database of its kind, measuring the opinions and behaviors of more than 292,000 healthcare consumers in the top 300 markets across the country annually. NRC Health’s Market Insights is a syndicated survey that provides clients with an independent third-party source of information that is used to understand consumer perception and preferences and optimize marketing strategies. NRC Health’s Market Insights solutions provide clients with on-demand tools to measure brand value and build brand equity in their markets, evaluate and optimize advertising efficacy and consumer recall, and tailor research to obtain the real time voice of customer feedback to support branding and loyalty initiatives. The Company’s Market Insights solutions were historically marketed under the Healthcare Market Guide and Ticker brands.

NRC Health’s Experience Solutions – NRC Health’s Experience solutions provide hospitals and healthcare providers the ability to receive and take action on customer and employee feedback across all care settings in real-time. Experience solutions include patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools, which are provided through the Experience, Transitions and National Research Canada Corporation operating segments. These solutions enable clients to comply with regulatory requirements and to improve their reimbursement under value-based purchasing models. More importantly, NRC Health’s Experience solutions provide quantitative and qualitative real-time feedback, improvement plans, and coaching tools to enable clients to improve the experiences of patients, residents, physicians and staff. By illuminating the complete care journey in real time, the Company’s clients are able to ensure each individual receives the care, respect, and experience he or she deserves. Developing a longitudinal profile of what healthcare customers want and need allows for organizational improvement, increased clinician and staff engagement, loyal relationships and personal well-being.

Table of Contents

NRC Health’s Experience solutions are provided on a subscription basis via a cross-continuum platform that collects and measures data and then delivers business intelligence that the Company’s clients utilize to improve patient experience, engagement and loyalty. Patient data can be collected on a longitudinal basis for improvement and regulatory compliance purposes as well as on a real time basis to support service recovery, rapid cycle improvement, and engagement activities. NRC Health provides these performance results and prescriptive analytics to its clients via web-based improvement planning and business intelligence portals. These solutions have previously been marketed under NRC Picker, My InnerView (“MIV”), Customer-Connect LLC (doing business as Connect), and NRC Canada.

NRC Health’s Health Risk Assessment solutions (formerly Payer Solutions) enable the Company’s clients to understand the health risks associated with populations of patients, analyze and address readmission risks, and efficiently reach out to patients to impact their behaviors outside of the healthcare provider settings. These health risk assessment solutions enable clients to effectively segment populations and manage care for those who are most at-risk, engage individuals, increase preventative care and manage wellness programs to improve patient experience and outcomes.

NRC Health’s Transitions solutions are provided to healthcare organizations on a subscription basis to drive effective communication between healthcare providers and patients in the critical 24-72 hours post discharge using a discharge call program. Through preference-based communications and real-time alerts, these solutions enable organizations to identify and manage high-risk patients to reduce readmissions, increase patient satisfaction and support safe care transitions. Tracking, trending and benchmarking tools isolate the key areas for process improvement allowing organizations to implement changes and reduce future readmissions. NRC Health’s Transitions solutions were previously provided by Connect. Connect was formed in June 2013 to develop and provide patient outreach and discharge call solutions. NRC Health originally had a 49% ownership interest in Connect but by March 2016 had acquired all of the remaining interest and subsequently dissolved Customer-Connect LLC in June 2016.

NRC Health’s Transparency Solutions – NRC Health’s Transparency solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making. NRC Health’s star ratings solution (formerly Reputation) enables clients to publish a five-star rating metric and verified patient feedback derived from actual patient survey data to complement their online physician information. Sharing this feedback not only results in better-informed consumer decision-making but also has the ability to drive new patient acquisition and grow online physician reputation. NRC Health’s reputation monitoring solution alerts clients to ratings and reviews on third-party websites and provides workflows for response and service recovery. These solutions raise physician awareness of survey results and provide access to improvement resources and educational development opportunities designed to improve the way care is delivered.

NRC Health’s Governance Solutions – NRC Health’s Governance solutions, branded as The Governance Institute (“TGI”), serves not-for-profit hospital and health system boards of directors, executives, and physician leadership. TGI’s subscription-based, value-driven membership services are provided through national conferences, publications, advisory services, and an on-line portal designed to improve the effectiveness of hospital and healthcare systems by continually strengthening their board governance, strategic planning, medical leadership, management performance, and transparency positioning. TGI also conducts research studies and tracks industry trends showcasing emerging healthcare trends and best practice solutions of healthcare boards across the country.

Table of Contents

NRC Health’s Competitive Strengths

The Company believes that its competitive strengths include the following:

A leading provider of patient experience solutions for healthcare providers, payers and other healthcare organizations. The Company’s history is based on capturing the voice of the consumer in healthcare markets. The Company’s solutions build on the “Eight Dimensions of Patient-Centered Care,” a philosophy developed by noted patient advocate Harvey Picker, who believed patients’ experiences are integral to quality healthcare. NRC Health has extended this philosophy to include families, caregivers, employees and other stakeholders.

Premier client portfolio across the care continuum. NRC Health’s client portfolio encompasses leading healthcare organizations across the healthcare continuum, from acute care hospitals and post-acute providers to healthcare payers. The Company’s client base is diverse, with its top ten clients representing approximately 19% of total revenue for the year ended December 31, 2017 and no single client representing more than 5% of the Company’s revenue.

Highly scalable and visible revenue model. The Company’s solutions are offered to healthcare providers, payers and other healthcare organizations primarily through subscription-based service agreements. The solutions NRC Health provides are also recurring in nature, which enables an ongoing relationship with its clients. This combination of subscription-based revenue, a base of ongoing client renewals and automated platforms creates a highly visible and scalable revenue model for the Company.

Comprehensive portfolio of solutions. Since NRC Health offers solutions encompassing market insights, experience, transparency, and governance, its clients can engage with the Company at multiple levels and, over time, increase their commitment and the financial value of their business relationship.

Exclusive focus on healthcare. The Company focuses exclusively on healthcare and serving the unique needs of healthcare organizations across the continuum, which NRC Health believes gives it a distinct competitive advantage compared to other survey and analytics software providers. The Company’s platform includes features and capabilities built specifically for healthcare providers, including a library of performance improvement content which can be tailored to the provider based on their specific customer feedback profile.

Experienced senior management team led by NRC Health’s founder. NRC Health’s senior management team has extensive industry and leadership experience. Michael D. Hays, the Company’s Chief Executive Officer, founded NRC Health in 1981. Prior to launching the Company, Mr. Hays served as Vice President and as a Director of SRI Research Center, Inc. (now known as the Gallup Organization). The Chief Financial Officer, Kevin Karas, CPA, has extensive financial experience having served as CFO at two previous companies, along with healthcare experience at Rehab Designs of America, Inc. and NovaCare, Inc. Steven D. Jackson, the Company’s President, served as Chief Strategy Officer for Vocera Communications, and he also served as Chief Operating Officer for ExperiaHealth.

Competition

The healthcare information and market research services industry is highly competitive. The Company has traditionally competed with healthcare organizations’ internal marketing, market research, and/or quality improvement departments which create their own performance measurement tools, and with relatively small specialty research firms which provide survey-based healthcare market research and/or performance assessment. The Company’s primary competitors among such specialty firms include Press Ganey, which has significantly higher annual revenue than the Company, and three or four other organizations that NRC Health believes have less annual revenue than the Company. The Company, to a certain degree, currently competes with, and anticipates that in the future it may increasingly compete with, (1) market research firms and technology solutions which provide survey-based, general market research or Voice of the Customer feedback capabilities and (2) firms which provide services or products that complement healthcare performance assessments such as healthcare software or information systems. Although only a few of these competitors have offered specific services that compete directly with the Company’s solutions, many of these competitors have substantially greater financial, information gathering, and marketing resources than the Company and could decide to increase their resource commitments to the Company’s market. There are relatively few barriers to entry into the Company’s market, and the Company expects increased competition in its market which could adversely affect the Company’s operating results through pricing pressure, increased marketing expenditures, and market share losses, among other factors. There can be no assurance that the Company will continue to compete successfully against existing or new competitors.

Table of Contents

The Company believes the primary competitive factors within its market include quality of service, timeliness of delivery, unique service capabilities, credibility of provider, industry experience, and price. NRC Health believes that its industry leadership position, exclusive focus on the healthcare industry, cross-continuum presence, comprehensive portfolio of solutions and relationships with leading healthcare payers and providers position the Company to compete in this market.

Growth Strategy

NRC Health believes that the value proposition of its current solutions, combined with the favorable alignment of its solutions with emerging market demand, positions the Company to benefit from multiple growth opportunities. The Company believes that it can accelerate its growth through (1) increasing sales of its existing solutions to its existing clients (or cross-selling), (2) winning additional new clients through market share growth in existing market segments, (3) developing and introducing new solutions to new and existing clients, and (4) pursuing acquisitions of, or investments in, firms providing products, solutions or technologies which complement those of the Company.

Selling additional solutions to existing clients. Approximately 22% of the Company’s existing clients purchase more than one of its solutions. NRC Health’s sales organization actively identifies and pursues these cross-sell opportunities in order to accelerate the growth of the Company.

Adding new clients. NRC Health believes that there is an opportunity to add new clients in each of the acute care, post-acute care and health plan market segments. The Company’s sales organization is actively identifying and engaging new client prospects in each of the segments noted above, with a focus on featuring its comprehensive cross continuum portfolio of solutions.

Adding new solutions. The need for growth, engagement and informing solutions in the market segments that NRC Health serves is evolving to align with emerging healthcare regulatory and reimbursement trends. The evolving market creates an opportunity for the Company to introduce new solutions that leverage its existing core competencies. The Company believes that there is an opportunity to drive sales growth with both existing and new clients, across all of the market segments that it serves, through the introduction of new solutions.

Pursue strategic acquisitions and investments. The Company has historically complemented its organic growth with strategic acquisitions, having completed seven such transactions over the past sixteen years. These transactions have added new capabilities and access to market segments that are adjacent and complementary to the Company’s existing solutions and market segments. NRC Health believes that additional strategic acquisition and/or investment opportunities exist for the Company to complement its organic growth by further expanding its service capabilities, technology offerings and end markets.

Sales and Marketing

The Company generates the majority of its revenue from the renewal of subscription-based client service agreements, supplemented by sales of other solutions to existing clients and the addition of new clients. NRC Health sales activities are carried out by a direct sales organization staffed with professional, trained sales associates. As compared to the typical industry practice of compensating sales associates with relatively high base pay and a relatively small sales commission, NRC Health compensates its sales staff with relatively low base pay and a relatively high commission component. The Company believes this compensation structure provides incentives to its sales associates to surpass sales goals and increases the Company’s ability to attract top-quality sales associates.

Table of Contents

NRC Health conducts various marketing programs to generate new opportunities for its sales organization. The Company also maintains an active public relations program which includes (1) an ongoing presence in leading industry trade press and in the mainstream press, (2) public speaking at strategic industry conferences, (3) fostering relationships with key industry constituencies, and (4) annual awards programs that recognize top-ranking healthcare organizations.

Clients

NRC Health’s clients include many of the nation’s largest healthcare systems. The Company provides solutions to over 47 payer health plans and 148 of the 200 largest health systems.

The Company’s ten largest clients accounted for 19%, 17%, and 15% of the Company’s total revenue in 2017, 2016 and 2015, respectively. Approximately 4%, 5% and 5% of the Company’s revenue was derived from foreign customers in 2017, 2016, and 2015, respectively.

For financial information by geographic area, see Note 15 to the Company’s consolidated financial statements.

Intellectual Property and Other Proprietary Rights

The Company’s success depends in part upon its data collection processes, research methods, data analysis techniques and internal systems, and procedures that it has developed specifically to serve clients in the healthcare industry. The Company has no patents. Consequently, it relies on a combination of copyright and trade secret laws and associate nondisclosure agreements to protect its systems, survey instruments and procedures. There can be no assurance that the steps taken by the Company to protect its rights will be adequate to prevent misappropriation of such rights or that third parties will not independently develop functionally equivalent or superior systems or procedures. The Company believes that its systems and procedures and other proprietary rights do not infringe upon the proprietary rights of third parties. There can be no assurance, however, that third parties will not assert infringement claims against the Company in the future or that any such claims will not result in protracted and costly litigation, regardless of the merits of such claims or whether the Company is ultimately successful in defending against such claims.

Associates

As of December 31, 2017, the Company employed a total of 430 persons on a full-time basis. In addition, as of such date, the Company had 28 part-time associates primarily in its survey operations, representing approximately 14 full-time equivalent associates. None of the Company’s associates are represented by a collective bargaining unit. The Company considers its relationship with its associates to be good.

Executive Officers of the Company

The following table sets forth certain information as of February 1, 2018, regarding the executive officers of the Company:

Name	Age	Position

Michael D. Hays	63	Chief Executive Officer

Steven D. Jackson	42	President

Kevin R. Karas	60	Senior Vice President Finance, Chief Financial Officer, Treasurer and Secretary

Table of Contents

Michael D. Hays has served as Chief Executive Officer and a director since he founded the Company in 1981. He also served as President of the Company from 1981 to 2004 and from July 2008 to July 2011. Prior to founding the Company, Mr. Hays served for seven years as a Vice President and a director of SRI Research Center, Inc. (n/k/a the Gallup Organization).

Steven D. Jackson has served as President of the Company since October 2015. He served as Group President from October 2014 until September 2015, during which time he oversaw the Company’s Market Insights, Transparency, and Predictive Analytics business units. Prior to joining the Company, Mr. Jackson served as Chief Strategy Officer for Vocera Communications where he was employed from 2007 to 2014. He also served as Chief Operating Officer for ExperiaHealth, a subsidiary of Vocera. Earlier in his career, Mr. Jackson held positions of increasing responsibility at The Advisory Board Company, Neoforma, and Stockamp & Associates.

Kevin R. Karas has served as Chief Financial Officer, Treasurer and Secretary of the Company since September 2011, and as Senior Vice President Finance since he joined the Company in December 2010. From 2005 to 2010, he served as Vice President of Finance for Lifetouch Portrait Studios, Inc., a national retail photography company. Mr. Karas also previously served as Chief Financial Officer at CARSTAR, Inc., an automobile collision repair franchise business, from 2000 to 2005, Chief Financial Officer at Rehab Designs of America, Inc., a provider of orthotic and prosthetic services, from 1993 to 2000, and as a regional Vice President of Finance and Vice President of Operations at Novacare, Inc., a provider of physical rehabilitation services, from 1988 to 1993. He began his career as a Certified Public Accountant at Ernst & Young.

Executive officers of the Company are elected by and serve at the discretion of the Company’s Board of Directors. There are no family relationships between any directors or executive officers of NRC Health.

Available Information

More information regarding NRC Health is available on the Company's website at www.nrchealth.com. NRC Health is not including the information contained on or available through its website as part of, or incorporating such information by reference into, this Annual Report on Form 10-K. The Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports are made available to the public at no charge through a link appearing on the Company's website. NRC Health provides access to such materials through its website as soon as reasonably practicable after electronically filing such material with, or furnishing it to, the Securities and Exchange Commission. Reports and amendments posted on the Company’s website do not include access to exhibits and supplemental schedules electronically filed with the reports or amendments.

Item 1A.

Risk Factors

You should carefully consider each of the risks described below, together with all of the other information contained in this Annual Report on Form 10-K, before making an investment decision with respect to our securities. If any of the following risks develop into actual events, our business, financial condition or results of operations could be materially and adversely affected and you may lose all or part of your investment.

We depend on contract renewals, including retention of key clients, for a large share of our revenue and our operating results could be adversely affected.

We expect that a substantial portion of our revenue for the foreseeable future will continue to be derived from renewable service contracts. Substantially all contracts are renewable annually at the option of our clients, although contracts with clients under unit-based arrangements generally have no minimum purchase commitments. Client contracts are generally cancelable on short notice without penalty, however we are entitled to payment for services through the cancellation date. To the extent that clients fail to renew or defer their renewals, we anticipate our results may be materially adversely affected. We rely on a limited number of key clients for a substantial portion of our revenue. The Company’s ten largest clients accounted for 19%, 17%, and 15% of the Company’s total revenue in 2017, 2016, and 2015, respectively. Our ability to secure renewals depends on, among other things, our ability to gather and analyze performance data in a consistent, high-quality, and timely fashion. In addition, the service needs of our clients are affected by accreditation requirements, enrollment in managed care plans, the level of use of satisfaction measures in healthcare organizations’ overall management and compensation programs, the size of operating budgets, clients’ operating performance, industry and economic conditions, and changes in management or ownership. As these factors are beyond our control, we cannot ensure that we will be able to maintain our renewal rates. Any material decline in renewal rates from existing levels would have an adverse effect on our revenue and a corresponding effect on our operating and net income.

Table of Contents

Our operating results may fluctuate and this may cause our stock price to decline.

Our overall operating results may fluctuate as a result of a variety of factors, including the size and timing of orders from clients, client demand for our services (which, in turn, is affected by factors such as accreditation requirements, enrollment in managed care plans, operating budgets and clients’ operating performance), the hiring and training of additional staff, expense increases, and industry and general economic conditions. Because a significant portion of our overhead is fixed in the short-term, particularly some costs associated with owning and occupying our building and full-time personnel expenses, our results of operations may be materially adversely affected in any particular period if revenue falls below our expectations. These factors, among others, make it possible that in some future period our operating results may be below the expectations of securities analysts and investors which would have a material adverse effect on the market price of our class A common stock and/or our class B common stock.

We operate in a highly competitive market and could experience increased price pressure and expenses as a result.

The healthcare information and market research services industry is highly competitive. We have traditionally competed with healthcare organizations’ internal marketing, market research and/or quality improvement departments that create their own performance measurement tools, and with relatively small specialty research firms that provide survey-based healthcare market research and/or performance assessment. The Company’s primary competitors among such specialty firms include Press Ganey, which we believe has significantly higher annual revenue than us, and three or four other firms that we believe have lower annual revenue than us. To a certain degree, we currently compete with, and anticipate that in the future we may increasingly compete with, (1) market research firms and technology solutions which provide survey-based, general market research or Voice of the Customer Feedback capabilities and (2) firms which provide services or products that complement healthcare performance assessments, such as healthcare software or information systems. Although only a few of these competitors have offered specific services that compete directly with our services, many of these competitors have substantially greater financial, information gathering, and marketing resources than the Company and could decide to increase their resource commitments to our market. There are relatively few barriers to entry into the Company’s market, and we expect increased competition in our market which could adversely affect our operating results through pricing pressure, increased marketing expenditures, and market share losses, among other factors. There can be no assurance that the Company will continue to compete successfully against existing or new competitors.

Because our clients are concentrated in the healthcare industry, our revenue and operating results may be adversely affected by changes in regulations, a business downturn or consolidation with respect to the healthcare industry.

Substantially all of our revenue is derived from clients in the healthcare industry. As a result, our business, financial condition and results of operations are influenced by conditions affecting this industry, including changing political, economic, competitive and regulatory influences that may affect the procurement practices and operation of healthcare providers and payers. The 2010 Federal comprehensive healthcare reform plan, which includes provisions to control healthcare costs, improve healthcare quality and expand access to affordable health insurance, could result in lower reimbursement rates and otherwise change the environment in which providers and payers operate. In addition, large private purchasers of healthcare services are placing increasing cost pressure on providers. Healthcare providers may react to these cost pressures and other uncertainties by curtailing or deferring purchases, including purchases of our services. Moreover, there has been consolidation of companies in the healthcare industry, a trend which we believe will continue to grow. Consolidation in this industry, including the potential acquisition of certain of our clients, could adversely affect aggregate client budgets for our services or could result in the termination of a client’s relationship with us. The impact of these developments on the healthcare industry is difficult to predict and could have an adverse effect on our revenue and a corresponding effect on our operating and net income.

Table of Contents

We rely on third parties whose actions could have a material adverse effect on our business.

We outsource certain operations and engage third parties to perform work needed to fulfill our client services. For example, we use vendors to perform certain printing, mailing, information transmittal and other services related to our survey operations. If any of these vendors cease to operate or fail to adequately perform the contracted services and alternative resources and processes are not utilized in a timely manner, our business could be adversely affected. The loss of any of our key vendors could impair our ability to perform our client services and result in lower revenues and income. It would also be time-consuming and expensive to replace, either directly or through other vendors, the services performed by these vendors, which could adversely impact revenues, expenses and net income. Furthermore, our ability to monitor and direct our vendors’ activities is limited. If their actions and business practices violate policies, regulations or procedures otherwise considered illegal, we could be subject to reputational damage or litigation which would adversely affect our business.

We face several risks relating to our ability to collect the data on which our business relies.

Our ability to provide timely and accurate performance measurement and improvement services to our clients depends on our ability to collect large quantities of high-quality data through surveys and interviews. If our mail survey operations are disrupted and we are unable to mail our surveys in a timely manner, then our revenue and net income could be negatively impacted. If receptivity to our survey and interview methods by respondents declines, or, for some other reason, their willingness to complete and return surveys declines, or if we, for any reason, cannot rely on the integrity of the data we receive, then our revenue could be adversely affected with a corresponding effect on our operating and net income. We also rely on third-party panels of pre-recruited consumer households to produce NRC Health’s Market Insights in a timely manner. If we are not able to continue to use these panels, or the time period in which we use these panels is altered and we cannot find alternative panels on a timely, cost-competitive basis, we could face an increase in our costs or an inability to effectively produce NRC Health’s Market Insights. In either case, our operating and net income could be negatively affected.

Our principal shareholder effectively controls the Company, and holders of class A common stock are not able to independently elect directors of NRC Health or control any of the Company's management policies or business decisions because the holders of class A common stock have substantially less voting power than the holders of the Company's class B common stock, a majority of which is beneficially owned by our principal shareholder.

The Company's outstanding stock is divided into two classes of common stock: class A common stock and class B common stock. The class B common stock has one vote per share on all matters and the class A common stock has one-one-hundredth (1/100^th) of one vote per share. As of February 16, 2018, the class B common stock constituted approximately 94% of NRC Health's total voting power. As a result, holders of class B common stock are able to exercise a controlling influence over the Company's business, have the power to elect its directors and indirectly control decisions such as whether to issue additional shares, declare and pay dividends or enter into significant corporate transactions. A majority of the class B common stock was historically owned by Michael D. Hays, our Chief Executive Officer. However, in January and February 2018 Mr. Hays, for estate planning purposes, gifted and/or transferred all of his directly owned class B common stock and class A common stock indirectly to the Amandla MK Trust (the “New Trust”), a trust for the benefit of Mr. Hays’ family.

Table of Contents

As of February 16, 2018, approximately 53% of the outstanding class B common stock and approximately 26% of the outstanding class A common stock was owned by the New Trust, and that collectively constituted approximately 52% of the Company's total voting power. As a result, the New Trust can control matters requiring shareholder approval, including the election of directors and the approval of significant corporate matters such as change of control transactions. The effects of such influence could be to delay or prevent a change of control of the Company unless the terms are approved by the New Trust.

The market prices of our two classes of common stock may be volatile and shareholders may be unable to resell shares at or above the price at which the shares were acquired.

The market price of stock can be highly volatile. As a result, the market prices and trading volumes of each of our two classes of common stock may also be highly volatile, and investors in our common stock may experience a decrease in the value of their shares, including decreases that are in response to factors beyond our control, including, but not limited to:

●

Variations in our financial performance and that of similar companies;

●

Regulatory and other developments that may impact the demand for our services;

●

Reaction to our press releases, public announcements and filings with the Securities and Exchange Commission;

●

Client, market and industry perception of our services and performance;

●

Actions of our competitors;

●

Changes in earnings estimates or recommendations by analysts who follow our stock;

●

Loss of key personnel;

●

Investor or management team sales of our stock;

●

Changes in accounting principles; and

●

Variations in general market, economic and political conditions or financial markets.

Any of these factors, among others, may result in changes in the trading volumes and/or market prices of each of our classes common stock. Following periods of volatility in the market price of a company’s securities, shareholders have often filed securities class-action lawsuits. Our involvement in a class-action lawsuit would result in substantial legal fees and divert our senior management’s attention from operating our business, which could harm our business and net income.

Our business and operating results could be adversely affected if we are unable to attract or retain key managers and other personnel.

Our future performance may depend, to a significant extent, upon the efforts and ability of our key personnel who have expertise in gathering, interpreting and marketing survey-based performance information for healthcare markets. Although client relationships are managed at many levels within our company, the loss of the services of Michael D. Hays, our Chief Executive Officer, or one or more of our other senior managers, could have a material adverse effect, at least in the short to medium term, on most significant aspects of our business, including strategic planning, product development, and sales and customer relations. Our success will also depend on our ability to hire, train and retain skilled personnel in all areas of our business. Currently, we do not have employment agreements with our officers or our other key personnel. Competition for qualified personnel in our industry is intense, and many of the companies that compete with us for qualified personnel have substantially greater financial and other resources than us. Furthermore, we expect competition for qualified personnel to become more intense as competition in our industry increases. We cannot assure you that we will be able to recruit, retain and motivate a sufficient number of qualified personnel to compete successfully.

Table of Contents

If intellectual property and other proprietary information technology were copied or independently developed by our competitors, our operating results could be negatively affected.

Our success depends in part upon our data collection process, research methods, data analysis techniques, and internal systems and procedures that we have developed specifically to serve clients in the healthcare industry. We have no patents. Consequently, we rely on a combination of copyright, trade secret laws and associate nondisclosure agreements to protect our systems, survey instruments and procedures. We cannot assure you that the steps we have taken to protect our rights will be adequate to prevent misappropriation of such rights, or that third parties will not independently develop functionally equivalent or superior systems or procedures. We believe that our systems and procedures and other proprietary rights do not infringe upon the proprietary rights of third parties. We cannot assure you, however, that third parties will not assert infringement claims against us in the future, or that any such claims will not result in protracted and costly litigation, regardless of the merits of such claims, or whether we are ultimately successful in defending against such claims.

Our business and operating results could be adversely affected if we experience business interruptions or failure of our information technology and communication systems.

Our ability to provide timely and accurate performance measurement and improvement services to our clients depends on the efficient and uninterrupted operation of our information technology and communication systems, and those of our external service providers. Our systems and those of our external service providers, could be exposed to damage or interruption from fire, natural disasters, energy loss, telecommunication failure, security breach and computer viruses. An operational failure or outage in our information technology and communication systems or those of our external service providers, could result in loss of customers, damage to customer relationships, reduced revenue and profits, refunds of customer charges and damage our reputation and may result in additional expense to repair or replace damaged equipment and recover data loss resulting from the interruption. Although we have taken steps to prevent system failures and have back-up systems and procedures to prevent or reduce disruptions, such steps may not prevent an interruption of services and our disaster recovery planning may not account for all contingencies. Additionally, our insurance may not adequately compensate us for all losses or failures that may occur. Any one of the above situations could have a material adverse effect on our business, financial condition, results of operations and reputation.

Security breaches or computer viruses could harm our business.

In connection with our client services, we receive, process, store and transmit sensitive business information electronically over the internet. Computer viruses could spread throughout our systems and disrupt operations and service delivery. Unauthorized access to our computer systems or databases could result in the theft or publication of confidential information or the deletion or modification of records or could otherwise cause interruption in our operations. We cannot be certain that the technology protecting our networks and information will successfully prevent computer viruses, data thefts, release of confidential information or security breaches. A compromise in our data security systems that results in inappropriate disclosure of our associates', customers' or vendors' confidential information, could harm our reputation and expose us to regulatory action and claims. Changes in privacy and information security laws and standards may require we incur significant expense to ensure compliance due to increased technology investment and operational procedures. An inability to prevent security breaches or computer viruses or failure to comply with privacy and information security laws could result in litigation and regulatory risk, loss of customers, damage to customer relationships, reduced revenue and profits, refunds of customer charges and damage our reputation, which could adversely affect our business, financial condition, results of operations and reputation.

Reputational harm could have a material adverse effect on our business, financial condition and results of operations.

Our ability to maintain a good reputation is critical to selling our services. Our reputation could be adversely impacted by any of the following (whether or not valid): the failure to maintain high ethical and social standards; the failure to perform our client services in a timely manner; violations of laws and regulations; and the failure to maintain an effective system of internal controls or to provide accurate and timely financial information. Damage to our reputation or loss of our clients’ confidence in our services for any of these, or any other reasons, could adversely impact our business, revenues, financial condition, and results of operations, as well as require additional resources to rebuild our reputation.

Table of Contents

Our operations are subject to laws and regulations that impose significant compliance costs and create reputational and legal risk.

Due to the nature of the services we offer, we are subject to significant commercial, trade and privacy regulations. We cannot predict the nature, scope or effect of future regulatory requirements to which our operations might be subject or the manner in which existing laws might be administered or interpreted, which could have a material and negative impact on our business and our results of operation. For example, recent years have seen an increase in the development or enforcement of legislation related to healthcare reform, privacy, trade compliance and anti-corruption. Additionally, some of the services we provide include information our clients need to fulfill regulatory reporting requirements. If our services result in errors or omissions in our clients’ regulatory reporting, we may be subject to loss of clients, reputational harm or litigation, each potentially adversely impacting our business. Furthermore, although we maintain a variety of internal policies and controls designed to educate, discourage, prevent and detect violations of such laws, we cannot guarantee that such actions will be effective or sufficient or that individual employees will not engage in inappropriate behavior in breach of our policies. Such conduct, or even an allegation of misbehavior, could result in material adverse reputational harm, costly investigations, severe criminal or civil sanctions, or could disrupt our business, and could negatively affect our results of operations or financial condition.

Failure to comply with public company regulations could adversely impact our profitability.

As a public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934, the Sarbanes-Oxley Act of 2002, the Dodd-Frank Act Wall Street Reform and Consumer Protection Act, the listing requirements of NASDAQ and other applicable securities rules and regulations. Additionally, laws, regulations and standards relating to corporate governance and public disclosure are subject to varying interpretations and continue to develop and change. If we misinterpret or fail to comply with these rules and regulations, our legal and financial compliance costs and net income may be adversely affected.

Our growth strategy includes future acquisitions and/or investments which involve inherent risk.

In order to expand services or technologies to existing clients and increase our client base, we have historically, and may in the future, make strategic business acquisitions and/or investments that we believe complement our business. Acquisitions have inherent risks which may have material adverse effects on our business, financial condition, or results of operations, including, among other things: (1) failure to successfully integrate the purchased operations, technologies, products or services and maintain uniform standard controls, policies and procedures; (2) substantial unanticipated integration costs; (3) loss of key associates including those of the acquired business; (4) diversion of management’s attention from other operations; (5) failure to retain the customers of the acquired business; (6) failure to achieve any projected synergies and performance targets; (7) additional debt and/or assumption of known or unknown liabilities; (8) dilutive issuances of equity securities; and (9) a write-off of goodwill, software development costs, client lists, other intangibles and amortization of expenses. If we fail to successfully complete acquisitions or integrate acquired businesses, we may not achieve projected results and there may be a material adverse effect on our business, financial condition and results of operations.

Item 1B.

Unresolved Staff Comments

The Company has no unresolved staff comments to report pursuant to this item.

Item 2.

Properties

The Company’s headquarters is located in an owned office building in Lincoln, Nebraska, of which 62,000 square feet are used for the Company’s operations. This facility houses all the capabilities necessary for NRC Health’s survey programming, printing and distribution, data processing, analysis and report generation, marketing, and corporate administration. The Company’s term note is secured by this property, among other things.

Table of Contents

The Company is leasing 4,000 square feet of office space in Markham, Ontario, 3,900 square feet of office space in San Diego, California, 8,100 square feet of office space in Seattle, Washington and 6,200 square feet of office space in Atlanta, Georgia.

Item 3.

Legal Proceedings

From time to time, the Company is involved in certain claims and litigation arising in the normal course of business. Management assesses the probability of loss for such contingencies and recognizes a liability when a loss is probable and estimable.

Since the September 2017 announcement of the original proposed recapitalization plan (see Note 13 to the Company’s consolidated financial statements), three purported class action and/or derivative complaints have been filed in state or federal courts by three individuals claiming to be shareholders of the Company. All of the complaints name as defendants the Company and the individual directors of the Company. Two of these lawsuits were filed in the United States District Court for the District of Nebraska— a putative class action lawsuit captioned Gennaro v. National Research Corporation, et al., which was filed on November 15, 2017, and a putative class and derivative action lawsuit captioned Gerson v. Hays, et al., which was filed on November 16, 2017. These lawsuits were consolidated by order of the federal court. A third lawsuit was filed the Circuit Court for Milwaukee County, Wisconsin—a putative class action lawsuit captioned Apfel v. Hays, et al, which was filed on December 1, 2017. The allegations in all of the lawsuits are very similar. The plaintiffs allege, among other things, that the defendants breached their fiduciary duties in connection with the allegedly unfair proposed transaction, at an allegedly unfair price, conducted in an allegedly unfair and conflicted process and in alleged violation of Wisconsin law and the Company’s Articles of Incorporation. One of the lawsuits also alleges the proposed transaction is a voidable “conflict of interest transaction” under Wisconsin statutes. The plaintiffs in these lawsuits seek, among other things, an injunction enjoining the defendants from consummating the original proposed recapitalization plan, damages, equitable relief and an award of attorneys’ fees and costs of litigation. The Company believes that the allegations of the complaints are without merit and intends to defend these lawsuits vigorously. Despite the changes to the original proposed recapitalization plan that culminated in the December 13, 2017 announcement of a revised proposed recapitalization plan (the “Proposed Recapitalization”), the Company expects that these shareholders or other shareholders might assert similar claims regarding the Proposed Recapitalization. The Company will defend any such lawsuits vigorously. As of December 31, 2017, no losses have been accrued as the Company does not believe the losses are probable or estimable.

Item 4.

Mine Safety Disclosures

Not applicable.

Table of Contents

PART II

Item 5.

Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

In May 2013, the Company consummated a recapitalization (the “May 2013 Recapitalization”) pursuant to which the Company established two classes of common stock (class A common stock and class B common stock), issued a dividend of three shares of class A common stock for each share of the Company’s then existing common stock and reclassified each then existing share of common stock as one-half of one share of class B common stock. Following the May 2013 Recapitalization, the Company’s class A common stock and the Company’s class B common stock are traded on the NASDAQ Global Market under the symbols “NRCIA” and “NRCIB,” respectively.

The following table sets forth the range of high and low sales prices for, and dividends declared on the class A common stock and class B common stock for the period from January 1, 2016, through December 31, 2017:

	Class A						Class B
	High		Low		Dividends Declared Per Common Share		High		Low		Dividends Declared Per Common Share
2016 Quarter Ended:
March 31	$	16.10	$	13.70	$	0.08	$	36.87	$	32.99	$	0.48
June 30	$	16.67	$	12.53	$	0.08	$	44.60	$	33.19	$	0.48
September 30	$	17.14	$	13.26	$	0.08	$	38.50	$	32.18	$	0.48
December 31	$	20.00	$	14.35	$	0.10	$	46.37	$	32.57	$	0.60
2017 Quarter Ended
March 31	$	20.93	$	16.50	$	0.10	$	41.73	$	38.76	$	0.60
June 30	$	28.75	$	19.15	$	0.10	$	49.29	$	39.00	$	0.60
September 30	$	41.99	$	26.70	$	0.10	$	57.21	$	47.07	$	0.60
December 31	$	39.00	$	31.40	$	0.10	$	58.16	$	50.46	$	0.60

Cash dividends in the aggregate amount of $16.9 million were declared in 2017 with $12.7 million paid in 2017 and the remaining $4.2 million paid in January 2018. Cash dividends in the aggregate amount of $14.3 million were declared in 2016 with $10.1 million paid in 2016 and the remaining $4.2 million paid in January 2017. The payment and amount of future dividends, if any, is at the discretion of the Company’s Board of Directors and will depend on the Company’s future earnings, financial condition, general business conditions, alternative uses of the Company’s earnings and other factors.

On February 16, 2018, there were approximately 15 shareholders of record and approximately 3,863 beneficial owners of the class A common stock and approximately 11 shareholders of record and approximately 1,447 beneficial owners of the class B common stock.

In February 2006, the Board of Directors of the Company authorized the repurchase of 2,250,000 shares of class A common stock and 375,000 shares of class B common stock (on a post-May 2013 Recapitalization basis) in the open market or in privately negotiated transactions. Unless terminated earlier by resolution of the Company’s Board of Directors, the repurchase program will expire when the Company has repurchased all shares authorized for repurchase thereunder. As of February 16, 2018, 1,969,509 shares of class A common stock and 305,509 shares of class B common stock have been repurchased under that authorization. No class A or class B common stock was repurchased during the three-month period ended December 31, 2017. The remaining shares that may be purchased under that authorization are 280,491 and 69,491 for class A and class B common stock, respectively.

Table of Contents

The following graph compares the cumulative 5-year total return provided shareholders on the Company’s common stock relative to the cumulative total returns of the NASDAQ Composite Index and the Russell 2000 Index. An investment of $100 (with reinvestment of all dividends) is assumed to have been made in our common stock and in each of the indexes on December 31, 2012 (or on May 23, 2013 for our class A common stock which was the first day it was traded), and its relative performance is tracked through December 31, 2017. In accordance with Securities and Exchange Commission guidance, in calculating the cumulative 5-year total return on our class B common stock, we gave retroactive effect to the May 2013 Recapitalization (i.e., as if it had occurred on December 31, 2012).

The stock price performance included in this graph is not necessarily indicative of future stock price performance.

12/12

5/23/13

12/13

12/14

12/15

12/16

12/17

National Research Corporation - Class B

100.00

116.56

122.01

135.26

166.45

235.18

National Research Corporation - Class A

---

100.00

94.10

70.25

83.85

101.51

202.11

NASDAQ Composite

100.00

141.63

162.09

173.33

187.19

242.29

Russell 2000

100.00

138.82

145.62

139.19

168.85

193.58

Table of Contents

Item 6.

Selected Financial Data

The selected statement of income data for the years ended December 31, 2017, 2016 and 2015, and the selected balance sheet data at December 31, 2017 and 2016, are derived from, and are qualified by reference to, the audited consolidated financial statements of the Company included elsewhere in this Annual Report on Form 10-K. The selected statement of income data for the year ended December 31, 2014 and 2013, and the balance sheet data at December 31, 2015, 2014 and 2013, are derived from audited consolidated financial statements not included herein. The Company acquired Digital Assent, LLC on October 28, 2014 and disposed of selected assets and liabilities related to the clinical workflow product of its Predictive Analytics operating segment on December 21, 2015. The acquisition and disposal did not have a significant impact on the Company’s financial results, therefore, the historical data in the table below have not been adjusted.

	Year Ended December 31, (a)
	2017		2016		2015		2014			2013
	(In thousands, except per share data)
Statement of Income Data:
Revenue	$	117,559	$	109,384	$	102,343	$	98,837		$	92,590
Operating expenses:
Direct		49,068		45,577		44,610		41,719			38,844
Selling, general and administrative		29,686		28,385		27,177		25,018			25,208
Depreciation and amortization		4,586		4,225		4,109		3,804			3,732
Total operating expenses		83,340		78,187		75,896		70,541			67,784
Operating income		34,219		31,197		26,447		28,296			24,806
Other income (expense)		64		159		913		(204	)		(318	)
Income before income taxes		34,283		31,356		27,360		28,092			24,488
Provision for income taxes		11,340		10,838		9,750		9,936			9,004
Net income	$	22,943	$	20,518	$	17,610	$	18,156		$	15,484
Earnings per share common stock: Basic Earnings per share:
Class A	$	0.54	$	0.49	$	0.42	$	0.44		$	0.37
Class B	$	3.26	$	2.93	$	2.52	$	2.62		$	2.25
Diluted Earnings per share:
Class A	$	0.52	$	0.48	$	0.41	$	0.43		$	0.37
Class B	$	3.18	$	2.88	$	2.49	$	2.57		$	2.20
Weighted average share and share equivalents outstanding:
Class A – basic		20,770		20,713		20,741		20,764			20,677
Class B – basic		3,514		3,505		3,478		3,473			3,447
Class A – diluted		21,627		21,037		20,981		21,076			21,099
Class B – diluted		3,603		3,560		3,522		3,536			3,514

	2017		2016		2015		2014		2013
	(In thousands)
Balance Sheet Data:
Working capital surplus (deficiency)	$	19,949	$	15,551	$	10,890	$	25,262	$	12,784
Total assets		127,316		120,624		128,049		129,510		111,088
Total debt and capital lease obligations, including current portion		1,225		3,732		5,917		8,386		10,546
Total shareholders’ equity	$	90,041	$	82,806	$	74,222	$	87,748	$	71,755

^(a)

All share and per share data have been retroactively adjusted to give effect to the May 2013 Recapitalization as further described in Item 5.

Table of Contents

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

Investments

The Company makes equity investments to promote business and strategic objectives. For investments that do not have a readily determinable fair value, the Company applies either cost or equity method of accounting depending on the nature of its investment and its ability to exercise significant influence. Investments are periodically analyzed to determine whether or not there are any indicators of impairment and written down to fair value if the investment has incurred an other than temporary impairment. During 2017, the Company acquired a $1.3 million investment in convertible preferred stock of PracticingExcellence.com, Inc., a privately-held Delaware Corporation (“PX”), which is carried at cost and included in other non-current assets. The Company has a seat on PX's board of directors and the Company's investment, which is not considered to be in-substance common stock, represents approximately 15.7% of the issued and outstanding equity interests in PX.

Divestitures

On December 21, 2015, the Company completed the sale of selected assets and liabilities related to the clinical workflow product of the former Predictive Analytics operating segment, for a net cash amount of approximately $1.6 million. The Company recorded a gain of approximately $1.1 million from the sale in the fourth quarter of 2015, which is included in other income on the Consolidated Statement of Income. An additional gain was recorded in December 2016, when $223,000 was received from proceeds placed in escrow at the time of sale.

Table of Contents

Critical Accounting Policies and Estimates

The preparation of financial statements requires management to make estimates and assumptions that affect amounts reported therein. The most significant of these areas involving difficult or complex judgments made by management with respect to the preparation of the Company’s consolidated financial statements for 2017 include:

●

Revenue recognition;

●

Valuation of goodwill and identifiable intangible assets; and

●

Income taxes.

Revenue Recognition

Services are provided under subscription-based service agreements. The Company recognizes subscription-based service revenue over the period of time the service is provided. Generally, the subscription periods are for twelve months and revenue is recognized equally over the subscription period.

Certain contracts, excluding subscription-based service agreements, are fixed-fee arrangements with a portion of the project fee billed in advance and the remainder billed periodically over the duration of the project. Revenue and direct expenses for services provided under these contracts are recognized under the proportional performance method. Under the proportional performance method, the Company recognizes revenue based on output measures or key milestones such as survey set-up, survey mailings, survey returns and reporting. The Company measures its progress based on the level of completion of these output measures and recognizes revenue accordingly. Management judgments and estimates must be made and used in connection with revenue recognized using the proportional performance method. If management made different judgments and estimates, then the amount and timing of revenue for any period could differ materially from the reported revenue.

The Company’s revenue arrangements with a client may include combinations of performance measurement and improvement services, healthcare analytics or governance education services which may be executed at the same time, or within close proximity of one another (referred to as a multiple-element arrangement). When the periods or patterns of revenue recognition differ, each element of a multiple-element arrangement is accounted for as a separate unit of accounting provided each delivered element is sold separately by the Company or another vendor; and for an arrangement that includes a general right of return relative to the undelivered elements, delivery or performance of the undelivered services are considered probable and substantially in the control of the Company. The Company’s arrangements generally do not include a general right of return related to the delivered services. If these criteria are not met, the arrangement is accounted for as a single unit of accounting with revenue generally recognized equally over the subscription period or recognized under the proportional performance method.

When a contract contains multiple elements, revenue is allocated to each separate unit of accounting based on relative selling price using a selling price hierarchy: vendor specific objective evidence (“VSOE”), if available, third-party evidence (“TPE”) if VSOE is not available, or estimated selling price if VSOE nor TPE is available. VSOE is established based on the services normal selling price and discounts for the specific services when sold separately. TPE is established by evaluating similar competitor services in standalone arrangements. If neither exists for a deliverable, the best estimate of the selling price (“ESP”) is used for that deliverable based on list price, representing a component of management’s market strategy, and an analysis of historical prices for bundled and standalone arrangements. Revenue allocated to an element is limited to revenue that is not subject to refund or otherwise represents contingent revenue. VSOE, TPE, and ESP are periodically adjusted to reflect current market conditions. These adjustments are not expected to differ significantly from historical results.

Table of Contents

Valuation of Goodwill and Identifiable Intangible Assets

Intangible assets include customer relationships, trade names, technology, non-compete agreements and goodwill. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The Company reviews intangible assets with indefinite lives for impairment annually as of October 1 and whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable.

When performing the impairment assessment, the Company will first assess qualitative factors to determine whether it is necessary to recalculate the fair value of the intangible assets with indefinite lives. If the Company believes, as a result of the qualitative assessment, that it is more likely than not that the fair value of the indefinite-lived intangibles is less than their carrying amount, the Company calculates the fair value using a market or income approach. If the carrying value of intangible assets with indefinite lives exceeds their fair value, then the intangible assets are written-down to their fair values. The Company did not recognize any impairments related to indefinite-lived intangibles during 2017, 2016 or 2015.

Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. All of the Company’s goodwill is allocated to its reporting units, which are the same as its six operating segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Transitions. Goodwill is reviewed for impairment at least annually, as of October 1, and whenever events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable.

The Company reviews for goodwill impairment by first assessing qualitative factors to determine whether any impairment may exist. If the Company believes, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative analysis will be performed, and the fair value of the reporting unit is compared with its carrying value (including goodwill). If the fair value of the reporting unit exceeds its carrying value, no impairment exists. If the fair value of the reporting unit is less than its carrying value, then goodwill is written down by this difference. The Company performed a qualitative analysis as of October 1, 2017 and determined the fair value of each reporting unit likely significantly exceeded its carrying value. No impairments were recorded during the years ended December 31, 2017, 2016 or 2015.

Income Taxes

The Company uses the asset and liability method of accounting for income taxes. Under that method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases using enacted tax rates. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances, if any, are established when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. Management judgment is required to determine the provision for income taxes and to determine whether deferred income taxes will be realized in full or in part. Such judgments include, but are not limited to, the likelihood we would realize the benefits of net operating loss carryforwards, the adequacy of valuation allowances, the election to capitalize or expense costs incurred, and the probability of outcomes of uncertain tax positions. It is possible that the various taxing authorities could challenge those judgments or positions and reach conclusions that would cause us to incur tax liabilities in excess of, or realize benefits less than, those currently recorded. In addition, changes in the geographical mix or estimated amount of annual pretax income could impact our overall effective tax rate.

Table of Contents

On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cut and Jobs Act (the “Tax Act”). The Tax Act makes broad and complex changes to the U.S. tax code that affects 2017, including, but not limited to, a federal corporate tax rate decrease from 35% to 21% for tax years beginning after December 31, 2017, the transition of U.S international taxation from a worldwide tax system to a territorial system, a one-time transition tax on the mandatory deemed repatriation of foreign earnings and accelerated depreciation that will allow for full expensing of qualified property.

On December 22, 2017, the staff of the United States Securities and Exchange Commission issued Staff Accounting Bulletin No. 118 (“SAB 118”), which provides guidance on accounting for the tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740, Income Taxes. In accordance with SAB 118, a company must reflect the income tax effects of those aspects of the Tax Act for which the accounting under ASC 740 is complete. To the extent that a company’s accounting for certain income tax effects of the Tax Act is incomplete but it is able to determine a reasonable estimate, it must record and provisional estimate in the financial statements.

Results of Operations

The following table and graphs set forth, for the periods indicated, selected financial information derived from the Company’s consolidated financial statements, including amounts expressed as a percentage of total revenue and the percentage change in such items versus the prior comparable period (please note that all columns may not add up to 100% due to rounding). The trends illustrated in the following table and graphs may not necessarily be indicative of future results. The discussion that follows the information should be read in conjunction with the Company’s consolidated financial statements.

	Percentage of Total Revenue Year Ended December 31,									Percentage Increase (Decrease)
	2017			2016			2015			2017 over 2016			2016 over 2015

Revenue		100.0	%		100.0	%		100.0	%		7.5	%		6.9	%
Operating expenses:
Direct		41.7			41.7			43.6			7.7			2.2
Selling, general and administrative		25.3			25.9			26.6			4.6			4.4
Depreciation and amortization		3.9			3.9			4.0			8.5			2.8
Total operating expenses		70.9			71.5			74.2			6.6			3.0
Operating income		29.1	%		28.5	%		25.8	%		9.7	%		18.0	%

Table of Contents

Year Ended December 31, 2017, Compared to Year Ended December 31, 2016

Revenue. Revenue in 2017 increased 7.5% to $117.6 million, compared to $109.4 million in 2016, which was driven primarily by a combination of continued gains in market share and vertical growth in our existing client base. Revenue from subscription-based agreements comprised 89.3% of the total revenue in 2017, compared to 88.0 % of total revenue in 2016.

Direct expenses. Direct expenses increased 7.7% to $49.1 million in 2017, compared to $45.6 million in 2016. This was due to an increase in variable expenses of $555,000 and fixed expenses of $2.9 million. Variable expense increased mainly due to increased costs to support the larger revenue and higher contracted voice recognition technology, phone costs, and labor costs, partially offset by decreased postage, printing and paper costs due to a reduction in postage fees and changes in survey methodologies. Conference expenses also decreased over the same period in 2016. Fixed expenses increased primarily as a result of increased salary and benefit costs in the customer service area, partially offset by decreased contracted service costs. Direct expenses remained the same as a percentage of revenue at 41.7% in 2017 and 2016 as expenses increased by 7.7% while revenue for the same period increased by 7.5%.

Selling, general and administrative expenses. Selling, general and administrative expenses increased 4.6% to $29.7 million in 2017 compared to $28.4 million in 2016, primarily due to expenses associated with the Proposed Recapitalization of $1.4 million, higher computer supplies and software license fees of $513,000, and higher recruiting fees of $412,000, partially offset by lower salary and benefit costs of $308,000, lower travel costs of $234,000, lower development and training costs of $205,000, $177,000 reduction for shelf registration fees expensed in 2016, and lower marketing expenses of $162,000. Selling, general, and administrative expenses decreased as a percentage of revenue to 25.3% in 2017, from 25.9% for the same period in 2016 as expenses increased by 4.6% while revenue increased by 7.5% during the same period.

Depreciation and amortization. Depreciation and amortization expenses increased 8.5% to $4.6 million in 2017 compared to $4.2 million in 2016 due to increased depreciation and amortization of $405,000 primarily from additional computer software investments, partially offset by decreased amortization of $45,000 as a result of certain intangibles becoming fully amortized. Depreciation and amortization expenses as a percentage of revenue remained the same at 3.9% in 2017 and 2016.

Other income (expense). Other income (expense) decreased to $64,000 in 2017 compared to $159,000 in 2016. In December 2016, an additional gain of $223,000 was recorded due to receipt of funds placed in escrow at the time of the sale of selected assets and liabilities related to the clinical workflow product of the Company’s former Predictive Analytics operating segment. This was partially offset by lower interest expense on the term loan in 2017.

Table of Contents

Provision for income taxes. Provision for income taxes was $11.3 million (33.1% effective tax rate) in 2017, compared to $10.8 million (34.6% effective tax rate) in 2016. The effective tax rate for the year ended December 31, 2017 decreased primarily due to the net benefit of approximately $1.9 million associated with remeasuring deferred tax assets and liabilities to the new lower federal rate, partially offset by a one-time mandatory deemed repatriation tax under the Tax Act. In addition, as a result of the Tax Act, the Company determined that it would no longer indefinitely reinvest the earnings of its Canadian subsidiary and recorded the withholding tax of $706,000 associated with this planned repatriation. The 2017 effective tax rate was also impacted by a benefit of $609,000 related to the vesting and exercise of stock awards, net of certain excess compensation limits, $504,000 of tax expense due to non-deductible recapitalization expenses and increases in the estimated state tax rates. Pursuant to the guidance in SAB 118, the Company’s estimate of impacts of the Tax Act are provisional and are subject to adjustment during 2018 based upon further analysis and interpretation of the Tax Act. See Note 7 to the Company’s consolidated financial statements for more details on tax adjustments related to the Tax Act.

Year Ended December 31, 2016, Compared to Year Ended December 31, 2015

Revenue. Revenue in 2016 increased 6.9% to $109.4 million, compared to $102.3 million in 2015, which was driven primarily by a combination of continued gains in market share and vertical growth in our existing client base. Revenue from subscription-based agreements comprised 88.0% of the total revenue in 2016, compared to 86.6% of total revenue in 2015.

Direct expenses. Direct expenses increased 2.2% to $45.6 million in 2016, compared to $44.6 million in 2015. Variable expenses increased by $327,000 due to higher survey volumes and increased contracted survey costs, partially offset by decreased survey operations expenses due to a reduction in postage fees and changes in survey methodologies. Fixed expenses increased $641,000 as a result of higher salary and benefit costs in the client service area, increased travel expenses and increased software license amortization. Direct expenses decreased as a percentage of revenue to 41.7% in 2016 from 43.6% in 2015 as expenses increased by 2.2% while revenue for the same period increased by 6.9%.

Selling, general and administrative expenses. Selling, general and administrative expenses increased 4.4% to $28.4 million in 2016 compared to $27.2 million in 2015, primarily due to increased salary and benefits of $991,000 (mainly from increased incentives and share based compensation expense), increased marketing expenses of $510,000, higher annual incentive trip expenses of $348,000, Securities and Exchange Commission registration fees expensed in 2016 of $177,000, and increased professional development costs for associates of $172,000. These were partially offset by a reduction of $238,000 in repairs and maintenance on the Company’s headquarters building and the $657,000 write off of a purchase option in 2015 when the Company chose not to exercise the option and it expired. Selling, general, and administrative expenses decreased as a percentage of revenue to 25.9% in 2016, from 26.6% for the same period in 2015 as expenses increased by 4.4% while revenue increased by 6.9% during the same period.

Depreciation and amortization. Depreciation and amortization expenses increased 2.8% to $4.2 million in 2016 compared to $4.1 million in 2015 primarily due to increased depreciation and amortization from increased computer software investments and computer software license expense being included in depreciation and amortization in 2016, resulting from the adoption of Accounting Standards Update (“ASU”) 2015-05, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Fees Paid in a Cloud Computing Arrangement. These increases were offset by decreased amortization as a result of the sale of the clinical workflow product of the former Predictive Analytics operating segment in 2015 and other intangibles becoming fully amortized. Depreciation and amortization expenses as a percentage of revenue decreased to 3.9% in 2016 from 4.0% during in 2015.

Other income (expense). Other income (expense) decreased to $159,000 in 2016 compared to $913,000 in 2015. This was primarily due to the $1.1 million gain on the sale of selected assets and liabilities related to the clinical workflow product of the former Predictive Analytics operating segment in 2015. In December 2016, an additional gain of $223,000 was recorded due to receipt of funds placed in escrow at the time of the sale.

Table of Contents

Provision for income taxes. Provision for income taxes was $10.8 million (34.6% effective tax rate) in 2016, compared to $9.8 million (35.6% effective tax rate) in 2015. The decrease in the effective tax rate was mainly due to the prospective adoption of ASU 2016-09, Compensation – Stock Compensation (Topic 718) Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”), which reduced tax expense by $460,000 in 2016. ASU 2016-09 requires excess tax benefits and tax deficiencies to be recorded in the income statement when share based compensation awards vest or are settled rather than to additional paid-in capital.

Inflation and Changing Prices

Inflation and changing prices have not had a material impact on revenue or net income in the last three years.

Liquidity and Capital Resources

The Company believes that its existing sources of liquidity, including cash and cash equivalents, borrowing availability, and operating cash flows will be sufficient to meet its projected capital and debt maturity needs and dividend policy for the foreseeable future.

As of December 31, 2017, our principal sources of liquidity included $34.7 million of cash and cash equivalents and up to $12 million of unused borrowings under our revolving credit note. The amount of unused borrowings actually available under the revolving credit note varies in accordance with the terms of the agreement. Of this cash, $14.2 million was held in Canada.

Working Capital

The Company had a working capital surplus of $19.9 million and $15.6 million on December 31, 2017 and 2016, respectively.

The change was primarily due to increases in cash and cash equivalents of $1.7 million, $2.5 million increase in trade accounts receivable and $1.6 million reduction in current portion of notes payable. This was partially offset by increases in accrued wages of $2.1 million and deferred revenue of $1.4 million. Trade accounts receivable increased due to the timing of billings and collections on new and renewal contracts. Current notes payable decreased due to monthly payments on the term note that will be fully paid in April 2018. Accrued wages increased mainly due to a payroll tax accrual from the vesting of non-vested stock award at year end. The Company’s working capital is significantly impacted by its large deferred revenue balances which will vary based on the timing and frequency of billings on annual agreements. The deferred revenue balances as of December 31, 2017 and December 31, 2016, were $16.9 million and $15.5 million, respectively.

The deferred revenue balance is primarily due to timing of initial billings on new and renewal contracts. The Company typically invoices clients for performance tracking services and custom research projects before they have been completed. Billed amounts are recorded as billings in excess of revenue earned, or deferred revenue, on the Company’s consolidated financial statements, and are recognized as income when earned. In addition, when work is performed in advance of billing, the Company records this work as revenue earned in excess of billings, or unbilled revenue. Substantially all deferred revenue and all unbilled revenue will be earned and billed respectively, within 12 months of the respective period ends.

Table of Contents

Cash Flow Analysis

A summary of operating, investing, and financing activities are shown in the following table:

	For the Year Ended December 31,
	2017			2016			2015
	(In thousands)
Provided by operating activities	$	28,091		$	26,843		$	21,886
Used in investing activities		(6,118	)		(3,750	)		(1,326	)
Used in financing activities		(21,116	)		(32,502	)		(16,869	)
Effect of exchange rate changes on cash		855			285			(1,588	)
Net increase (decrease) in cash and cash equivalents		1,712			(9,124	)		2,103
Cash and cash equivalents at end of period	$	34,733		$	33,021		$	42,145

Cash Flows from Operating Activities

Cash flows from operating activities consist of net income adjusted for non-cash items including depreciation and amortization, deferred taxes, share-based compensation and related taxes, gain on sale from operating segment and the effect of working capital changes.

Net cash provided by operating activities was $28.1 million for the year ended December 31, 2017, which included net income of $22.9 million, plus non-cash charges (benefits) for deferred tax expense, depreciation and amortization, reserve for uncertain tax positions, loss on disposal of property and equipment and non-cash stock compensation totaling $6.0 million. Changes in working capital decreased cash flows from operating activities by $806,000, primarily from increases in prepaid expenses, income taxes recoverable and accounts receivables, which fluctuate due to the timing and frequency of billings on new and renewal contracts. These decreases to cash flows were partially offset by the timing of payments on accounts payable, accrued expenses, wages, bonus and profit sharing, decreases in unbilled revenue and increases in deferred revenue.

Net cash provided by operating activities was $26.8 million for the year ended December 31, 2016, which included net income of $20.5 million, plus non-cash charges (benefits) for deferred tax expense, depreciation and amortization, reserve for uncertain tax positions, gain on sale from operating segment, loss on disposal of property and equipment and non-cash stock compensation totaling $6.8 million. Changes in working capital decreased cash flows from operating activities by $499,000, primarily due to the timing of payments on accounts payable and increases in prepaid expenses, accounts receivables, and unbilled revenue, which fluctuate due to the timing and frequency of billings on new and renewal contracts. These decreases to cash flows were partially offset by decreases in income taxes recoverable, and timing of payments related to accrued expenses, wages, bonus and profit sharing and deferred revenue.

Net cash provided by operating activities was $21.9 million for the year ended December 31, 2015, which included net income of $17.6 million, plus non-cash charges (benefits) for deferred tax expense, depreciation and amortization, reserve for uncertain tax positions, gain on sale from operating segment, write off of purchase option, tax benefit from exercise of stock options, and non-cash stock compensation totaling $3.8 million. Changes in working capital increased cash flows from operating activities by $472,000, primarily due to decreases in income taxes recoverable, and timing of payments related to accrued expenses, wages, bonus and profit sharing and deferred revenue. These increases were offset in part by decreases in accounts payable, and increases in accounts receivables and unbilled revenues which fluctuate due to the timing and frequency of billings on new and renewal contracts and increases in prepaid expenses. .

Cash Flows from Investing Activities

Net cash of $6.1 million was used for investing activities in the year ended December 31, 2017. Purchases of property and equipment totaled $4.6 million. In addition, the Company used $1.3 million of cash to acquire a strategic investment in convertible preferred stock of PX, which is carried at cost and included in other non-current assets.

Table of Contents

Net cash of $3.8 million was used for investing activities in the year ended December 31, 2016. Purchases of property and equipment totaled $4.0 million. The Company received $223,000 in cash from funds put in escrow at the time of the December 21, 2015 sale of selected assets and liabilities related to the clinical workflow product of the former Predictive Analytics operating segment.

Net cash of $1.3 million was used for investing activities in the year ended December 31, 2015. Purchases of property and equipment totaled $2.9 million. The Company received $1.6 million in cash for the December 21, 2015 sale of selected assets and liabilities related to the clinical workflow product of the former Predictive Analytics operating segment.

Cash Flows from Financing Activities

Net cash used in financing activities was $21.1 million in the year ended December 31, 2017. Cash was used to repay borrowings under the term note totaling $2.5 million and for capital lease obligations of $108,000. Cash was used to pay $16.9 million of dividends, and repurchase shares for payroll tax withholdings related to share-based compensation of $1.7 million.

Net cash used in financing activities was $32.5 million in the year ended December 31, 2016. Cash was used to repay borrowings under the term note totaling $2.2 million and for capital lease obligations of $95,000. Cash was used to pay $28.6 million of dividends, purchase non-controlling interests in Connect totaling $2.0 million, and repurchase shares for payroll tax withholdings related to share-based compensation of $204,000. These were partially offset by the cash provided from the proceeds from the exercise of stock options of $548,000.

Net cash used in financing activities was $16.9 million in the year ended December 31, 2015. Cash was used to repay borrowings under the term note totaling $2.3 million and for capital lease obligations of $173,000. Cash was used to pay $10.1 million of dividends, purchase non-controlling interests in Connect totaling $2.8 million, purchase treasury stock totaling $1.7 million and repurchase shares for payroll tax withholdings related to share-based compensation of $92,000. These were partially offset by the cash provided from the excess tax benefit from share-based compensation of $240,000.

Capital Expenditures

Capital expenditures for the year ended December 31, 2017 were $4.6 million. These expenditures consisted mainly of computer equipment and software. The Company expects similar capital expenditure purchases in 2018 consisting primarily of computer equipment and software and other equipment, to be funded through cash generated from operations.

Debt and Equity

The Company’s term note is payable in monthly installments of $212,468. Borrowings under the term note bear interest at an annual rate of 3.12%. The outstanding balance of the term note at December 31, 2017 was $1.1 million which will be fully paid in April 2018.

The Company also has a revolving credit note which was amended and extended effective June 30, 2017 with a maturity date of June 30, 2018. The maximum aggregate amount available under the revolving credit note is $12.0 million. Borrowings under the revolving credit note bear interest at a variable annual rate, with three rate options at the discretion of management as follows: (1) 2.1% plus the one-month London Interbank Offered Rate (“LIBOR”) or (2) 2.1% plus the one-, two- or three- month LIBOR rate, or (3) the bank’s one-, two, three, six, or twelve month Money Market Loan Rate. As of December 31, 2017 the revolving credit note did not have a balance and the Company had the capacity to borrow $12.0 million.

Table of Contents

The term note and revolving credit note are secured by certain of the Company’s assets, including the Company’s land, building, accounts receivable and intangible assets. The term note and the revolving credit note contain various restrictions and covenants applicable to the Company, including requirements that the Company maintain certain financial ratios at prescribed levels and restrictions on the ability of the Company to consolidate or merge, create liens, incur additional indebtedness or dispose of assets. As of December 31, 2017, the Company was in compliance with the financial covenants.

The Company has capital leases for computer equipment, office equipment, printing and inserting equipment. The balance of the capital leases as of December 31, 2017 was $158,000.

In December 2017, the Company’s Board of Directors approved the Proposed Recapitalization that will exchange each share of class B common stock for one share of class A common stock plus $19.59 in cash, for total value of $53.44 per class B share. The Proposed Recapitalization replaces the proposed plan announced in September 2017. The Proposed Recapitalization is designed to eliminate the public market trading confusion related to the Company’s two classes of common stock (the class A common stock and class B common stock), to simplify the corporate structure of the Company and to provide a timely and cost-effective liquidity event for the holders of the Company’s class B common stock. The transaction will be funded by cash on hand and a $40 million term loan. The Proposed Recapitalization is subject to closing of financing and approval by the holders of the Company’s class A common stock, class B common stock and both classes of stock voting together as a group.

In December 2017, the Company entered into a commitment letter with First National Bank of Omaha (“FNB”), which expires on April 30, 2018, to provide a senior secured term loan of $40 million (the “Term Loan”), a senior secured delayed draw term loan facility of $15 million (the “Delayed Draw Term Loan”) and a senior secured revolving line of credit facility of $15 million (“the “Line of Credit” and, collectively with the Term Loan and Delayed Draw Term Loan, the “Credit Facilities”). If the Company closes on the Credit Facilities with FNB, any balances remaining on the existing term note and revolving credit note will be repaid. The Term Loan will be used to fund, in part, the Proposed Recapitalization and related costs. The Delayed Draw Term Loan, if used, is designated to fund any future business acquisitions or repurchasing of class A common stock. The Line of Credit has a three year term and will be used to fund ongoing working capital needs and for other general purpose corporate purposes. The Company will also pay loan origination fees equal to 0.25% of the amount borrowed under the Term Loan at closing. The Company will also be obligated to pay unused commitment fees quarterly in arrears.

The Company incurred expenses related to the Proposed Recapitalization of approximately $1.4 million in the year ended December 31, 2017, which are included in selling and administrative expenses.

Contractual Obligations

The Company had contractual obligations to make payments in the following amounts in the future as of December 31, 2017:

Contractual Obligations⁽¹⁾	Total Payments		Less than One Year		One to Three Years		Three to Five Years		After Five Years
(In thousands)
Operating leases	$	2,966	$	708	$	1,164	$	567	$	527
Capital leases		172		80		85		7		--
Uncertain tax positions⁽²⁾		--		--		--		--		--
Long-term debt		1,075		1,075		--		--		--
Total	$	4,213	$	1,863	$	1,249	$	574	$	527

⁽¹⁾	Amounts are inclusive of interest payments, where applicable.

⁽²⁾	We have $848,000 in liabilities associated with uncertain tax positions. We are unable to reasonably estimate the expected cash settlement dates of these uncertain tax positions with the taxing authorities.

Table of Contents

The Company generally does not make unconditional, non-cancelable purchase commitments. The Company enters into purchase orders in the normal course of business, but these purchase obligations do not exceed one year.

Stock Repurchase Program

Off-Balance Sheet Obligations

The Company has no significant off-balance sheet obligations other than the operating lease commitments disclosed in “Liquidity and Capital Resources.”

Recent Accounting Pronouncements

See Note 1 to the Company’s consolidated financial statements for a description of recently issued accounting pronouncements.

Item 7A.

Quantitative and Qualitative Disclosure About Market Risk

The Company’s primary market risk exposure is changes in foreign currency exchange rates and interest rates.

The Company’s Canadian subsidiary uses as its functional currency the local currency of the country in which it operates. It translates its assets and liabilities into U.S. dollars at the exchange rate in effect at the balance sheet date. It translates its revenue and expenses at the average exchange rate during the period. The Company includes translation gains and losses in accumulated other comprehensive income (loss), a component of shareholders’ equity. Foreign currency translation gains (losses) were $991,000, $369,000, and ($2.2 million) in 2017, 2016 and 2015, respectively. Gains and losses related to transactions denominated in a currency other than the functional currency of the countries in which the Company operates and short-term intercompany accounts are included in other income (expense) in the consolidated statements of income. A portion of our cash in our Canadian subsidiary is denominated in foreign currencies, where fluctuations in exchange rates will impact our cash balances in U.S. dollar terms. A sensitivity analysis assuming a hypothetical 10% change in the value of the U.S. dollar would impact our reported cash balance by approximately $1.8 million. We have not entered into any foreign currency hedging transactions. We do not purchase or hold any derivative financial instruments for the purpose of speculation or arbitrage.

We are exposed to interest rate risk with both our fixed-rate term debt and variable rate revolving line of credit facility. Interest rate changes for borrowings under our fixed-rate term debt would impact the fair value of such debt, but do not impact earnings or cash flow. At December 31, 2017, our fixed-rate term debt totaled $1.1 million. Based on a sensitivity analysis, a one percent change in market interest rates as of December 31, 2017, would not have a material effect on the estimated fair value of our fixed-rate debt outstanding at December 31, 2017.

Borrowings under our revolving credit note bear interest at a variable annual rate, with three rate options at the discretion of management. Borrowings under the revolving credit note may not exceed the $12.0 million. There were no borrowings outstanding under our revolving credit note at December 31, 2017, or at any time during 2017. A sensitivity analysis assuming a hypothetical 10% movement in interest rates applied to the average daily borrowings and the maximum borrowings available under the revolving credit note indicated that such a movement would not have a material impact on our consolidated financial position, results of operations or cash flows.

Table of Contents

Item 8.

Financial Statements and Supplementary Data

Quarterly Financial Data (Unaudited)

The following table sets forth selected financial information for each of the eight quarters in the two-year period ended December 31, 2017. This unaudited information has been prepared by the Company on the same basis as the consolidated financial statements and includes all normal recurring adjustments necessary to present fairly this information when read in conjunction with the Company’s audited consolidated financial statements and the notes thereto.

	(In thousands, except per share data)
	Quarter Ended
	Dec. 31, 2017			Sept 30, 2017		June 30, 2017		Mar. 31, 2017			Dec. 31, 2016		Sept 30, 2016			June 30, 2016		Mar. 31, 2016

Revenue	$	29,897		$	28,951	$	28,435	$	30,276		$	28,368	$	27,032		$	26,114	$	27,870
Direct expenses		12,362			12,267		11,939		12,500			11,836		11,468			10,734		11,539
Selling, general and administrative expenses		7,665			8,430		6,905		6,686			6,619		7,139			7,270		7,357
Depreciation and amortization		1,209			1,132		1,139		1,106			1,079		1,086			1,092		968
Operating income		8,661			7,122		8,452		9,984			8,834		7,339			7,018		8,006
Other income (expense)		(2	)		51		19		(4	)		171		(30	)		18		--
Provision for income taxes		2,142			3,020		2,719		3,459			3,280		2,580			2,478		2,500
Net income	$	6,517		$	4,153	$	5,752	$	6,521		$	5,725	$	4,729		$	4,558	$	5,506
Earnings per share of common stock:
Basic earnings per share
Class A	$	0.15		$	0.10	$	0.14	$	0.15		$	0.14	$	0.11		$	0.11	$	0.13
Class B	$	0.93		$	0.59	$	0.82	$	0.93		$	0.82	$	0.67		$	0.65	$	0.79
Dilutive earnings per share
Class A	$	0.15		$	0.09	$	0.13	$	0.15		$	0.13	$	0.11		$	0.11	$	0.13
Class B	$	0.90		$	0.57	$	0.80	$	0.91		$	0.80	$	0.66		$	0.64	$	0.77
Weighted average shares outstanding – basic
Class A		20,802			20,788		20,752		20,737			20,717		20,716			20,711		20,710
Class B		3,515			3,514		3,514		3,513			3,511		3,511			3,508		3,489
Weighted average shares outstanding - diluted
Class A		21,843			21,740		21,525		21,245			21,118		21,068			20,992		21,012
Class B		3,625			3,620		3,591		3,576			3,569		3,556			3,565		3,549

Table of Contents

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors
National Research Corporation:

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of National Research Corporation and subsidiary (the “Company”) as of December 31, 2017 and 2016, the related consolidated statements of income, comprehensive income, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2017, and the related notes (collectively, the consolidated financial statements.) In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2017 and 2016, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2017, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the Company’s internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated March 14, 2018 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ KPMG LLP

We have served as the Company’s auditor since 1997.

Lincoln, Nebraska

March 14, 2018

Table of Contents

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY

Consolidated Balance Sheets
(In thousands, except share amounts)

	2017			2016
Assets
Current assets:
Cash and cash equivalents	$	34,733		$	33,021
Trade accounts receivable, less allowance for doubtful accounts of $200 and $169, respectively		13,343			10,864
Unbilled revenue		1,463			1,546
Prepaid expenses		2,310			1,585
Income taxes receivable		375			14
Other current assets		35			35
Total current assets		52,259			47,065

Net property and equipment		12,359			11,806
Intangible assets, net		2,764			3,124
Goodwill		58,021			57,861
Other		1,913			768

Total assets	$	127,316		$	120,624

Liabilities and Shareholders’ Equity
Current liabilities:
Current portion of notes payable	$	1,067		$	2,683
Accounts payable		593			765
Accrued wages, bonus and profit sharing		6,597			4,543
Accrued expenses		2,882			3,069
Current portion of capital lease obligations		71			82
Income taxes payable		--			662
Dividends payable		4,222			4,213
Deferred revenue		16,878			15,497
Total current liabilities		32,310			31,514

Notes payable, net of current portion		-			857
Deferred income taxes		4,030			4,670
Other long term liabilities		935			777
Total liabilities		37,275			37,818

Shareholders’ equity:
Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued		--			--
Class A Common stock, $0.001 par value; authorized 60,000,000 shares, issued 25,835,230 in 2017 and 25,656,760 in 2016, outstanding 20,936,703 in 2017 and 20,891,069 in 2016		26			26
Class B Common stock, $0.001 par value; authorized 80,000,000 shares, issued 4,319,256 in 2017 and 4,308,875 in 2016, outstanding 3,535,238 in 2017 and 3,539,931 in 2016		4			4
Additional paid-in capital		51,025			46,725
Retained earnings		77,574			71,507
Accumulated other comprehensive (loss) income, foreign currency translation adjustment		(1,635	)		(2,626	)
Treasury stock, at cost; 4,898,527 Class A shares, 784,018 Class B shares in 2017 and 4,765,691 Class A shares, 768,944 Class B shares in 2016		(36,953	)		(32,830	)
Total shareholders’ equity		90,041			82,806

Total liabilities and shareholders’ equity	$	127,316		$	120,624

See accompanying notes to consolidated financial statements.

Table of Contents

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY

Consolidated Statements of Income
(In thousands, except share amounts)

2017

2016

2015

Revenue

117,559

109,384

102,343

Operating expenses:

Direct

49,068

45,577

44,610

Selling, general and administrative

29,686

28,385

27,177

Depreciation and amortization

4,586

4,225

4,109

Total operating expenses

83,340

78,187

75,896

Operating income

34,219

31,197

26,447

Other income (expense):

Interest income

Interest expense

(82

)

(190

)

(220

)

Other, net

302

1,073

Total other income

159

913

Income before income taxes

34,283

31,356

27,360

Provision for income taxes

11,340

10,838

9,750

Net income

22,943

20,518

17,610

Earnings per share of common stock:

Basic earnings per share:

Class A

0.54

0.49

0.42

Class B

3.26

2.93

2.52

Diluted earnings per share:

Class A

0.52

0.48

0.41

Class B

3.18

2.88

2.49

Weighted average shares and share equivalents outstanding

Class A - basic

20,770

20,713

20,741

Class B - basic

3,514

3,505

3,478

Class A - diluted

21,627

21,037

20,981

Class B - diluted

3,603

3,560

3,522

See accompanying notes to consolidated financial statements.

Table of Contents

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY

Consolidated Statements of comprehensive income
(In thousands)

2017

2016

2015

Net Income

22,943

20,518

17,610

Other comprehensive income (loss):

Cumulative translation adjustment

991

369

(2,222

)

Other comprehensive income (loss)

991

369

(2,222

)

Comprehensive Income

23,934

20,887

15,388

See accompanying notes to consolidated financial statements.

Table of Contents

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY

Consolidated Statements of Shareholders’ Equity
(In thousands except share and per share amounts)

	Common Stock A		Common Stock B		Additional Paid-in Capital			Retained Earnings			Accumulated Other Comprehensive Income(Loss)			Treasury Stock			Total
Balances at December 31, 2014	$	25	$	4	$	44,864		$	73,686		$	(773	)	$	(30,058	)	$	87,748
Purchase of 163,268 shares of class A and 4,239 shares of class B treasury stock		--		--		--			--			--			(2,171	)		(2,171	)
Issuance of 43,983 class A common shares and 7,330 class B shares for the exercise of stock options		--		--		406			--			--			--			406
Tax benefit from the exercise of options and restricted stock		--		--		240			--			--			--			240
Issuance of restricted common shares, net of forfeitures (73,168 class A and 12,194 class B)		1		--		(1	)		--			--			--			--
Non-cash stock compensation expense		--		--		1,383			--			--			--			1,383
Dividends declared of $0.62 and $3.72 per A and B common share, respectively		--		--		--			(25,983	)		--			--			(25,983	)
Acquisition of non-controlling interest		--		--		(2,789	)		--			--			--			(2,789	)
Other comprehensive loss, foreign currency translation adjustment		--		--		--			--			(2,222	)		--			(2,222	)
Net income		--		--		--			17,610			--			--			17,610
Balances at December 31, 2015	$	26	$	4	$	44,103		$	65,313		$	(2,995	)	$	(32,229	)	$	74,222
Purchase of 21,047 shares of class A and 7,681 shares of class B treasury stock		--		--		--			--			--			(601	)		(601	)
Issuance of 52,383 class A common shares and 35,534 class B shares for the exercise of stock options		--		--		945			--			--			--			945
Issuance of restricted common shares, net of forfeitures (11,565 class A and 1,928 class B)		--		--		--			--			--			--			--
Non-cash stock compensation expense		--		--		1,929			--			--			--			1,929
Dividends declared of $0.34 and $2.04 per A and B common share, respectively		--		--		--			(14,324	)		--			--			(14,324	)
Acquisition of non-controlling interest		--		--		(252	)		--			--			--			(252	)
Other comprehensive income, foreign currency translation adjustment		--		--		--			--			369			--			369
Net income		--		--		--			20,518			--			--			20,518
Balances at December 31, 2016	$	26	$	4	$	46,725		$	71,507		$	(2,626	)	$	(32,830	)	$	82,806
Purchase of 132,836 shares of class A and 15,074 shares of class B treasury stock		--		--		--			--			--			(4,123	)		(4,123	)
Issuance of 197,784 class A common shares and 13,600 class B shares for the exercise of stock options		--		--		2,455			--			--			--			2,455
Issuance of restricted common shares, net of forfeitures (19,314 class A and 3,219 class B)		--		--		--			--			--			--			--
Non-cash stock compensation expense		--		--		1,845			--			--			--			1,845
Dividends declared of $0.40 and $2.40 per A and B common share, respectively		--		--		--			(16,876	)		--			--			(16,876	)
Other comprehensive income, foreign currency translation adjustment		--		--		--			--			991			--			991
Net income		--		--		--			22,943			--			--			22,943
Balances at December 31, 2017	$	26	$	4	$	51,025		$	77,574		$	(1,635	)	$	(36,953	)	$	90,041

See accompanying notes to consolidated financial statements.

Table of Contents

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY

Consolidated Statements of Cash Flows
(In thousands)

2017

2016

2015

Cash flows from operating activities:

Net income

22,943

20,518

17,610

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

4,586

4,225

4,109

Deferred income taxes

(684

)

798

(1,387

)

Reserve for uncertain tax positions

181

119

Loss on disposal of property and equipment

Gain on sale from operating segment

(223

)

(1,102

)

Write-off of purchase option

657

Tax benefit from exercise of stock options

Non-cash share-based compensation expense

1,845

1,929

1,383

Change in assets and liabilities, net of effect of acquisition and disposal:

Trade accounts receivable

(2,463

)

(1,044

)

(1,777

)

Unbilled revenue

123

(93

)

(390

)

Prepaid expenses and other current assets

(565

)

(535

)

207

Accounts payable

(15

)

(224

)

Accrued expenses, wages, bonus and profit sharing

1,759

440

755

Income taxes receivable and payable

(1,023

)

105

1,504

Deferred revenue

1,351

643

397

Net cash provided by operating activities

28,091

26,843

21,886

Cash flows from investing activities:

Purchases of property and equipment

(4,568

)

(3,973

)

(2,939

)

Purchase of equity investment

(1,300

)

Purchase of intangible content license

(250

)

Net proceeds from sale of operating segment

223

1,613

Net cash used in investing activities

(6,118

)

(3,750

)

(1,326

)

Cash flows from financing activities:

Payments on notes payable

(2,473

)

(2,199

)

(2,328

)

Payments on capital lease obligations

(108

)

(95

)

(173

)

Cash paid for non-controlling interest

(2,000

)

(2,789

)

Proceeds from exercise of stock options

548

Excess tax benefit from share-based compensation

240

Repurchase of shares for payroll tax withholdings related to share-based compensation

(1,668

)

(204

)

(92

)

Purchase of Treasury Stock

(1,673

)

Payment of dividends on common stock

(16,867

)

(28,552

)

(10,054

)

Net cash used in financing activities

(21,116

)

(32,502

)

(16,869

)

Effect of exchange rate changes on cash

855

285

(1,588

)

Net increase (decrease) in cash and cash equivalents

1,712

(9,124

)

2,103

Cash and cash equivalents at beginning of period

33,021

42,145

40,042

Cash and cash equivalents at end of period

34,733

33,021

42,145

Supplemental disclosure of cash paid for:

Interest expense, net of $0, $10, and $14 capitalized, respectively

192

207

Income taxes

12,827

9,963

9,377

Supplemental disclosure of non-cash investing and financing activities:

Capital lease obligations originated for property and equipment

109

Stock tendered to the Company for cashless exercise of stock options in connection with equity incentive plans

2,455

397

406

See accompanying notes to consolidated financial statements.

Table of Contents

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY

Notes to Consolidated Financial Statements

(1)

Summary of Significant Accounting Policies

Description of Business and Basis of Presentation

National Research Corporation, doing business as NRC Health (“NRC Health,” the “Company,” “we,” “our,” “us” or similar terms), is a leading provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers and other healthcare organizations in the United States and Canada. The Company’s solutions enable its clients to understand the voice of the customer with greater clarity, immediacy and depth.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, National Research Corporation Canada. Prior to becoming a wholly-owned subsidiary in March 2016, the accounts of Customer-Connect LLC (“Connect”), then a variable interest entity for which NRC Health was deemed the primary beneficiary, were included in the consolidated financial statements of the Company. On June 30, 2016, Customer-Connect LLC was dissolved. All significant intercompany transactions and balances have been eliminated.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Translation of Foreign Currencies

Revenue Recognition

The Company derives a majority of its operating revenue from its annually renewable services, which include performance measurement and improvement services, healthcare analytics and governance education services. The Company provides these services to its clients under annual client service contracts, although such contracts are generally cancelable on short or no notice without penalty. Services are provided under subscription-based service agreements. The Company recognizes subscription-based service revenue over the period of time the service is provided. Generally, the subscription periods are for twelve months and revenue is recognized equally over the subscription period.

Certain contracts, excluding subscription-based service agreements, are fixed-fee arrangements with a portion of the project fee billed in advance and the remainder billed periodically over the duration of the project. Revenue for services provided under these contracts are recognized under the proportional performance method. Under the proportional performance method, the Company recognizes revenue based on output measures or key milestones such as survey set-up, survey mailings, survey returns and reporting. The Company measures its progress based on the level of completion of these output measures and recognizes revenue accordingly. Management judgments and estimates must be made and used in connection with revenue recognized using the proportional performance method. If management made different judgments and estimates, then the amount and timing of revenue for any period could differ materially from the reported revenue.

Table of Contents

The Company’s revenue arrangements with a client may include combinations of NRC Health’s Experience, Transparency, Governance, and Market Insights solutions which may be executed at the same time, or within close proximity of one another (referred to as a multiple-element arrangement). When the periods or patterns of revenue recognition differ, each element of a multiple-element arrangement is accounted for as a separate unit of accounting provided each delivered element is sold separately by the Company or another vendor; and for an arrangement that includes a general right of return relative to the undelivered elements, delivery or performance of the undelivered services are considered probable and substantially in the control of the Company. The Company’s arrangements generally do not include a general right of return related to the delivered services. If these criteria are not met, the arrangement is accounted for as a single unit of accounting with revenue generally recognized equally over the subscription period or recognized under the proportional performance method.

When a contract contains multiple elements, revenue is allocated to each separate unit of accounting based on relative selling price using a selling price hierarchy: vendor-specific objective evidence (“VSOE”), if available, third-party evidence (“TPE”) if VSOE is not available, or estimated selling price if VSOE nor TPE is available. VSOE is established based on the services normal selling price and discounts for the specific services when sold separately. TPE is established by evaluating similar competitor services in standalone arrangements. If neither exists for a deliverable, the best estimate of the selling price (“ESP”) is used for that deliverable based on list price, representing a component of management’s market strategy, and an analysis of historical prices for bundled and standalone arrangements. Revenue allocated to an element is limited to revenue that is not subject to refund or otherwise represents contingent revenue. VSOE, TPE and ESP are periodically adjusted to reflect current market conditions. These adjustments are not expected to differ significantly from historical results.

Business Combinations

The Company uses the acquisition method of accounting for acquired businesses. Under the acquisition method, the financial statements reflect the operations of an acquired business starting from the completion of the acquisition. The assets acquired and liabilities assumed are recorded at their respective estimated fair values at the date of the acquisition. Any excess of the purchase price over the estimated fair values of the identifiable net assets acquired is recorded as goodwill. Significant judgment is required in estimating the fair value of assets acquired, especially intangible assets. As a result, in the case of significant acquisitions the Company typically engages third-party valuation specialists in estimating fair values of tangible and intangible assets. The fair value estimates are based on available historical information and on expectations and assumptions about the future, considering the perspective of marketplace participants.

Table of Contents

Trade Accounts Receivable

Trade accounts receivable are recorded at the invoiced amount. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in the Company’s existing accounts receivable. The Company determines the allowance based on the Company’s historical write-off experience and current economic conditions. The Company reviews the allowance for doubtful accounts monthly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The following table provides the activity in the allowance for doubtful accounts for the years ended December 31, 2017, 2016 and 2015:

Balance at

Beginning

of Year

Bad Debt

Expense

Write-offs

Net of

Recoveries

Balance

at End

of Year

(In thousands)

Year Ended December 31, 2015

206

111

144

173

Year Ended December 31, 2016

173

218

222

169

Year Ended December 31, 2017

169

249

218

200

Property and Equipment

Property and equipment is stated at cost. Major expenditures to purchase property or to substantially increase useful lives of property are capitalized. Maintenance, repairs and minor renewals are expensed as incurred. When assets are retired or otherwise disposed of, their costs and related accumulated depreciation are removed from the accounts and resulting gains or losses are included in income.

The Company capitalizes certain costs incurred in connection with obtaining or developing internal-use software, including payroll and payroll-related costs for employees who are directly associated with the internal-use software projects and external direct costs of materials and services. Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose. Costs incurred during the preliminary project and post-implementation stages, as well as software maintenance and training costs are expensed as incurred. The Company capitalized approximately $3.0 million and $2.5 million of costs incurred for the development of internal-use software for the years ended December 31, 2017 and 2016, respectively.

The Company provides for depreciation and amortization of property and equipment using annual rates which are sufficient to amortize the cost of depreciable assets over their estimated useful lives. The Company uses the straight-line method of depreciation and amortization over estimated useful lives of three to ten years for furniture and equipment, three to five years for computer equipment, one to five years for capitalized software, and seven to forty years for the Company’s office building and related improvements.

Leases are categorized as operating or capital at the inception of the lease. Assets under capital lease obligations are reported at the lower of fair value or the present value of the aggregate future minimum lease payments at the beginning of the lease term. The Company depreciates capital lease assets without transfer-of-ownership or bargain-purchase-options using the straight-line method over the lease terms, excluding any lease renewals, unless the lease renewals are reasonably assured. Capital lease assets with transfer-of-ownership or bargain-purchase-options are depreciated using the straight-line method over the assets’ estimated useful lives.

Impairment of Long-Lived Assets and Amortizing Intangible Assets

Long-lived assets, such as property and equipment and purchased intangible assets subject to depreciation or amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. No impairments were recorded during the years ended December 31, 2017, 2016, or 2015.

Table of Contents

Among others, management believes the following circumstances are important indicators of potential impairment of such assets and as a result may trigger an impairment review:

●

Significant underperformance in comparison to historical or projected operating results;

●

Significant changes in the manner or use of acquired assets or the Company’s overall strategy;

●

Significant negative trends in the Company’s industry or the overall economy;

●

A significant decline in the market price for the Company’s common stock for a sustained period; and

●

The Company’s market capitalization falling below the book value of the Company’s net assets.

Goodwill and Intangible Assets

Intangible assets include customer relationships, trade names, technology, non-compete agreements and goodwill. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The Company reviews intangible assets with indefinite lives for impairment annually as of October 1 and whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable.

When performing the impairment assessment, the Company will first assess qualitative factors to determine whether it is necessary to recalculate the fair value of the intangible assets with indefinite lives. If the Company believes, as a result of the qualitative assessment, that it is more likely than not that the fair value of the indefinite-lived intangibles is less than their carrying amount, the Company calculates the fair value using a market or income approach. If the carrying value of intangible assets with indefinite lives exceeds their fair value, then the intangible assets are written-down to their fair values. The Company did not recognize any impairments related to indefinite-lived intangibles during 2017, 2016 or 2015.

Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. All of the Company’s goodwill is allocated to its reporting units, which are the same as its operating segments. Goodwill is reviewed for impairment at least annually, as of October 1, and whenever events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable.

In January 2017, the FASB issued Accounting Standards Update (“ASU”) 2017-04, Intangibles—Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment (“ASU 2017-04”). In connection with the October 1, 2017 annual impairment analysis, the Company early adopted ASU 2017-04, which eliminates the need to determine the fair value of individual assets and liabilities of a reporting unit to measure goodwill impairment (Step 2). The new guidance may result in more or less impairment than could previously be recognized. The adoption of this guidance did not impact the Company's results of operations or financial position since only a qualitative analysis was performed as part of the October 1, 2017 annual impairment analysis.

The Company reviews for goodwill impairment by first assessing qualitative factors to determine whether any impairment may exist. If the Company believes, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative analysis will be performed, and the fair value of the reporting unit is compared with its carrying value (including goodwill). If the fair value of the reporting unit exceeds its carrying value, then goodwill is written down by this difference. The Company performed a qualitative analysis as of October 1, 2017 and determined the fair value of each reporting unit likely significantly exceeded its carrying value. No impairments were recorded during the years ended December 31, 2017, 2016 or 2015.

Table of Contents

Income Taxes

The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.

Share-Based Compensation

The compensation expense on share-based payments is recognized based on the grant-date fair value of those awards. All of the Company’s existing stock option awards and non-vested stock awards have been determined to be equity-classified awards. The Company prospectively elected ASU 2016-09, Compensation – Stock Compensation (Topic 718) Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”) in 2016. As a result, the tax benefit from stock options exercised was recognized as a reduction to our provision for income taxes for the years ended December 31, 2017 and 2016 rather than as an increase to additional paid-in capital for the year ended December 31, 2015 prior to adoption.

Amounts recognized in the financial statements with respect to these plans:

	2017			2016			2015
	(In thousands)
Amounts charged against income, before income tax benefit	$	1,845		$	1,929		$	1,383
Amount of related income tax benefit		(2,310	)		(1,164	)		(505	)
Net (benefit) expense to net income	$	(465	)	$	765		$	878

Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash equivalents were $34.5 million and $32.7 million as of December 31, 2017, and 2016, respectively, consisting primarily of money market accounts, Eurodollar deposits and funds invested in commercial paper. At certain times, cash equivalent balances may exceed federally insured limits.

Reclassifications

Reclassifications of $191,000 have been made from noncurrent deferred income taxes to other noncurrent liabilities in the 2016 consolidated balance sheet to present the unrecognized tax benefits related to state taxes gross of federal tax benefits, consistent with the 2017 financial statement presentation. There was no impact on the previously reported net income and earnings per share.

Table of Contents

Fair Value Measurements

The Company’s valuation techniques are based on maximizing observable inputs and minimizing the use of unobservable inputs when measuring fair value. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect the Company’s market assumptions. The inputs are then classified into the following hierarchy: (1) Level 1 Inputs—quoted prices in active markets for identical assets and liabilities; (2) Level 2 Inputs—observable market-based inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities in active markets, quoted prices for similar or identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data; (3) Level 3 Inputs—unobservable inputs.

Commercial paper and Eurodollar deposits are included in cash equivalents and are valued at amortized cost, which approximates fair value due to its short-term nature. Eurodollar deposits are United States dollars deposited in a foreign bank branch of a United States bank and have daily liquidity. Both of these are included as a Level 2 measurement in the table below.

The following details the Company’s financial assets within the fair value hierarchy at December 31, 2017 and 2016:

Level 1

Level 2

Level 3

Total

(In thousands)

As of December 31, 2017

Money Market Funds

13,971

Commercial Paper

10,490

Eurodollar Deposits

10,017

Total Cash Equivalents

13,971

20,507

34,478

As of December 31, 2016

Money Market Funds

11,200

Commercial Paper

21,450

Total Cash Equivalents

11,200

21,450

32,650

There were no transfers between levels during the years ended December 31, 2017 and 2016.

The Company's long-term debt described in Note 8 is recorded at historical cost. The fair value of long-term debt is classified in Level 2 of the fair value hierarchy and was estimated based primarily on estimated current rates available for debt of the same remaining duration and adjusted for nonperformance and credit.

The following are the carrying amount and estimated fair values of long-term debt:

	December 31, 2017		December 31, 2016
	(In thousands)
Total carrying amount of long-term debt	$	1,067	$	3,540
Estimated fair value of long-term debt	$	1,066	$	3,533

The carrying amounts of accounts receivable, accounts payable, and accrued expenses approximate their fair value. All non-financial assets that are not recognized or disclosed at fair value in the financial statements on a recurring basis, which includes property and equipment, goodwill, intangibles and cost method investments, are measured at fair value in certain circumstances (for example, when there is evidence of impairment). As of December 31, 2017 and 2016, there was no indication of impairment related to these assets.

Contingencies

From time to time, the Company is involved in certain claims and litigation arising in the normal course of business. Management assesses the probability of loss for such contingencies and recognizes a liability when a loss is probable and estimable.

Table of Contents

Since the September 2017 announcement of the original proposed recapitalization plan (see Note 13), three purported class action and/or derivative complaints have been filed in state or federal courts by three individuals claiming to be shareholders of the Company. All of the complaints name as defendants the Company and the individual directors of the Company. Two of these lawsuits were filed in the United States District Court for the District of Nebraska— a putative class action lawsuit captioned Gennaro v. National Research Corporation, et al., and a putative class and derivative action lawsuit captioned Gerson v. Hays, et al.,. These lawsuits were consolidated by order of the federal court. A third lawsuit was filed the Circuit Court for Milwaukee County, Wisconsin—a putative class action lawsuit captioned Apfel v. Hays, et al. The allegations in all of the lawsuits are very similar. The plaintiffs allege, among other things, that the defendants breached their fiduciary duties in connection with the allegedly unfair proposed transaction, at an allegedly unfair price, conducted in an allegedly unfair and conflicted process and in alleged violation of Wisconsin law and the Company’s Articles of Incorporation. One of the lawsuits also alleges the proposed transactions is a voidable “conflict of interest transaction” under Wisconsin statutes. The plaintiffs in these lawsuits seek, among other things, an injunction enjoining the defendants from consummating the original proposed recapitalization plan, damages, equitable relief and an award of attorneys’ fees and costs of litigation. The Company believes that the allegations of the complaints are without merit and intends to defend these lawsuits vigorously. Despite the changes to the original proposed recapitalization plan that culminated in the December 13, 2017 announcement of a revised proposed recapitalization plan, the Company expects that these shareholders or other shareholders might assert similar claims regarding the proposed recapitalization plan. The Company will defend any such lawsuits vigorously. As of December 31, 2017, no losses have been accrued as the Company does not believe the losses are probable or estimable.

Earnings Per Share

Net income per share of class A common stock and class B common stock is computed using the two-class method. Basic net income per share is computed by allocating undistributed earnings to common shares and using the weighted-average number of common shares outstanding during the period.

Diluted net income per share is computed using the weighted-average number of common shares and, if dilutive, the potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and vesting of restricted stock. The dilutive effect of outstanding stock options is reflected in diluted earnings per share by application of the treasury stock method.

The liquidation rights and the rights upon the consummation of an extraordinary transaction are the same for the holders of class A common stock and class B common stock. Other than share distributions and liquidation rights, the amount of any dividend or other distribution payable on each share of class A common stock will be equal to one-sixth (1/6^th) of the amount of any such dividend or other distribution payable on each share of class B common stock. As a result, the undistributed earnings for each year are allocated based on the contractual participation rights of the class A and class B common stock as if the earnings for the year had been distributed.

At December 31, 2016, and 2015, the Company had 156,610 and 487,639 options of class A shares and 49,262, and 58,429 options of class B shares, respectively, which have been excluded from the diluted net income per share computation because the exercise price exceeds the fair market value. At December 31, 2017, 2016, and 2015 an additional 104,647, 390,300, and 68,779 options of class A shares and 1,858, 34,178, and 1,101 options of class B shares, respectively were excluded as their inclusion would be anti-dilutive.

Table of Contents

2017

2016

2015

Class A

Class B

Class A

Class B

Class A

Class B

(In thousands, except per share data)

Numerator for net income per share - basic:

Net income

11,388

11,555

10,178

10,341

8,759

8,851

Allocation of distributed and undistributed income to unvested restricted stock shareholders

(88

)

(87

)

(88

)

(88

)

(76

)

(77

)

Net income attributable to common shareholders

11,300

11,468

10,090

10,253

8,683

8,774

Denominator for net income per share - basic:

Weighted average common shares outstanding - basic

20,770

3,514

20,713

3,505

20,741

3,478

Net income per share - basic

0.54

3.26

0.49

2.93

0.42

2.52

Numerator for net income per share - diluted:

Net income attributable to common shareholders for
basic computation

11,300

11,468

10,090

10,253

8,683

8,774

Denominator for net income per share - diluted:

Weighted average common shares outstanding - basic

20,770

3,514

20,713

3,505

20,741

3,478

Weighted average effect of dilutive securities – stock options:

857

324

240

Denominator for diluted earnings per share – adjusted weighted average shares

21,627

3,603

21,037

3,560

20,981

3,522

Net income per share - diluted

0.52

3.18

0.48

2.88

0.41

2.49

Recent Accounting Pronouncements Not Yet Adopted

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”). ASU 2014-09 requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 will replace most existing revenue recognition guidance in accounting principles generally accepted in the United States when it becomes effective. The standard is effective for annual and interim reporting periods in fiscal years beginning after December 15, 2017. An entity may choose to adopt ASU 2014-09 either retrospectively or through a cumulative effect adjustment as of the start of the first period for which it applies the standard. The Company has completed system changes and is analyzing the resulting impact that this new guidance will have on its consolidated financial statements. The Company will adopt this new guidance using the modified retrospective approach beginning January 1, 2018 by recording a cumulative effect adjustment. The Company expects the most significant change to result from deferring direct and incremental costs of obtaining a contract, consisting of commissions and incentives, and recognizing the expense over the estimated life of the client contract, including renewal periods, rather than expensing as incurred, which is the Company’s current practice. The Company expects adjustments to retained earnings of no more than $2.7 million, net of related tax effects, upon adoption of deferring and amortizing direct and incremental contract costs. The Company also expects to record other immaterial adjustments, related to performance obligation determinations and estimating variable contingent consideration for certain contracts which were previously only recognized once the contingency was resolved and the services were performed. These amounts are only estimates and involve significant judgements by management including estimating the lives of its contracts, the value of performance deliverables and the expected amount to be earned from the satisfaction of those deliverables. The Company will finalize its calculation of the financial impact of the adoption of ASU 2014-09 in the first quarter of 2018. ASU 2014-09 also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract.

Table of Contents

In January 2016, the FASB issued ASU 2016-01, Financial Instruments—Overall: Recognition and Measurement of Financial Assets and Financial Liabilities. ASU 2016-01 changes certain recognition, measurement, presentation and disclosure aspects related to financial instruments. ASU 2016-01 is effective for financial statements issued for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is not permitted. The Company believes its adoption will not significantly impact the Company’s results of operations and financial position.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). This ASU requires lessees to recognize a lease liability and a right-to-use asset for all leases, including operating leases, with a term greater than twelve months on its balance sheet. This ASU is effective in fiscal years beginning after December 15, 2018, with early adoption permitted, and requires a modified retrospective transition method. As of December 31, 2017, the Company had approximately $3.0 million of operating lease commitments which would be recorded on the balance sheet under the new guidance. However, the Company is currently in the process of further evaluating the impact that this new guidance will have on its consolidated financial statements and does not plan to elect early adoption.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This ASU will require the measurement of all expected credit losses for financial assets, including trade receivables, held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. The guidance is effective for annual reporting periods beginning after December 15, 2019 and interim periods within those fiscal years. The Company believes its adoption will not significantly impact the Company’s results of operations and financial position.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments which eliminates the diversity in practice related to eight cash flow classification issues. This ASU is effective for the Company on January 1, 2018 with early adoption permitted. The Company will adopt this ASU on January 1, 2018 and believes it will not impact the Company’s results of operations and financial position.

In October 2016, the FASB issued ASU 2016-16, Intra-Entity Transfers of Asset Other Than Inventory (“ASU 2016-16”), which requires entities to recognize the tax consequences of intercompany asset transfers other than inventory transfers in the period in which the transfer takes place. ASU 2016-16 is effective for fiscal years and interim periods within fiscal years beginning after December 15, 2017. ASU 2016-16 is to be adopted using a modified retrospective approach with a cumulative effect adjustment to retained earnings as of the beginning of the period of adoption. The cumulative effect adjustment will include recognition of the income tax consequences of intra-entity transfers of assets other than inventory that occur before the adoption date. The Company believes the adoption of ASU 2016-16 will not impact the Company’s consolidated financial statements.

(2)

Equity Investments

The Company makes equity investments to promote business and strategic objectives. For investments that do not have a readily determinable fair value, the Company applies either cost or equity method of accounting depending on the nature of its investment and its ability to exercise significant influence. Investments are periodically analyzed to determine whether or not there are any indicators of impairment and written down to fair value if the investment has incurred an other than temporary impairment. During 2017, the Company acquired a $1.3 million investment in convertible preferred stock of Practicing Excellence.com, Inc., a privately-held Delaware Corporation (“PX”), which is carried at cost and included in other non-current assets. The Company has a seat on PX's board of directors and the Company's investment, which is not considered to be in-substance common stock, represents approximately 15.7% of the issued and outstanding equity interests in PX.

Table of Contents

(3)

Divestitures

On December 21, 2015, the Company completed the sale of selected assets and liabilities related to the clinical workflow product of the Predictive Analytics operating segment, for a net cash amount of approximately $1.6 million. The Company recorded a gain of approximately $1.1 million from the sale, which is included in other income on the Statement of Income. In connection with the closing of the transaction, $300,000 was placed in escrow to cover certain indemnification claims for one year following the transaction pursuant to the purchase agreement. Due to the uncertainty related to the settlement of the claims, escrowed amounts were recognized when the contingency was removed and the cash was released from escrow rather than at the time of sale. The Company received $223,000 of the escrow funds in December 2016 upon final resolution of the claims and recorded an additional gain on the sale from these funds. The lack of operating results from this business due to its divestiture did not have a major effect on our operations and financial results, and, accordingly, it was not classified as a discontinued operation for any of the periods presented.

(4)

Connect

Customer-Connect LLC was formed in June 2013 to develop and commercialize the Connect programs. Connect programs provide healthcare organizations the technology to engage patients through real-time identification and management of individual patient needs, preferences, risks, and experiences. The platform ensures that organizations have access to a longitudinal view of the patient to more effectively manage patient engagement across the continuum of care. At inception, NRC Health had a 49% ownership interest in Connect. NG Customer-Connect, LLC held a 25% interest, and the remaining 26% was held by Illuminate Health, LLC. Profits and losses were allocated under the hypothetical liquidation at book value approach.

In July 2015, the Company acquired all of NG Customer-Connect, LLC’s interest in Connect and a portion of Illuminate Health LLC’s interest in Connect for combined consideration of $2.8 million. As a result, as of December 31, 2015, the Company owned approximately 89% of Connect and Illuminate Health, LLC owned 11%. Under the amended operating agreement, NRC Health had the option to acquire additional equity units from Illuminate Health when new annual recurring contract value reached targeted levels. On March 7, 2016, the Company elected to exercise its first option to acquire one-third of the outstanding non-controlling interest for $1.0 million. Subsequently, on March 28, 2016, NRC Health and Illuminate Health reached an agreement whereby NRC Health acquired the remaining interest held by Illuminate Health for $1.0 million. Following these transactions, Customer-Connect LLC was a wholly owned subsidiary of NRC Health. All of Connect’s previous net income (losses) had been attributable to NRC Health. Since the Company previously consolidated Connect, the transactions to acquire additional ownership interests in Connect were accounted for as equity transactions, resulting in a reduction to additional paid-in capital of $252,000 and $2.8 million in 2016 and 2015, respectively. The acquisition of the remaining interest resulted in differences between the book and tax basis of Connect’s assets. As a result, the Company recorded deferred tax assets of $1.7 million, with a corresponding increase to additional paid-in capital during 2016. On June 30, 2016, Customer-Connect LLC was dissolved.

Table of Contents

(5)

Property and Equipment

At December 31, 2017, and 2016, property and equipment consisted of the following:

	2017		2016
	(In thousands)
Furniture and equipment	$	5,064	$	4,737
Computer equipment		2,721		2,750
Computer software		22,569		20,592
Building		9,386		9,386
Leaseholds		41		--
Land		425		425
Property and equipment at cost		40,206		37,890
Less accumulated depreciation and amortization		27,847		26,084
Net property and equipment	$	12,359	$	11,806

Depreciation and amortization expense related to property and equipment, including assets under capital lease, for the years ended December 31, 2017, 2016, and 2015 was $4.0 million, $3.6 million, and
$3.1 million, respectively.

Property and equipment included the following amounts under capital lease:

	2017		2016
	(In thousands)
Furniture and equipment	$	843	$	769
Property and equipment under capital lease, gross		843		769
Less accumulated amortization		684		530
Net assets under capital lease	$	159	$	239

(6)

Goodwill and Intangible Assets

Goodwill and intangible assets consisted of the following at December 31, 2017:

Useful Life

Gross

Accumulated Amortization

Net

(In years)

(In thousands)

Goodwill

58,021

Non-amortizing intangible assets:

Indefinite trade name

1,191

Amortizing intangible assets:

Customer related

9,347

8,611

736

Technology

1,360

523

837

Trade names

1,572

Total amortizing intangible assets

12,279

10,706

1,573

Total intangible assets other than goodwill

13,470

10,706

2,764

Table of Contents

Goodwill and intangible assets consisted of the following at December 31, 2016:

Useful Life

Gross

Accumulated Amortization

Net

(In years)

(In thousands)

Goodwill

57,861

Non-amortizing intangible assets:

Indefinite trade name

1,191

Amortizing intangible assets:

Customer related

9,331

8,164

1,167

Technology

1,110

344

766

Trade names

1,572

Total amortizing intangible assets

12,013

10,080

1,933

Total intangible assets other than goodwill

13,204

10,080

3,124

The following represents a summary of changes in the Company’s carrying amount of goodwill for the years ended December 31, 2017, and 2016 (in thousands):

Balance as of December 31, 2015	$	57,792
Foreign currency translation		69
Balance as of December 31, 2016	$	57,861
Foreign currency translation		160
Balance as of December 31, 2017	$	58,021

Aggregate amortization expense for customer related intangibles, trade names, technology and non-competes for the years ended December 31, 2017, 2016 and 2015 was $610,000, $654,000, and $995,000, respectively. Estimated amortization expense for the next five years is: 2018—$662,000; 2019—$374,000; 2020—$318,000; 2021—$180,000; 2022—$39,000.

(7)	Income Taxes

For the years ended December 31, 2017, 2016, and 2015, income before income taxes consists of the following:

	2017		2016		2015
	(In thousands)
U.S. Operations	$	32,750	$	29,848	$	25,536
Foreign Operations		1,533		1,508		1,824
Income before income taxes	$	34,283	$	31,356	$	27,360

Table of Contents

Income tax expense consisted of the following components:

	2017			2016			2015
	(In thousands)
Federal:
Current	$	10,947		$	8,930		$	9,955
Deferred		(1,596	)		847			(1,232	)
Total	$	9,351		$	9,777		$	8,723

Foreign:
Current	$	387		$	409		$	455
Deferred		704			(18	)		(23	)
Total	$	1,091		$	391		$	432

State:
Current	$	837		$	634		$	680
Deferred		61			36			(85	)
Total	$	898		$	670		$	595

Total	$	11,340		$	10,838		$	9,750

Federal Tax Reform

On December 22, 2017, the Tax Cut and Jobs Act (the “Tax Act”) was enacted which, among other changes, reduces the U.S. federal corporate tax rate from 35% to 21% effective January 1, 2018. The Tax Act makes broad and complex changes to the U.S. tax code and it will take time to fully analyze the impact of the changes. Based on the information available, and the current interpretation of the Tax Act, the Company was able to make a reasonable estimate and recorded a provisional net tax benefit related to the remeasurement of the deferred tax assets and liabilities due to the reduction in the U.S. federal corporate tax rate, offset by the one-time mandatory deemed repatriation tax, payable over eight years. Pursuant to the Staff Accounting Bulletin published by the United States Securities and Exchange Commission on December 22, 2017, addressing the challenges in accounting for the effects of the Tax Act in the period of enactment, companies must report provisional amounts for those specific income tax effects of the Tax Act for which the accounting is incomplete but a reasonable estimate can be determined. Those provisional amounts will be subject to adjustment during a measurement period of up to one year from the enactment date. Pursuant to this guidance, the estimated impact of the Tax Act is based on a preliminary review of the new tax law and projected future financial results and is subject to revision based upon further analysis and interpretation of the Tax Act and to the extent that future results differ from currently available projections. The Company’s accounting for the following elements of the Tax Act is incomplete. However, the Company was able to make reasonable estimates and recorded a provisional net tax benefit of $1.9 million related to the following elements of the Tax Act pursuant to the Staff Accounting Bulletin referred to above:

●

Reduction of U.S. Federal Corporate Tax Rate: The Tax Act reduces the corporate tax rate to 21%, effective January 1, 2018. Consequently, we have recorded a decrease related to deferred tax assets and liabilities with a corresponding net adjustment to deferred income tax benefit for the year ended December 31, 2017. Since the Company has recorded provisional amounts related to certain portions of the Tax Act, any corresponding deferred tax remeasurement is also provisional. For example, the Tax Act had several changes that were depreciation related. The primary change for the Company would be the availability of 100% bonus depreciation on assets placed in service after September 27, 2017. The Company is still evaluating which assets meet the requirements of this and therefore, no adjustments have been recorded related to this portion of the Tax Act as of December 31, 2017. In addition, under the Tax Act, expense under certain stock compensation plans may now be subject to limitations as to deductibility and the Company is still reviewing and analyzing each plan to determine the impact.

Table of Contents

●

One-Time Mandatory Deemed Repatriation Tax: Under the Tax Act, the Company will be subject to a one-time mandatory deemed repatriation tax on accumulated non-U.S. earnings. The estimated impact of the Tax Act is based on a preliminary review of the new law. Several estimates were used in these calculations and the Company is still finalizing the material inputs, therefore all repatriation adjustments are considered provisional. For example, the Company’s expected use of foreign tax credits and credit carryforwards may be impacted once the analysis is completed. Currently, the Company estimates that it will be unable to use approximately $535,000 of foreign tax credit carryforwards and has provided a full valuation allowance against such amount.

●

Global Intangible Low-Taxed Income (“GILTI”) Policy Election: The GILTI provisions of the Tax Act do not apply to the Company until 2018 and we are still evaluating its impact. The FASB allows companies to adopt an accounting policy to either recognize deferred taxes for GILTI or treat such tax cost as a current-period expense when incurred. We have not yet determined our accounting policy because determining the impact of the GILTI provisions requires analysis of our existing legal entity structure, the reversal of our U.S. generally accepted accounting principles and U.S. tax basis differences in the assets and liabilities of our foreign subsidiary, and our ability to offset any tax with foreign tax credits. As such, we have not made a policy decision regarding whether to record deferred taxes on GILTI or treat such tax cost as a current-period expense.

In addition, as a result of the Tax Act, the Company determined that it would no longer indefinitely reinvest the earnings of its Canadian subsidiary and recorded the withholding tax of $706,000 associated with this planned repatriation.

The difference between the Company’s income tax expense as reported in the accompanying consolidated financial statements and the income tax expense that would be calculated applying the U.S. federal income tax rate of 35% for 2017, 2016, and 2015 on pretax income was as follows:

	2017			2016			2015
	(In thousands)
Expected federal income taxes	$	11,999		$	10,975		$	9,576
Foreign tax rate differential		(131	)		(129	)		(139	)
State income taxes, net of federal benefit and state tax credits		608			436			391
Federal tax credits		(130	)		(165	)		(150	)
Uncertain tax positions		151			6			93
Nondeductible expenses related to proposed recapitalization		504			--			--
Share based compensation		(1,564	)		(441	)		--
Compensation limit for covered employees		955			--			--
Impact of 2017 Tax Act		(2,415	)		--			--
Valuation allowance		535			--			--
Withholding tax on repatriation of foreign earnings		706			--			--
Other		122			156			(21	)
Total	$	11,340		$	10,838		$	9,750

Table of Contents

Deferred tax assets and liabilities at December 31, 2017 and 2016, were comprised of the following:

	2017			2016
	(In thousands)
Deferred tax assets:
Allowance for doubtful accounts	$	46		$	62
Accrued expenses		416			580
Share based compensation		1,457			2,357
Accrued bonuses		113			84
Foreign tax credit from repatriation		535			--
Other		166			244
Gross deferred tax assets		2,733			3,327
Less Valuation Allowance		(535	)		--
Deferred Tax Assets		2,198			3,327
Deferred tax liabilities:
Prepaid expenses		169			270
Property and equipment		856			1,206
Intangible assets		4,497			6,521
Repatriation withholding		706			--
Deferred tax liabilities		6,228			7,997
Net deferred tax liabilities	$	(4,030	)	$	(4,670	)

In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion, or all, of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company considers projected future taxable income, carry-back opportunities, and tax planning strategies in making this assessment. Based upon the level of historical taxable income and projections for future taxable income over the periods which the deferred tax assets are deductible, the Company believes it is more likely than not that it will realize the benefits of these deductible differences excluding the foreign tax credit carryforward.

The Company had an unrecognized tax benefit at December 31, 2017 and 2016, of $843,000 and $662,000, respectively, excluding interest of $5,000 and $2,000 at December 31, 2017 and 2016, respectively. Of these amounts, $620,000 and $472,000 at December 31, 2017 and 2016, respectively, represents the net unrecognized tax benefits that, if recognized, would favorably impact the effective income tax rate. The change in the unrecognized tax benefits for 2017 and 2016 is as follows:

		(In thousands)
Balance of unrecognized tax benefits at December 31, 2015	$	589
Reductions due to lapse of applicable statute of limitations		(148	)
Additions based on tax positions of prior years		5
Additions based on tax positions related to the current year		216
Balance of unrecognized tax benefits at December 31, 2016	$	662
Reductions due to lapse of applicable statute of limitations		--
Reductions due to tax positions of prior years		(7	)
Additions based on tax positions related to the current year		188
Balance of unrecognized tax benefits at December 31, 2017	$	843

Table of Contents

The Company files a U.S. federal income tax return, various state jurisdictions returns and a Canada federal and provincial income tax return. All years prior to 2014 are now closed for US federal income tax and for years prior to 2014 for state income tax returns, and no exposure items exist for these years. The Company completed a United States federal tax examination for the tax year ended December 31, 2013 in the first quarter of 2016. The 2013 to 2017 Canada federal and provincial income tax returns remain open to examination.

(8)

Notes Payable

Notes payable consisted of the following:

	2017		2016
	(In thousands)
Revolving credit note with U.S. Bank, maximum available $12.0 million, matures June 30, 2018	$	--	$	--
Note payable to U.S. Bank for $11.8 million, interest at a 3.12% fixed rate, monthly principal and interest payments of $212,468 through April 2018		1,067		3,540
Total notes payable		1,067		3,540
Less current portion		1,067		2,683
Note payable, net of current portion	$	--	$	857

The Company’s revolving credit note was amended and extended effective June 30, 2017 with a maturity date of June 30, 2018. The maximum aggregate amount available under the revolving credit note is $12.0 million. Borrowings under the revolving credit note bear interest at a variable annual rate, with three rate options at the discretion of management as follows: (1) 2.1% plus the one-month London Interbank Offered Rate (“LIBOR”) or (2) 2.1% plus the one-, two- or three- month LIBOR rate, or (3) the bank’s one-, two, three, six, or twelve month Money Market Loan Rate. As of December 31, 2017 the revolving credit note did not have a balance and the Company had the capacity to borrow $12.0 million.

The term note and revolving credit note are secured by certain of the Company’s assets, including the Company’s land, building, accounts receivable and intangible assets. The term note and the revolving credit note contain various restrictions and covenants applicable to the Company, including requirements that the Company maintain certain financial ratios at prescribed levels and restrictions on the ability of the Company to consolidate or merge, create liens, incur additional indebtedness or dispose of assets. As of December 31, 2017, the Company was in compliance with the financial covenants.

(9)

Share-Based Compensation

The Company measures and recognizes compensation expense for all share-based payments based on the grant-date fair value of those awards. All of the Company’s existing stock option awards and non-vested stock awards have been determined to be equity-classified awards.

The National Research Corporation 2001 Equity Incentive Plan (“2001 Equity Incentive Plan”) provided for the granting of stock options, stock appreciation rights, restricted stock, performance shares and other share-based awards and benefits up to an aggregate of 1,800,000 shares of class A common stock and 300,000 shares of class B common stock. Stock options granted could have been either nonqualified or incentive stock options. Stock options vest over one to five years following the date of grant and option terms are generally five to ten years following the date of grant. Due to the expiration of the 2001 Equity Incentive Plan, at December 31, 2015, there were no shares of stock available for future grants. The Company has accounted for grants of 1,683,309 class A and 280,552 class B options and restricted stock under the 2001 Equity Incentive Plan using the date of grant as the measurement date for financial accounting purposes.

Table of Contents

The Company’s 2004 Non-Employee Director Stock Plan, as amended (the “2004 Director Plan”), is a nonqualified plan that provides for the granting of options with respect to 3,000,000 shares of class A common stock and 500,000 shares of class B common stock. The 2004 Director Plan provides for grants of nonqualified stock options to each director of the Company who is not employed by the Company. On the date of each annual meeting of shareholders of the Company, options to purchase 36,000 shares of class A common stock and 6,000 shares of class B common stock are granted to directors that are elected or retained as a director at such meeting. Stock options vest one year following the date of grant and option terms are generally ten years following the date of grant, or three years in the case of termination of the outside director’s service. At December 31, 2017, there were 921,000 shares of class A common stock and 153,500 shares of class B common stock available for issuance pursuant to future grants under the 2004 Director Plan. The Company has accounted for grants of 2,079,000 class A and 346,500 class B options under the 2004 Director Plan using the date of grant as the measurement date for financial accounting purposes.

The National Research Corporation 2006 Equity Incentive Plan (the “2006 Equity Incentive Plan”) provides for the granting of stock options, stock appreciation rights, restricted stock, performance shares and other share-based awards and benefits up to an aggregate of 1,800,000 shares of class A common stock and 300,000 shares of class B common stock. Stock options granted may be either incentive stock options or nonqualified stock options. Vesting terms vary with each grant and option terms are generally five to ten years following the date of grant. At December 31, 2017, there were 865,465 shares of class A common stock and 145,189 shares of class B common stock available for issuance pursuant to future grants under the 2006 Equity Incentive Plan. The Company has accounted for grants of 934,535 class A and 154,811 class B options and restricted stock under the 2006 Equity Incentive Plan using the date of grant as the measurement date for financial accounting purposes.

The Company granted options to purchase 299,917 shares of class A common stock and 49,986 shares of class B common stock during 2017. During 2016, the Company granted options to purchase 315,620 shares of class A common stock and 52,603 shares of class B common stock, and during 2015 granted options to purchase 261,306 shares of class A common stock and 43,551 shares of class B common stock. Options to purchase shares of common stock are typically granted with exercise prices equal to the fair value of the common stock on the date of grant. The Company does, in certain limited situations, grant options with exercise prices that exceed the fair value of the common shares on the date of grant. The fair value of stock options granted was estimated using a Black-Scholes valuation model with the following weighted average assumptions:

2017

2016

2015

Class A

Class B

Class A

Class B

Class A

Class B

Expected dividend yield at date of grant

2.62

8.06

2.99

7.29

2.22

5.48

Expected stock price volatility

32.45

26.75

32.74

29.41

31.97

31.17

Risk-free interest rate

2.18

1.69

1.58

1.60

Expected life of options (in years)

6.80

6.86

5.49

5.62

The risk-free interest rate assumptions were based on the U.S. Treasury yield curve in effect at the time of the grant. The expected volatility was based on historical monthly price changes of the Company’s stock based on the expected life of the options at the date of grant. The expected life of options is the average number of years the Company estimates that options will be outstanding. The Company considers groups of associates that have similar historical exercise behavior separately for valuation purposes.

Table of Contents

The following table summarizes stock option activity under the 2001 and 2006 Equity Incentive Plans and the 2004 Director Plan for the year ended December 31, 2017:

Number of
Options

Weighted

Average

Exercise

Price

Weighted

Average

Remaining Contractual

Terms (Years)

Aggregate

Intrinsic

Value

(In thousands)

Class A

Outstanding at December 31, 2016

1,705,483

12.31

Granted

299,917

22.13

Exercised

(197,784

)

10.55

2,681

Forfeited

(60,982

)

21.35

Outstanding at December 31, 2017

1,746,634

13.88

5.39

40,901

Exercisable at December 31, 2017

1,274,361

12.14

4.32

32,060

Class B

Outstanding at December 31, 2016

250,493

29.70

Granted

49,986

42.90

Exercised

(13,600

)

27.04

202

Forfeited

(10,163

)

41.53

Outstanding at December 31, 2017

276,716

31.78

5.52

6,719

Exercisable at December 31, 2017

198,950

29.16

4.44

5,353

The following table summarizes information related to stock options for the years ended December 31, 2017, 2016 and 2015:

2017

2016

2015

Class A

Class B

Class A

Class B

Class A

Class B

Weighted average grant date fair value of stock options granted

5.83

3.66

3.62

3.90

3.49

5.45

Intrinsic value of stock options exercised (in thousands)

2,681

202

459

632

350

151

Intrinsic value of stock options vested (in thousands)

5,258

787

1,627

535

1,351

415

As of December 31, 2017, the total unrecognized compensation cost related to non-vested stock option awards was approximately $1.2 million and $152,000 for class A and class B common stock shares, respectively, which was expected to be recognized over a weighted average period of 2.53 years and 2.57 years for class A and class B common stock shares, respectively.

Cash received from stock options exercised for the years ended December 31, 2016 was $548,000. There was no cash received from stock options exercised for the year ended December 31, 2017 or 2015. The Company recognized $1.2 million, $964,000 and $828,000 of non-cash compensation for the years ended December 31, 2017, 2016, and 2015, respectively, related to options, which is included in selling, general and administrative expenses.

The actual tax benefit realized for the tax deduction from stock options exercised was $1.1 million, $398,000 and $183,000 for the years ended December 31, 2017, 2016 and 2015, respectively. The Company prospectively elected ASU 2016-09, Compensation – Stock Compensation (Topic 718) Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”) in 2016. As a result, the excess tax benefit from stock options exercised was recognized as a reduction to our provision for income taxes for the years ended December 31, 2017 and 2016 rather than as an increase to additional paid-in capital for the years ended December 31, 2015 prior to adoption.

Table of Contents

During 2016 and 2015, the Company granted 20,578 and 89,416 non-vested shares of class A and 3,430 and 14,902 non-vested shares of class B common stock, respectively, under the 2006 Equity Incentive Plan. No shares were granted during the year ended December 31, 2017. As of December 31, 2017, the Company had 81,677 and 13,611 non-vested shares of class A and class B common stock, respectively, outstanding under the 2006 Equity Incentive Plan. These shares vest over five years following the date of grant and holders thereof are entitled to receive dividends from the date of grant, whether or not vested. The fair value of the awards is calculated as the fair market value of the shares on the date of grant. The Company recognized $629,000, $966,000 and $555,000 of non-cash compensation for the years ended December 31, 2017, 2016, and 2015, respectively, related to this non-vested stock, which is included in selling, general and administrative expenses. The actual tax benefit realized for the tax deduction from vesting of restricted stock was $1.3 million and $161,000 for the years ended December 31, 2017 and 2016, respectively. There were no shares that vested in the year ended December 31, 2015.

The following table summarizes information regarding non-vested stock granted to associates under the 2006 Equity Incentive Plans for the year ended December 31, 2017:

Class A Shares Outstanding

Class A

Weighted

Average Grant

Date Fair Value

Per Share

Class B Shares Outstanding

Class B

Weighted

Average Grant

Date Fair Value

Per Share

Outstanding at December 31, 2016

174,487

13.93

29,081

37.21

Granted

Vested

(73,506

)

13.99

(12,251

)

38.50

Forfeited

(19,314

)

14.27

(3,219

)

34.69

Outstanding at December 31, 2017

81,677

13.80

13,611

36.65

As of December 31, 2017, the total unrecognized compensation cost related to non-vested stock awards was approximately $806,000 and is expected to be recognized over a weighted average period of 2.54 years.

(10)	Leases

The Company leases printing equipment in the United States, and office space in Canada, California, Georgia, and Washington. The Company also leased additional office space in Nebraska through June 2016. The Company recorded rent expense in connection with its operating leases of $869,000, $920,000 and $1.0 million in 2017, 2016, and 2015, respectively. The Company also has capital leases for production, mailing and computer equipment.

Payments under non-cancelable operating leases and capital leases at December 31, 2017 for the next five years are:

Year Ending December 31,	Capital Leases		Operating Leases
	(In thousands)
2018	$	80	$	708
2019		51		679
2020		34		485
2021		6		377
2022		1		190
Total minimum lease payments		172
Less: Amount representing interest		14
Present value of minimum lease payments		158
Less: Current maturities		71
Capital lease obligations, net of current portion	$	87

Table of Contents

(11)

Related Party

A director of the Company also serves as an officer of Ameritas Life Insurance Corp. (“Ameritas”). In connection with the Company’s regular assessment of its insurance-based associate benefits, which is conducted by an independent insurance broker, and the costs associated therewith, the Company purchases dental and vision insurance for certain of its associates from Ameritas. The total value of these purchases was $248,000, $232,000 and $227,000 in 2017, 2016 and 2015 respectively.

Mr. Hays, the Chief Executive Officer and director of the Company, is an owner of 14% of the equity interest of Nebraska Global Investment Company LLC (“Nebraska Global”). The Company, directly or indirectly through its former subsidiary Customer-Connect LLC, purchased certain services from Nebraska Global, primarily consisting of software development services. The total value of these purchases were $12,500, $488,000 and $440,000 in 2017, 2016 and 2015, respectively.

Mr. Hays personally incurred approximately $538,000 of fees and expenses in connection with exploring strategic alternatives for the Company, including the proposed recapitalization (see Note 13), for which the Company has reimbursed Mr. Hays in 2017. These fees and expenses were attributable to the evaluation of alternatives and the sourcing and negotiating of financing for the alternatives, all of which would have been borne directly by the Company if they had been advanced by Mr. Hays. Mr. Hays advanced these funds personally in order to maintain the confidentiality of the evaluation of such alternatives and allow the management team to maintain its focus on the Company’s business and operations.

During 2017, the Company acquired a cost method investment in convertible preferred stock of PX (see Note 2). Also in 2017, the Company paid $250,000 to acquire certain perpetual content licenses from PX for content the Company includes in certain of its subscription services. The Company also has an agreement with PX which commenced in 2016 under which the Company acts as a reseller of PX services and receives a portion of the revenues. The total revenue earned from the PX reseller agreement in the years ended December 31, 2017 and 2016 was $633,000 and $28,000, respectively.

(12)

Associate Benefits

The Company sponsors a qualified 401(k) plan covering substantially all associates with no eligibility service requirement. Under the 401(k) plan, the Company matches 25.0% of the first 6.0% of compensation contributed by each associate. Employer contributions, which are discretionary, vest to participants at a rate of 20% per year. The Company contributed $350,000, $291,000 and $330,000 in 2017, 2016 and 2015, respectively, as a matching percentage of associate 401(k) contributions.

(13)

Proposed Recapitalization

In December 2017, the Company’s Board of Directors approved a recapitalization plan that will exchange each share of class B common stock for one share of class A common stock plus $19.59 in cash, for total value of $53.44 per class B share. This proposed recapitalization plan replaces the proposed plan announced in September 2017.

In December 2017, the Company entered into a commitment letter with First National Bank of Omaha, which expires on April 30, 2018, to provide a senior secured term loan of $40 million, a delayed draw term loan facility of $15 million and a senior secured revolving line of credit facility of $15 million.

The proposed recapitalization is subject to closing of financing and approval by the holders of the Company’s class A common stock, class B common stock and both classes of stock voting together as a group. The Company incurred expenses related to the proposed recapitalization of approximately $1.4 million in the year ended December 31, 2017, which are included in selling and administrative expenses. These expenses include certain amounts reimbursed to Mr. Hays (see Note 11).

Table of Contents

(14)	Segment Information

The Company’s six operating segments are aggregated into one reporting segment because they have similar economic characteristics and meet the other aggregation criteria from the FASB guidance on segment disclosure. The six operating segments are Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Transitions, which offer a portfolio of solutions that address specific needs around market insight, experience, transparency and governance for healthcare providers, payers and other healthcare organizations. On December 21, 2015, selected assets and liabilities were sold from a seventh operating segment, Predictive Analytics, reducing the number of operating segments from seven to six as of December 31, 2015.

The table below presents entity-wide information regarding the Company’s revenue and assets by geographic area:

2017

2016

2015

(In thousands)

Revenue:

United States

112,885

104,445

97,097

Canada

4,674

4,939

5,246

Total

117,559

109,384

102,343

Long-lived assets:

United States

72,562

71,192

70,624

Canada

2,495

2,367

2,364

Total

75,057

73,559

72,988

Total assets:

United States

110,785

106,288

115,480

Canada

16,531

14,336

12,569

Total

127,316

120,624

128,049

Table of Contents

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Not applicable.

Item 9A.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), the Company’s management evaluated, with the participation of the Company’s Chief Executive Officer and the Company’s Chief Financial Officer, the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2017. Based upon their evaluation of these disclosure controls and procedures, the Chief Executive Officer and the Chief Financial Officer concluded that the disclosure controls and procedures were effective as of December 31, 2017.

Management’s Report on Internal Control over Financial Reporting

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act). The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, however, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies of procedures may deteriorate.

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s internal control over financial reporting using the framework in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on such evaluation, the Company’s management concluded that the Company’s internal control over financial reporting was effective as of December 31, 2017.

The effectiveness of the Company’s internal control over financial reporting as of December 31, 2017, has been audited by KPMG LLP, an independent registered public accounting firm, as stated in their report, a copy of which is included in this Annual Report on Form 10-K.

Changes in Internal Control over Financial Reporting

There was no change in the Company’s internal control over financial reporting that occurred during the quarter ended December 31, 2017, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

Item 9B.

Other Information

The Company has no other information to report pursuant to this item.

Table of Contents

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors
National Research Corporation:

Opinion on Internal Control Over Financial Reporting

We have audited National Research Corporation and subsidiary’s (the “Company”) internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the consolidated balance sheets of the Company as of December 31, 2017 and 2016, the related consolidated statements of income, comprehensive income, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2017, and the related notes (collectively, the consolidated financial statements), and our report dated March 14, 2018 expressed an unqualified opinion on those consolidated financial statements.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Table of Contents

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ KPMG LLP

Lincoln, Nebraska
March 14, 2018

Table of Contents

PART III

Item 10.

Directors, Executive Officers and Corporate Governance

The information required by this Item with respect to directors and Section 16 compliance is included under the captions “Election of Directors” and “Section 16(a) Beneficial Ownership Reporting Compliance,” respectively, in the Company’s definitive Proxy Statement for its 2018 Annual Meeting of Shareholders (“Proxy Statement”) and is hereby incorporated herein by reference. Information with respect to the executive officers of the Company appears in Item 1 of this Annual Report on Form 10-K. The information required by this Item with respect to audit committees and audit committee financial experts is included under the caption “Corporate Governance” in the Proxy Statement and is incorporated herein by reference.

The Company has adopted a Code of Business Conduct and Ethics that applies to all of the Company’s associates, including the Company’s Chief Executive Officer and Chief Financial Officer and other persons performing similar functions. The Company has posted a copy of the Code of Business Conduct and Ethics on its website at www.nrchealth.com, and such Code of Business Conduct and Ethics is available, in print, without charge, to any shareholder who requests it from the Company’s Secretary. The Company intends to satisfy the disclosure requirements under Item 5.05 of Form 8-K regarding amendments to, or waivers from, the Code of Business Conduct and Ethics by posting such information on its website at www.nrchealth.com. The Company is not including the information contained on its website as part of, or incorporating it by reference into, this report.

Item 11.

Executive Compensation

The information required by this Item is included under the captions “Compensation Discussion and Analysis,” “2017 Summary Compensation Table,” “Grants of Plan-Based Awards in 2017,” “Outstanding Equity Awards at December 31, 2017,” “2017 Director Compensation,” “Compensation Committee Report,” “Corporate Governance-Transactions with Related Persons” and “CEO Pay Ratio” in the Proxy Statement and is hereby incorporated herein by reference.

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters

The information required by this Item with respect to security ownership of certain beneficial owners and management is included under the caption “Principal Shareholders” in the Proxy Statement and is hereby incorporated by reference.

Table of Contents

The following table sets forth information with respect to compensation plans under which equity securities of the Company are authorized for issuance as of December 31, 2017.

Plan Category Class A shares	Number of securities to be issued upon the exercise of outstanding options, warrants and rights		Weighted-average exercise price of outstanding options, warrants and rights		Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in the first column)
Equity compensation plans approved by security holders ⁽¹⁾		1,746,634	$	13.88		1,786,465	⁽²⁾
Equity compensation plans not approved by security holders		--		--		--
Total		1,746,634	$	13.88		1,786,465

Plan Category Class B shares	Number of securities to be issued upon the exercise of outstanding options, warrants and rights		Weighted-average exercise price of outstanding options, warrants and rights		Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in the first column)
Equity compensation plans approved by security holders ⁽¹⁾		276,716	$	31.78		298,689	⁽²⁾
Equity compensation plans not approved by security holders		--		--		--
Total		276,716	$	31.78		298,689

⁽¹⁾

Includes the Company’s 2006 Equity Incentive Plan, 2004 Director Plan, and the 2001 Equity Incentive Plan.

⁽²⁾

Under the 2006 Equity Incentive Plan, the Company had authority to award up to 327,590 additional shares of restricted class A common stock and 54,599 additional shares of restricted class B common stock to participants, provided that the total of such shares awarded may not exceed the total number of shares remaining available for issuance under the 2006 Equity Incentive Plan, which totaled 865,465 shares of class A common stock and 145,189 shares of class B common stock as of December 31, 2017. The Director Plan provides for granting options for 3,000,000 shares of Class A common stock and 500,000 shares of Class B common stock. Option awards through December 31, 2017 totaled 2,079,000 shares of Class A common stock and 346,500 of Class B common stock. No future awards are available under the 2001 Equity Incentive Plan due to its expiration.

Item 13. Certain Relationships and Related Transactions, and Director Independence

The information required by this Item is included under the caption “Corporate Governance” in the Proxy Statement and is hereby incorporated by reference.

Item 14. Principal Accountant Fees and Services

The information required by this Item is included under the caption “Miscellaneous — Independent Registered Public Accounting Firm” in the Proxy Statement and is hereby incorporated by reference.

Table of Contents

PART IV

Item 15.

Exhibits, Financial Statement Schedules

1.	Consolidated financial statements. The consolidated financial statements listed in the accompanying index to the consolidated financial statements are filed as part of this Annual Report on Form 10-K.

2.	Financial statement schedules. All financial statement schedules have been omitted because they are not applicable or the required information is included in the consolidated financial statements and the related notes thereto.

3.	Exhibits. The exhibits listed in the exhibit index below are filed as part of this Annual Report on Form 10-K.

EXHIBIT INDEX

Exhibit Number	Exhibit Description

(3.1)	Amended and Restated Articles of Incorporation of National Research Corporation, effective May 22, 2013 [Incorporated by reference to Exhibit (3.2) to National Research Corporation’s Current Report on Form 8-K dated May 22, 2013 and filed May 24, 2013 (File No. 0-29466)]

(3.2)	By-Laws of National Research Corporation, as amended to date [Incorporated by reference to Exhibit (3.2) to National Research Corporation’s Current Report on Form 8-K dated October 26, 2015 and filed on October 28, 2015 (File No. 0-29466)]

(4)	Installment Note, dated as of May 9, 2013, from National Research Corporation to U.S. Bank National Association [Incorporated by reference to Exhibit (4) to National Research Corporation’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 and filed on August 8, 2015 (File No. 0-29466)]

(10.1)*	National Research Corporation 2001 Equity Incentive Plan [Incorporated by reference to Appendix A to National Research Corporation’s Proxy Statement for the 2002 Annual Meeting of Shareholders filed on April 3, 2002 (File No. 0-29466)]

(10.2)*	National Research Corporation 2006 Equity Incentive Plan, as amended [Incorporated by reference to Exhibit (4.3) to National Research Corporation’s Registration Statement on Form S-8 (Registration No. 333-189141) filed on June 6, 2013]

(10.3)*	National Research Corporation 2004 Non-Employee Director Stock Plan, as amended [Incorporated by reference to Appendix A to National Research Corporation’s Proxy Statement for its 2015 Annual Meeting of Shareholders filed on April 1, 2015]

(10.4)*	Form of Nonqualified Stock Option Agreement (for new associates) used in connection with the 2001 Equity Incentive Plan [Incorporated by reference to Exhibit 4.4 to National Research Corporation’s Registration Statement on Form S-8 (Registration No. 333-120530) filed on November 16, 2004]

(10.5)*	Form of Nonqualified Stock Option Agreement (for officers) used in connection with the 2001 Equity Incentive Plan [Incorporated by reference to Exhibit 4.5 to National Research Corporation’s Registration Statement on Form S-8 (Registration No. 333-120530) filed on November 16, 2004]

Table of Contents

Exhibit Number	Exhibit Description

(10.6)*	Form of Restricted Stock Agreement for executive officers used in connection with the 2001 Equity Incentive Plan [Incorporated by reference to Exhibit 10.2 to National Research Corporation’s Current Report on Form 8-K dated March 19, 2005 and filed on March 23, 2005 (File No. 0-29466)]

(10.7)*	Form of Restricted Stock Agreement (one year vesting) used in connection with the 2001 Equity Incentive Plan [Incorporated by reference to Exhibit 4.6 to National Research Corporation’s Registration Statement on Form S-8 (Registration No. 333-120530) filed on November 16, 2004]

(10.8)*	Form of Restricted Stock Agreement (five year vesting) used in connection with the 2001 Equity Incentive Plan [Incorporated by reference to Exhibit 4.7 to National Research Corporation’s Registration Statement on Form S-8 (Registration No. 333-120530) filed on November 16, 2004]

(10.9)*	Form of Nonqualified Stock Option Agreement used in connection with the 2006 Equity Incentive Plan [Incorporated by reference to Exhibit (10.14) to National Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2006 and filed on April 2, 2007 (File No. 0-29466)]

(10.10)*	Form of Restricted Stock Agreement used in connection with the 2006 Equity Incentive Plan [Incorporated by reference to Exhibit (10.15) to National Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2006 and filed on April 2, 2007 (File No. 0-29466)]

(11)	Computation of per share earnings (contained in Note 1 of “Notes to Consolidated Financial Statements” of the Company’s Annual Report in Form 10-K for the year ended December 31, 2017).

(21)	Subsidiary of National Research Corporation

(23)	Consent of Independent Registered Public Accounting Firm

(31.1)	Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

(31.2)	Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

(32)	Certification of Periodic Financial Report by the Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(99)	Proxy Statement for the 2018 Annual Meeting of Shareholders [To be filed with the Securities and Exchange Commission under Regulation 14A within 120 days after December 31, 2017; except to the extent specifically incorporated by reference, the Proxy Statement for the 2018 Annual Meeting of Shareholders shall not be deemed to be filed with the Securities and Exchange Commission as part of this Annual Report on Form 10-K]

Table of Contents

Exhibit Number	Exhibit Description

(101)**	Financial statements from the Annual Report on Form 10-K of National Research Corporation for the year ended December 31, 2017, formatted in eXtensible Business Reporting Language (XBRL): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) Consolidated Statements of Comprehensive Income, (iv) Consolidated Statements of Shareholders’ Equity, (v) the Consolidated Statements of Cash Flows, (vi) the Notes to the Consolidated Financial Statements, and (vii) document and entity information.

*	A management contract or compensatory plan or arrangement.

In accordance with Rule 406T of Regulation S-T, the information in these exhibits shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

Item 16.

Form 10-K Summary

None.

Table of Contents

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

	Page in this Form 10-K

Report of Independent Registered Public Accounting Firm	30

Consolidated Balance Sheets as of December 31, 2017 and 2016

Consolidated Statements of Income for the Three Years Ended December 31, 2017	32

Consolidated Statements of Comprehensive Income for the Three Years Ended December 31, 2017	33

Consolidated Statements of Shareholders’ Equity for the Three Years Ended December 31, 2017	34

Consolidated Statements of Cash Flows for the Three Years Ended December 31, 2017

Notes to Consolidated Financial Statements

All other financial statement schedules are omitted since the required information is not present or is not present in amounts sufficient to require submission of the schedules, or because the information required is included in the consolidated financial statements and notes thereto.

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on this 14th day of March 2018.

	NATIONAL RESEARCH CORPORATION

	By:	/s/ Michael D. Hays
		Michael D. Hays
		Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Signature	Title	Date

/s/ Michael D. Hays	Chief Executive Officer and Director	March 14, 2018
Michael D. Hays	(Principal Executive Officer)


/s/ Kevin R. Karas	Senior Vice President Finance, Chief Financial	March 14, 2018
Kevin R. Karas	Officer, Treasurer and Secretary (Principal
	Financial and Accounting Officer)

/s/ Donald M. Berwick	Director	March 14, 2018
Donald M. Berwick

/s/ JoAnn M. Martin	Director	March 14, 2018
JoAnn M. Martin

/s/ Barbara J. Mowry	Director	March 14, 2018
Barbara J. Mowry

/s/ John N. Nunnelly	Director	March 14, 2018
John N. Nunnelly

EX-21 2 ex_107093.htm EXHIBIT 21 ex_107093.htm

Exhibit 21

Subsidiary of National Research Corp.

National Research Corporation’s subsidiary as of December 31, 2017 is listed below:

Subsidiary	Jurisdiction of organization

National Research Corporation Canada	Ontario

EX-23 3 ex_107095.htm EXHIBIT 23 ex_107095.htm

Exhibit 23

Consent of Independent Registered Public Accounting Firm

The Board of Directors

National Research Corporation:

We consent to the incorporation by reference in the registration statements (File Nos. 333-120530, 333-137763, 333-137769, 333-173097, 333-189139, 333-189140, 333-189141, and 333-209934) on Forms S-8 and (File Nos. 333-120529 and 333-211190) on Forms S-3 of National Research Corporation of our reports dated March 14, 2018, with respect to the consolidated balance sheets of National Research Corporation and subsidiary as of December 31, 2017 and 2016, and the related consolidated statements of income, comprehensive income, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2017, and the related notes (collectively, the consolidated financial statements), and the effectiveness of internal control over financial reporting as of December 31, 2017, which reports appear in the December 31, 2017 annual report on Form 10-K of National Research Corporation.

/s/ KPMG LLP

Lincoln, Nebraska

March 14, 2018

EX-31.1 4 ex_107096.htm EXHIBIT 31.1 ex_107096.htm

Exhibit 31.1

Certification of Chief Executive Officer

Pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934

I, Michael D. Hays, certify that:

1.	I have reviewed this Annual Report on Form 10-K of National Research Corporation;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiary, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 14, 2018

/s/ Michael D. Hays

Michael D. Hays

Chief Executive Officer

EX-31.2 5 ex_107097.htm EXHIBIT 31.2 ex_107097.htm

Exhibit 31.2

Certification of Chief Financial Officer

Pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934

I, Kevin R. Karas, certify that:

1.	I have reviewed this Annual Report on Form 10-K of National Research Corporation;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(a)

(b)

(c)

(d)

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 14, 2018

/s/ Kevin R. Karas

Kevin R. Karas

Chief Financial Officer

EX-32 6 ex_107098.htm EXHIBIT 32 ex_107098.htm

Exhibit 32

Certification Pursuant to 18 U.S.C. Section 1350
as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the accompanying Annual Report on Form 10-K of National Research Corporation (the “Company”) for the year ended December 31, 2017 (the “Report”), I, Michael D. Hays, Chief Executive Officer of the Company, and I, Kevin R. Karas, Chief Financial Officer, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, based on my knowledge, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	/s/ Michael D. Hays
	Michael D. Hays
	Chief Executive Officer


	/s/ Kevin R. Karas
	Kevin R. Karas
	Chief Financial Officer

	Date: March 14, 2018

A signed original of this written statement required by Section 906 has been provided to National Research Corporation and will be retained by National Research Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 7 nrci-20171231.xml XBRL INSTANCE DOCUMENT false --12-31 FY 2017 2017-12-31 10-K 0000070487 3540857 20970575 Yes Accelerated Filer 458611975 National Research Corporation No No nrci 252000 2800000 40000000 15000000 15000000 0.157 706000 0.06 706000 504000 53.44 955000 1564000 441000 -2415000 151000 6000 93000 1759000 440000 755000 0.14 0.3333 0.0016667 19.59 -1900000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 54pt;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>) </div></div></div> </td> <td> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">Proposed Recapitalization</div></div></div></div> </td> </tr> </table> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 2017, </div>the Company<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">’s Board of Directors approved a recapitalization plan that will exchange each share of class B common stock for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> share of class A common stock plus <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$19.59</div> in cash, for total value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$53.44</div> per class B share. This proposed recapitalization plan replaces the proposed plan announced in <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> September 2017. </div></div></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 2017, </div>the Company entered into a commitment letter with First National Bank of Omaha, which expires on <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> April 30, 2018, </div>to provide a senior secured term loan of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$40</div> million, a delayed draw term loan facility of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$15</div> million and a senior secured revolving line of credit facility of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$15</div> million.</div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The proposed recapitalization is subject to closing of financing and approval by the holders of the Company<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">’s class A common stock, class B common stock and both classes of stock voting together as a group. The Company incurred expenses related to the proposed recapitalization of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.4</div> million in the year ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017, </div>which are included in selling and administrative expenses. These expenses include certain amounts reimbursed to Mr. Hays (see Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div>).</div></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div></div> 181000 73000 119000 P1Y <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 10%; margin-left: 36pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="width: 66%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; text-decoration: underline;">Year Ending <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">December 31,</div></div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Capital<br /> <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Leases</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Operating Leases</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">8</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">708</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">9</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">51</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">679</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">20<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">20</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">34</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">485</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">20<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">21</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">377</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">20<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">22</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">190</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total minimum lease payments</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">172</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Less: Amount representing interest</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Present value of minimum lease payments</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">158</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Less: Current maturities</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Capital lease obligations, net of current portion</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">87</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 5%; margin-left: 27pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="3" style="width: 42%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><br /> <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Useful Life </div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><br /> <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Gross</div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Accumulated Amortization</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><br /> <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Net</div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="3" style="width: 42%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In years)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Goodwill</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 2%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 4%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58,021</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58,021</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-amortizing intangible assets:</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 2%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Indefinite trade name</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 2%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 4%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,191</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,191</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Amortizing intangible assets:</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 2%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Customer related</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> 5</div></td> <td style="width: 2%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,347</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,611</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">736</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Technology</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 2%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></td> <td style="width: 4%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,360</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">523</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">837</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Trade names</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> 5</div></td> <td style="width: 2%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,572</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,572</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total amortizing intangible assets</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 2%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 4%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,279</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,706</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,573</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total intangible assets other than goodwill</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 2%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 4%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,470</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,706</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,764</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 5%; margin-left: 27pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="3" style="width: 42%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><br /> <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Useful Life </div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><br /> <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Gross</div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Accumulated Amortization</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><br /> <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Net</div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="3" style="width: 42%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In years)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Goodwill</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 2%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 4%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57,861</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57,861</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-amortizing intangible assets:</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 2%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Indefinite trade name</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 2%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 4%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,191</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,191</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Amortizing intangible assets:</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 2%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Customer related</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> 5</div></td> <td style="width: 2%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,331</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,164</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,167</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Technology</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 2%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></td> <td style="width: 4%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,110</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">344</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">766</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Trade names</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> 5</div></td> <td style="width: 2%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,572</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,572</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total amortizing intangible assets</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 2%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 4%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,013</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,080</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,933</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total intangible assets other than goodwill</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 2%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 4%; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,204</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,080</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,124</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div> 81677 13611 36000 6000 1683309 280552 2079000 346500 934535 154811 156610 487639 49262 58429 2455000 397000 406000 1300000 161000

593000

765000

13343000

10864000

662000

2882000

3069000

27847000

26084000

-1635000

-2626000

51025000

46725000

1383000

1929000

1845000

240000

1200000

964000

828000

629000

966000

555000

-465000

765000

878000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin: 0pt 2.5%; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; min-; min-width: 700px;"> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt; vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Balance at</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Beginning</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">of Year</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Bad Debt</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Expense</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Write-offs</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Net of</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Recoveries</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Balance</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">at End</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">of Year</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt; vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="14" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 48%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Year Ended December 31, 2015</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">206</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">111</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">144</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">173</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt; vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Year Ended December 31, 2016</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">173</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">218</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">222</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">169</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Year Ended December 31, 2017</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">169</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">249</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">218</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">200</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

206000

173000

169000

200000

169000

144000

222000

218000

610000

654000

995000

104647

390300

68779

1858

34178

1101

127316000

120624000

110785000

106288000

115480000

16531000

14336000

12569000

128049000

52259000

47065000

72562000

71192000

70624000

2495000

2367000

2364000

75057000

73559000

72988000

1700000

71000

82000

74000

109000

32000

87000

843000

769000

843000

769000

159000

239000

172000

80000

1000

6000

34000

51000

14000

158000

684000

530000

3000000

2500000

33021000

42145000

40042000

34733000

13971000

10490000

10017000

13971000

20507000

34478000

11200000

21450000

11200000

21450000

32650000

1712000

-9124000

2103000

34500000

32700000

0.62

3.72

0.34

2.04

0.40

2.40

0.001

60000000

80000000

25835230

25656760

4319256

4308875

20936703

20891069

3535238

3539931

26000

4000

23934000

20887000

15388000

538000

10947000

8930000

9955000

387000

409000

455000

837000

634000

680000

0.021

11800000

0.0312

212468

-1596000

847000

-1232000

704000

-18000

-23000

-684000

798000

-1387000

6228000

7997000

16878000

15497000

61000

36000

-85000

2733000

3327000

2198000

3327000

166000

244000

535000

113000

84000

1457000

2357000

416000

580000

46000

62000

535000

4030000

4670000

4497000

6521000

4030000

4670000

169000

270000

856000

1206000

350000

291000

330000

0.25

0.2

4000000

3600000

3100000

4586000

4225000

4109000

49068000

45577000

44610000

1100000

223000

1102000

25983000

14324000

16876000

4222000

4213000

0.54

0.49

0.42

3.26

2.93

2.52

0.52

0.48

0.41

3.18

2.88

2.49

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Earnings Per Share</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Net income per share of class A common stock and class B common stock is computed using the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div>-class method. Basic net income per share is computed by allocating undistributed earnings to common shares and using the weighted-average number of common shares outstanding during the period.</div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Diluted net income per share is computed using the weighted-average number of common shares and, if dilutive, the potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and vesting of restricted stock. The dilutive effect of outstanding stock options is reflected in diluted earnings per share by application of the treasury stock method.</div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The liquidation rights and the rights upon the consummation of an extraordinary transaction are the same for the holders of class A common stock and class B common stock. Other than share distributions and liquidation rights, the amount of any dividend or other distribution payable on each share of class A common stock will be equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">sixth</div> (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1/6</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; bottom:.33em; font-size: 82%; position: relative; vertical-align: baseline;">th</div>) of the amount of any such dividend or other distribution payable on each share of class B common stock. As a result, the undistributed earnings for each year are allocated based on the contractual participation rights of the class A and class B common stock as if the earnings for the year had been distributed.</div></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">At <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">156,610</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">487,639</div> options of class A shares and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">49,262,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58,429</div> options of class B shares, respectively, which have been excluded from the diluted net income per share computation because the exercise price exceeds the fair market value. At <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> an additional <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">104,647,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">390,300,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">68,779</div> options of class A shares and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,858,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">34,178,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,101</div> options of class B shares, respectively were excluded as their inclusion would be anti-dilutive.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"></div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; min-width: 700px;"> <tr> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" rowspan="1" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">2017</td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" rowspan="1" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">2016</td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" rowspan="1" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">2015</td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class A<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class B</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class A</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class B</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class A</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class B</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="22" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands, except per share data)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 28%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Numerato<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">r for net income per share - basic:</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Net income</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,388</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,555</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,178</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,341</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,759</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,851</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Allocation of distributed and undistributed income to unvested restricted stock shareholders</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(88</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(87</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(88</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(88</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(76</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(77</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Net income attributable to common shareholders</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,300</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,468</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,090</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,253</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,683</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,774</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Denominator for net income per <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">share - basic: </div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Weighted average common shares outstanding - basic</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,770</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,514</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,713</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,505</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,741</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,478</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Net income per share - basic</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.54</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.26</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.49</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.93</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.42</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.52</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Numerator for net income per share - diluted:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Net income attributable to common shareholders for<br /> <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">basic computation</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,300</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,468</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,090</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,253</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,683</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,774</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Denominator for net income per share - diluted:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Weighted average common <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> s</div>hares outstanding - basic </div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,770</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,514</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,713</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,505</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,741</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,478</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Weighted average effect of dilutive securities <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">– stock options:</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">857</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">89</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">324</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">55</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">240</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Denominator for diluted earnings per share <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">– adjusted weighted average shares</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,627</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,603</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,037</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,560</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,981</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,522</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income per share - diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.52</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.18</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.48</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.88</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.41</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.49</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table> </div></div></div></div></div>

855000

285000

-1588000

0.35

0.21

6597000

4543000

1200000

152000

806000

P2Y193D

P2Y208D

P2Y197D

2310000

1164000

505000

1100000

398000

183000

300000

240000

-25000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 2.5%; margin-left: 2.5%; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="width: 64%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">December 31,<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> 2017 </div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">December 31, 201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">6</div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 64%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="width: 115111%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 64%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total carrying amount of long-term debt</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,067</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,540</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 64%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Estimated fair value of long-term debt</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,066</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,533</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

9351000

9777000

8723000

P5Y

P15Y

P7Y

P5Y

P10Y

P5Y

P15Y

P7Y

P5Y

P10Y

8611000

523000

1572000

10706000

8164000

344000

1572000

10080000

662000

39000

180000

318000

374000

9347000

1360000

1572000

12279000

9331000

1110000

1572000

12013000

736000

837000

1573000

1167000

766000

1933000

1091000

391000

432000

-26000

-22000

57792000

57861000

58021000

69000

160000

32750000

29848000

25536000

34283000

31356000

27360000

1533000

1508000

1824000

34283000

31356000

27360000

4000

77000

156000

11340000

10838000

9750000

535000

-131000

-129000

-139000

11999000

10975000

9576000

122000

156000

-21000

608000

436000

391000

130000

165000

150000

12827000

9963000

9377000

375000

14000

12000

-15000

-224000

2463000

1044000

1777000

1351000

643000

397000

-1023000

105000

1504000

565000

535000

-207000

-123000

93000

390000

857000

89000

324000

55000

240000

44000

1191000

13470000

13204000

2764000

3124000

82000

190000

220000

76000

192000

207000

10000

14000

96000

47000

60000

37275000

37818000

127316000

120624000

32310000

31514000

12000000

1067000

3540000

1067000

3540000

1067000

2683000

1066000

3533000

857000

2789000

252000

0.11

-21116000

-32502000

-16869000

-6118000

-3750000

-1326000

28091000

26843000

21886000

22943000

20518000

17610000

20518000

22943000

11388000

11555000

10178000

10341000

8759000

8851000

11300000

11468000

10090000

10253000

8683000

8774000

2700000

64000

159000

913000

1067000

2683000

83340000

78187000

75896000

34219000

31197000

26447000

3000000

708000

190000

377000

485000

679000

869000

920000

1000000

35000

1913000

768000

-2222000

369000

991000

369000

-2222000

935000

777000

50000

302000

1073000

657000

88000

87000

88000

76000

77000

1673000

16867000

28552000

10054000

1668000

204000

92000

250000

1300000

4568000

3973000

2939000

2800000

1000000

2000000

2789000

0.01

2000000

2310000

1585000

191000

1600000

223000

1613000

548000

5064000

4737000

2721000

2750000

22569000

20592000

9386000

41000

425000

40206000

37890000

12359000

11806000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 10%; margin-left: 27pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">7</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">6</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands)</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 66%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Furniture and equipment</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,064</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,737</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Computer equipment</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,721</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,750</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Computer software</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22,569</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,592</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Building</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,386</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,386</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Leaseholds</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Land</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">425</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">425</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Property and equipment at cost</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,206</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37,890</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Less accumulated depreciation and amortization</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27,847</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26,084</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net property and equipment</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,359</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,806</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

P3Y

P10Y

P3Y

P5Y

P1Y

P5Y

P7Y

P40Y

111000

218000

249000

1400000

248000

232000

227000

12500

488000

440000

108000

95000

173000

2473000

2199000

2328000

77574000

71507000

633000

28000

117559000

109384000

102343000

112885000

104445000

97097000

4674000

4939000

5246000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 10%; margin-left: 27pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">2017</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">2016</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 66%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Furniture and equipment</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">843</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">769</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Property and equipment under capital lease, gross</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">843</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">769</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Less accumulated amortization</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">684</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">530</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net assets under capital lease</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">159</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">239</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 5%; margin-left: 5%; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">7</div></td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">6</div></td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">5</div></td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td colspan="10" style="text-align: center;">(In thousands)</td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; text-decoration: underline;">Federal<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">:</div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Current</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,947</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,930</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,955</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Deferred</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,596</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">847</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,232</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,351</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,777</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,723</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; text-decoration: underline;">Foreign</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">:</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Current</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">387</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">409</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">455</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Deferred</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">704</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(18</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(23</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,091</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">391</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">432</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; text-decoration: underline;">State</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">:</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Current</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">837</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">634</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">680</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Deferred</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">61</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(85</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">898</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">670</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">595</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,340</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,838</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,750</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 10%; margin-left: 18pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">2<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">017</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">20<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">16</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt 7.5pt 0pt 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 66%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Revolving credit note with U.S. Bank, maximum available $12.0 million, matures June 30, 2018</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Note payable to U.S. Bank for $11.8 million, interest at a 3.12% fixed rate, monthly principal and interest payments of $212,468 through April 2018</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 3pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,067</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 3pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,540</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total notes payable</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,067</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,540</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Less current portion</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,067</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,683</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Note payable, net of current portion</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">857</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 10%; margin-left: 10%; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 47.85pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">2017</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 35.35pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">2016</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 35.35pt;"> <div style=" margin: 0pt 10.3pt 0pt 35.35pt; text-align: center; text-indent: -35.35pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 62%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Deferred tax assets:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Allowance for doubtful accounts</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">62</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Accrued expenses</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">416</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">580</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Share based compensation</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,457</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,357</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Accrued bonuses</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">113</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">84</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Foreign tax credit <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">from repatriation</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 9.95pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">535</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 9.95pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Other</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">166</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">244</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt;">Gross deferred tax assets</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,733</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,327</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Less Valuation Allowance</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(535</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Deferred Tax Assets</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,198</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,327</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>Deferred tax liabilities:</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Prepaid expenses</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">169</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">270</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Property and equipment</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">856</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,206</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Intangible assets</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,497</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 44.95pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,521</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Repatriation withholding</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">706</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt;">Deferred tax liabilities</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,228</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,997</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt;">Net deferred tax liabilities</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4,030</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4,670</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; min-; min-width: 700px;"> <tr> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" rowspan="1" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">2017</td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" rowspan="1" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">2016</td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" rowspan="1" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">2015</td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class A<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class B</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class A</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class B</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class A</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class B</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="22" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands, except per share data)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 28%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Numerato<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">r for net income per share - basic:</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Net income</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,388</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,555</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,178</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,341</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,759</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,851</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Allocation of distributed and undistributed income to unvested restricted stock shareholders</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(88</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(87</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(88</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(88</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(76</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(77</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Net income attributable to common shareholders</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,300</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,468</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,090</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,253</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,683</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,774</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Denominator for net income per <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">share - basic: </div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Weighted average common shares outstanding - basic</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,770</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,514</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,713</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,505</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,741</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,478</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Net income per share - basic</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.54</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.26</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.49</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.93</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.42</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.52</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Numerator for net income per share - diluted:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Net income attributable to common shareholders for<br /> <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">basic computation</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,300</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,468</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,090</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,253</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,683</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,774</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Denominator for net income per share - diluted:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Weighted average common <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> s</div>hares outstanding - basic </div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,770</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,514</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,713</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,505</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,741</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,478</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Weighted average effect of dilutive securities <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">– stock options:</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">857</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">89</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">324</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">55</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">240</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Denominator for diluted earnings per share <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">– adjusted weighted average shares</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,627</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,603</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,037</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,560</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,981</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,522</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income per share - diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.52</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.18</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.48</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.88</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.41</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.49</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 10%; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">20<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">17</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">20<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">16</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">20<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">15</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">In thousands)</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Expected federal income taxes</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,999</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,975</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,576</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Foreign tax rate differential</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(131</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(129</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(139</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">State income taxes, net of federal benefit and state tax credits</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">608</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">436</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">391</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Federal tax<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> credits</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(130</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(165</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(150</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Uncertain tax positions</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">151</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">93</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Nondeductible expenses related to <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">proposed recapitalization</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">504</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Share based compensation</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,564</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(441</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Compensation limit for covered employees</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">955</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Impact of<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> 2017 Tax Act</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,415</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Valuation allowance</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">535</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Withholding tax on repatriation<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> of foreign earnings</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">706</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">122</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">156</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(21</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Total</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,340</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,838</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,750</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 2.5%; margin-left: 2.5%; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">20<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">17</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">20<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">16</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">20<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">15</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 52%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Amounts charged against income, before income tax benefit</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,845</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,929</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,383</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Amount of related income tax benefit</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,310</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,164</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(505</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net (benefit) expense<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> to net income</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(465</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">765</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">878</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 2.5%; margin-left: 2.5%; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Level 1</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Level 2</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Level 3</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Total</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td colspan="14" style="text-align: center;">(In thousands)</td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 48%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; text-decoration: underline;">As of December 31, 201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">7</div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="padding-left: 0pt;">Money Market Funds</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,971</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,971</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>Commercial Paper</td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 10%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,490</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 10%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 10%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,490</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>Eurodollar Deposits</td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,017</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,017</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="padding-left: 9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Total<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> Cash Equivalents</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,971</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,507</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">34,478</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; text-decoration: underline;">As of December 31, 201</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; text-decoration: underline;">6</div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>Money Market Funds</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,200</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,200</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>Commercial Paper</td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,450</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,450</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="padding-left: 9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Total<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> Cash Equivalents</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,200</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,450</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32,650</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 10%; margin-left: 10%; min-; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 81%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of December 31, 201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">5</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 17.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 17.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57,792</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Foreign currency translation</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 17.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">69</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of December 31, 201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">6</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 17.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 17.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57,861</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Foreign currency translation</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 17.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">160</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of December 31, 201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">7</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 17.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 17.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58,021</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 5%; margin-left: 5%; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 47.85pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">7</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 47.85pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">20<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">16</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 40.5pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">5</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 49%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">U.S. Operations</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32,750</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29,848</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25,536</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Foreign Operations</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,533</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,508</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,824</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Income before income taxes</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">34,283</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,356</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27,360</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 10%; margin-left: 10%; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">7</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">6</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">20<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">15</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; text-indent: 36pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 43%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Revenue:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">United States</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 3.6pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 3.6pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">112,885</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 3.6pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 3.6pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">104,445</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">97,097</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Canada</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,674</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,939</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,246</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt;">Total</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">117,559</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">109,384</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">102,343</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Long-lived assets:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">United States</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">72,562</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71,192</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">70,624</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Canada</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,495</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,367</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,364</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt;">Total</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">75,057</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">73,559</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">72,988</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total assets:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">United States</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">110,785</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">106,288</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115,480</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Canada</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16,531</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,336</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,569</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt;">Total</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">127,316</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">120,624</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 8.1pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">128,049</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 10%; margin-left: 9pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Number of<br /> <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Options</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Weighted</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Average</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Exercise</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Price</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Weighted</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Average</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Remaining Contractual</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Terms (Years)</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Aggregate</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Intrinsic</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Value</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands)</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 44%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; text-decoration: underline;">Class A</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at December 31, 201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">6</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,705,483</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12.31</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">299,917</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22.13</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(197,784</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10.55</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,681</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Forfeited</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(60,982</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21.35</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">December 31, 2017</div></div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,746,634</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13.88</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.39</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,901</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercisable at <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">December 31, 2017</div></div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,274,361</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12.14</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.32</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32,060</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; text-decoration: underline;">Class B</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at December 31, 201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">6 </div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250,493</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29.70</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">49,986</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">42.90</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(13,600</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27.04</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">202</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Forfeited</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(10,163</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41.53</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">December 31, 2017</div></div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">276,716</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31.78</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.52</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,719</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercisable at <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">December 31, 2017</div></div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">198,950</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29.16</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.44</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,353</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 5%; margin-left: 18pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">2<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">017</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">2016</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">2015</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class A</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class B</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class A</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class B</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class A</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class B</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 22%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Expected dividend yield at date of grant</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.62</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.06</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.99</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.29</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.22</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.48</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Expected stock price volatility</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32.45</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26.75</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32.74</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29.41</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31.97</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31.17</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Risk-free interest rate</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.18</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.18</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.69</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.69</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.58</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.60</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Expected life of options (in years)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.80</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.80</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.86</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.86</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.49</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.62</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 10%; margin-left: 10%; min-; min-width: 700px;"> <tr> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 16%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; text-decoration: underline;">(In thousands)</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt 13.95pt 0pt 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Balance of unrecognized tax benefits at December 31, 2015</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">589</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt 13.95pt 0pt 9pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Reductions due to lapse of applicable statute of limitations</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(148</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt 13.95pt 0pt 9pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Additions based on tax positions of prior years</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 11pt;"> <div style=" margin: 0pt 13.95pt 0pt 20pt; text-align: left; text-indent: -11pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Additions based on tax positions related to the current year</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">216</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt 13.95pt 0pt 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Balance of unrecognized tax benefits at December 31, 2016</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">662</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt 13.95pt 0pt 9pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Reductions due to lapse of applicable statute of limitations</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt 13.95pt 0pt 9pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Reductions due to tax positions of prior years</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(7</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 11pt;"> <div style=" margin: 0pt 13.95pt 0pt 20pt; text-align: left; text-indent: -11pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Additions based on tax positions related to the current year</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">188</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt 13.95pt 0pt 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Balance of unrecognized tax benefits at December 31, 2017</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">843</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

29686000

28385000

27177000

1845000

1929000

1383000

P1Y

P5Y

P1Y

P5Y

19314

3219

14.27

34.69

174487

29081

81677

13611

13.93

37.21

13.80

36.65

73506

12251

13.99

38.50

0.0262

0.0806

0.0299

0.0729

0.0222

0.0548

0.3245

0.2675

0.3274

0.2941

0.3197

0.3117

0.0218

0.0169

0.0158

0.016

1800000

300000

3000000

500000

1800000

300000

921000

153500

865465

145189

1274361

198950

12.14

29.16

2681000

202000

459000

632000

350000

151000

60982

10163

21.35

41.53

299917

49986

315620

52603

261306

43551

5.83

3.66

3.62

3.90

3.49

5.45

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 5%; margin-left: 9pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">2<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">017</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">2016</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">2015</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class A</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class B</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class A</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class B</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class A</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class B</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 22%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Weighted average grant date fair value of stock options granted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.83</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.66</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.62</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.90</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.49</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.45</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Intrinsic value of stock options exercised (in thousands)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,681</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">202</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">459</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">632</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">151</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Intrinsic value of stock options vested (in thousands)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,258</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">787</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,627</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">535</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,351</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">415</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

40901000

6719000

1705483

1746634

250493

276716

12.31

13.88

29.70

31.78

10.55

27.04

22.13

42.90

P5Y

P10Y

P3Y

P5Y

P10Y

P6Y292D

P6Y313D

P5Y178D

P5Y226D

32060000

5353000

P4Y116D

P4Y160D

P5Y142D

P5Y189D

5258000

787000

1627000

535000

1351000

415000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 81pt;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>)<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div></div></div> </td> <td> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">Summary of Significant Accounting Policies</div></div></div></div> </td> </tr> </table> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Description of Business and Basis of Presentation</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">National Research Corporation<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">, doing business as NRC Health (“NRC Health,” the “Company,” “we,” “our,” “us” or similar terms), is a leading provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers and other healthcare organizations in the United States and Canada. The Company’s solutions enable its clients to understand the voice of the customer with greater clarity, immediacy and depth. </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Principles of Consolidation</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The consolidated financial statements include the accounts of the Company<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> and its wholly-owned subsidiary, National Research Corporation Canada. Prior to becoming a wholly-owned subsidiary in <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> March 2016, </div>the accounts of Customer-Connect LLC (“Connect”), then a variable interest entity for which NRC Health was deemed the primary beneficiary, were included in the consolidated financial statements of the Company. On <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> June 30, 2016, </div>Customer-Connect LLC was dissolved. All significant intercompany transactions and balances have been eliminated.</div></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><br /> <div style="display: inline; font-weight: bold;"><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Use of Estimates</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Translation of Foreign Currencies</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The Company<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">’s Canadian subsidiary uses as its functional currency the local currency of the country in which it operates. It translates its assets and liabilities into U.S. dollars at the exchange rate in effect at the balance sheet date. It translates its revenue and expenses at the average exchange rate during the period. The Company includes translation gains and losses in accumulated other comprehensive income (loss), a component of shareholders’ equity. Gains and losses related to transactions denominated in a currency other than the functional currency of the country in which the Company operates and short-term intercompany accounts are included in other income (expense) in the consolidated statements of income. </div></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><br /> <div style="display: inline; font-weight: bold;"><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Revenue Recognition</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The Company derives a majority of its operating revenue from its annually renewable services, which include performance measurement and improvement services, healthcare analytics and governance education services. The Company provides these services to its clients under annual client service contracts, although such contracts are generally cancelable <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">on short or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> notice without penalty. Services are provided under subscription-based service agreements. The Company recognizes subscription-based service revenue over the period of time the service is provided. Generally, the subscription periods are for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> months and revenue is recognized equally over the subscription period.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Certain contracts<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">, excluding subscription-based service agreements, are fixed-fee arrangements with a portion of the project fee billed in advance and the remainder billed periodically over the duration of the project. Revenue for services provided under these contracts are recognized under the proportional performance method. Under the proportional performance method, the Company recognizes revenue based on output measures or key milestones such as survey set-up, survey mailings, survey returns and reporting. The Company measures its progress based on the level of completion of these output measures and recognizes revenue accordingly. Management judgments and estimates must be made and used in connection with revenue recognized using the proportional performance method. If management made different judgments and estimates, then the amount and timing of revenue for any period could differ materially from the reported revenue.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The Company<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">’s revenue arrangements with a client <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> may </div>include combinations of NRC Health’s Experience, Transparency, Governance, and Market Insights solutions which <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> may </div>be executed at the same time, or within close proximity of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> another (referred to as a multiple-element arrangement). When the periods or patterns of revenue recognition differ, each element of a multiple-element arrangement is accounted for as a separate unit of accounting provided each delivered element is sold separately by the Company or another vendor; and for an arrangement that includes a general right of return relative to the undelivered elements, delivery or performance of the undelivered services are considered probable and substantially in the control of the Company. The Company’s arrangements generally do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include a general right of return related to the delivered services. If these criteria are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> met, the arrangement is accounted for as a single unit of accounting with revenue generally recognized equally over the subscription period or recognized under the proportional performance method.</div></div> <div style=" text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><br /> <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">When a contract contains multiple elements, revenue is allocated to each separate unit of accounting based on relative selling price using a selling price hierarchy: vendor-specific objective evidence (“VSOE”), if available, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div>-party evidence (“TPE”) if VSOE is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> available, or estimated selling price if VSOE nor TPE is available. VSOE is established based on the services normal selling price and discounts for the specific services when sold separately. TPE is established by evaluating similar competitor services in standalone arrangements. If neither exists for a deliverable, the best estimate of the selling price (“ESP”) is used for that deliverable based on list price, representing a component of management’s market strategy, and an analysis of historical prices for bundled and standalone arrangements. Revenue allocated to an element is limited to revenue that is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> subject to refund or otherwise represents contingent revenue. VSOE, TPE and ESP are periodically adjusted to reflect current market conditions. These adjustments are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expected to differ significantly from historical results.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Business Combinations</div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The Company uses the acquisition method of accounting for acquired businesses. Under the acquisition method, the financial statements reflect the operations of an acquired business starting from the completion of the acquisition. The assets acquired and liabilities assumed are recorded at their respective estimated fair values at the date of the acquisition. Any excess of the purchase price over the<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> estimated fair values of the identifiable net assets acquired is recorded as goodwill. Significant judgment is required in estimating the fair value of assets acquired, especially intangible assets. As a result, in the case of significant acquisitions the Company typically engages <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div>-party valuation specialists in estimating fair values of tangible and intangible assets. The fair value estimates are based on available historical information and on expectations and assumptions about the future, considering the perspective of marketplace participants. </div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Trade Accounts Receivable</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Trade accounts receivable are recorded at the invoiced amount. The allowance for doubtful accounts is the Company<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">’s best estimate of the amount of probable credit losses in the Company’s existing accounts receivable. The Company determines the allowance based on the Company’s historical write-off experience and current economic conditions. The Company reviews the allowance for doubtful accounts monthly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The following table provides the activity in the allowance for doubtful accounts for the years ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015:</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin: 0pt 2.5%; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; min-width: 700px;"> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt; vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Balance at</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Beginning</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">of Year</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Bad Debt</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Expense</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Write-offs</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Net of</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Recoveries</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Balance</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">at End</div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">of Year</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt; vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="14" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 48%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Year Ended December 31, 2015</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">206</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">111</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">144</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">173</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt; vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Year Ended December 31, 2016</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">173</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">218</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">222</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">169</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="font-family: "Times New Roman", Times, serif; font-size: 10pt; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Year Ended December 31, 2017</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">169</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">249</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">218</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">200</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Property and Equipment</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Property and equipment is stated at cost. Major expenditures to purchase property or to substantially increase useful lives of property are capitalized. Maintenance, repairs and minor renewals are expensed as incurred. When assets are retired or otherwise disposed of, their costs and related accumulated depreciation are removed from the accounts and resulting gains or losses are included in income.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The Company capitalizes certain costs incurred in connection with obtaining or developing internal-use software, including payroll and payroll-related costs for employees who are directly associated with the internal-use software projects and external direct costs of materials and services. Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose. Costs incurred during the preliminary project and post-implementation stages, as well as software maintenance and training costs are expensed as incurred. <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> The Company capitalized approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.0</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.5</div> million of costs incurred for the development of internal-use software for the years ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively. </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">T<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">he Company provides for depreciation and amortization of property and equipment using annual rates which are sufficient to amortize the cost of depreciable assets over their estimated useful lives. The Company uses the straight-line method of depreciation and amortization over estimated useful lives of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> years for furniture and equipment, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years for computer equipment, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years for capitalized software, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">forty</div> years for the Company’s office building and related improvements. </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Leases are categorized as operating or capital at the inception of the lease. Assets under capital lease obligations are reported at the lower of fair value or the present value of the aggregate future minimum lease payments at the beginning of the lease term. The Company depreciates capital lease assets<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> without transfer-of-ownership or bargain-purchase-options using the straight-line method over the lease terms, excluding any lease renewals, unless the lease renewals are reasonably assured. Capital lease assets with transfer-of-ownership or bargain-purchase-options are depreciated using the straight-line method over the assets’ estimated useful lives.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Impairment of Long-L<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">ived Assets and Amortizing Intangible Assets</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Long-lived<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> assets, such as property and equipment and purchased intangible assets subject to depreciation or amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, the Company <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div>-party independent appraisals, as considered necessary. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div></div></div> impairments were recorded during the years ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Among others, m<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">anagement believes the following circumstances are important indicators of potential impairment of such assets and as a result <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> may </div>trigger an impairment review:</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <table border="0" cellpadding="0" cellspacing="0" style="; font-family: "Times New Roman", Times, serif; font-size: 10pt; min-width: 700px;"> <tr> <td style="width: 22pt;"> </td> <td style="width: 18pt; vertical-align: top;"> <div style=" text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 36pt; margin-bottom: 0pt;">●</div> </td> <td style="vertical-align: top;"> <div style=" text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 36pt; margin-bottom: 0pt;">Significant underperformance in comparison to historical or projected operating results;</div> </td> </tr> </table> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <table border="0" cellpadding="0" cellspacing="0" style="; font-family: "Times New Roman", Times, serif; font-size: 10pt; min-width: 700px;"> <tr> <td style="width: 22pt;"> </td> <td style="width: 18pt; vertical-align: top;"> <div style=" text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 36pt; margin-bottom: 0pt;">●</div> </td> <td style="vertical-align: top;"> <div style=" text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 36pt; margin-bottom: 0pt;">Significant changes in the manner or use of acquired assets or the Company<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">’s overall strategy;</div></div> </td> </tr> </table> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <table border="0" cellpadding="0" cellspacing="0" style="; font-family: "Times New Roman", Times, serif; font-size: 10pt; min-width: 700px;"> <tr> <td style="width: 22pt;"> </td> <td style="width: 18pt; vertical-align: top;"> <div style=" text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 36pt; margin-bottom: 0pt;">●</div> </td> <td style="vertical-align: top;"> <div style=" text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 36pt; margin-bottom: 0pt;">Significant negative trends in the Company<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">’s industry or the overall economy;</div></div> </td> </tr> </table> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <table border="0" cellpadding="0" cellspacing="0" style="; font-family: "Times New Roman", Times, serif; font-size: 10pt; min-width: 700px;"> <tr> <td style="width: 22pt;"> </td> <td style="width: 18pt; vertical-align: top;"> <div style=" text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 36pt; margin-bottom: 0pt;">●</div> </td> <td style="vertical-align: top;"> <div style=" text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 36pt; margin-bottom: 0pt;">A significant decline in the market price for the Company<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">’s common stock for a sustained period; and</div></div> </td> </tr> </table> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <table border="0" cellpadding="0" cellspacing="0" style="; font-family: "Times New Roman", Times, serif; font-size: 10pt; min-width: 700px;"> <tr> <td style="width: 22pt;"> </td> <td style="width: 18pt; vertical-align: top;"> <div style=" text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 36pt; margin-bottom: 0pt;">●</div> </td> <td style="vertical-align: top;"> <div style=" text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 36pt; margin-bottom: 0pt;">The Company<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">’s market capitalization falling below the book value of the Company’s net assets.</div></div> </td> </tr> </table> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Goodwill and <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Intangible Assets</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Intangible assets include customer relationships, trade names, <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">technology, non-compete agreements and goodwill. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recoverable. The Company reviews intangible assets with indefinite lives for impairment annually as of <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> October 1 </div>and whenever events or changes in circumstances indicate that the carrying value of an asset <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recoverable. </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">When performing the impairment assessment, the Company will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> assess qualitative factors to determine whether it is necessary to recalculate the fair value of the intangible assets with indefinite lives. If the Company believes, as a result of the qualitative assessment, that it is more likely than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> that the fair value of the indefinite<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">-lived intangibles is less than their carrying amount, the Company calculates the fair value using a market or income approach. If the carrying value of intangible assets with indefinite lives exceeds their fair value, then the intangible assets are written-down to their fair values. The Company did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div></div></div> recognize any impairments related to indefinite-lived intangibles during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> individually identified and separately recognized. All of the Company<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">’s goodwill is allocated to its reporting units, which are the same as its operating segments. Goodwill is reviewed for impairment at least annually, as of <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> October 1, </div>and whenever events or changes in circumstances indicate that the carrying value of goodwill <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recoverable. </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> January 2017, </div>the FASB issued A<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">ccounting Standards Update (“ASU”) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">04,</div> <div style="display: inline; font-style: italic;">Intangibles—Goodwill and Other</div> (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350</div>), <div style="display: inline; font-style: italic;">Simplifying the Test for Goodwill Impairment</div> (“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">04”</div>). In connection with the <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> October 1, 2017 </div>annual impairment analysis, the Company early adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">04,</div> which eliminates the need to determine the fair value of individual assets and liabilities of a reporting unit to measure goodwill impairment (Step <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>). The new guidance <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> may </div>result in more or less impairment than could previously be recognized. The adoption of this guidance did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> impact the Company's results of operations or financial position since only a qualitative analysis was performed as part of the <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> October 1, 2017 </div>annual impairment analysis.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The Company reviews for<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> goodwill impairment by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> assessing qualitative factors to determine whether any impairment <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> may </div>exist. If the Company believes, as a result of the qualitative assessment, that it is more likely than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> that the fair value of a reporting unit is less than its carrying amount, a quantitative analysis will be performed, and the fair value of the reporting unit is compared with its carrying value (including goodwill). If the fair value of the reporting unit exceeds its carrying value, then goodwill is written down by this difference. The Company performed a qualitative analysis as of <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> October 1, 2017 </div>and determined the fair value of each reporting unit likely significantly exceeded its carrying value. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div></div></div> impairments were recorded during the years ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Income Taxes</div></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The Company uses the asset and liability method of accounting for income taxes. Under that method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bas<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">is using enacted tax rates. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances, if any, are established when necessary to reduce deferred tax assets to the amount that is more likely than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> to be realized. The Company uses the deferral method of accounting for its investment tax credits related to state tax incentives. During the years ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company recorded income tax benefits relating to these tax credits of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,000,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$77,000,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$156,000,</div> respectively.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">T<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">he Company recognizes the effect of income tax positions only if those positions are more likely than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> of being sustained. Recognized income tax positions are measured at the largest amount that is greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50%</div> likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. </div></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Share-Based Compensation</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The compensation expense <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">on share-based payments is recognized based on the grant-date fair value of those awards. All of the Company’s existing stock option awards and non-vested stock awards have been determined to be equity-classified awards. The Company prospectively elected ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div><div style="display: inline; font-style: italic;"> Compensation – Stock Compensation (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div>) Improvements to Employee Share-Based Payment Accounting </div>(“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09”</div>) in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> As a result, the tax benefit from stock options exercised was recognized as a reduction to our provision for income taxes for the years ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> rather than as an increase to additional paid-in capital for the year ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2015 </div>prior to adoption.<br /> <br /> Amounts recognized in the financial statements with respect to these plans: </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 2.5%; margin-left: 2.5%; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">20<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">17</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">20<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">16</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">20<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">15</div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 52%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Amounts charged against income, before income tax benefit</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,845</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,929</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,383</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Amount of related income tax benefit</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,310</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,164</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(505</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net (benefit) expense<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> to net income</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(465</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">765</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">878</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><br /> <div style="display: inline; font-weight: bold;"><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Cash and Cash Equivalents</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">T<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">he Company considers all highly liquid investments with original maturities of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months or less to be cash equivalents. Cash equivalents were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$34.5</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$32.7</div> million as of <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017, </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively, consisting primarily of money market accounts, Eurodollar deposits and funds invested in commercial paper. At certain times, cash equivalent balances <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> may </div>exceed federally insured limits.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Reclassifications</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Reclassifications <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$191,000</div> have been made from noncurrent deferred income taxes to other noncurrent liabilities in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> consolidated balance sheet to present the unrecognized tax benefits related to state taxes gross of federal tax benefits, consistent with the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> financial statement presentation. There was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impact on the previously reported net income and earnings per share.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Fair Value <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Measurements</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The Company<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">’s valuation techniques are based on maximizing observable inputs and minimizing the use of unobservable inputs when measuring fair value. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect the Company’s market assumptions. The inputs are then classified into the following hierarchy: (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> Inputs—quoted prices in active markets for identical assets and liabilities; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> Inputs—observable market-based inputs other than Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> inputs, such as quoted prices for similar assets or liabilities in active markets, quoted prices for similar or identical assets or liabilities in markets that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> active, or other inputs that are observable or can be corroborated by observable market data; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>) Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> Inputs—unobservable inputs.</div></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Commercial paper<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> and Eurodollar deposits are included in cash equivalents and are valued at amortized cost, which approximates fair value due to its short-term nature. Eurodollar deposits are United States dollars deposited in a foreign bank branch of a United States bank and have daily liquidity. Both of these are included as a Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> measurement in the table below. </div></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><br /> <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The following details the Company’s financial assets within the fair value hierarchy at <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016:</div></div></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 2.5%; margin-left: 2.5%; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Level 1</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Level 2</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Level 3</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Total</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td colspan="14" style="text-align: center;">(In thousands)</td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 48%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; text-decoration: underline;">As of December 31, 201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">7</div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="padding-left: 0pt;">Money Market Funds</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,971</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,971</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>Commercial Paper</td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 10%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,490</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 10%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 10%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,490</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>Eurodollar Deposits</td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,017</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,017</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="padding-left: 9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Total<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> Cash Equivalents</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,971</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,507</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">34,478</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; text-decoration: underline;">As of December 31, 201</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; text-decoration: underline;">6</div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>Money Market Funds</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,200</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,200</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>Commercial Paper</td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,450</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,450</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="padding-left: 9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Total<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> Cash Equivalents</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,200</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,450</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">--</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32,650</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" margin: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> transfers between levels during the years ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">201</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The Company's long-term <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">debt described in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div> is recorded at historical cost. The fair value of long-term debt is classified in Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> of the fair value hierarchy and was estimated based primarily on estimated current rates available for debt of the same remaining duration and adjusted for nonperformance and credit. </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The following are the carrying a<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">mount and estimated fair values of long-term debt: </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-right: 2.5%; margin-left: 2.5%; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="width: 64%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">December 31,<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> 2017 </div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">December 31, 201<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">6</div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 64%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="width: 115111%; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 64%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total carrying amount of long-term debt</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,067</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,540</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 64%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Estimated fair value of long-term debt</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,066</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,533</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The carrying amounts of accounts receivable, accounts payable, and accrued expenses approximate their fair value. All non-financial assets that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> recognized or disclosed at fair value in the financial statements on a recurring basis, which includes <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">property and equipment, goodwill, intangibles and cost method investments, are measured at fair value in certain circumstances (for example, when there is evidence of impairment). As of <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> indication of impairment related to these assets.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">C<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">ontingencies</div></div><br /> <br /> <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">From time to time, the Company is involved in certain claims and litigation arising in the normal course of business. Management assesses the probability of loss for such contingencies and recognizes a liability when a loss is probable and estimable. </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Since the Septembe<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">r <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> announcement of the original proposed recapitalization plan (see Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div>), <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> purported class action and/or derivative complaints have been filed in state or federal courts by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> individuals claiming to be shareholders of the Company. All of the complaints name as defendants the Company and the individual directors of the Company. Two of these lawsuits were filed in the United States District Court for the District of Nebraska— a putative class action lawsuit captioned <div style="display: inline; font-style: italic;">Gennaro v. National Research Corporation, et al.</div>, and a putative class and derivative action lawsuit captioned <div style="display: inline; font-style: italic;">Gerson v. Hays, et al.</div>,. These lawsuits were consolidated by order of the federal court. A <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> lawsuit was filed the Circuit Court for Milwaukee County, Wisconsin—a putative class action lawsuit captioned <div style="display: inline; font-style: italic;">Apfel </div>v. <div style="display: inline; font-style: italic;">Hays, et al</div>. The allegations in all of the lawsuits are very similar. The plaintiffs allege, among other things, that the defendants breached their fiduciary duties in connection with the allegedly unfair proposed transaction, at an allegedly unfair price, conducted in an allegedly unfair and conflicted process and in alleged violation of Wisconsin law and the Company’s Articles of Incorporation. One of the lawsuits also alleges the proposed transactions is a voidable “conflict of interest transaction” under Wisconsin statutes. The plaintiffs in these lawsuits seek, among other things, an injunction enjoining the defendants from consummating the original proposed recapitalization plan, damages, equitable relief and an award of attorneys’ fees and costs of litigation. The Company believes that the allegations of the complaints are without merit and intends to defend these lawsuits vigorously. Despite the changes to the original proposed recapitalization plan that culminated in the <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 13, 2017 </div>announcement of a revised proposed recapitalization plan, the Company expects that these shareholders or other shareholders might assert similar claims regarding the proposed recapitalization plan. The Company will defend any such lawsuits vigorously.<div style="display: inline; font-weight: bold;"> </div>As of <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> losses have been accrued as the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe the losses are probable or estimable.</div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline;"></div>Earnings Per Share</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Net income per share of class A common stock and class B common stock is computed using the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div>-class method. Basic net income per share is computed by allocating undistributed earnings to common shares and using the weighted-average number of common shares outstanding during the period.</div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Diluted net income per share is computed using the weighted-average number of common shares and, if dilutive, the potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and vesting of restricted stock. The dilutive effect of outstanding stock options is reflected in diluted earnings per share by application of the treasury stock method.</div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The liquidation rights and the rights upon the consummation of an extraordinary transaction are the same for the holders of class A common stock and class B common stock. Other than share distributions and liquidation rights, the amount of any dividend or other distribution payable on each share of class A common stock will be equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">sixth</div> (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1/6</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; bottom:.33em; font-size: 82%; position: relative; vertical-align: baseline;">th</div>) of the amount of any such dividend or other distribution payable on each share of class B common stock. As a result, the undistributed earnings for each year are allocated based on the contractual participation rights of the class A and class B common stock as if the earnings for the year had been distributed.</div></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">At <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div><div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">156,610</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">487,639</div> options of class A shares and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">49,262,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58,429</div> options of class B shares, respectively, which have been excluded from the diluted net income per share computation because the exercise price exceeds the fair market value. At <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> an additional <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">104,647,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">390,300,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">68,779</div> options of class A shares and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,858,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">34,178,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,101</div> options of class B shares, respectively were excluded as their inclusion would be anti-dilutive.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"></div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; min-width: 700px;"> <tr> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" rowspan="1" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">2017</td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" rowspan="1" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">2016</td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" rowspan="1" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">2015</td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class A<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div></div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class B</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class A</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class B</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class A</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Class B</div> </td> <td style="padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="22" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(In thousands, except per share data)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 28%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Numerato<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">r for net income per share - basic:</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Net income</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,388</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,555</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,178</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,341</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,759</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,851</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Allocation of distributed and undistributed income to unvested restricted stock shareholders</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(88</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(87</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(88</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(88</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(76</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(77</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Net income attributable to common shareholders</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,300</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,468</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,090</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,253</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,683</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,774</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Denominator for net income per <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">share - basic: </div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Weighted average common shares outstanding - basic</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,770</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,514</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,713</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,505</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,741</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,478</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Net income per share - basic</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.54</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.26</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.49</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.93</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.42</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.52</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Numerator for net income per share - diluted:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Net income attributable to common shareholders for<br /> <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">basic computation</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,300</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,468</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,090</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,253</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,683</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,774</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Denominator for net income per share - diluted:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Weighted average common <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> s</div>hares outstanding - basic </div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,770</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,514</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,713</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,505</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,741</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,478</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Weighted average effect of dilutive securities <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">– stock options:</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">857</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">89</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">324</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">55</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">240</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" text-indent: -9pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Denominator for diluted earnings per share <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">– adjusted weighted average shares</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,627</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,603</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,037</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,560</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,981</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,522</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income per share - diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.52</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.18</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.48</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.88</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.41</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.49</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><br /> <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Recent Accounting Pronouncements <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Not</div> Yet Adopted </div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> May 2014, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Revenue from Contracts with Customers (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>) </div>(“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09”</div>). ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> will replace most existing revenue recognition guidance in accounting principles generally accepted in the United States when it becomes effective. The standard is effective for annual and interim reporting periods in fiscal years beginning after <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 15, 2017. </div>An entity <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> may </div>choose to adopt ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> either retrospectively or through a cumulative effect adjustment as of the start of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> period for which it applies the standard. The Company has completed system changes and is analyzing the resulting impact that this new guidance will have on its consolidated financial statements. The Company will adopt this new guidance using the modified retrospective approach beginning <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> January 1, 2018 </div>by recording a cumulative effect adjustment. The Company expects the most significant change to result from deferring direct and incremental costs of obtaining a contract, consisting of commissions and incentives, and recognizing the expense over the estimated life of the client contract, including renewal periods, rather than expensing as incurred, which is the Company’s current practice. The Company expects adjustments to retained earnings of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.7</div> million, net of related tax effects, upon adoption of deferring and amortizing direct and incremental contract costs. The Company also expects to record other immaterial adjustments, related to performance obligation determinations and estimating variable contingent consideration for certain contracts which were previously only recognized once the contingency was resolved and the services were performed. These amounts are only estimates and involve significant judgements by management including estimating the lives of its contracts, the value of performance deliverables and the expected amount to be earned from the satisfaction of those deliverables. The Company will finalize its calculation of the financial impact of the adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. </div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> January 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01,</div> Financial Instruments<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">—Overall: Recognition and Measurement of Financial Assets and Financial Liabilities. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01</div> changes certain recognition, measurement, presentation and disclosure aspects related to financial instruments. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01</div> is effective for financial statements issued for fiscal years beginning after <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 15, 2017, </div>and interim periods within those fiscal years. Early adoption is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> permitted. The Company believes its adoption will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> significantly impact the Company’s results of operations and financial position. </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> Leases (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>). This ASU requires lessees to recognize a lease liability and a right-to-use asset for all leases, including operating leases, with a term greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> months on its balance sheet. This ASU is effective in fiscal years beginning after <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 15, 2018, </div>with early adoption permitted, and requires a modified retrospective transition method. As of <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017, </div>the Company had approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.0</div> million of operating lease commitments which would be recorded on the balance sheet under the new guidance. However, the Company is currently in the process of further evaluating the impact that this new guidance will have on its consolidated financial statements and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> plan to elect early adoption.  </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> June 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,</div> Financial Instruments <div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">– Credit Losses (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">326</div>):  Measurement of Credit Losses on Financial Instruments.  This ASU will require the measurement of all expected credit losses for financial assets, including trade receivables, held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. The guidance is effective for annual reporting periods beginning after <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 15, 2019 </div>and interim periods within those fiscal years. The Company believes its adoption will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> significantly impact the Company’s results of operations and financial position.  </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> August 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>) Classification of Certain Cash Receipts and Cash Payments which eliminates the diversity in practice related to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> cash flow classification issues.<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">  This ASU is effective for the Company on <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> January 1, 2018 </div>with early adoption permitted.  The Company will adopt this ASU on <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> January 1, 2018 </div>and believes it will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> impact the Company’s results of operations and financial position.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> October 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16,</div> Intra-Entity Transfers of Asset Other Than Inventory (“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16”</div>), which requires entities to recognize the tax consequences of intercompany asset transfers other than inventory transfers in the period in which the transfer takes place. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16</div> is effective for fiscal years and interim periods within fiscal years beginning after <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 15, 2017. </div>ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16</div> is to be adopted using a modified retrospective approach with a cumulative effect adjustment to retained earnings as of the beginning of the period of adoption. The cumulative effect adjustment will include recognition of the income tax consequences of intra-entity transfers of assets other than inventory that occur before the adoption date.<div style="display: inline; font-family: "Times New Roman", Times, serif; font-size: 10pt;">  The Company believes the adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16</div> will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> impact the Company’s consolidated financial statements. </div></div></div>

898000

670000

595000

20578

89416

3430

14902

73168

12194

11565

1928

19314

3219

43983

7330

52383

35534

197784

13600

197784

13600

1000

-1000

406000

945000

2455000

25000

4000

44864000

73686000

-773000

-30058000

87748000

26000

4000

44103000

65313000

-2995000

-32229000

74222000

26000

4000

46725000

71507000

-2626000

-32830000

82806000

26000

4000

51025000

77574000

-1635000

-36953000

90041000

0.89

4898527

4765691

784018

768944

163268

4239

21047

7681

132836

15074

36953000

32830000

2171000

601000

4123000

1463000

1546000

843000

662000

589000

7000

216000

188000

5000

2000

148000

620000

472000

0.49

0.25

0.26

21627000

21037000

20981000

3603000

3560000

3522000

20770000

20713000

20741000

3514000

3505000

3478000

xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares 0000070487 nrci:IlluminateHealthLLCMember nrci:ConnectMember 2013-06-01 2013-06-30 0000070487 nrci:NGCustomerConnectLLCMember nrci:ConnectMember 2013-06-01 2013-06-30 0000070487 nrci:ConnectMember 2013-06-01 2013-06-30 0000070487 2015-01-01 2015-12-21 0000070487 2015-01-01 2015-12-31 0000070487 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2015-01-01 2015-12-31 0000070487 us-gaap:EmployeeStockOptionMember us-gaap:CommonClassAMember 2015-01-01 2015-12-31 0000070487 us-gaap:EmployeeStockOptionMember us-gaap:CommonClassBMember 2015-01-01 2015-12-31 0000070487 nrci:NonvestedMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2015-01-01 2015-12-31 0000070487 nrci:NonvestedMember nrci:The2006EquityIncentivePlanMember us-gaap:CommonClassAMember 2015-01-01 2015-12-31 0000070487 nrci:NonvestedMember nrci:The2006EquityIncentivePlanMember us-gaap:CommonClassBMember 2015-01-01 2015-12-31 0000070487 us-gaap:RestrictedStockMember 2015-01-01 2015-12-31 0000070487 nrci:ConnectMember 2015-01-01 2015-12-31 0000070487 nrci:IncludingAssetsHeldUnderCapitalLeaseMember 2015-01-01 2015-12-31 0000070487 nrci:AmeritasLifeInsuranceCorpMember 2015-01-01 2015-12-31 0000070487 nrci:NebraskaGlobalInvestmentCompanyLLCMember 2015-01-01 2015-12-31 0000070487 us-gaap:CommonClassAMember 2015-01-01 2015-12-31 0000070487 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2015-01-01 2015-12-31 0000070487 us-gaap:CommonClassBMember 2015-01-01 2015-12-31 0000070487 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2015-01-01 2015-12-31 0000070487 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-01-01 2015-12-31 0000070487 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-12-31 0000070487 us-gaap:RetainedEarningsMember 2015-01-01 2015-12-31 0000070487 us-gaap:TreasuryStockMember 2015-01-01 2015-12-31 0000070487 country:CA 2015-01-01 2015-12-31 0000070487 country:US 2015-01-01 2015-12-31 0000070487 nrci:ConnectMember 2015-07-01 2015-07-31 0000070487 us-gaap:DisposalGroupNotDiscontinuedOperationsMember nrci:PredictiveAnalyticsMember 2015-12-21 2015-12-21 0000070487 nrci:PredictiveAnalyticsMember us-gaap:OtherIncomeMember 2015-12-21 2015-12-21 0000070487 2015-12-22 2015-12-31 0000070487 2016-01-01 2016-12-31 0000070487 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-01-01 2016-12-31 0000070487 us-gaap:EmployeeStockOptionMember us-gaap:CommonClassAMember 2016-01-01 2016-12-31 0000070487 us-gaap:EmployeeStockOptionMember us-gaap:CommonClassBMember 2016-01-01 2016-12-31 0000070487 nrci:NonvestedMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-01-01 2016-12-31 0000070487 nrci:NonvestedMember nrci:The2006EquityIncentivePlanMember us-gaap:CommonClassAMember 2016-01-01 2016-12-31 0000070487 nrci:NonvestedMember nrci:The2006EquityIncentivePlanMember us-gaap:CommonClassBMember 2016-01-01 2016-12-31 0000070487 us-gaap:RestrictedStockMember 2016-01-01 2016-12-31 0000070487 nrci:ConnectMember 2016-01-01 2016-12-31 0000070487 nrci:TermNoteMember 2016-01-01 2016-12-31 0000070487 us-gaap:CustomerRelationshipsMember us-gaap:MaximumMember 2016-01-01 2016-12-31 0000070487 us-gaap:CustomerRelationshipsMember us-gaap:MinimumMember 2016-01-01 2016-12-31 0000070487 us-gaap:TechnologyBasedIntangibleAssetsMember 2016-01-01 2016-12-31 0000070487 us-gaap:TradeNamesMember us-gaap:MaximumMember 2016-01-01 2016-12-31 0000070487 us-gaap:TradeNamesMember us-gaap:MinimumMember 2016-01-01 2016-12-31 0000070487 nrci:IncludingAssetsHeldUnderCapitalLeaseMember 2016-01-01 2016-12-31 0000070487 nrci:AmeritasLifeInsuranceCorpMember 2016-01-01 2016-12-31 0000070487 nrci:NebraskaGlobalInvestmentCompanyLLCMember 2016-01-01 2016-12-31 0000070487 nrci:PracticingExcellencecomMember 2016-01-01 2016-12-31 0000070487 us-gaap:CommonClassAMember 2016-01-01 2016-12-31 0000070487 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2016-01-01 2016-12-31 0000070487 us-gaap:CommonClassBMember 2016-01-01 2016-12-31 0000070487 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2016-01-01 2016-12-31 0000070487 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-12-31 0000070487 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-12-31 0000070487 us-gaap:RetainedEarningsMember 2016-01-01 2016-12-31 0000070487 us-gaap:TreasuryStockMember 2016-01-01 2016-12-31 0000070487 country:CA 2016-01-01 2016-12-31 0000070487 country:US 2016-01-01 2016-12-31 0000070487 nrci:ConnectMember nrci:IlluminateHealthLLCMember 2016-03-07 2016-03-07 0000070487 nrci:ConnectMember nrci:IlluminateHealthLLCMember 2016-03-28 2016-03-28 0000070487 nrci:PredictiveAnalyticsMember 2016-12-01 2016-12-31 0000070487 2017-01-01 2017-12-31 0000070487 us-gaap:AccountingStandardsUpdate201409Member nrci:CapitalizedContractCostsMember 2017-01-01 2017-12-31 0000070487 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-12-31 0000070487 us-gaap:EmployeeStockOptionMember nrci:The2001EquityIncentivePlanMember us-gaap:MaximumMember 2017-01-01 2017-12-31 0000070487 us-gaap:EmployeeStockOptionMember nrci:The2001EquityIncentivePlanMember us-gaap:MinimumMember 2017-01-01 2017-12-31 0000070487 us-gaap:EmployeeStockOptionMember us-gaap:CommonClassAMember 2017-01-01 2017-12-31 0000070487 us-gaap:EmployeeStockOptionMember us-gaap:CommonClassBMember 2017-01-01 2017-12-31 0000070487 nrci:NonqualifiedStockOptionsMember nrci:DirectorPlan2004Member us-gaap:MaximumMember us-gaap:DirectorMember 2017-01-01 2017-12-31 0000070487 nrci:NonqualifiedStockOptionsMember nrci:DirectorPlan2004Member us-gaap:MinimumMember us-gaap:DirectorMember 2017-01-01 2017-12-31 0000070487 nrci:NonqualifiedStockOptionsMember nrci:DirectorPlan2004Member us-gaap:DirectorMember 2017-01-01 2017-12-31 0000070487 nrci:NonvestedMember 2017-01-01 2017-12-31 0000070487 nrci:NonvestedMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-12-31 0000070487 nrci:NonvestedMember nrci:The2006EquityIncentivePlanMember 2017-01-01 2017-12-31 0000070487 us-gaap:RestrictedStockMember 2017-01-01 2017-12-31 0000070487 nrci:December312016Member nrci:ReclassificationFromNoncurrentDeferredIncomeTaxesToOtherNoncurrentLiabilitiesMember 2017-01-01 2017-12-31 0000070487 us-gaap:RevolvingCreditFacilityMember nrci:OneMonthLiborMember 2017-01-01 2017-12-31 0000070487 us-gaap:RevolvingCreditFacilityMember nrci:OneTwoOrThreeMonthLIBORMember 2017-01-01 2017-12-31 0000070487 nrci:TermNoteMember 2017-01-01 2017-12-31 0000070487 us-gaap:FairValueMeasurementsRecurringMember 2017-01-01 2017-12-31 0000070487 us-gaap:CustomerRelationshipsMember us-gaap:MaximumMember 2017-01-01 2017-12-31 0000070487 us-gaap:CustomerRelationshipsMember us-gaap:MinimumMember 2017-01-01 2017-12-31 0000070487 us-gaap:TechnologyBasedIntangibleAssetsMember 2017-01-01 2017-12-31 0000070487 us-gaap:TradeNamesMember us-gaap:MaximumMember 2017-01-01 2017-12-31 0000070487 us-gaap:TradeNamesMember us-gaap:MinimumMember 2017-01-01 2017-12-31 0000070487 nrci:SellingAndAdministrativeExpensesMember 2017-01-01 2017-12-31 0000070487 nrci:The2006EquityIncentivePlanMember us-gaap:MaximumMember 2017-01-01 2017-12-31 0000070487 nrci:The2006EquityIncentivePlanMember us-gaap:MinimumMember 2017-01-01 2017-12-31 0000070487 us-gaap:BuildingAndBuildingImprovementsMember us-gaap:MaximumMember 2017-01-01 2017-12-31 0000070487 us-gaap:BuildingAndBuildingImprovementsMember us-gaap:MinimumMember 2017-01-01 2017-12-31 0000070487 us-gaap:ComputerEquipmentMember us-gaap:MaximumMember 2017-01-01 2017-12-31 0000070487 us-gaap:ComputerEquipmentMember us-gaap:MinimumMember 2017-01-01 2017-12-31 0000070487 us-gaap:FurnitureAndFixturesMember us-gaap:MaximumMember 2017-01-01 2017-12-31 0000070487 us-gaap:FurnitureAndFixturesMember us-gaap:MinimumMember 2017-01-01 2017-12-31 0000070487 nrci:IncludingAssetsHeldUnderCapitalLeaseMember 2017-01-01 2017-12-31 0000070487 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember us-gaap:MaximumMember 2017-01-01 2017-12-31 0000070487 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember us-gaap:MinimumMember 2017-01-01 2017-12-31 0000070487 nrci:AmeritasLifeInsuranceCorpMember 2017-01-01 2017-12-31 0000070487 nrci:MrHaysMember 2017-01-01 2017-12-31 0000070487 nrci:NebraskaGlobalInvestmentCompanyLLCMember 2017-01-01 2017-12-31 0000070487 nrci:PracticingExcellencecomMember 2017-01-01 2017-12-31 0000070487 nrci:PracticingExcellencecomMember 2017-01-01 2017-12-31 0000070487 us-gaap:CommonClassAMember 2017-01-01 2017-12-31 0000070487 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-01-01 2017-12-31 0000070487 us-gaap:CommonClassBMember 2017-01-01 2017-12-31 0000070487 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2017-01-01 2017-12-31 0000070487 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-12-31 0000070487 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-12-31 0000070487 us-gaap:RetainedEarningsMember 2017-01-01 2017-12-31 0000070487 us-gaap:TreasuryStockMember 2017-01-01 2017-12-31 0000070487 country:CA 2017-01-01 2017-12-31 0000070487 country:US 2017-01-01 2017-12-31 0000070487 us-gaap:CommonClassBMember 2017-12-01 2017-12-31 0000070487 us-gaap:ScenarioForecastMember 2018-01-01 2018-12-31 0000070487 2014-12-31 0000070487 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2014-12-31 0000070487 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2014-12-31 0000070487 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0000070487 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0000070487 us-gaap:RetainedEarningsMember 2014-12-31 0000070487 us-gaap:TreasuryStockMember 2014-12-31 0000070487 us-gaap:DisposalGroupNotDiscontinuedOperationsMember nrci:PredictiveAnalyticsMember 2015-12-21 0000070487 2015-12-31 0000070487 nrci:IlluminateHealthLLCMember 2015-12-31 0000070487 nrci:The2001EquityIncentivePlanMember 2015-12-31 0000070487 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2015-12-31 0000070487 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2015-12-31 0000070487 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0000070487 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0000070487 us-gaap:RetainedEarningsMember 2015-12-31 0000070487 us-gaap:TreasuryStockMember 2015-12-31 0000070487 country:CA 2015-12-31 0000070487 country:US 2015-12-31 0000070487 2016-12-31 0000070487 nrci:ConnectMember nrci:IlluminateHealthLLCMember 2016-12-31 0000070487 nrci:RevolvingCreditNoteMember 2016-12-31 0000070487 nrci:TermNoteMember 2016-12-31 0000070487 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000070487 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000070487 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000070487 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000070487 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000070487 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000070487 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000070487 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000070487 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000070487 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000070487 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000070487 us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000070487 us-gaap:CustomerRelationshipsMember 2016-12-31 0000070487 us-gaap:TechnologyBasedIntangibleAssetsMember 2016-12-31 0000070487 us-gaap:TradeNamesMember 2016-12-31 0000070487 nrci:TradeNames1Member 2016-12-31 0000070487 us-gaap:BuildingAndBuildingImprovementsMember 2016-12-31 0000070487 us-gaap:ComputerEquipmentMember 2016-12-31 0000070487 us-gaap:FurnitureAndFixturesMember 2016-12-31 0000070487 us-gaap:LandMember 2016-12-31 0000070487 us-gaap:LeaseholdImprovementsMember 2016-12-31 0000070487 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2016-12-31 0000070487 nrci:NebraskaGlobalInvestmentCompanyLLCMember us-gaap:ChiefExecutiveOfficerMember 2016-12-31 0000070487 us-gaap:CommonClassAMember 2016-12-31 0000070487 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2016-12-31 0000070487 us-gaap:CommonClassBMember 2016-12-31 0000070487 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2016-12-31 0000070487 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0000070487 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0000070487 us-gaap:RetainedEarningsMember 2016-12-31 0000070487 us-gaap:TreasuryStockMember 2016-12-31 0000070487 country:CA 2016-12-31 0000070487 country:US 2016-12-31 0000070487 2017-06-30 0000070487 2017-12-31 0000070487 us-gaap:AccountingStandardsUpdate201602Member us-gaap:NewAccountingPronouncementEarlyAdoptionEffectMember 2017-12-31 0000070487 us-gaap:EmployeeStockOptionMember us-gaap:CommonClassAMember 2017-12-31 0000070487 us-gaap:EmployeeStockOptionMember us-gaap:CommonClassBMember 2017-12-31 0000070487 nrci:NonqualifiedStockOptionsMember nrci:DirectorPlan2004Member us-gaap:CommonClassAMember us-gaap:DirectorMember 2017-12-31 0000070487 nrci:NonqualifiedStockOptionsMember nrci:DirectorPlan2004Member us-gaap:CommonClassBMember us-gaap:DirectorMember 2017-12-31 0000070487 nrci:NonvestedMember 2017-12-31 0000070487 nrci:NonvestedMember nrci:The2006EquityIncentivePlanMember us-gaap:CommonClassAMember 2017-12-31 0000070487 nrci:NonvestedMember nrci:The2006EquityIncentivePlanMember us-gaap:CommonClassBMember 2017-12-31 0000070487 us-gaap:RevolvingCreditFacilityMember 2017-12-31 0000070487 nrci:RevolvingCreditNoteMember 2017-12-31 0000070487 nrci:TermNoteMember 2017-12-31 0000070487 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000070487 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000070487 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000070487 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000070487 nrci:EurodollarDepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000070487 nrci:EurodollarDepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000070487 nrci:EurodollarDepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000070487 nrci:EurodollarDepositsMember us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000070487 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000070487 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000070487 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000070487 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000070487 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000070487 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000070487 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000070487 us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000070487 us-gaap:CustomerRelationshipsMember 2017-12-31 0000070487 us-gaap:TechnologyBasedIntangibleAssetsMember 2017-12-31 0000070487 us-gaap:TradeNamesMember 2017-12-31 0000070487 nrci:TradeNames1Member 2017-12-31 0000070487 nrci:FirstNationalBankOfOmahaMember nrci:DelayedDrawTermLoanFacilityCommitmentLetterMember 2017-12-31 0000070487 nrci:FirstNationalBankOfOmahaMember nrci:RevolvingCreditFacilityCommitmentLetterMember 2017-12-31 0000070487 nrci:FirstNationalBankOfOmahaMember nrci:TermLoanCommitmentLetterMember 2017-12-31 0000070487 nrci:DirectorPlan2004Member us-gaap:CommonClassAMember 2017-12-31 0000070487 nrci:DirectorPlan2004Member us-gaap:CommonClassBMember 2017-12-31 0000070487 nrci:The2001EquityIncentivePlanMember us-gaap:CommonClassAMember 2017-12-31 0000070487 nrci:The2001EquityIncentivePlanMember us-gaap:CommonClassBMember 2017-12-31 0000070487 nrci:The2006EquityIncentivePlanMember us-gaap:CommonClassAMember 2017-12-31 0000070487 nrci:The2006EquityIncentivePlanMember us-gaap:CommonClassBMember 2017-12-31 0000070487 us-gaap:BuildingAndBuildingImprovementsMember 2017-12-31 0000070487 us-gaap:ComputerEquipmentMember 2017-12-31 0000070487 us-gaap:FurnitureAndFixturesMember 2017-12-31 0000070487 us-gaap:LandMember 2017-12-31 0000070487 us-gaap:LeaseholdImprovementsMember 2017-12-31 0000070487 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2017-12-31 0000070487 nrci:PracticingExcellencecomMember 2017-12-31 0000070487 us-gaap:CommonClassAMember 2017-12-31 0000070487 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-12-31 0000070487 us-gaap:CommonClassBMember 2017-12-31 0000070487 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2017-12-31 0000070487 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000070487 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000070487 us-gaap:RetainedEarningsMember 2017-12-31 0000070487 us-gaap:TreasuryStockMember 2017-12-31 0000070487 country:CA 2017-12-31 0000070487 country:US 2017-12-31 0000070487 us-gaap:CommonClassAMember 2018-02-28 0000070487 us-gaap:CommonClassBMember 2018-02-28

EX-101.SCH 8 nrci-20171231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Income link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Comprehensive Income link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Shareholders' Equity link:calculationLink link:definitionLink link:presentationLink 006 - Statement - Consolidated Statements of Shareholders' Equity (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 007 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink 008 - Statement - Consolidated Statements of Cash Flows (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 1 - Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 2 - Equity Investments link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 3 - Divestitures link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 4 - Connect link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 5 - Property and Equipment link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 6 - Goodwill and Intangible Assets link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 7 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 8 - Notes Payable link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 9 - Share-based Compensation link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 10 - Leases link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 12 - Associate Benefits link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 13 - Proposed Recapitalization link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 14 - Segment Information link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 1 - Summary of Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 5 - Property and Equipment (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 6 - Goodwill and Intangible Assets (Tables) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 7 - Income Taxes (Tables) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 8 - Notes Payable (Tables) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 9 - Share-based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 10 - Leases (Tables) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 14 - Segment Information (Tables) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 1 - Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Allowance for Doubtful Accounts (Details) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Share-based Compensation Amounts Recognized in Financial Statements (Details) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Fair Value of Financial Assets and Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Fair Values of Long-term Debt (Details) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 2 - Equity Investments (Details Textual) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 3 - Divestitures (Details Textual) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 4 - Connect (Details Textual) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 5 - Property and Equipment (Details Textual) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 5 - Property and Equipment - Summary of Property and Equipment (Details) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 5 - Property and Equipment - Schedule of Capital Lease Assets (Details) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 6 - Goodwill and Intangible Assets (Details Textual) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 6 - Goodwill and Intangible Assets - Summary of Goodwill and Intangible Assets (Details) link:calculationLink link:definitionLink link:presentationLink 046 - Disclosure - Note 6 - Goodwill and Intangible Assets - Summary of Changes in the Carrying Amount of Goodwill (Details) link:calculationLink link:definitionLink link:presentationLink 047 - Disclosure - Note 7 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 048 - Disclosure - Note 7 - Income Taxes - Income Before Income Taxes (Details) link:calculationLink link:definitionLink link:presentationLink 049 - Disclosure - Note 7 - Income Taxes - Income Tax Expense (Details) link:calculationLink link:definitionLink link:presentationLink 050 - Disclosure - Note 7 - Income Taxes - Income Tax Reconciliation (Details) link:calculationLink link:definitionLink link:presentationLink 051 - Disclosure - Note 7 - Income Taxes - Deferred Tax Assets and Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 052 - Disclosure - Note 7 - Income Taxes - Change in Unrecognized Tax Benefits (Details) link:calculationLink link:definitionLink link:presentationLink 053 - Disclosure - Note 8 - Notes Payable (Details Textual) link:calculationLink link:definitionLink link:presentationLink 054 - Disclosure - Note 8 - Notes Payable - Summary of Notes Payable (Details) link:calculationLink link:definitionLink link:presentationLink 055 - Disclosure - Note 8 - Notes Payable - Summary of Notes Payable (Details) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 056 - Disclosure - Note 9 - Share-based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 057 - Disclosure - Note 9 - Share-based Compensation - Stock Options Valuation Assumptions (Details) link:calculationLink link:definitionLink link:presentationLink 058 - Disclosure - Note 9 - Share-based Compensation - Stock Option Activity Under Equity Incentive Plans and Director Plan (Details) link:calculationLink link:definitionLink link:presentationLink 059 - Disclosure - Note 9 - Share-based compensation - Stock Option Activity (Details) link:calculationLink link:definitionLink link:presentationLink 060 - Disclosure - Note 9 - Share-based Compensation - Non-vested Stock (Details) link:calculationLink link:definitionLink link:presentationLink 061 - Disclosure - Note 10 - Leases (Details Textual) link:calculationLink link:definitionLink link:presentationLink 062 - Disclosure - Note 10 - Leases - Payments Under Non-cancelable Operating Leases and Capital Leases (Details) link:calculationLink link:definitionLink link:presentationLink 064 - Disclosure - Note 12 - Associate Benefits (Details Textual) link:calculationLink link:definitionLink link:presentationLink 065 - Disclosure - Note 13 - Proposed Recapitalization (Details Textual) link:calculationLink link:definitionLink link:presentationLink 066 - Disclosure - Note 14 - Segment Information (Details Textual) link:calculationLink link:definitionLink link:presentationLink 067 - Disclosure - Note 14 - Segment Information - Revenue and Assets by Geographic Area (Details) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 9 nrci-20171231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 10 nrci-20171231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 11 nrci-20171231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Note To Financial Statement Details Textual Significant Accounting Policies us-gaap_VariableInterestEntityOwnershipPercentage Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage Note 1 - Summary of Significant Accounting Policies Note 5 - Property and Equipment Note 6 - Goodwill and Intangible Assets Note 7 - Income Taxes Note 8 - Notes Payable Variable Rate [Domain] Note 9 - Share-based Compensation Operating expenses: Variable Rate [Axis] Note 10 - Leases Note 14 - Segment Information December 31, 2016 [Member] Represents information that applies to December 31, 2016. Note 1 - Summary of Significant Accounting Policies - Allowance for Doubtful Accounts (Details) Note 1 - Summary of Significant Accounting Policies - Share-based Compensation Amounts Recognized in Financial Statements (Details) Nondeductible expenses related to proposed recapitalization Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to a proposed recapitalization. nrci_ExchangeValuePerShare Exchange Value Per Share Represents the value per share of an exchange from class B common stock to class A common stock plus cash under the proposed recapitalization plan. Note 1 - Summary of Significant Accounting Policies - Fair Value of Financial Assets and Liabilities (Details) Revenue Revenues Note 1 - Summary of Significant Accounting Policies - Fair Values of Long-term Debt (Details) Note 1 - Summary of Significant Accounting Policies - Net Income Per Share Computation (Details) Note 5 - Property and Equipment - Summary of Property and Equipment (Details) Note 5 - Property and Equipment - Schedule of Capital Lease Assets (Details) Note 6 - Goodwill and Intangible Assets - Summary of Goodwill and Intangible Assets (Details) Note 6 - Goodwill and Intangible Assets - Summary of Changes in the Carrying Amount of Goodwill (Details) Variable Interest Entities [Axis] Note 7 - Income Taxes - Income Before Income Taxes (Details) Note 7 - Income Taxes - Income Tax Expense (Details) Note 7 - Income Taxes - Income Tax Reconciliation (Details) Variable Interest Entity, Classification [Domain] Note 7 - Income Taxes - Deferred Tax Assets and Liabilities (Details) Note 7 - Income Taxes - Change in Unrecognized Tax Benefits (Details) Note 8 - Notes Payable - Summary of Notes Payable (Details) Note 8 - Notes Payable - Summary of Notes Payable (Details) (Parentheticals) Note 9 - Share-based Compensation - Stock Options Valuation Assumptions (Details) Note 9 - Share-based Compensation - Stock Option Activity Under Equity Incentive Plans and Director Plan (Details) Note 9 - Share-based compensation - Stock Option Activity (Details) Note 9 - Share-based Compensation - Non-vested Stock (Details) Note 10 - Leases - Payments Under Non-cancelable Operating Leases and Capital Leases (Details) Note 14 - Segment Information - Revenue and Assets by Geographic Area (Details) Notes To Financial Statements Notes To Financial Statements [Abstract] Cash flows from investing activities: First National Bank of Omaha [Member] Related to the entity First National Bank of Omaha. Recapitalization [Text Block] The complete disclosure of recapitalization of the company. Leases of Lessee Disclosure [Text Block] Selling and Administrative Expenses [Member] Related to the income statement line item selling and administrative expenses. Term Loan Commitment Letter [Member] Related to a term loan that has been committed to be lent. Delayed Draw Term Loan Facility Commitment Letter [Member] Related to the delayed draw term loan facility that has been committed to be lent. Money Market Funds [Member] Mr. Hays [Member] Related to the individual Mr. Hays. us-gaap_IncreaseDecreaseInDeferredRevenue Deferred revenue us-gaap_ComprehensiveIncomeNetOfTax Comprehensive Income nrci_CostMethodInvestmentOwnershipPercentage Cost Method Investment, Ownership Percentage The percentage of ownership of common stock or equity participation in the investee accounted for under the cost method of accounting. us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity Line of Credit Facility, Remaining Borrowing Capacity Shares of treasury stock purchased (in shares) nrci_IncomeTaxReconciliationDeductionsExcessTaxBenefitOfShareBasedCompensation Share based compensation Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for excess tax benefit of share-based compensation. Use of Estimates, Policy [Policy Text Block] Common stock, shares outstanding (in shares) us-gaap_PriorPeriodReclassificationAdjustment Prior Period Reclassification Adjustment us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity New Accounting Pronouncements, Policy [Policy Text Block] Reclassification, Policy [Policy Text Block] us-gaap_IncreaseDecreaseInAccountsPayable Accounts payable Consolidation, Policy [Policy Text Block] Director [Member] Related Party [Axis] us-gaap_RevenueFromRelatedParties Revenue from Related Parties Line of Credit Facility, Lender [Domain] Lender Name [Axis] Related Party [Domain] Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period us-gaap_DividendsCommonStockCash Dividends declared us-gaap_CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value Tax benefit from the exercise of options and restricted stock Debt Disclosure [Text Block] Non-cash stock compensation expense Income taxes receivable and payable us-gaap_TreasuryStockValueAcquiredCostMethod Purchase of treasury stock us-gaap_TreasuryStockValue Treasury stock, at cost; 4,898,527 Class A shares, 784,018 Class B shares in 2017 and 4,765,691 Class A shares, 768,944 Class B shares in 2016 Relationship to Entity [Domain] Title of Individual [Axis] us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Prepaid expenses and other current assets us-gaap_AllocatedShareBasedCompensationExpense Allocated Share-based Compensation Expense us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax Net (benefit) expense to net income Issuance of restricted common shares, net of forfeitures (in shares) Shares of common stock issued for the exercise of stock options (in shares) Exercised, number of options (in shares) Issuance of shares for the exercise of stock options Supplemental disclosure of non-cash investing and financing activities: Issuance of restricted common shares, net of forfeitures us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross us-gaap_IncreaseDecreaseInUnbilledReceivables Unbilled revenue us-gaap_IncreaseDecreaseInAccountsReceivable Trade accounts receivable us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) Granted, number of options (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Allowance for Credit Losses on Financing Receivables [Table Text Block] nrci_CommitmentToProvideSeniorNotes Commitment to Provide Senior Notes The amount of unfunded senior notes that has been committed to be provided to the Company by certain parties. nrci_CommtimentToProvideLineOfCreditMaximumProposedBorrowingCapacity Commtiment to Provide Line of Credit, Maximum Proposed Borrowing Capacity The amount of unfunded line of credit that has been committed to be provided to the Company by certain parties. us-gaap_AllowanceForDoubtfulAccountsReceivable Balance Balance nrci_CommitmentToProvideLongtermDebt Commitment to Provide Long-term Debt The amount of unfunded long term debt that has been committed to be provided to the Company by certain parties. Revolving Credit Facility Commitment Letter [Member] Related to the commitment by certain parties to provide a revolving credit facility. us-gaap_DeferredTaxAssetsValuationAllowance Less Valuation Allowance Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and shareholders’ equity Retained earnings us-gaap_DeferredTaxAssetsNet Deferred Tax Assets us-gaap_DeferredIncomeTaxLiabilities Deferred tax liabilities us-gaap_DeferredTaxAssetsGross Gross deferred tax assets us-gaap_DeferredTaxAssetsOther Other us-gaap_NumberOfReportableSegments Number of Reportable Segments us-gaap_NumberOfOperatingSegments Number of Operating Segments us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Accrued expenses Accumulated other comprehensive (loss) income, foreign currency translation adjustment CANADA Segment Reporting Disclosure [Text Block] Fair Value Measurement, Policy [Policy Text Block] us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts Allowance for doubtful accounts us-gaap_AssetsNoncurrent Long-lived assets Foreign Currency Transactions and Translations Policy [Policy Text Block] us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses Accrued bonuses Business Combinations Policy [Policy Text Block] us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Share based compensation us-gaap_NonoperatingIncomeExpense Total other income Earnings Per Share, Policy [Policy Text Block] Fair Value, Measurements, Recurring [Member] Other, net Fair Value, Measurement Frequency [Domain] Measurement Frequency [Axis] Income Tax, Policy [Policy Text Block] Change in assets and liabilities, net of effect of acquisition and disposal: us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign Foreign tax credit from repatriation nrci_RevenueRecognitionSubscriptionPeriod Revenue Recognition Subscription Period Subscription period for revenue recognition under subscription-based service agreements. Property, Plant and Equipment [Table Text Block] Interest income Property, Plant and Equipment Disclosure [Text Block] Deferred tax assets: Other income (expense): us-gaap_IncomeTaxCreditsAndAdjustments Income Tax Credits and Adjustments us-gaap_OperatingIncomeLoss Operating income us-gaap_OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net us-gaap_DeferredTaxLiabilities Net deferred tax liabilities Accrued expenses, wages, bonus and profit sharing The net change during the reporting period in the aggregate amount of expenses and accrued compensation incurred but not yet paid. us-gaap_DeferredIncomeTaxExpenseBenefit Deferred income taxes us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets Intangible assets Treasury stock, shares (in shares) Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Amendment Flag NG Customer-Connect, LLC [Member] Represents NG Customer-Connect, LLC. Illuminate Health, LLC [Member] Represents Illuminate Health, LLC. Common stock, value us-gaap_IntangibleAssetsGrossExcludingGoodwill Total intangible assets other than goodwill us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Tax benefit from exercise of stock options Common stock, shares authorized (in shares) Common stock, shares issued (in shares) Other us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Assets, Amortization Expense, Year Three Common stock, par value (in dollars per share) us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Assets, Amortization Expense, Year Two us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Assets, Amortization Expense, Year Five Non-cash share-based compensation expense us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Assets, Amortization Expense, Year Four us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months Current Fiscal Year End Date Document Fiscal Period Focus Document Fiscal Year Focus Deferred tax liabilities: Document Period End Date Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued us-gaap_DeferredTaxLiabilitiesPrepaidExpenses Prepaid expenses us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment Property and equipment us-gaap_FiniteLivedIntangibleAssetUsefulLife Finite-lived intangible assets, useful life (Year) Preferred stock, shares issued (in shares) Chief Executive Officer [Member] Document Type us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other comprehensive income (loss) Preferred stock, shares authorized (in shares) Document Information [Line Items] Document Information [Table] Preferred stock, par value (in dollars per share) us-gaap_AssetsCurrent Total current assets Entity Public Float Entity Filer Category Entity Current Reporting Status Entity Voluntary Filers Entity Well-known Seasoned Issuer Income taxes receivable Uncertain tax positions The sum of the differences between total income tax expense or benefit as reported in the Income Statement for the period and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations attributable uncertain tax positions. EX-101.PRE 12 nrci-20171231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 13 img02.jpg begin 644 img02.jpg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end GRAPHIC 14 img01.jpg begin 644 img01.jpg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ņ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htm IDEA: XBRL DOCUMENT v3.8.0.1

Document And Entity Information - USD ($)
12 Months Ended

Dec. 31, 2017

Feb. 28, 2018

Jun. 30, 2017

Document Information [Line Items]

Entity Registrant Name National Research Corporation

Entity Central Index Key 0000070487

Trading Symbol nrci

Current Fiscal Year End Date --12-31

Entity Filer Category Accelerated Filer

Entity Current Reporting Status Yes

Entity Voluntary Filers No

Entity Well-known Seasoned Issuer No

Entity Public Float $ 458,611,975

Document Type 10-K

Document Period End Date Dec. 31, 2017

Document Fiscal Year Focus 2017

Document Fiscal Period Focus FY

Amendment Flag false

Common Class A [Member]

Document Information [Line Items]

Entity Common Stock, Shares Outstanding (in shares) 20,970,575

Common Class B [Member]

Document Information [Line Items]

Entity Common Stock, Shares Outstanding (in shares) 3,540,857

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: dei_DocumentInformationLineItems

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.
+ References
No definition available.
+ Details

Name: dei_EntityPublicFloat

Namespace Prefix: dei_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 16 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1

Consolidated Balance Sheets - USD ($)
$ in Thousands

Dec. 31, 2017

Dec. 31, 2016

Current assets:

Cash and cash equivalents $ 34,733 $ 33,021

Trade accounts receivable, less allowance for doubtful accounts of $200 and $169, respectively 13,343 10,864

Unbilled revenue 1,463 1,546

Prepaid expenses 2,310 1,585

Income taxes receivable 375 14

Other current assets 35 35

Total current assets 52,259 47,065

Net property and equipment 12,359 11,806

Intangible assets, net 2,764 3,124

Goodwill 58,021 57,861

Other 1,913 768

Total assets 127,316 120,624

Current liabilities:

Current portion of notes payable 1,067 2,683

Accounts payable 593 765

Accrued wages, bonus and profit sharing 6,597 4,543

Accrued expenses 2,882 3,069

Current portion of capital lease obligations 71 82

Income taxes payable 662

Dividends payable 4,222 4,213

Deferred revenue 16,878 15,497

Total current liabilities 32,310 31,514

Notes payable, net of current portion 857

Deferred income taxes 4,030 4,670

Other long term liabilities 935 777

Total liabilities 37,275 37,818

Shareholders’ equity:

Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued 0 0

Additional paid-in capital 51,025 46,725

Retained earnings 77,574 71,507

Accumulated other comprehensive (loss) income, foreign currency translation adjustment (1,635) (2,626)

Treasury stock, at cost; 4,898,527 Class A shares, 784,018 Class B shares in 2017 and 4,765,691 Class A shares, 768,944 Class B shares in 2016 (36,953) (32,830)

Total shareholders’ equity 90,041 82,806

Total liabilities and shareholders’ equity 127,316 120,624

Common Class A [Member]

Shareholders’ equity:

Common stock, value 26 26

Common Class B [Member]

Shareholders’ equity:

Common stock, value $ 4 $ 4

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(4))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(15)(b)(1))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(20))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(15)(1))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_AccruedIncomeTaxesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=84228862&loc=d3e681-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84228862&loc=SL7669646-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=84228862&loc=d3e637-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=64808268&loc=d3e32022-110900

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=84228862&loc=SL7669686-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapitalCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of capital lease obligation due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84164758&loc=d3e45023-112735
+ Details

Name: us-gaap_CapitalLeaseObligationsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3044-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3(b).Q1(c))
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6935-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 13.A.4(a).Q1)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3(b).Q2)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3(b))
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3(c).Q3)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780
+ Details

Name: us-gaap_DeferredRevenueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e31931-109318

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e31958-109318

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e31917-109318
+ Details

Name: us-gaap_DeferredTaxLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6935-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DividendsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.5(c))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.3(a)(4))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.10)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_IncomeTaxesReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph ((a)(1),(b))
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_NotesPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of current assets classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of noncurrent assets classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6787-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 05
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765
+ Details

Name: us-gaap_PrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29,30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656
+ Details

Name: us-gaap_TreasuryStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.3(c)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 912
-SubTopic 310
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=68054760&loc=d3e55302-109406
+ Details

Name: us-gaap_UnbilledContractsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 17 R3.htm IDEA: XBRL DOCUMENT v3.8.0.1

Consolidated Balance Sheets (Parentheticals) - USD ($)
$ in Thousands

Dec. 31, 2017

Dec. 31, 2016

Allowance for doubtful accounts $ 200 $ 169

Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01

Preferred stock, shares authorized (in shares) 2,000,000 2,000,000

Preferred stock, shares issued (in shares) 0 0

Common Class A [Member]

Common stock, par value (in dollars per share) $ 0.001 $ 0.001

Common stock, shares authorized (in shares) 60,000,000 60,000,000

Common stock, shares issued (in shares) 25,835,230 25,656,760

Common stock, shares outstanding (in shares) 20,936,703 20,891,069

Treasury stock, shares (in shares) 4,898,527 4,765,691

Common Class B [Member]

Common stock, par value (in dollars per share) $ 0.001 $ 0.001

Common stock, shares authorized (in shares) 80,000,000 80,000,000

Common stock, shares issued (in shares) 4,319,256 4,308,875

Common stock, shares outstanding (in shares) 3,535,238 3,539,931

Treasury stock, shares (in shares) 784,018 768,944

X

- Definition
A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84173941&loc=d3e5074-111524
+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29,30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655
+ Details

Name: us-gaap_TreasuryStockShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 18 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1

Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Revenue $ 117,559 $ 109,384 $ 102,343

Operating expenses:

Direct 49,068 45,577 44,610

Selling, general and administrative 29,686 28,385 27,177

Depreciation and amortization 4,586 4,225 4,109

Total operating expenses 83,340 78,187 75,896

Operating income 34,219 31,197 26,447

Other income (expense):

Interest income 96 47 60

Interest expense (82) (190) (220)

Other, net 50 302 1,073

Total other income 64 159 913

Income before income taxes 34,283 31,356 27,360

Provision for income taxes 11,340 10,838 9,750

Net income 22,943 20,518 17,610

Common Class A [Member]

Other income (expense):

Net income $ 11,388 $ 10,178 $ 8,759

Basic earnings per share:

Basic earnings per share (in dollars per share) $ 0.54 $ 0.49 $ 0.42

Diluted earnings per share:

Diluted earnings per share (in dollars per share) $ 0.52 $ 0.48 $ 0.41

Weighted average shares and share equivalents outstanding

Weighted average shares and share equivalents outstanding, basic (in shares) 20,770 20,713 20,741

Weighted average shares and share equivalents outstanding, diluted (in shares) 21,627 21,037 20,981

Common Class B [Member]

Other income (expense):

Net income $ 11,555 $ 10,341 $ 8,851

Basic earnings per share:

Basic earnings per share (in dollars per share) $ 3.26 $ 2.93 $ 2.52

Diluted earnings per share:

Diluted earnings per share (in dollars per share) $ 3.18 $ 2.88 $ 2.49

Weighted average shares and share equivalents outstanding

Weighted average shares and share equivalents outstanding, basic (in shares) 3,514 3,505 3,478

Weighted average shares and share equivalents outstanding, diluted (in shares) 3,603 3,560 3,522

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate direct operating costs incurred during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_DirectOperatingCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=96948231&loc=d3e4984-109258

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=96947427&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=96947427&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareDilutedAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28555-108399

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7(b))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_InvestmentIncomeInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of income (expense) related to nonoperating activities, classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.9)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311
+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=96947427&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=96947427&loc=d3e1448-109256
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 19 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1

Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Net income $ 22,943 $ 20,518 $ 17,610

Other comprehensive income (loss):

Cumulative translation adjustment 991 369 (2,222)

Other comprehensive income (loss) 991 369 (2,222)

Comprehensive Income $ 23,934 $ 20,887 $ 15,388

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=84228862&loc=d3e557-108580
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(3)
-URI http://asc.fasb.org/extlink&oid=84161450&loc=SL4573702-111684

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=96868048&loc=SL4569643-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=96868048&loc=SL4569616-111683
+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of other comprehensive income (loss) attributable to parent entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(3)
-URI http://asc.fasb.org/extlink&oid=84161450&loc=SL4573702-111684

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=96868048&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=96868048&loc=SL4569643-111683
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 20 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1

Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands

Common Stock [Member]

Common Class A [Member]

Common Stock [Member]

Common Class B [Member]

Additional Paid-in Capital [Member]

Retained Earnings [Member]

AOCI Attributable to Parent [Member]

Treasury Stock [Member]

Common Class A [Member]

Common Class B [Member]

Total

Balances at Dec. 31, 2014 $ 25 $ 4 $ 44,864 $ 73,686 $ (773) $ (30,058) $ 87,748

Purchase of treasury stock (2,171) (2,171)

Issuance of shares for the exercise of stock options 406 406

Tax benefit from the exercise of options and restricted stock 240 240

Issuance of restricted common shares, net of forfeitures 1 (1)

Non-cash stock compensation expense 1,383 1,383

Dividends declared (25,983) (25,983)

Acquisition of non-controlling interest (2,789) (2,789)

Other comprehensive income (loss), foreign currency translation adjustment (2,222) (2,222)

Net income 17,610 $ 8,759 $ 8,851 17,610

Balances at Dec. 31, 2015 26 4 44,103 65,313 (2,995) (32,229) 74,222

Purchase of treasury stock (601) (601)

Issuance of shares for the exercise of stock options 945 945

Issuance of restricted common shares, net of forfeitures

Non-cash stock compensation expense 1,929 1,929

Dividends declared (14,324) (14,324)

Acquisition of non-controlling interest (252) (252)

Other comprehensive income (loss), foreign currency translation adjustment 369 369

Net income 20,518 10,178 10,341 20,518

Balances at Dec. 31, 2016 26 4 46,725 71,507 (2,626) (32,830) 82,806

Purchase of treasury stock (4,123) (4,123)

Issuance of shares for the exercise of stock options 2,455 2,455

Issuance of restricted common shares, net of forfeitures

Non-cash stock compensation expense 1,845 1,845

Dividends declared (16,876) (16,876)

Other comprehensive income (loss), foreign currency translation adjustment 991 991

Net income 22,943 $ 11,388 $ 11,555 22,943

Balances at Dec. 31, 2017 $ 26 $ 4 $ 51,025 $ 77,574 $ (1,635) $ (36,953) $ 90,041

X

- Definition
Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=79507207&loc=d3e4534-113899

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=96864182&loc=d3e11149-113907

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=96864182&loc=d3e11178-113907
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase in additional paid in capital (APIC) resulting from a tax benefit associated with share-based compensation plan other than an employee stock ownership plan (ESOP). Includes, but is not limited to, excess tax benefit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 740
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=79981250&loc=d3e23524-113945

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_DividendsCommonStockCash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 23
-URI http://asc.fasb.org/extlink&oid=96868048&loc=SL4569655-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=96868048&loc=SL4616395-111683
+ Details

Name: us-gaap_MinorityInterestDecreaseFromRedemptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(3)
-URI http://asc.fasb.org/extlink&oid=84161450&loc=SL4573702-111684

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=96868048&loc=SL4569643-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=96868048&loc=SL4569616-111683
+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of stock issued as a result of the exercise of stock options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_TreasuryStockValueAcquiredCostMethod

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 21 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1

Consolidated Statements of Shareholders' Equity (Parentheticals) - $ / shares
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Common Stock [Member] | Common Class A [Member]

Shares of treasury stock purchased (in shares) 132,836 21,047 163,268

Shares of common stock issued for the exercise of stock options (in shares) 197,784 52,383 43,983

Issuance of restricted common shares, net of forfeitures (in shares) 19,314 11,565 73,168

Dividends declared per common share (in dollars per share) $ 0.40 $ 0.34 $ 0.62

Common Stock [Member] | Common Class B [Member]

Shares of treasury stock purchased (in shares) 15,074 7,681 4,239

Shares of common stock issued for the exercise of stock options (in shares) 13,600 35,534 7,330

Issuance of restricted common shares, net of forfeitures (in shares) 3,219 1,928 12,194

Dividends declared per common share (in dollars per share) $ 2.40 $ 2.04 $ 3.72

Common Class A [Member]

Shares of common stock issued for the exercise of stock options (in shares) 197,784

Common Class B [Member]

Shares of common stock issued for the exercise of stock options (in shares) 13,600

X

- Definition
Aggregate dividends paid during the period for each share of common stock outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_CommonStockDividendsPerShareCashPaid

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares that have been repurchased during the period and are being held in treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644
+ Details

Name: us-gaap_TreasuryStockSharesAcquired

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 22 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1

Consolidated Statements of Cash Flows - USD ($)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Cash flows from operating activities:

Net income $ 22,943,000 $ 20,518,000 $ 17,610,000

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization 4,586,000 4,225,000 4,109,000

Deferred income taxes (684,000) 798,000 (1,387,000)

Reserve for uncertain tax positions 181,000 73,000 119,000

Loss on disposal of property and equipment 26,000 22,000

Gain on sale from operating segment (223,000) (1,102,000)

Write-off of purchase option 657,000

Tax benefit from exercise of stock options 25,000

Non-cash share-based compensation expense 1,845,000 1,929,000 1,383,000

Change in assets and liabilities, net of effect of acquisition and disposal:

Trade accounts receivable (2,463,000) (1,044,000) (1,777,000)

Unbilled revenue 123,000 (93,000) (390,000)

Prepaid expenses and other current assets (565,000) (535,000) 207,000

Accounts payable 12,000 (15,000) (224,000)

Accrued expenses, wages, bonus and profit sharing 1,759,000 440,000 755,000

Income taxes receivable and payable (1,023,000) 105,000 1,504,000

Deferred revenue 1,351,000 643,000 397,000

Net cash provided by operating activities 28,091,000 26,843,000 21,886,000

Cash flows from investing activities:

Purchases of property and equipment (4,568,000) (3,973,000) (2,939,000)

Purchase of equity investment (1,300,000)

Purchase of intangible content license (250,000)

Net proceeds from sale of operating segment 223,000 1,613,000

Net cash used in investing activities (6,118,000) (3,750,000) (1,326,000)

Cash flows from financing activities:

Payments on notes payable (2,473,000) (2,199,000) (2,328,000)

Payments on capital lease obligations (108,000) (95,000) (173,000)

Cash paid for non-controlling interest (2,000,000) (2,789,000)

Proceeds from exercise of stock options 0 548,000 0

Excess tax benefit from share-based compensation 240,000

Repurchase of shares for payroll tax withholdings related to share-based compensation (1,668,000) (204,000) (92,000)

Purchase of Treasury Stock (1,673,000)

Payment of dividends on common stock (16,867,000) (28,552,000) (10,054,000)

Net cash used in financing activities (21,116,000) (32,502,000) (16,869,000)

Effect of exchange rate changes on cash 855,000 285,000 (1,588,000)

Net increase (decrease) in cash and cash equivalents 1,712,000 (9,124,000) 2,103,000

Cash and cash equivalents at beginning of period 33,021,000 42,145,000 40,042,000

Cash and cash equivalents at end of period 34,733,000 33,021,000 42,145,000

Supplemental disclosure of cash paid for:

Interest expense, net of $0, $10, and $14 capitalized, respectively 76,000 192,000 207,000

Income taxes 12,827,000 9,963,000 9,377,000

Supplemental disclosure of non-cash investing and financing activities:

Capital lease obligations originated for property and equipment 74,000 109,000 32,000

Stock tendered to the Company for cashless exercise of stock options in connection with equity incentive plans $ 2,455,000 $ 397,000 $ 406,000

X

- Definition
The net change during the reporting period in the aggregate amount of expenses and accrued compensation incurred but not yet paid.
+ References
No definition available.
+ Details

Name: nrci_IncreaseDecreaseInAccruedExpensesWagesBonusesAndProfitSharing

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The current period expense charged against earnings to reserve for uncertain tax positions.
+ References
No definition available.
+ Details

Name: nrci_ReserveForUncertainTaxPositions

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The value of stock tendered to the company for cashless exercise of stock options in connection with equity incentive plans.
+ References
No definition available.
+ Details

Name: nrci_StockTenderedCashlessExerciseOfStockOptions

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase during the period in capital lease obligations due to entering into new capital leases.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586
+ Details

Name: us-gaap_CapitalLeaseObligationsIncurred

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3044-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817
+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68055307&loc=d3e2443-110228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84176398&loc=d3e2941-110230
+ Details

Name: us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906
+ Details

Name: us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=96864182&loc=d3e11374-113907
+ Details

Name: us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash outflow for realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=96864182&loc=d3e11374-113907
+ Details

Name: us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68055307&loc=d3e2443-110228
+ Details

Name: us-gaap_GainLossOnDispositionOfAssets1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586
+ Details

Name: us-gaap_IncomeTaxesPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInDeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes, and in deferred and other tax liabilities and assets.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInIncomeTaxes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in prepaid expenses, and assets classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period of the amount of revenue for work performed for which billing has not occurred, net of uncollectible accounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInUnbilledReceivables

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash paid for interest. Includes, but is not limited to, payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3536-108585
+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3536-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of other than temporary impairment (OTTI) losses on equity securities, OTTI related to credit losses on debt securities, and OTTI losses on debt securities when the entity intends to sell the securities or it is more likely than not that the entity will be required to sell the securities before recovery of its amortized cost basis. Additionally, this item includes OTTI losses recognized during the period on investments accounted for under the cost method of accounting.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 8B
-URI http://asc.fasb.org/extlink&oid=82897076&loc=SL6284393-111563
+ Details

Name: us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow to reacquire common stock during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDividendsCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash outflow to satisfy an employee's income tax withholding obligation as part of a net-share settlement of a share-based award.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 25
-Paragraph 19A
-URI http://asc.fasb.org/extlink&oid=96949009&loc=SL79513924-113897

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the purchase of all investments (debt, security, other) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsToMinorityShareholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This element represents the cash inflow during the period from the sale of a component of the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3179-108585
+ Details

Name: us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=SL79508275-113901
+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585
+ Details

Name: us-gaap_RepaymentsOfLongTermCapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for a borrowing supported by a written promise to pay an obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585
+ Details

Name: us-gaap_RepaymentsOfNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowElementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 23 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1

Consolidated Statements of Cash Flows (Parentheticals) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Interest expense, capitalized amount $ 0 $ 10 $ 14

X

- Definition
The amount of cash paid during the current period for interest that is capitalized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585
+ Details

Name: us-gaap_InterestPaidCapitalized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 24 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 1 - Summary of Significant Accounting Policies
12 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Significant Accounting Policies [Text Block]

(
1
)

Summary of Significant Accounting Policies

Description of Business and Basis of Presentation

National Research Corporation
, doing business as NRC Health (“NRC Health,” the “Company,” “we,” “our,” “us” or similar terms), is a leading provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers and other healthcare organizations in the United States and Canada. The Company’s solutions enable its clients to understand the voice of the customer with greater clarity, immediacy and depth.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company
and its wholly-owned subsidiary, National Research Corporation Canada. Prior to becoming a wholly-owned subsidiary in
March 2016,
the accounts of Customer-Connect LLC (“Connect”), then a variable interest entity for which NRC Health was deemed the primary beneficiary, were included in the consolidated financial statements of the Company. On
June 30, 2016,
Customer-Connect LLC was dissolved. All significant intercompany transactions and balances have been eliminated.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Translation of Foreign Currencies

The Company
’s Canadian subsidiary uses as its functional currency the local currency of the country in which it operates. It translates its assets and liabilities into U.S. dollars at the exchange rate in effect at the balance sheet date. It translates its revenue and expenses at the average exchange rate during the period. The Company includes translation gains and losses in accumulated other comprehensive income (loss), a component of shareholders’ equity. Gains and losses related to transactions denominated in a currency other than the functional currency of the country in which the Company operates and short-term intercompany accounts are included in other income (expense) in the consolidated statements of income.

Revenue Recognition

The Company derives a majority of its operating revenue from its annually renewable services, which include performance measurement and improvement services, healthcare analytics and governance education services. The Company provides these services to its clients under annual client service contracts, although such contracts are generally cancelable
on short or
no
notice without penalty. Services are provided under subscription-based service agreements. The Company recognizes subscription-based service revenue over the period of time the service is provided. Generally, the subscription periods are for
twelve
months and revenue is recognized equally over the subscription period.

Certain contracts
, excluding subscription-based service agreements, are fixed-fee arrangements with a portion of the project fee billed in advance and the remainder billed periodically over the duration of the project. Revenue for services provided under these contracts are recognized under the proportional performance method. Under the proportional performance method, the Company recognizes revenue based on output measures or key milestones such as survey set-up, survey mailings, survey returns and reporting. The Company measures its progress based on the level of completion of these output measures and recognizes revenue accordingly. Management judgments and estimates must be made and used in connection with revenue recognized using the proportional performance method. If management made different judgments and estimates, then the amount and timing of revenue for any period could differ materially from the reported revenue.

The Company
’s revenue arrangements with a client
may
include combinations of NRC Health’s Experience, Transparency, Governance, and Market Insights solutions which
may
be executed at the same time, or within close proximity of
one
another (referred to as a multiple-element arrangement). When the periods or patterns of revenue recognition differ, each element of a multiple-element arrangement is accounted for as a separate unit of accounting provided each delivered element is sold separately by the Company or another vendor; and for an arrangement that includes a general right of return relative to the undelivered elements, delivery or performance of the undelivered services are considered probable and substantially in the control of the Company. The Company’s arrangements generally do
not
include a general right of return related to the delivered services. If these criteria are
not
met, the arrangement is accounted for as a single unit of accounting with revenue generally recognized equally over the subscription period or recognized under the proportional performance method.

When a contract contains multiple elements, revenue is allocated to each separate unit of accounting based on relative selling price using a selling price hierarchy: vendor-specific objective evidence (“VSOE”), if available,
third
-party evidence (“TPE”) if VSOE is
not
available, or estimated selling price if VSOE nor TPE is available. VSOE is established based on the services normal selling price and discounts for the specific services when sold separately. TPE is established by evaluating similar competitor services in standalone arrangements. If neither exists for a deliverable, the best estimate of the selling price (“ESP”) is used for that deliverable based on list price, representing a component of management’s market strategy, and an analysis of historical prices for bundled and standalone arrangements. Revenue allocated to an element is limited to revenue that is
not
subject to refund or otherwise represents contingent revenue. VSOE, TPE and ESP are periodically adjusted to reflect current market conditions. These adjustments are
not
expected to differ significantly from historical results.

Business Combinations

The Company uses the acquisition method of accounting for acquired businesses. Under the acquisition method, the financial statements reflect the operations of an acquired business starting from the completion of the acquisition. The assets acquired and liabilities assumed are recorded at their respective estimated fair values at the date of the acquisition. Any excess of the purchase price over the
estimated fair values of the identifiable net assets acquired is recorded as goodwill. Significant judgment is required in estimating the fair value of assets acquired, especially intangible assets. As a result, in the case of significant acquisitions the Company typically engages
third
-party valuation specialists in estimating fair values of tangible and intangible assets. The fair value estimates are based on available historical information and on expectations and assumptions about the future, considering the perspective of marketplace participants.

Trade Accounts Receivable

Trade accounts receivable are recorded at the invoiced amount. The allowance for doubtful accounts is the Company
’s best estimate of the amount of probable credit losses in the Company’s existing accounts receivable. The Company determines the allowance based on the Company’s historical write-off experience and current economic conditions. The Company reviews the allowance for doubtful accounts monthly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The following table provides the activity in the allowance for doubtful accounts for the years ended
December 31, 2017,
2016
and
2015:

Balance at

Beginning

of Year

Bad Debt

Expense

Write-offs

Net of

Recoveries

Balance

at End

of Year

(In thousands)

Year Ended December 31, 2015
$
206
$
111
$
144
$
173

Year Ended December 31, 2016
$
173
$
218
$
222
$
169

Year Ended December 31, 2017
$
169
$
249
$
218
$
200

Property and Equipment

Property and equipment is stated at cost. Major expenditures to purchase property or to substantially increase useful lives of property are capitalized. Maintenance, repairs and minor renewals are expensed as incurred. When assets are retired or otherwise disposed of, their costs and related accumulated depreciation are removed from the accounts and resulting gains or losses are included in income.

The Company capitalizes certain costs incurred in connection with obtaining or developing internal-use software, including payroll and payroll-related costs for employees who are directly associated with the internal-use software projects and external direct costs of materials and services. Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose. Costs incurred during the preliminary project and post-implementation stages, as well as software maintenance and training costs are expensed as incurred.
The Company capitalized approximately
$3.0
million and
$2.5
million of costs incurred for the development of internal-use software for the years ended
December 31, 2017
and
2016,
respectively.

T
he Company provides for depreciation and amortization of property and equipment using annual rates which are sufficient to amortize the cost of depreciable assets over their estimated useful lives. The Company uses the straight-line method of depreciation and amortization over estimated useful lives of
three
to
ten
years for furniture and equipment,
three
to
five
years for computer equipment,
one
to
five
years for capitalized software, and
seven
to
forty
years for the Company’s office building and related improvements.

Leases are categorized as operating or capital at the inception of the lease. Assets under capital lease obligations are reported at the lower of fair value or the present value of the aggregate future minimum lease payments at the beginning of the lease term. The Company depreciates capital lease assets
without transfer-of-ownership or bargain-purchase-options using the straight-line method over the lease terms, excluding any lease renewals, unless the lease renewals are reasonably assured. Capital lease assets with transfer-of-ownership or bargain-purchase-options are depreciated using the straight-line method over the assets’ estimated useful lives.

Impairment of Long-L
ived Assets and Amortizing Intangible Assets

Long-lived
assets, such as property and equipment and purchased intangible assets subject to depreciation or amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset
may
not
be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, the Company
first
compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is
not
recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and
third
-party independent appraisals, as considered necessary.
No
impairments were recorded during the years ended
December 31, 2017,
2016,
or
2015.

Among others, m
anagement believes the following circumstances are important indicators of potential impairment of such assets and as a result
may
trigger an impairment review:

●

Significant underperformance in comparison to historical or projected operating results;

●

Significant changes in the manner or use of acquired assets or the Company
’s overall strategy;

●

Significant negative trends in the Company
’s industry or the overall economy;

●

A significant decline in the market price for the Company
’s common stock for a sustained period; and

●

The Company
’s market capitalization falling below the book value of the Company’s net assets.

Goodwill and
Intangible Assets

Intangible assets include customer relationships, trade names,
technology, non-compete agreements and goodwill. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets
may
not
be recoverable. The Company reviews intangible assets with indefinite lives for impairment annually as of
October 1
and whenever events or changes in circumstances indicate that the carrying value of an asset
may
not
be recoverable.

When performing the impairment assessment, the Company will
first
assess qualitative factors to determine whether it is necessary to recalculate the fair value of the intangible assets with indefinite lives. If the Company believes, as a result of the qualitative assessment, that it is more likely than
not
that the fair value of the indefinite
-lived intangibles is less than their carrying amount, the Company calculates the fair value using a market or income approach. If the carrying value of intangible assets with indefinite lives exceeds their fair value, then the intangible assets are written-down to their fair values. The Company did
not
recognize any impairments related to indefinite-lived intangibles during
2017,

2016
or
2015.

Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are
not
individually identified and separately recognized. All of the Company
’s goodwill is allocated to its reporting units, which are the same as its operating segments. Goodwill is reviewed for impairment at least annually, as of
October 1,
and whenever events or changes in circumstances indicate that the carrying value of goodwill
may
not
be recoverable.

In
January 2017,
the FASB issued A
ccounting Standards Update (“ASU”)
2017
-
04,

Intangibles—Goodwill and Other
(Topic
350
),
Simplifying the Test for Goodwill Impairment
(“ASU
2017
-
04”
). In connection with the
October 1, 2017
annual impairment analysis, the Company early adopted ASU
2017
-
04,
which eliminates the need to determine the fair value of individual assets and liabilities of a reporting unit to measure goodwill impairment (Step
2
). The new guidance
may
result in more or less impairment than could previously be recognized. The adoption of this guidance did
not
impact the Company's results of operations or financial position since only a qualitative analysis was performed as part of the
October 1, 2017
annual impairment analysis.

The Company reviews for
goodwill impairment by
first
assessing qualitative factors to determine whether any impairment
may
exist. If the Company believes, as a result of the qualitative assessment, that it is more likely than
not
that the fair value of a reporting unit is less than its carrying amount, a quantitative analysis will be performed, and the fair value of the reporting unit is compared with its carrying value (including goodwill). If the fair value of the reporting unit exceeds its carrying value, then goodwill is written down by this difference. The Company performed a qualitative analysis as of
October 1, 2017
and determined the fair value of each reporting unit likely significantly exceeded its carrying value.
No
impairments were recorded during the years ended
December 31, 2017,
2016
or
2015.

Income Taxes

The Company uses the asset and liability method of accounting for income taxes. Under that method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bas
is using enacted tax rates. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances, if any, are established when necessary to reduce deferred tax assets to the amount that is more likely than
not
to be realized. The Company uses the deferral method of accounting for its investment tax credits related to state tax incentives. During the years ended
December 31, 2017,
2016
and
2015,
the Company recorded income tax benefits relating to these tax credits of
$4,000,

$77,000,
and
$156,000,
respectively.

T
he Company recognizes the effect of income tax positions only if those positions are more likely than
not
of being sustained. Recognized income tax positions are measured at the largest amount that is greater than
50%
likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.

Share-Based Compensation

The compensation expense
on share-based payments is recognized based on the grant-date fair value of those awards. All of the Company’s existing stock option awards and non-vested stock awards have been determined to be equity-classified awards. The Company prospectively elected ASU
2016
-
09,
Compensation – Stock Compensation (Topic
718
) Improvements to Employee Share-Based Payment Accounting
(“ASU
2016
-
09”
) in
2016.
As a result, the tax benefit from stock options exercised was recognized as a reduction to our provision for income taxes for the years ended
December 31, 2017
and
2016
rather than as an increase to additional paid-in capital for the year ended
December 31, 2015
prior to adoption.

Amounts recognized in the financial statements with respect to these plans:

20
17

20
16

20
15

(In thousands)

Amounts charged against income, before income tax benefit
$
1,845
$
1,929
$
1,383

Amount of related income tax benefit

(2,310
)
(1,164
)
(505
)

Net (benefit) expense
to net income
$
(465
) $
765
$
878

Cash and Cash Equivalents

T
he Company considers all highly liquid investments with original maturities of
three
months or less to be cash equivalents. Cash equivalents were
$34.5
million and
$32.7
million as of
December 31, 2017,
and
2016,
respectively, consisting primarily of money market accounts, Eurodollar deposits and funds invested in commercial paper. At certain times, cash equivalent balances
may
exceed federally insured limits.

Reclassifications

Reclassifications
of
$191,000
have been made from noncurrent deferred income taxes to other noncurrent liabilities in the
2016
consolidated balance sheet to present the unrecognized tax benefits related to state taxes gross of federal tax benefits, consistent with the
2017
financial statement presentation. There was
no
impact on the previously reported net income and earnings per share.

Fair Value
Measurements

The Company
’s valuation techniques are based on maximizing observable inputs and minimizing the use of unobservable inputs when measuring fair value. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect the Company’s market assumptions. The inputs are then classified into the following hierarchy: (
1
) Level
1
Inputs—quoted prices in active markets for identical assets and liabilities; (
2
) Level
2
Inputs—observable market-based inputs other than Level
1
inputs, such as quoted prices for similar assets or liabilities in active markets, quoted prices for similar or identical assets or liabilities in markets that are
not
active, or other inputs that are observable or can be corroborated by observable market data; (
3
) Level
3
Inputs—unobservable inputs.

Commercial paper
and Eurodollar deposits are included in cash equivalents and are valued at amortized cost, which approximates fair value due to its short-term nature. Eurodollar deposits are United States dollars deposited in a foreign bank branch of a United States bank and have daily liquidity. Both of these are included as a Level
2
measurement in the table below.

The following details the Company’s financial assets within the fair value hierarchy at
December 31, 2017
and
2016:

Level 1

Level 2

Level 3

Total

(In thousands)

As of December 31, 201
7

Money Market Funds $
13,971
$
--
$
--
$
13,971

Commercial Paper
--

10,490

--

10,490

Eurodollar Deposits
--

10,017

--

10,017

Total
Cash Equivalents
$
13,971
$
20,507
$
--
$
34,478

As of December 31, 201
6

Money Market Funds $
11,200
$
--
$
--
$
11,200

Commercial Paper
--

21,450

--

21,450

Total
Cash Equivalents
$
11,200
$
21,450
$
--
$
32,650

There were
no
transfers between levels during the years ended
December 31,
201
7
and
2016.

The Company's long-term
debt described in Note
8
is recorded at historical cost. The fair value of long-term debt is classified in Level
2
of the fair value hierarchy and was estimated based primarily on estimated current rates available for debt of the same remaining duration and adjusted for nonperformance and credit.

The following are the carrying a
mount and estimated fair values of long-term debt:

December 31,
2017

December 31, 201
6

(In thousands)

Total carrying amount of long-term debt
$
1,067
$
3,540

Estimated fair value of long-term debt
$
1,066
$
3,533

The carrying amounts of accounts receivable, accounts payable, and accrued expenses approximate their fair value. All non-financial assets that are
not
recognized or disclosed at fair value in the financial statements on a recurring basis, which includes
property and equipment, goodwill, intangibles and cost method investments, are measured at fair value in certain circumstances (for example, when there is evidence of impairment). As of
December 31, 2017
and
2016,
there was
no
indication of impairment related to these assets.

C
ontingencies

From time to time, the Company is involved in certain claims and litigation arising in the normal course of business. Management assesses the probability of loss for such contingencies and recognizes a liability when a loss is probable and estimable.

Since the Septembe
r
2017
announcement of the original proposed recapitalization plan (see Note
13
),
three
purported class action and/or derivative complaints have been filed in state or federal courts by
three
individuals claiming to be shareholders of the Company. All of the complaints name as defendants the Company and the individual directors of the Company. Two of these lawsuits were filed in the United States District Court for the District of Nebraska— a putative class action lawsuit captioned
Gennaro v. National Research Corporation, et al.
, and a putative class and derivative action lawsuit captioned
Gerson v. Hays, et al.
,. These lawsuits were consolidated by order of the federal court. A
third
lawsuit was filed the Circuit Court for Milwaukee County, Wisconsin—a putative class action lawsuit captioned
Apfel
v.
Hays, et al
. The allegations in all of the lawsuits are very similar. The plaintiffs allege, among other things, that the defendants breached their fiduciary duties in connection with the allegedly unfair proposed transaction, at an allegedly unfair price, conducted in an allegedly unfair and conflicted process and in alleged violation of Wisconsin law and the Company’s Articles of Incorporation. One of the lawsuits also alleges the proposed transactions is a voidable “conflict of interest transaction” under Wisconsin statutes. The plaintiffs in these lawsuits seek, among other things, an injunction enjoining the defendants from consummating the original proposed recapitalization plan, damages, equitable relief and an award of attorneys’ fees and costs of litigation. The Company believes that the allegations of the complaints are without merit and intends to defend these lawsuits vigorously. Despite the changes to the original proposed recapitalization plan that culminated in the
December 13, 2017
announcement of a revised proposed recapitalization plan, the Company expects that these shareholders or other shareholders might assert similar claims regarding the proposed recapitalization plan. The Company will defend any such lawsuits vigorously.

As of
December 31, 2017,
no
losses have been accrued as the Company does
not
believe the losses are probable or estimable.

Earnings Per Share

Net income per share of class A common stock and class B common stock is computed using the
two
-class method. Basic net income per share is computed by allocating undistributed earnings to common shares and using the weighted-average number of common shares outstanding during the period.

Diluted net income per share is computed using the weighted-average number of common shares and, if dilutive, the potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and vesting of restricted stock. The dilutive effect of outstanding stock options is reflected in diluted earnings per share by application of the treasury stock method.

The liquidation rights and the rights upon the consummation of an extraordinary transaction are the same for the holders of class A common stock and class B common stock. Other than share distributions and liquidation rights, the amount of any dividend or other distribution payable on each share of class A common stock will be equal to
one
-
sixth
(
1/6
th
) of the amount of any such dividend or other distribution payable on each share of class B common stock. As a result, the undistributed earnings for each year are allocated based on the contractual participation rights of the class A and class B common stock as if the earnings for the year had been distributed.

At
December 31,
20
16,
and
2015,
the Company had
156,610
and
487,639
options of class A shares and
49,262,
and
58,429
options of class B shares, respectively, which have been excluded from the diluted net income per share computation because the exercise price exceeds the fair market value. At
December 31, 2017,
2016,
and
2015
an additional
104,647,

390,300,
and
68,779
options of class A shares and
1,858,

34,178,
and
1,101
options of class B shares, respectively were excluded as their inclusion would be anti-dilutive.

2017 2016 2015

Class A

Class B

Class A

Class B

Class A

Class B

(In thousands, except per share data)

Numerato
r for net income per share - basic:

Net income
$
11,388
$
11,555
$
10,178
$
10,341
$
8,759
$
8,851

Allocation of distributed and undistributed income to unvested restricted stock shareholders

(88
)
(87
)
(88
)
(88
)
(76
)
(77
)

Net income attributable to common shareholders
$
11,300
$
11,468
$
10,090
$
10,253
$
8,683
$
8,774

Denominator for net income per
share - basic:

Weighted average common shares outstanding - basic

20,770

3,514

20,713

3,505

20,741

3,478

Net income per share - basic
$
0.54
$
3.26
$
0.49
$
2.93
$
0.42
$
2.52

Numerator for net income per share - diluted:

Net income attributable to common shareholders for

basic computation
$
11,300
$
11,468
$
10,090
$
10,253
$
8,683
$
8,774

Denominator for net income per share - diluted:

Weighted average common
s
hares outstanding - basic

20,770

3,514

20,713

3,505

20,741

3,478

Weighted average effect of dilutive securities
– stock options:

857

89

324

55

240

44

Denominator for diluted earnings per share
– adjusted weighted average shares

21,627

3,603

21,037

3,560

20,981

3,522

Net income per share - diluted
$
0.52
$
3.18
$
0.48
$
2.88
$
0.41
$
2.49

Recent Accounting Pronouncements
Not
Yet Adopted

In
May 2014,
the FASB issued ASU
2014
-
09,

Revenue from Contracts with Customers (Topic
606
)
(“ASU
2014
-
09”
). ASU
2014
-
09
requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU
2014
-
09
will replace most existing revenue recognition guidance in accounting principles generally accepted in the United States when it becomes effective. The standard is effective for annual and interim reporting periods in fiscal years beginning after
December 15, 2017.
An entity
may
choose to adopt ASU
2014
-
09
either retrospectively or through a cumulative effect adjustment as of the start of the
first
period for which it applies the standard. The Company has completed system changes and is analyzing the resulting impact that this new guidance will have on its consolidated financial statements. The Company will adopt this new guidance using the modified retrospective approach beginning
January 1, 2018
by recording a cumulative effect adjustment. The Company expects the most significant change to result from deferring direct and incremental costs of obtaining a contract, consisting of commissions and incentives, and recognizing the expense over the estimated life of the client contract, including renewal periods, rather than expensing as incurred, which is the Company’s current practice. The Company expects adjustments to retained earnings of
no
more than
$2.7
million, net of related tax effects, upon adoption of deferring and amortizing direct and incremental contract costs. The Company also expects to record other immaterial adjustments, related to performance obligation determinations and estimating variable contingent consideration for certain contracts which were previously only recognized once the contingency was resolved and the services were performed. These amounts are only estimates and involve significant judgements by management including estimating the lives of its contracts, the value of performance deliverables and the expected amount to be earned from the satisfaction of those deliverables. The Company will finalize its calculation of the financial impact of the adoption of ASU
2014
-
09
in the
first
quarter of
2018.
ASU
2014
-
09
also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract.

In
January 2016,
the FASB issued ASU
2016
-
01,
Financial Instruments
—Overall: Recognition and Measurement of Financial Assets and Financial Liabilities. ASU
2016
-
01
changes certain recognition, measurement, presentation and disclosure aspects related to financial instruments. ASU
2016
-
01
is effective for financial statements issued for fiscal years beginning after
December 15, 2017,
and interim periods within those fiscal years. Early adoption is
not
permitted. The Company believes its adoption will
not
significantly impact the Company’s results of operations and financial position.

In
February 2016,
the FASB issued ASU
2016
-
02,
Leases (Topic
842
). This ASU requires lessees to recognize a lease liability and a right-to-use asset for all leases, including operating leases, with a term greater than
twelve
months on its balance sheet. This ASU is effective in fiscal years beginning after
December 15, 2018,
with early adoption permitted, and requires a modified retrospective transition method. As of
December 31, 2017,
the Company had approximately
$3.0
million of operating lease commitments which would be recorded on the balance sheet under the new guidance. However, the Company is currently in the process of further evaluating the impact that this new guidance will have on its consolidated financial statements and does
not
plan to elect early adoption.

In
June 2016,
the FASB issued ASU
2016
-
13,
Financial Instruments
– Credit Losses (Topic
326
): Measurement of Credit Losses on Financial Instruments. This ASU will require the measurement of all expected credit losses for financial assets, including trade receivables, held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. The guidance is effective for annual reporting periods beginning after
December 15, 2019
and interim periods within those fiscal years. The Company believes its adoption will
not
significantly impact the Company’s results of operations and financial position.

In
August 2016,
the FASB issued ASU
2016
-
15,
Statement of Cash Flows (Topic
230
) Classification of Certain Cash Receipts and Cash Payments which eliminates the diversity in practice related to
eight
cash flow classification issues.
This ASU is effective for the Company on
January 1, 2018
with early adoption permitted. The Company will adopt this ASU on
January 1, 2018
and believes it will
not
impact the Company’s results of operations and financial position.

In
October 2016,
the FASB issued ASU
2016
-
16,
Intra-Entity Transfers of Asset Other Than Inventory (“ASU
2016
-
16”
), which requires entities to recognize the tax consequences of intercompany asset transfers other than inventory transfers in the period in which the transfer takes place. ASU
2016
-
16
is effective for fiscal years and interim periods within fiscal years beginning after
December 15, 2017.
ASU
2016
-
16
is to be adopted using a modified retrospective approach with a cumulative effect adjustment to retained earnings as of the beginning of the period of adoption. The cumulative effect adjustment will include recognition of the income tax consequences of intra-entity transfers of assets other than inventory that occur before the adoption date.
The Company believes the adoption of ASU
2016
-
16
will
not
impact the Company’s consolidated financial statements.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 25 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 2 - Equity Investments
12 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Cost and Equity Method Investments Disclosure [Text Block]

(
2
)

Equity Investments

The Company
makes equity investments to promote business and strategic objectives. For investments that do
not
have a readily determinable fair value, the Company applies either cost or equity method of accounting depending on the nature of its investment and its ability to exercise significant influence. Investments are periodically analyzed to determine whether or
not
there are any indicators of impairment and written down to fair value if the investment has incurred an other than temporary impairment. During
2017,
the Company acquired a
$1.3
million investment in convertible preferred stock of Practicing Excellence.com, Inc., a privately-held Delaware Corporation (“PX”), which is carried at cost and included in other non-current assets. The Company has a seat on PX's board of directors and the Company's investment, which is
not
considered to be in-substance common stock, represents approximately
15.7%
of the issued and outstanding equity interests in PX.

X

- Definition
The entire disclosure for cost method and equity method investments included basis, impairment losses, recognized or unrecognized gains (losses).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 325
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=2197087

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-URI http://asc.fasb.org/topic&trid=2196965
+ Details

Name: us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 26 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 3 - Divestitures
12 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

(
3
)

Divestitures

On
December 21
,
2015,
the Company completed the sale of selected assets and liabilities related to the clinical workflow product of the Predictive Analytics operating segment, for a net cash amount of approximately
$1.6
million. The Company recorded a gain of approximately
$1.1
million from the sale, which is included in other income on the Statement of Income. In connection with the closing of the transaction,
$300,000
was placed in escrow to cover certain indemnification claims for
one
year following the transaction pursuant to the purchase agreement. Due to the uncertainty related to the settlement of the claims, escrowed amounts were recognized when the contingency was removed and the cash was released from escrow rather than at the time of sale. The Company received
$223,000
of the escrow funds in
December 2016
upon final resolution of the claims and recorded an additional gain on the sale from these funds. The lack of operating results from this business due to its divestiture did
not
have a major effect on our operations and financial results, and, accordingly, it was
not
classified as a discontinued operation for any of the periods presented.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-URI http://asc.fasb.org/topic&trid=2155823

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=2122178
+ Details

Name: us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 27 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 4 - Connect
12 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Noncontrolling Interest Disclosure [Text Block]

(
4
)

Connect

Customer-Connect LLC was formed in
June 2013
to develop and commercialize the Connect programs. Connect programs provide healthcare organizations the technology to engage patients through real-time identification and management of individual patient needs, preferences, risks, and experiences.
The platform ensures that organizations have access to a longitudinal view of the patient to more effectively manage patient engagement across the continuum of care. At inception, NRC Health had a
49%
ownership interest in Connect. NG Customer-Connect, LLC held a
25%
interest, and the remaining
26%
was held by Illuminate Health, LLC. Profits and losses were allocated under the hypothetical liquidation at book value approach.

In
July 2015,
the
Company acquired all of NG Customer-Connect, LLC’s interest in Connect and a portion of Illuminate Health LLC’s interest in Connect for combined consideration of
$2.8
million. As a result, as of
December 31, 2015,
the Company owned approximately
89%
of Connect and Illuminate Health, LLC owned
11%.
Under the amended operating agreement, NRC Health had the option to acquire additional equity units from Illuminate Health when new annual recurring contract value reached targeted levels. On
March 7, 2016,
the Company elected to exercise its
first
option to acquire
one
-
third
of the outstanding non-controlling interest for
$1.0
million. Subsequently, on
March 28, 2016,
NRC Health and Illuminate Health reached an agreement whereby NRC Health acquired the remaining interest held by Illuminate Health for
$1.0
million. Following these transactions, Customer-Connect LLC was a wholly owned subsidiary of NRC Health. All of Connect’s previous net income (losses) had been attributable to NRC Health. Since the Company previously consolidated Connect, the transactions to acquire additional ownership interests in Connect were accounted for as equity transactions, resulting in a reduction to additional paid-in capital of
$252,000
and
$2.8
million in
2016
and
2015,
respectively.
The acquisition of the remaining interest resulted in differences between the book and tax basis of Connect’s assets. As a result, the Company recorded deferred tax assets of
$1.7
million, with a corresponding increase to additional paid-in capital during
2016.
On
June 30, 2016,
Customer-Connect LLC was dissolved.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-URI http://asc.fasb.org/topic&trid=2197479
+ Details

Name: us-gaap_MinorityInterestDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 5 - Property and Equipment
12 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Property, Plant and Equipment Disclosure [Text Block]

(
5
)

Property and Equipment

At
December 31,
2017,
and
2016,
property and equipment consisted of the following:

201
7

201
6

(In thousands)

Furniture and equipment
$
5,064
$
4,737

Computer equipment

2,721

2,750

Computer software

22,569

20,592

Building

9,386

9,386

Leaseholds

41

--

Land

425

425

Property and equipment at cost

40,206

37,890

Less accumulated depreciation and amortization

27,847

26,084

Net property and equipment
$
12,359
$
11,806

Depreciation and amortization expense related to property and equipment
, including assets under capital lease, for the years ended
December 31, 2017,
2016,
and
2015
was
$4.0
million,
$3.6
million, and

$3.1
million, respectively.

Property and equipment included the following amounts under capital lease:

2017

2016

(In thousands)

Furniture and equipment
$
843
$
769

Property and equipment under capital lease, gross

843

769

Less accumulated amortization

684

530

Net assets under capital lease
$
159
$
239

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-URI http://asc.fasb.org/topic&trid=2155823
+ Details

Name: us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 6 - Goodwill and Intangible Assets
12 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Goodwill and Intangible Assets Disclosure [Text Block]

(
6
)

Goodwill and Intangible Assets

Goodwill and intangible assets consisted of the following at
December 31,
201
7:

Useful Life

Gross

Accumulated Amortization

Net

(In years)

(In thousands)

Goodwill

$
58,021

$
58,021

Non-amortizing intangible assets:

Indefinite trade name

1,191

1,191

Amortizing intangible assets:

Customer related

5

-

15

9,347

8,611

736

Technology

7

1,360

523

837

Trade names

5

-

10

1,572

1,572

--

Total amortizing intangible assets

12,279

10,706

1,573

Total intangible assets other than goodwill

$
13,470
$
10,706
$
2,764

G
oodwill and intangible assets consisted of the following at
December 31, 2016:

Useful Life

Gross

Accumulated Amortization

Net

(In years)

(In thousands)

Goodwill

$
57,861

$
57,861

Non-amortizing intangible assets:

Indefinite trade name

1,191

1,191

Amortizing intangible assets:

Customer related

5

-

15

9,331

8,164

1,167

Technology

7

1,110

344

766

Trade names

5

-

10

1,572

1,572

--

Total amortizing intangible assets

12,013

10,080

1,933

Total intangible assets other than goodwill

$
13,204
$
10,080
$
3,124

The following represents a summary of changes in the Company’s carrying amount of goodwill for the years ended
December 31, 2017,
and
2016
(in thousands):

Balance as of December 31, 201
5
$
57,792

Foreign currency translation

69

Balance as of December 31, 201
6
$
57,861

Foreign currency translation

160

Balance as of December 31, 201
7
$
58,021

Aggregate amortization expense for customer
related intangibles, trade names, technology and non-competes for the years ended
December 31, 2017,
2016
and
2015
was
$610,000,

$654,000,
and
$995,000,
respectively. Estimated amortization expense for the next
five
years is:
2018—
$662,000;

2019—
$374,000;

2020—
$318,000;

2021—
$180,000;

2022—
$39,000.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-URI http://asc.fasb.org/topic&trid=2144416
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 30 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 7 - Income Taxes
12 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Income Tax Disclosure [Text Block]

(
7
)

Income Taxes

For
the years ended
December 31, 2017,
2016,
and
2015,
income before income taxes consists of the following:

201
7

20
16

201
5

(In thousands)

U.S. Operations
$
32,750
$
29,848
$
25,536

Foreign Operations

1,533

1,508

1,824

Income before income taxes
$
34,283
$
31,356
$
27,360

Income tax expense consisted of the following components
:

201
7
201
6
201
5

(In thousands)

Federal
:

Current
$
10,947
$
8,930
$
9,955

Deferred

(1,596
)
847

(1,232
)

Total
$
9,351
$
9,777
$
8,723

Foreign
:

Current
$
387
$
409
$
455

Deferred

704

(18
)
(23
)

Total
$
1,091
$
391
$
432

State
:

Current
$
837
$
634
$
680

Deferred

61

36

(85
)

Total
$
898
$
670
$
595

Total
$
11,340
$
10,838
$
9,750

Federal Tax Reform

On
December 22, 2017,
the Tax Cut and Jobs Act (the “Tax Act”)
was enacted which, among other changes, reduces the U.S. federal corporate tax rate from
35%
to
21%
effective
January 1, 2018.
The Tax Act makes broad and complex changes to the U.S. tax code and it will take time to fully analyze the impact of the changes. Based on the information available, and the current interpretation of the Tax Act, the Company was able to make a reasonable estimate and recorded a provisional net tax benefit related to the remeasurement of the deferred tax assets and liabilities due to the reduction in the U.S. federal corporate tax rate, offset by the
one
-time mandatory deemed repatriation tax, payable over
eight
years. Pursuant to the Staff Accounting Bulletin published by the United States Securities and Exchange Commission on
December 22, 2017,
addressing the challenges in accounting for the effects of the Tax Act in the period of enactment, companies must report provisional amounts for those specific income tax effects of the Tax Act for which the accounting is incomplete but a reasonable estimate can be determined. Those provisional amounts will be subject to adjustment during a measurement period of up to
one
year from the enactment date. Pursuant to this guidance, the estimated impact of the Tax Act is based on a preliminary review of the new tax law and projected future financial results and is subject to revision based upon further analysis and interpretation of the Tax Act and to the extent that future results differ from currently available projections. The Company’s accounting for the following elements of the Tax Act is incomplete. However, the Company was able to make reasonable estimates and recorded a provisional net tax benefit of
$1.9
million related to the following elements of the Tax Act pursuant to the Staff Accounting Bulletin referred to above:

●

Reduction of U.S. Federal Corporate Tax Rate: The Tax Act reduces the corporate tax rate to
21%,
effective
January 1, 2018.
Consequently, we have recorded a decrease related to deferred tax assets and liabilities with a corresponding net adjustment to deferred income tax benefit for the year ended
December 31, 2017.
Since the Company has recorded provisional amounts related to certain portions of the Tax Act, any corresponding deferred tax remeasurement is also provisional.
For example, the Tax Act had several changes that were depreciation related. The primary change for the Company would be the availability of
100%
bonus depreciation on assets placed in service after
September 27, 2017.
The Company is still evaluating which assets meet the requirements of this and therefore,
no
adjustments have been recorded related to this portion of the Tax Act as of
December 31, 2017.
In addition, under the Tax Act, expense under certain stock compensation plans
may
now be subject to limitations as to deductibility and the Company is still reviewing and analyzing each plan to determine the impact.

●

One-Time Mandatory Deemed Repatriation Tax: Under the Tax Act, the Company will be subject to a
one
-time mandatory deemed repatriation tax on accumulated non-U.S. earnings. The estimated impact of the Tax Act is based on a preliminary review of the new law.
Several estimates were used in these calculations and the Company is still finalizing the material inputs, therefore all repatriation adjustments are considered provisional. For example, the Company’s expected use of foreign tax credits and credit carryforwards
may
be impacted once the analysis is completed. Currently, the Company estimates that it will be unable to use approximately
$535,000
of foreign tax credit carryforwards and has provided a full valuation allowance against such amount.

●

Global Intangible Low-Taxed Income (
“GILTI”) Policy Election: The GILTI provisions of the Tax Act do
not
apply to the Company until
2018
and we are still evaluating its impact. The FASB allows companies to adopt an accounting policy to either recognize deferred taxes for GILTI or treat such tax cost as a current-period expense when incurred. We have
not
yet determined our accounting policy because determining the impact of the GILTI provisions requires analysis of our existing legal entity structure, the reversal of our U.S. generally accepted accounting principles and U.S. tax basis differences in the assets and liabilities of our foreign subsidiary, and our ability to offset any tax with foreign tax credits. As such, we have
not
made a policy decision regarding whether to record deferred taxes on GILTI or treat such tax cost as a current-period expense.

In addition, as a result of the Tax Act, the Company determined that it would
no
longer indefinitely reinvest the earnings of its Canadian subsidiary and recorded the withholding tax of
$706,000
associated with this planned repatriation.

The difference between the Company
’s income tax expense as reported in the accompanying consolidated financial statements and the income tax expense that would be calculated applying the U.S. federal income tax rate of
35%
for
2017,

2016,
and
2015
on pretax income was as follows:

20
17

20
16

20
15

(
In thousands)

Expected federal income taxes
$
11,999
$
10,975
$
9,576

Foreign tax rate differential

(131
)
(129
)
(139
)

State income taxes, net of federal benefit and state tax credits

608

436

391

Federal tax
credits

(130
)
(165
)
(150
)

Uncertain tax positions

151

6

93

Nondeductible expenses related to
proposed recapitalization

504

--

--

Share based compensation

(1,564
)
(441
)
--

Compensation limit for covered employees

955

--

--

Impact of
2017 Tax Act

(2,415
)
--

--

Valuation allowance

535

--

--

Withholding tax on repatriation
of foreign earnings

706

--

--

Other

122

156

(21
)

Total
$
11,340
$
10,838
$
9,750

Deferred tax assets and liabilities at
December 31,
2017
and
2016,
were comprised of the following:

2017

2016

(In thousands)

Deferred tax assets:

Allowance for doubtful accounts
$
46
$
62

Accrued expenses

416

580

Share based compensation

1,457

2,357

Accrued bonuses

113

84

Foreign tax credit
from repatriation

535

--

Other

166

244

Gross deferred tax assets

2,733

3,327

Less Valuation Allowance

(535
)
--

Deferred Tax Assets

2,198

3,327

Deferred tax liabilities:

Prepaid expenses

169

270

Property and equipment

856

1,206

Intangible assets

4,497

6,521

Repatriation withholding

706

--

Deferred tax liabilities

6,228

7,997

Net deferred tax liabilities
$
(4,030
) $
(4,670
)

In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than
not
that some portion
, or all, of the deferred tax assets will
not
be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company considers projected future taxable income, carry-back opportunities, and tax planning strategies in making this assessment. Based upon the level of historical taxable income and projections for future taxable income over the periods which the deferred tax assets are deductible, the Company believes it is more likely than
not
that it will realize the benefits of these deductible differences excluding the foreign tax credit carryforward.

The Company had an unrecognized tax benefit at
December 31,
201
7
and
2016,
of
$843,000
and
$662,000,
respectively, excluding interest of
$5,000
and
$2,000
at
December 31, 2017
and
2016,
respectively. Of these amounts,
$620,000
and
$472,000
at
December 31, 2017
and
2016,
respectively, represents the net unrecognized tax benefits that, if recognized, would favorably impact the effective income tax rate. The change in the unrecognized tax benefits for
2017
and
2016
is as follows:

(In thousands)

Balance of unrecognized tax benefits at December 31, 2015
$
589

Reductions due to lapse of applicable statute of limitations

(148
)

Additions based on tax positions of prior years

5

Additions based on tax positions related to the current year

216

Balance of unrecognized tax benefits at December 31, 2016
$
662

Reductions due to lapse of applicable statute of limitations

--

Reductions due to tax positions of prior years

(7
)

Additions based on tax positions related to the current year

188

Balance of unrecognized tax benefits at December 31, 2017
$
843

The Company files a U.S. federal income tax return, various state jurisdictions
returns and a Canada federal and provincial income tax return. All years prior to
2014
are now closed for US federal income tax and for years prior to
2014
for state income tax returns, and
no
exposure items exist for these years. The Company completed a United States federal tax examination for the tax year ended
December 31, 2013
in the
first
quarter of
2016.
The
2013
to
2017
Canada federal and provincial income tax returns remain open to examination.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 8 - Notes Payable
12 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Debt Disclosure [Text Block]

(
8
)

Notes Payable

Note
s payable consisted of the following:

2
017

20
16

(In thousands)

Revolving credit note with U.S. Bank, maximum available $12.0 million, matures June 30, 2018
$
--
$
--

Note payable to U.S. Bank for $11.8 million, interest at a 3.12% fixed rate, monthly principal and interest payments of $212,468 through April 2018

1,067

3,540

Total notes payable

1,067

3,540

Less current portion

1,067

2,683

Note payable, net of current portion
$
--
$
857

The Company
’s revolving credit note was amended and extended effective
June 30, 2017
with a maturity date of
June 30, 2018.
The maximum aggregate amount available under the revolving credit note is
$12.0
million. Borrowings under the revolving credit note bear interest at a variable annual rate, with
three
rate options at the discretion of management as follows: (
1
)
2.1%
plus the
one
-month London Interbank Offered Rate (“LIBOR”) or (
2
)
2.1%
plus the
one
-,
two
- or
three
- month LIBOR rate, or (
3
) the bank’s
one
-, two, three, six, or
twelve
month Money Market Loan Rate. As of
December 31, 2017
the revolving credit note did
not
have a balance and the Company had the capacity to borrow
$12.0
million.

The term note and revolving credit note are secured by certain of the Company
’s assets, including the Company’s land, building, accounts receivable and intangible assets. The term note and the revolving credit note contain various restrictions and covenants applicable to the Company, including requirements that the Company maintain certain financial ratios at prescribed levels and restrictions on the ability of the Company to consolidate or merge, create liens, incur additional indebtedness or dispose of assets. As of
December 31, 2017,
the Company was in compliance with the financial covenants.

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564
+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 32 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 9 - Share-based Compensation
12 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

(
9
)

Share-Based Compensation

The Company measures and recognizes compensation expense for all share-based payments based on the grant-date fair value of those awards. All of the Company
’s existing stock option awards and non-vested stock awards have been determined to be equity-classified awards.

The
National Research Corporation
2001
Equity Incentive Plan (
“2001
Equity Incentive Plan”) provided for the granting of stock options, stock appreciation rights, restricted stock, performance shares and other share-based awards and benefits up to an aggregate of
1,800,000
shares of class A common stock and
300,000
shares of class B common stock. Stock options granted could have been either nonqualified or incentive stock options. Stock options vest over
one
to
five
years following the date of grant and option terms are generally
five
to
ten
years following the date of grant. Due to the expiration of the
2001
Equity Incentive Plan, at
December 31, 2015,
there were
no
shares of stock available for future grants. The Company has accounted for grants of
1,683,309
class A and
280,552
class B options and restricted stock under the
2001
Equity Incentive Plan using the date of grant as the measurement date for financial accounting purposes.

The Company
’s
2004
Non-Employee Director Stock Plan, as amended (the
“2004
Director Plan”), is a nonqualified plan that provides for the granting of options with respect to
3,000,000
shares of class A common stock and
500,000
shares of class B common stock. The
2004
Director Plan provides for grants of nonqualified stock options to each director of the Company who is
not
employed by the Company. On the date of each annual meeting of shareholders of the Company, options to purchase
36,000
shares of class A common stock and
6,000
shares of class B common stock are granted to directors that are elected or retained as a director at such meeting. Stock options vest
one
year following the date of grant and option terms are generally
ten
years following the date of grant, or
three
years in the case of termination of the outside director’s service. At
December 31, 2017,
there were
921,000
shares of class A common stock and
153,500
shares of class B common stock available for issuance pursuant to future grants under the
2004
Director Plan. The Company has accounted for grants of
2,079,000
class A and
346,500
class B options under the
2004
Director Plan using the date of grant as the measurement date for financial accounting purposes.

T
he National Research Corporation
2006
Equity Incentive Plan (the
“2006
Equity Incentive Plan”) provides for the granting of stock options, stock appreciation rights, restricted stock, performance shares and other share-based awards and benefits up to an aggregate of
1,800,000
shares of class A common stock and
300,000
shares of class B common stock. Stock options granted
may
be either incentive stock options or nonqualified stock options. Vesting terms vary with each grant and option terms are generally
five
to
ten
years following the date of grant. At
December 31, 2017,
there were
865,465
shares of class A common stock and
145,189
shares of class B common stock available for issuance pursuant to future grants under the
2006
Equity Incentive Plan. The Company has accounted for grants of
934,535
class A and
154,811
class B options and restricted stock under the
2006
Equity Incentive Plan using the date of grant as the measurement date for financial accounting purposes.

The
Company granted options to purchase
299,917
shares of class A common stock and
49,986
shares of class B common stock during
2017.
During
2016,
the Company granted options to purchase
315,620
shares of class A common stock and
52,603
shares of class B common stock, and during
2015
granted options to purchase
261,306
shares of class A common stock and
43,551
shares of class B common stock. Options to purchase shares of common stock are typically granted with exercise prices equal to the fair value of the common stock on the date of grant. The Company does, in certain limited situations, grant options with exercise prices that exceed the fair value of the common shares on the date of grant. The fair value of stock options granted was estimated using a Black-Scholes valuation model with the following weighted average assumptions:

2
017

2016

2015

Class A

Class B

Class A

Class B

Class A

Class B

Expected dividend yield at date of grant

2.62
%
8.06
%
2.99
%
7.29
%
2.22
%
5.48
%

Expected stock price volatility

32.45
%
26.75
%
32.74
%
29.41
%
31.97
%
31.17
%

Risk-free interest rate

2.18
%
2.18
%
1.69
%
1.69
%
1.58
%
1.60
%

Expected life of options (in years)

6.80

6.80

6.86

6.86

5.49

5.62

The risk-free interest rate assumptions were based on the U.S. Treasury yield curve in effect at the time of the grant. The expected volatility was based on historical monthly price changes of the Company
’s stock based on the expected life of the options at the date of grant. The expected life of options is the average number of years the Company estimates that options will be outstanding. The Company considers groups of associates that have similar historical exercise behavior separately for valuation purposes.

The following table summarizes stock option activity
under the
2001
and
2006
Equity Incentive Plans and the
2004
Director Plan for the year ended
December
31,

2017:

Number of

Options

Weighted

Average

Exercise

Price

Weighted

Average

Remaining Contractual

Terms (Years)

Aggregate

Intrinsic

Value

(In thousands)

Class A

Outstanding at December 31, 201
6

1,705,483
$
12.31

Granted

299,917
$
22.13

Exercised

(197,784
) $
10.55

$
2,681

Forfeited

(60,982
) $
21.35

Outstanding at
December 31, 2017

1,746,634
$
13.88

5.39
$
40,901

Exercisable at
December 31, 2017

1,274,361
$
12.14

4.32
$
32,060

Class B

Outstanding at December 31, 201
6

250,493
$
29.70

Granted

49,986
$
42.90

Exercised

(13,600
) $
27.04

$
202

Forfeited

(10,163
) $
41.53

Outstanding at
December 31, 2017

276,716
$
31.78

5.52
$
6,719

Exercisable at
December 31, 2017

198,950
$
29.16

4.44
$
5,353

The following table summarizes information related to stock options for the years ended
December 31, 2017,
2016
and
2015:

2
017

2016

2015

Class A

Class B

Class A

Class B

Class A

Class B

Weighted average grant date fair value of stock options granted
$
5.83
$
3.66
$
3.62
$
3.90
$
3.49
$
5.45

Intrinsic value of stock options exercised (in thousands)

2,681

202

459

632

350

151

Intrinsic value of stock options vested (in thousands)

5,258

787

1,627

535

1,351

415

As of
December 31, 2017,
the total unrecognized compensation cost related to non-vested stock option awards was approximately
$1.2
million and
$152,000
for class A and class B common stock shares, respectively, which was expected to be recognized over a weighted average period of
2.53
years and
2.57
years for class A and class B common stock shares, respectively.

Cash received from stock options exercised for the
years ended
December
31,

2016
was
$548,000.
There was
no
cash received from stock options exercised for the year ended
December 31, 2017
or
2015.
The Company recognized
$1.2
million,
$964,000
and
$828,000
of non-cash compensation for the years ended
December 31, 2017,
2016,
and
2015,
respectively, related to options, which is included in selling, general and administrative expenses.

The actual tax benefit realized for the tax deduction from stock options exercised was
$1.1
million,
$398,000
and
$183,000
for the years ended
December 31, 2017,
2016
and
2015,
respectively. The Company prospectively elected ASU
2016
-
09,
Compensation – Stock Compensation (Topic
718
) Improvements to Employee Share-Based Payment Accounting

(“ASU
2016
-
09”
) in
2016.
As a result, the excess tax benefit from stock options exercised was recognized as a reduction to our provision for income taxes for the years ended
December 31, 2017
and
2016
rather than as an increase to additional paid-in capital for the years ended
December 31, 2015
prior to adoption.

During
2016
and
2015,
the Company granted
20,578
and
89,416
non-vested shares of class A and
3,430
and
14,902
non-vested shares of class B common stock, respectively, under the
2006
Equity Incentive Plan.
No
shares were granted during the year ended
December 31, 2017.
As of
December 31, 2017,
the Company had
81,677
and
13,611
non-vested shares of class A and class B common stock, respectively, outstanding under the
2006
Equity Incentive Plan. These shares vest over
five
years following the date of grant and holders thereof are entitled to receive dividends from the date of grant, whether or
not
vested. The fair value of the awards is calculated as the fair market value of the shares on the date of grant. The Company recognized
$629,000,

$966,000
and
$555,000
of non-cash compensation for the years ended
December 31, 2017,
2016,
and
2015,
respectively, related to this non-vested stock, which is included in selling, general and administrative expenses. The actual tax benefit realized for the tax deduction from vesting of restricted stock was
$1.3
million and
$161,000
for the years ended
December 31, 2017
and
2016,
respectively. There were
no
shares that vested in the year ended
December 31, 2015.

The following
table summarizes information regarding non-vested stock granted to associates under the
2006
Equity Incentive Plans for the year ended
December
31,

2017:

Class A
Shares Outstanding

Class A

Weighted

Average Grant

Date Fair Value

Per Share
Class B Shares Outstanding
Class B

Weighted

Average Grant

Date Fair
Value

Per Share

Outstanding at December 31, 201
6

174,487
$
13.93

29,081
$
37.21

Granted

--
$
--

--
$
--

Vested

(73,506
) $
13.99

(12,251
) $
38.50

Forfeited

(19,314
) $
14.27

(3,219
) $
34.69

Outstanding at December 31, 2017

81,677
$
13.80

13,611
$
36.65

As of
December 31, 2017,
the total unrecognized compensation cost related to non-vested stock awards was approximately
$806,000
and is expected to be recognized over a weighted average period of
2.54
years.

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-URI http://asc.fasb.org/topic&trid=2228938

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-URI http://asc.fasb.org/subtopic&trid=2208855
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 33 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 10 - Leases
12 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Leases of Lessee Disclosure [Text Block]

(
10
)

Leases

The Company leases
printing equipment in the United States, and office space in Canada, California, Georgia, and Washington. The Company also leased additional office space in Nebraska through
June 2016.
The Company recorded rent expense in connection with its operating leases of
$869,000,

$920,000
and
$1.0
million in
2017,

2016,
and
2015,
respectively. The Company also has capital leases for production, mailing and computer equipment.

P
ayments under non-cancelable operating leases and capital leases at
December 31, 2017
for the next
five
years are:

Year Ending
December 31,

Capital

Leases

Operating Leases

(In thousands)

201
8
$
80
$
708

201
9

51

679

20
20

34

485

20
21

6

377

20
22

1

190

Total minimum lease payments

172

Less: Amount representing interest

14

Present value of minimum lease payments

158

Less: Current maturities

71

Capital lease obligations, net of current portion
$
87

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=77888251

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-URI http://asc.fasb.org/topic&trid=2208923
+ Details

Name: us-gaap_LeasesOfLesseeDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 34 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 11 - Related Party
12 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Related Party Transactions Disclosure [Text Block]

(
11
)

Related Party

A
director of the Company also serves as an officer of Ameritas Life Insurance Corp. (“Ameritas”). In connection with the Company’s regular assessment of its insurance-based associate benefits, which is conducted by an independent insurance broker, and the costs associated therewith, the Company purchases dental and vision insurance for certain of its associates from Ameritas. The total value of these purchases was
$248,000,

$232,000
and
$227,000
in
2017,

2016
and
2015
respectively.

Mr. Hays, the Chief Executive Officer and director of the Company, is an owner of
14%
of the equity interest of Nebraska Global Investment Company LLC (“Nebraska Global”).
The Company, directly or indirectly through its former subsidiary Customer-Connect LLC, purchased certain services from Nebraska Global, primarily consisting of software development services. The total value of these purchases were
$12,500,

$488,000
and
$440,000
in
2017,

2016
and
2015,
respectively.

Mr. Hays
personally incurred approximately
$538,000
of fees and expenses in connection with exploring strategic alternatives for the Company, including the proposed recapitalization (see Note
13
), for which the Company has reimbursed Mr. Hays in
2017.
These fees and expenses were attributable to the evaluation of alternatives and the sourcing and negotiating of financing for the alternatives, all of which would have been borne directly by the Company if they had been advanced by Mr. Hays. Mr. Hays advanced these funds personally in order to maintain the confidentiality of the evaluation of such alternatives and allow the management team to maintain its focus on the Company’s business and operations.

During
2017,
the Company acquired a cost method investment in convertible preferred stock of PX
(see Note
2
). Also in
2017,
the Company paid
$250,000
to acquire certain perpetual content licenses from PX for content the Company includes in certain of its subscription services. The Company also has an agreement with PX which commenced in
2016
under which the Company acts as a reseller of PX services and receives a portion of the revenues. The total revenue earned from the PX reseller agreement in the years ended
December 31, 2017
and
2016
was
$633,000
and
$28,000,
respectively.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-URI http://asc.fasb.org/topic&trid=2122745
+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 12 - Associate Benefits
12 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Compensation and Employee Benefit Plans [Text Block]

(
12
)

Associate Benefits

The Company sponsors a qualified
401
(k) plan covering substantially all associates with
no
eligibility service requirement. Under the
401
(k) plan, the Company matches
25.0%
of the
first

6.0%
of compensation contributed by each associate. Employer contributions, which are discretionary, vest to participants at a rate of
20%
per year. The Company contributed
$350,000,

$291,000
and
$330,000
in
2017,

2016
and
2015,
respectively, as a matching percentage of associate
401
(k) contributions.

X

- Definition
The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 712
-URI http://asc.fasb.org/topic&trid=2197446

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 710
-URI http://asc.fasb.org/topic&trid=2127225

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-URI http://asc.fasb.org/topic&trid=2228938
+ Details

Name: us-gaap_CompensationAndEmployeeBenefitPlansTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 36 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 13 - Proposed Recapitalization
12 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Recapitalization [Text Block]

(
1
3
)

Proposed Recapitalization

In
December 2017,
the Company
’s Board of Directors approved a recapitalization plan that will exchange each share of class B common stock for
one
share of class A common stock plus
$19.59
in cash, for total value of
$53.44
per class B share. This proposed recapitalization plan replaces the proposed plan announced in
September 2017.

In
December 2017,
the Company entered into a commitment letter with First National Bank of Omaha, which expires on
April 30, 2018,
to provide a senior secured term loan of
$40
million, a delayed draw term loan facility of
$15
million and a senior secured revolving line of credit facility of
$15
million.

The proposed recapitalization is subject to closing of financing and approval by the holders of the Company
’s class A common stock, class B common stock and both classes of stock voting together as a group. The Company incurred expenses related to the proposed recapitalization of approximately
$1.4
million in the year ended
December 31, 2017,
which are included in selling and administrative expenses. These expenses include certain amounts reimbursed to Mr. Hays (see Note
11
).

X

- Definition
The complete disclosure of recapitalization of the company.
+ References
No definition available.
+ Details

Name: nrci_RecapitalizationTextBlock

Namespace Prefix: nrci_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 37 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 14 - Segment Information
12 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

(
1
4
)

Segment Information

The Company
’s
six
operating segments are aggregated into
one
reporting segment because they have similar economic characteristics and meet the other aggregation criteria from the FASB guidance on segment disclosure. The
six
operating segments are Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Transitions, which offer a portfolio of solutions that address specific needs around market insight, experience, transparency and governance for healthcare providers, payers and other healthcare organizations.
On
December 21, 2015,
selected assets and liabilities were sold from a
seventh
operating segment, Predictive Analytics, reducing the number of operating segments from
seven
to
six
as of
December 31, 2015.

The table below presents entity-wide information regarding the Company’s revenue and assets by geographic area:

201
7

201
6

20
15

(In thousands)

Revenue:

United States
$
112,885
$
104,445
$
97,097

Canada

4,674

4,939

5,246

Total
$
117,559
$
109,384
$
102,343

Long-lived assets:

United States
$
72,562
$
71,192
$
70,624

Canada

2,495

2,367

2,364

Total
$
75,057
$
73,559
$
72,988

Total assets:

United States
$
110,785
$
106,288
$
115,480

Canada

16,531

14,336

12,569

Total
$
127,316
$
120,624
$
128,049

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510
+ Details

Name: us-gaap_SegmentReportingDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1

Significant Accounting Policies (Policies)
12 Months Ended

Dec. 31, 2017

Accounting Policies [Abstract]

Consolidation, Policy [Policy Text Block]
Principles of Consolidation

The consolidated financial statements include the accounts of the Company
and its wholly-owned subsidiary, National Research Corporation Canada. Prior to becoming a wholly-owned subsidiary in
March 2016,
the accounts of Customer-Connect LLC (“Connect”), then a variable interest entity for which NRC Health was deemed the primary beneficiary, were included in the consolidated financial statements of the Company. On
June 30, 2016,
Customer-Connect LLC was dissolved. All significant intercompany transactions and balances have been eliminated.

Use of Estimates, Policy [Policy Text Block]
Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Foreign Currency Transactions and Translations Policy [Policy Text Block]
Translation of Foreign Currencies

The Company
’s Canadian subsidiary uses as its functional currency the local currency of the country in which it operates. It translates its assets and liabilities into U.S. dollars at the exchange rate in effect at the balance sheet date. It translates its revenue and expenses at the average exchange rate during the period. The Company includes translation gains and losses in accumulated other comprehensive income (loss), a component of shareholders’ equity. Gains and losses related to transactions denominated in a currency other than the functional currency of the country in which the Company operates and short-term intercompany accounts are included in other income (expense) in the consolidated statements of income.

Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition

The Company derives a majority of its operating revenue from its annually renewable services, which include performance measurement and improvement services, healthcare analytics and governance education services. The Company provides these services to its clients under annual client service contracts, although such contracts are generally cancelable
on short or
no
notice without penalty. Services are provided under subscription-based service agreements. The Company recognizes subscription-based service revenue over the period of time the service is provided. Generally, the subscription periods are for
twelve
months and revenue is recognized equally over the subscription period.

Certain contracts
, excluding subscription-based service agreements, are fixed-fee arrangements with a portion of the project fee billed in advance and the remainder billed periodically over the duration of the project. Revenue for services provided under these contracts are recognized under the proportional performance method. Under the proportional performance method, the Company recognizes revenue based on output measures or key milestones such as survey set-up, survey mailings, survey returns and reporting. The Company measures its progress based on the level of completion of these output measures and recognizes revenue accordingly. Management judgments and estimates must be made and used in connection with revenue recognized using the proportional performance method. If management made different judgments and estimates, then the amount and timing of revenue for any period could differ materially from the reported revenue.

The Company
’s revenue arrangements with a client
may
include combinations of NRC Health’s Experience, Transparency, Governance, and Market Insights solutions which
may
be executed at the same time, or within close proximity of
one
another (referred to as a multiple-element arrangement). When the periods or patterns of revenue recognition differ, each element of a multiple-element arrangement is accounted for as a separate unit of accounting provided each delivered element is sold separately by the Company or another vendor; and for an arrangement that includes a general right of return relative to the undelivered elements, delivery or performance of the undelivered services are considered probable and substantially in the control of the Company. The Company’s arrangements generally do
not
include a general right of return related to the delivered services. If these criteria are
not
met, the arrangement is accounted for as a single unit of accounting with revenue generally recognized equally over the subscription period or recognized under the proportional performance method.

When a contract contains multiple elements, revenue is allocated to each separate unit of accounting based on relative selling price using a selling price hierarchy: vendor-specific objective evidence (“VSOE”), if available,
third
-party evidence (“TPE”) if VSOE is
not
available, or estimated selling price if VSOE nor TPE is available. VSOE is established based on the services normal selling price and discounts for the specific services when sold separately. TPE is established by evaluating similar competitor services in standalone arrangements. If neither exists for a deliverable, the best estimate of the selling price (“ESP”) is used for that deliverable based on list price, representing a component of management’s market strategy, and an analysis of historical prices for bundled and standalone arrangements. Revenue allocated to an element is limited to revenue that is
not
subject to refund or otherwise represents contingent revenue. VSOE, TPE and ESP are periodically adjusted to reflect current market conditions. These adjustments are
not
expected to differ significantly from historical results.

Business Combinations Policy [Policy Text Block]
Business Combinations

The Company uses the acquisition method of accounting for acquired businesses. Under the acquisition method, the financial statements reflect the operations of an acquired business starting from the completion of the acquisition. The assets acquired and liabilities assumed are recorded at their respective estimated fair values at the date of the acquisition. Any excess of the purchase price over the
estimated fair values of the identifiable net assets acquired is recorded as goodwill. Significant judgment is required in estimating the fair value of assets acquired, especially intangible assets. As a result, in the case of significant acquisitions the Company typically engages
third
-party valuation specialists in estimating fair values of tangible and intangible assets. The fair value estimates are based on available historical information and on expectations and assumptions about the future, considering the perspective of marketplace participants.

Trade and Other Accounts Receivable, Policy [Policy Text Block]
Trade Accounts Receivable

Trade accounts receivable are recorded at the invoiced amount. The allowance for doubtful accounts is the Company
’s best estimate of the amount of probable credit losses in the Company’s existing accounts receivable. The Company determines the allowance based on the Company’s historical write-off experience and current economic conditions. The Company reviews the allowance for doubtful accounts monthly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The following table provides the activity in the allowance for doubtful accounts for the years ended
December 31, 2017,
2016
and
2015:

Balance at

Beginning

of Year

Bad Debt

Expense

Write-offs

Net of

Recoveries

Balance

at End

of Year

(In thousands)

Year Ended December 31, 2015
$
206
$
111
$
144
$
173

Year Ended December 31, 2016
$
173
$
218
$
222
$
169

Year Ended December 31, 2017
$
169
$
249
$
218
$
200

Property, Plant and Equipment, Policy [Policy Text Block]
Property and Equipment

Property and equipment is stated at cost. Major expenditures to purchase property or to substantially increase useful lives of property are capitalized. Maintenance, repairs and minor renewals are expensed as incurred. When assets are retired or otherwise disposed of, their costs and related accumulated depreciation are removed from the accounts and resulting gains or losses are included in income.

The Company capitalizes certain costs incurred in connection with obtaining or developing internal-use software, including payroll and payroll-related costs for employees who are directly associated with the internal-use software projects and external direct costs of materials and services. Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose. Costs incurred during the preliminary project and post-implementation stages, as well as software maintenance and training costs are expensed as incurred.
The Company capitalized approximately
$3.0
million and
$2.5
million of costs incurred for the development of internal-use software for the years ended
December 31, 2017
and
2016,
respectively.

T
he Company provides for depreciation and amortization of property and equipment using annual rates which are sufficient to amortize the cost of depreciable assets over their estimated useful lives. The Company uses the straight-line method of depreciation and amortization over estimated useful lives of
three
to
ten
years for furniture and equipment,
three
to
five
years for computer equipment,
one
to
five
years for capitalized software, and
seven
to
forty
years for the Company’s office building and related improvements.

Leases are categorized as operating or capital at the inception of the lease. Assets under capital lease obligations are reported at the lower of fair value or the present value of the aggregate future minimum lease payments at the beginning of the lease term. The Company depreciates capital lease assets
without transfer-of-ownership or bargain-purchase-options using the straight-line method over the lease terms, excluding any lease renewals, unless the lease renewals are reasonably assured. Capital lease assets with transfer-of-ownership or bargain-purchase-options are depreciated using the straight-line method over the assets’ estimated useful lives.

Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]
Impairment of Long-L
ived Assets and Amortizing Intangible Assets

Long-lived
assets, such as property and equipment and purchased intangible assets subject to depreciation or amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset
may
not
be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, the Company
first
compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is
not
recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and
third
-party independent appraisals, as considered necessary.
No
impairments were recorded during the years ended
December 31, 2017,
2016,
or
2015.

Among others, m
anagement believes the following circumstances are important indicators of potential impairment of such assets and as a result
may
trigger an impairment review:

●

Significant underperformance in comparison to historical or projected operating results;

●

Significant changes in the manner or use of acquired assets or the Company
’s overall strategy;

●

Significant negative trends in the Company
’s industry or the overall economy;

●

A significant decline in the market price for the Company
’s common stock for a sustained period; and

●

The Company
’s market capitalization falling below the book value of the Company’s net assets.

Goodwill and Intangible Assets, Policy [Policy Text Block]
Goodwill and
Intangible Assets

Intangible assets include customer relationships, trade names,
technology, non-compete agreements and goodwill. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets
may
not
be recoverable. The Company reviews intangible assets with indefinite lives for impairment annually as of
October 1
and whenever events or changes in circumstances indicate that the carrying value of an asset
may
not
be recoverable.

When performing the impairment assessment, the Company will
first
assess qualitative factors to determine whether it is necessary to recalculate the fair value of the intangible assets with indefinite lives. If the Company believes, as a result of the qualitative assessment, that it is more likely than
not
that the fair value of the indefinite
-lived intangibles is less than their carrying amount, the Company calculates the fair value using a market or income approach. If the carrying value of intangible assets with indefinite lives exceeds their fair value, then the intangible assets are written-down to their fair values. The Company did
not
recognize any impairments related to indefinite-lived intangibles during
2017,

2016
or
2015.

Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are
not
individually identified and separately recognized. All of the Company
’s goodwill is allocated to its reporting units, which are the same as its operating segments. Goodwill is reviewed for impairment at least annually, as of
October 1,
and whenever events or changes in circumstances indicate that the carrying value of goodwill
may
not
be recoverable.

In
January 2017,
the FASB issued A
ccounting Standards Update (“ASU”)
2017
-
04,

Intangibles—Goodwill and Other
(Topic
350
),
Simplifying the Test for Goodwill Impairment
(“ASU
2017
-
04”
). In connection with the
October 1, 2017
annual impairment analysis, the Company early adopted ASU
2017
-
04,
which eliminates the need to determine the fair value of individual assets and liabilities of a reporting unit to measure goodwill impairment (Step
2
). The new guidance
may
result in more or less impairment than could previously be recognized. The adoption of this guidance did
not
impact the Company's results of operations or financial position since only a qualitative analysis was performed as part of the
October 1, 2017
annual impairment analysis.

The Company reviews for
goodwill impairment by
first
assessing qualitative factors to determine whether any impairment
may
exist. If the Company believes, as a result of the qualitative assessment, that it is more likely than
not
that the fair value of a reporting unit is less than its carrying amount, a quantitative analysis will be performed, and the fair value of the reporting unit is compared with its carrying value (including goodwill). If the fair value of the reporting unit exceeds its carrying value, then goodwill is written down by this difference. The Company performed a qualitative analysis as of
October 1, 2017
and determined the fair value of each reporting unit likely significantly exceeded its carrying value.
No
impairments were recorded during the years ended
December 31, 2017,
2016
or
2015.

Income Tax, Policy [Policy Text Block]
Income Taxes

The Company uses the asset and liability method of accounting for income taxes. Under that method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bas
is using enacted tax rates. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances, if any, are established when necessary to reduce deferred tax assets to the amount that is more likely than
not
to be realized. The Company uses the deferral method of accounting for its investment tax credits related to state tax incentives. During the years ended
December 31, 2017,
2016
and
2015,
the Company recorded income tax benefits relating to these tax credits of
$4,000,

$77,000,
and
$156,000,
respectively.

T
he Company recognizes the effect of income tax positions only if those positions are more likely than
not
of being sustained. Recognized income tax positions are measured at the largest amount that is greater than
50%
likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Share-Based Compensation

The compensation expense
on share-based payments is recognized based on the grant-date fair value of those awards. All of the Company’s existing stock option awards and non-vested stock awards have been determined to be equity-classified awards. The Company prospectively elected ASU
2016
-
09,
Compensation – Stock Compensation (Topic
718
) Improvements to Employee Share-Based Payment Accounting
(“ASU
2016
-
09”
) in
2016.
As a result, the tax benefit from stock options exercised was recognized as a reduction to our provision for income taxes for the years ended
December 31, 2017
and
2016
rather than as an increase to additional paid-in capital for the year ended
December 31, 2015
prior to adoption.

Amounts recognized in the financial statements with respect to these plans:

20
17

20
16

20
15

(In thousands)

Amounts charged against income, before income tax benefit
$
1,845
$
1,929
$
1,383

Amount of related income tax benefit

(2,310
)
(1,164
)
(505
)

Net (benefit) expense
to net income
$
(465
) $
765
$
878

Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents

T
he Company considers all highly liquid investments with original maturities of
three
months or less to be cash equivalents. Cash equivalents were
$34.5
million and
$32.7
million as of
December 31, 2017,
and
2016,
respectively, consisting primarily of money market accounts, Eurodollar deposits and funds invested in commercial paper. At certain times, cash equivalent balances
may
exceed federally insured limits.

Reclassification, Policy [Policy Text Block]
Reclassifications

Reclassifications
of
$191,000
have been made from noncurrent deferred income taxes to other noncurrent liabilities in the
2016
consolidated balance sheet to present the unrecognized tax benefits related to state taxes gross of federal tax benefits, consistent with the
2017
financial statement presentation. There was
no
impact on the previously reported net income and earnings per share.

Fair Value Measurement, Policy [Policy Text Block]
Fair Value
Measurements

The Company
’s valuation techniques are based on maximizing observable inputs and minimizing the use of unobservable inputs when measuring fair value. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect the Company’s market assumptions. The inputs are then classified into the following hierarchy: (
1
) Level
1
Inputs—quoted prices in active markets for identical assets and liabilities; (
2
) Level
2
Inputs—observable market-based inputs other than Level
1
inputs, such as quoted prices for similar assets or liabilities in active markets, quoted prices for similar or identical assets or liabilities in markets that are
not
active, or other inputs that are observable or can be corroborated by observable market data; (
3
) Level
3
Inputs—unobservable inputs.

Commercial paper
and Eurodollar deposits are included in cash equivalents and are valued at amortized cost, which approximates fair value due to its short-term nature. Eurodollar deposits are United States dollars deposited in a foreign bank branch of a United States bank and have daily liquidity. Both of these are included as a Level
2
measurement in the table below.

The following details the Company’s financial assets within the fair value hierarchy at
December 31, 2017
and
2016:

Level 1

Level 2

Level 3

Total

(In thousands)

As of December 31, 201
7

Money Market Funds $
13,971
$
--
$
--
$
13,971

Commercial Paper
--

10,490

--

10,490

Eurodollar Deposits
--

10,017

--

10,017

Total
Cash Equivalents
$
13,971
$
20,507
$
--
$
34,478

As of December 31, 201
6

Money Market Funds $
11,200
$
--
$
--
$
11,200

Commercial Paper
--

21,450

--

21,450

Total
Cash Equivalents
$
11,200
$
21,450
$
--
$
32,650

There were
no
transfers between levels during the years ended
December 31,
201
7
and
2016.

The Company's long-term
debt described in Note
8
is recorded at historical cost. The fair value of long-term debt is classified in Level
2
of the fair value hierarchy and was estimated based primarily on estimated current rates available for debt of the same remaining duration and adjusted for nonperformance and credit.

The following are the carrying a
mount and estimated fair values of long-term debt:

December 31,
2017

December 31, 201
6

(In thousands)

Total carrying amount of long-term debt
$
1,067
$
3,540

Estimated fair value of long-term debt
$
1,066
$
3,533

The carrying amounts of accounts receivable, accounts payable, and accrued expenses approximate their fair value. All non-financial assets that are
not
recognized or disclosed at fair value in the financial statements on a recurring basis, which includes
property and equipment, goodwill, intangibles and cost method investments, are measured at fair value in certain circumstances (for example, when there is evidence of impairment). As of
December 31, 2017
and
2016,
there was
no
indication of impairment related to these assets.

Commitments and Contingencies, Policy [Policy Text Block]
C
ontingencies

From time to time, the Company is involved in certain claims and litigation arising in the normal course of business. Management assesses the probability of loss for such contingencies and recognizes a liability when a loss is probable and estimable.

Since the Septembe
r
2017
announcement of the original proposed recapitalization plan (see Note
13
),
three
purported class action and/or derivative complaints have been filed in state or federal courts by
three
individuals claiming to be shareholders of the Company. All of the complaints name as defendants the Company and the individual directors of the Company. Two of these lawsuits were filed in the United States District Court for the District of Nebraska— a putative class action lawsuit captioned
Gennaro v. National Research Corporation, et al.
, and a putative class and derivative action lawsuit captioned
Gerson v. Hays, et al.
,. These lawsuits were consolidated by order of the federal court. A
third
lawsuit was filed the Circuit Court for Milwaukee County, Wisconsin—a putative class action lawsuit captioned
Apfel
v.
Hays, et al
. The allegations in all of the lawsuits are very similar. The plaintiffs allege, among other things, that the defendants breached their fiduciary duties in connection with the allegedly unfair proposed transaction, at an allegedly unfair price, conducted in an allegedly unfair and conflicted process and in alleged violation of Wisconsin law and the Company’s Articles of Incorporation. One of the lawsuits also alleges the proposed transactions is a voidable “conflict of interest transaction” under Wisconsin statutes. The plaintiffs in these lawsuits seek, among other things, an injunction enjoining the defendants from consummating the original proposed recapitalization plan, damages, equitable relief and an award of attorneys’ fees and costs of litigation. The Company believes that the allegations of the complaints are without merit and intends to defend these lawsuits vigorously. Despite the changes to the original proposed recapitalization plan that culminated in the
December 13, 2017
announcement of a revised proposed recapitalization plan, the Company expects that these shareholders or other shareholders might assert similar claims regarding the proposed recapitalization plan. The Company will defend any such lawsuits vigorously.

As of
December 31, 2017,
no
losses have been accrued as the Company does
not
believe the losses are probable or estimable.

Earnings Per Share, Policy [Policy Text Block]
Earnings Per Share

Net income per share of class A common stock and class B common stock is computed using the
two
-class method. Basic net income per share is computed by allocating undistributed earnings to common shares and using the weighted-average number of common shares outstanding during the period.

Diluted net income per share is computed using the weighted-average number of common shares and, if dilutive, the potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and vesting of restricted stock. The dilutive effect of outstanding stock options is reflected in diluted earnings per share by application of the treasury stock method.

The liquidation rights and the rights upon the consummation of an extraordinary transaction are the same for the holders of class A common stock and class B common stock. Other than share distributions and liquidation rights, the amount of any dividend or other distribution payable on each share of class A common stock will be equal to
one
-
sixth
(
1/6
th
) of the amount of any such dividend or other distribution payable on each share of class B common stock. As a result, the undistributed earnings for each year are allocated based on the contractual participation rights of the class A and class B common stock as if the earnings for the year had been distributed.

At
December 31,
20
16,
and
2015,
the Company had
156,610
and
487,639
options of class A shares and
49,262,
and
58,429
options of class B shares, respectively, which have been excluded from the diluted net income per share computation because the exercise price exceeds the fair market value. At
December 31, 2017,
2016,
and
2015
an additional
104,647,

390,300,
and
68,779
options of class A shares and
1,858,

34,178,
and
1,101
options of class B shares, respectively were excluded as their inclusion would be anti-dilutive.

2017 2016 2015

Class A

Class B

Class A

Class B

Class A

Class B

(In thousands, except per share data)

Numerato
r for net income per share - basic:

Net income
$
11,388
$
11,555
$
10,178
$
10,341
$
8,759
$
8,851

Allocation of distributed and undistributed income to unvested restricted stock shareholders

(88
)
(87
)
(88
)
(88
)
(76
)
(77
)

Net income attributable to common shareholders
$
11,300
$
11,468
$
10,090
$
10,253
$
8,683
$
8,774

Denominator for net income per
share - basic:

Weighted average common shares outstanding - basic

20,770

3,514

20,713

3,505

20,741

3,478

Net income per share - basic
$
0.54
$
3.26
$
0.49
$
2.93
$
0.42
$
2.52

Numerator for net income per share - diluted:

Net income attributable to common shareholders for

basic computation
$
11,300
$
11,468
$
10,090
$
10,253
$
8,683
$
8,774

Denominator for net income per share - diluted:

Weighted average common
s
hares outstanding - basic

20,770

3,514

20,713

3,505

20,741

3,478

Weighted average effect of dilutive securities
– stock options:

857

89

324

55

240

44

Denominator for diluted earnings per share
– adjusted weighted average shares

21,627

3,603

21,037

3,560

20,981

3,522

Net income per share - diluted
$
0.52
$
3.18
$
0.48
$
2.88
$
0.41
$
2.49

New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements
Not
Yet Adopted

In
May 2014,
the FASB issued ASU
2014
-
09,

Revenue from Contracts with Customers (Topic
606
)
(“ASU
2014
-
09”
). ASU
2014
-
09
requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU
2014
-
09
will replace most existing revenue recognition guidance in accounting principles generally accepted in the United States when it becomes effective. The standard is effective for annual and interim reporting periods in fiscal years beginning after
December 15, 2017.
An entity
may
choose to adopt ASU
2014
-
09
either retrospectively or through a cumulative effect adjustment as of the start of the
first
period for which it applies the standard. The Company has completed system changes and is analyzing the resulting impact that this new guidance will have on its consolidated financial statements. The Company will adopt this new guidance using the modified retrospective approach beginning
January 1, 2018
by recording a cumulative effect adjustment. The Company expects the most significant change to result from deferring direct and incremental costs of obtaining a contract, consisting of commissions and incentives, and recognizing the expense over the estimated life of the client contract, including renewal periods, rather than expensing as incurred, which is the Company’s current practice. The Company expects adjustments to retained earnings of
no
more than
$2.7
million, net of related tax effects, upon adoption of deferring and amortizing direct and incremental contract costs. The Company also expects to record other immaterial adjustments, related to performance obligation determinations and estimating variable contingent consideration for certain contracts which were previously only recognized once the contingency was resolved and the services were performed. These amounts are only estimates and involve significant judgements by management including estimating the lives of its contracts, the value of performance deliverables and the expected amount to be earned from the satisfaction of those deliverables. The Company will finalize its calculation of the financial impact of the adoption of ASU
2014
-
09
in the
first
quarter of
2018.
ASU
2014
-
09
also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract.

In
January 2016,
the FASB issued ASU
2016
-
01,
Financial Instruments
—Overall: Recognition and Measurement of Financial Assets and Financial Liabilities. ASU
2016
-
01
changes certain recognition, measurement, presentation and disclosure aspects related to financial instruments. ASU
2016
-
01
is effective for financial statements issued for fiscal years beginning after
December 15, 2017,
and interim periods within those fiscal years. Early adoption is
not
permitted. The Company believes its adoption will
not
significantly impact the Company’s results of operations and financial position.

In
February 2016,
the FASB issued ASU
2016
-
02,
Leases (Topic
842
). This ASU requires lessees to recognize a lease liability and a right-to-use asset for all leases, including operating leases, with a term greater than
twelve
months on its balance sheet. This ASU is effective in fiscal years beginning after
December 15, 2018,
with early adoption permitted, and requires a modified retrospective transition method. As of
December 31, 2017,
the Company had approximately
$3.0
million of operating lease commitments which would be recorded on the balance sheet under the new guidance. However, the Company is currently in the process of further evaluating the impact that this new guidance will have on its consolidated financial statements and does
not
plan to elect early adoption.

In
June 2016,
the FASB issued ASU
2016
-
13,
Financial Instruments
– Credit Losses (Topic
326
): Measurement of Credit Losses on Financial Instruments. This ASU will require the measurement of all expected credit losses for financial assets, including trade receivables, held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. The guidance is effective for annual reporting periods beginning after
December 15, 2019
and interim periods within those fiscal years. The Company believes its adoption will
not
significantly impact the Company’s results of operations and financial position.

In
August 2016,
the FASB issued ASU
2016
-
15,
Statement of Cash Flows (Topic
230
) Classification of Certain Cash Receipts and Cash Payments which eliminates the diversity in practice related to
eight
cash flow classification issues.
This ASU is effective for the Company on
January 1, 2018
with early adoption permitted. The Company will adopt this ASU on
January 1, 2018
and believes it will
not
impact the Company’s results of operations and financial position.

In
October 2016,
the FASB issued ASU
2016
-
16,
Intra-Entity Transfers of Asset Other Than Inventory (“ASU
2016
-
16”
), which requires entities to recognize the tax consequences of intercompany asset transfers other than inventory transfers in the period in which the transfer takes place. ASU
2016
-
16
is effective for fiscal years and interim periods within fiscal years beginning after
December 15, 2017.
ASU
2016
-
16
is to be adopted using a modified retrospective approach with a cumulative effect adjustment to retained earnings as of the beginning of the period of adoption. The cumulative effect adjustment will include recognition of the income tax consequences of intra-entity transfers of assets other than inventory that occur before the adoption date.
The Company believes the adoption of ASU
2016
-
16
will
not
impact the Company’s consolidated financial statements.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 05
-Paragraph 4
-Subparagraph (a)-(d)
-URI http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457
+ Details

Name: us-gaap_BusinessCombinationsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 305
-SubTopic 10
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790
+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 450
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6491354&loc=d3e6052-115624

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 450
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249
+ Details

Name: us-gaap_CommitmentsAndContingenciesPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=84161450&loc=d3e5614-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.3A-03)
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355100-122828

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.3A-02)
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828
+ Details

Name: us-gaap_ConsolidationPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790
+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueMeasurementPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895
+ Details

Name: us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.CC)
-URI http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 05
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=64802544&loc=d3e202-110218
+ Details

Name: us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 740
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e32247-109318

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e32280-109318
+ Details

Name: us-gaap_IncomeTaxPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755
+ Details

Name: us-gaap_PriorPeriodReclassificationAdjustmentDescription

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.B.Q1)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790
+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b),(f)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for trade and other accounts receivables. This disclosure may include the basis at which such receivables are carried in the entity's statements of financial position (for example, net realizable value), how the entity determines the level of its allowance for doubtful accounts, when impairments, charge-offs or recoveries are recognized, and the entity's income recognition policies for such receivables, including its treatment of related fees and costs, its treatment of premiums, discounts or unearned income, when accrual of interest is discontinued, how the entity records payments received on nonaccrual receivables and its policy for resuming accrual of interest on such receivables. If the enterprise holds a large number of similar loans, disclosure may include the accounting policy for the anticipation of prepayments and significant assumptions underlying prepayment estimates for amortization of premiums, discounts, and nonrefundable fees and costs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 11B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84173941&loc=SL6953423-111524

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(9))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(5))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(4))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 15
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=84173941&loc=d3e5212-111524

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84173941&loc=d3e5093-111524
+ Details

Name: us-gaap_TradeAndOtherAccountsReceivablePolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6061-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6132-108592
+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 1 - Summary of Significant Accounting Policies (Tables)
12 Months Ended

Dec. 31, 2017

Notes Tables

Allowance for Credit Losses on Financing Receivables [Table Text Block]

Balance at

Beginning

of Year

Bad Debt

Expense

Write-offs

Net of

Recoveries

Balance

at End

of Year

(In thousands)

Year Ended December 31, 2015
$
206
$
111
$
144
$
173

Year Ended December 31, 2016
$
173
$
218
$
222
$
169

Year Ended December 31, 2017
$
169
$
249
$
218
$
200

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

20
17

20
16

20
15

(In thousands)

Amounts charged against income, before income tax benefit
$
1,845
$
1,929
$
1,383

Amount of related income tax benefit

(2,310
)
(1,164
)
(505
)

Net (benefit) expense
to net income
$
(465
) $
765
$
878

Fair Value, by Balance Sheet Grouping [Table Text Block]

December 31,
2017

December 31, 201
6

(In thousands)

Total carrying amount of long-term debt
$
1,067
$
3,540

Estimated fair value of long-term debt
$
1,066
$
3,533

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

2017 2016 2015

Class A

Class B

Class A

Class B

Class A

Class B

(In thousands, except per share data)

Numerato
r for net income per share - basic:

Net income
$
11,388
$
11,555
$
10,178
$
10,341
$
8,759
$
8,851

Allocation of distributed and undistributed income to unvested restricted stock shareholders

(88
)
(87
)
(88
)
(88
)
(76
)
(77
)

Net income attributable to common shareholders
$
11,300
$
11,468
$
10,090
$
10,253
$
8,683
$
8,774

Denominator for net income per
share - basic:

Weighted average common shares outstanding - basic

20,770

3,514

20,713

3,505

20,741

3,478

Net income per share - basic
$
0.54
$
3.26
$
0.49
$
2.93
$
0.42
$
2.52

Numerator for net income per share - diluted:

Net income attributable to common shareholders for

basic computation
$
11,300
$
11,468
$
10,090
$
10,253
$
8,683
$
8,774

Denominator for net income per share - diluted:

Weighted average common
s
hares outstanding - basic

20,770

3,514

20,713

3,505

20,741

3,478

Weighted average effect of dilutive securities
– stock options:

857

89

324

55

240

44

Denominator for diluted earnings per share
– adjusted weighted average shares

21,627

3,603

21,037

3,560

20,981

3,522

Net income per share - diluted
$
0.52
$
3.18
$
0.48
$
2.88
$
0.41
$
2.49

Fair Value, Measurements, Recurring [Member]

Notes Tables

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

Level 1

Level 2

Level 3

Total

(In thousands)

As of December 31, 201
7

Money Market Funds $
13,971
$
--
$
--
$
13,971

Commercial Paper
--

10,490

--

10,490

Eurodollar Deposits
--

10,017

--

10,017

Total
Cash Equivalents
$
13,971
$
20,507
$
--
$
34,478

As of December 31, 201
6

Money Market Funds $
11,200
$
--
$
--
$
11,200

Commercial Paper
--

21,450

--

21,450

Total
Cash Equivalents
$
11,200
$
21,450
$
--
$
32,650

X

- Definition
Tabular disclosure of financing receivables (examples of financing receivables include loans, trade accounts receivable and notes receivable) and activity in the allowance for credit losses account.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 11B
-URI http://asc.fasb.org/extlink&oid=84173941&loc=SL6953423-111524
+ Details

Name: us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13476-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13467-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=75026489&loc=d3e13220-108610

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14172-108612

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13433-108611
+ Details

Name: us-gaap_FairValueByBalanceSheetGroupingTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809
+ Details

Name: us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19190-110258
+ Details

Name: us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 40 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 5 - Property and Equipment (Tables)
12 Months Ended

Dec. 31, 2017

Notes Tables

Property, Plant and Equipment [Table Text Block]

201
7

201
6

(In thousands)

Furniture and equipment
$
5,064
$
4,737

Computer equipment

2,721

2,750

Computer software

22,569

20,592

Building

9,386

9,386

Leaseholds

41

--

Land

425

425

Property and equipment at cost

40,206

37,890

Less accumulated depreciation and amortization

27,847

26,084

Net property and equipment
$
12,359
$
11,806

Schedule of Capital Leased Assets [Table Text Block]

2017

2016

(In thousands)

Furniture and equipment
$
843
$
769

Property and equipment under capital lease, gross

843

769

Less accumulated amortization

684

530

Net assets under capital lease
$
159
$
239

X

- Definition
Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of long-lived, depreciable assets that are subject to a lease meeting the criteria for capitalization and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737
+ Details

Name: us-gaap_ScheduleOfCapitalLeasedAsssetsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 41 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 6 - Goodwill and Intangible Assets (Tables)
12 Months Ended

Dec. 31, 2017

Notes Tables

Schedule of Intangible Assets [Table Text Block]

Useful Life

Gross

Accumulated Amortization

Net

(In years)

(In thousands)

Goodwill

$
58,021

$
58,021

Non-amortizing intangible assets:

Indefinite trade name

1,191

1,191

Amortizing intangible assets:

Customer related

5

-

15

9,347

8,611

736

Technology

7

1,360

523

837

Trade names

5

-

10

1,572

1,572

--

Total amortizing intangible assets

12,279

10,706

1,573

Total intangible assets other than goodwill

$
13,470
$
10,706
$
2,764

Useful Life

Gross

Accumulated Amortization

Net

(In years)

(In thousands)

Goodwill

$
57,861

$
57,861

Non-amortizing intangible assets:

Indefinite trade name

1,191

1,191

Amortizing intangible assets:

Customer related

5

-

15

9,331

8,164

1,167

Technology

7

1,110

344

766

Trade names

5

-

10

1,572

1,572

--

Total amortizing intangible assets

12,013

10,080

1,933

Total intangible assets other than goodwill

$
13,204
$
10,080
$
3,124

Schedule of Goodwill [Table Text Block]

Balance as of December 31, 201
5
$
57,792

Foreign currency translation

69

Balance as of December 31, 201
6
$
57,861

Foreign currency translation

160

Balance as of December 31, 201
7
$
58,021

X

- Definition
Represents the schedule of intangible assets.
+ References
No definition available.
+ Details

Name: nrci_ScheduleOfIntangibleAssetsTableTextBlock

Namespace Prefix: nrci_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267
+ Details

Name: us-gaap_ScheduleOfGoodwillTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 42 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 7 - Income Taxes (Tables)
12 Months Ended

Dec. 31, 2017

Notes Tables

Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]

201
7

20
16

201
5

(In thousands)

U.S. Operations
$
32,750
$
29,848
$
25,536

Foreign Operations

1,533

1,508

1,824

Income before income taxes
$
34,283
$
31,356
$
27,360

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

201
7
201
6
201
5

(In thousands)

Federal
:

Current
$
10,947
$
8,930
$
9,955

Deferred

(1,596
)
847

(1,232
)

Total
$
9,351
$
9,777
$
8,723

Foreign
:

Current
$
387
$
409
$
455

Deferred

704

(18
)
(23
)

Total
$
1,091
$
391
$
432

State
:

Current
$
837
$
634
$
680

Deferred

61

36

(85
)

Total
$
898
$
670
$
595

Total
$
11,340
$
10,838
$
9,750

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

20
17

20
16

20
15

(
In thousands)

Expected federal income taxes
$
11,999
$
10,975
$
9,576

Foreign tax rate differential

(131
)
(129
)
(139
)

State income taxes, net of federal benefit and state tax credits

608

436

391

Federal tax
credits

(130
)
(165
)
(150
)

Uncertain tax positions

151

6

93

Nondeductible expenses related to
proposed recapitalization

504

--

--

Share based compensation

(1,564
)
(441
)
--

Compensation limit for covered employees

955

--

--

Impact of
2017 Tax Act

(2,415
)
--

--

Valuation allowance

535

--

--

Withholding tax on repatriation
of foreign earnings

706

--

--

Other

122

156

(21
)

Total
$
11,340
$
10,838
$
9,750

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

2017

2016

(In thousands)

Deferred tax assets:

Allowance for doubtful accounts
$
46
$
62

Accrued expenses

416

580

Share based compensation

1,457

2,357

Accrued bonuses

113

84

Foreign tax credit
from repatriation

535

--

Other

166

244

Gross deferred tax assets

2,733

3,327

Less Valuation Allowance

(535
)
--

Deferred Tax Assets

2,198

3,327

Deferred tax liabilities:

Prepaid expenses

169

270

Property and equipment

856

1,206

Intangible assets

4,497

6,521

Repatriation withholding

706

--

Deferred tax liabilities

6,228

7,997

Net deferred tax liabilities
$
(4,030
) $
(4,670
)

Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]

(In thousands)

Balance of unrecognized tax benefits at December 31, 2015
$
589

Reductions due to lapse of applicable statute of limitations

(148
)

Additions based on tax positions of prior years

5

Additions based on tax positions related to the current year

216

Balance of unrecognized tax benefits at December 31, 2016
$
662

Reductions due to lapse of applicable statute of limitations

--

Reductions due to tax positions of prior years

(7
)

Additions based on tax positions related to the current year

188

Balance of unrecognized tax benefits at December 31, 2017
$
843

X

- Definition
Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319
+ Details

Name: us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319
+ Details

Name: us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of income before income tax between domestic and foreign jurisdictions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the change in unrecognized tax benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 55
-Paragraph 217
-URI http://asc.fasb.org/extlink&oid=96868398&loc=d3e36027-109320

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 43 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 8 - Notes Payable (Tables)
12 Months Ended

Dec. 31, 2017

Notes Tables

Schedule of Debt [Table Text Block]

2
017

20
16

(In thousands)

Revolving credit note with U.S. Bank, maximum available $12.0 million, matures June 30, 2018
$
--
$
--

Note payable to U.S. Bank for $11.8 million, interest at a 3.12% fixed rate, monthly principal and interest payments of $212,468 through April 2018

1,067

3,540

Total notes payable

1,067

3,540

Less current portion

1,067

2,683

Note payable, net of current portion
$
--
$
857

X

- Definition
Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfDebtTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 44 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 9 - Share-based Compensation (Tables)
12 Months Ended

Dec. 31, 2017

Notes Tables

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

2
017

2016

2015

Class A

Class B

Class A

Class B

Class A

Class B

Expected dividend yield at date of grant

2.62
%
8.06
%
2.99
%
7.29
%
2.22
%
5.48
%

Expected stock price volatility

32.45
%
26.75
%
32.74
%
29.41
%
31.97
%
31.17
%

Risk-free interest rate

2.18
%
2.18
%
1.69
%
1.69
%
1.58
%
1.60
%

Expected life of options (in years)

6.80

6.80

6.86

6.86

5.49

5.62

Share-based Compensation, Activity [Table Text Block]

Number of

Options

Weighted

Average

Exercise

Price

Weighted

Average

Remaining Contractual

Terms (Years)

Aggregate

Intrinsic

Value

(In thousands)

Class A

Outstanding at December 31, 201
6

1,705,483
$
12.31

Granted

299,917
$
22.13

Exercised

(197,784
) $
10.55

$
2,681

Forfeited

(60,982
) $
21.35

Outstanding at
December 31, 2017

1,746,634
$
13.88

5.39
$
40,901

Exercisable at
December 31, 2017

1,274,361
$
12.14

4.32
$
32,060

Class B

Outstanding at December 31, 201
6

250,493
$
29.70

Granted

49,986
$
42.90

Exercised

(13,600
) $
27.04

$
202

Forfeited

(10,163
) $
41.53

Outstanding at
December 31, 2017

276,716
$
31.78

5.52
$
6,719

Exercisable at
December 31, 2017

198,950
$
29.16

4.44
$
5,353

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]

2
017

2016

2015

Class A

Class B

Class A

Class B

Class A

Class B

Weighted average grant date fair value of stock options granted
$
5.83
$
3.66
$
3.62
$
3.90
$
3.49
$
5.45

Intrinsic value of stock options exercised (in thousands)

2,681

202

459

632

350

151

Intrinsic value of stock options vested (in thousands)

5,258

787

1,627

535

1,351

415

Schedule of Nonvested Share Activity [Table Text Block]

Class A
Shares Outstanding

Class A

Weighted

Average Grant

Date Fair Value

Per Share
Class B Shares Outstanding
Class B

Weighted

Average Grant

Date Fair
Value

Per Share

Outstanding at December 31, 201
6

174,487
$
13.93

29,081
$
37.21

Granted

--
$
--

--
$
--

Vested

(73,506
) $
13.99

(12,251
) $
38.50

Forfeited

(19,314
) $
14.27

(3,219
) $
34.69

Outstanding at December 31, 2017

81,677
$
13.80

13,611
$
36.65

X

- Definition
Tabular disclosure of the changes in outstanding nonvested shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure for share-based compensation plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 45 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 10 - Leases (Tables)
12 Months Ended

Dec. 31, 2017

Notes Tables

Schedule of Future Minimum Payments for Operating Leases and Capital Leases [Table Text Block]

Year Ending
December 31,

Capital

Leases

Operating Leases

(In thousands)

201
8
$
80
$
708

201
9

51

679

20
20

34

485

20
21

6

377

20
22

1

190

Total minimum lease payments

172

Less: Amount representing interest

14

Present value of minimum lease payments

158

Less: Current maturities

71

Capital lease obligations, net of current portion
$
87

X

- Definition
Tabular disclosure of future minimum operating and capital lease payments as of the date of the latest balance sheet presented, in aggregate and for each of the five years succeeding fiscal years, with separate deductions from the total for the amount representing executor costs, including any profit thereon, included in the minimum lease payments and for the amount of the imputed interest necessary to reduce the net minimum lease payments to present value.
+ References
No definition available.
+ Details

Name: nrci_ScheduleOfFutureMinimumPaymentsForOperatingLeasesAndCapitalLeasesTableTextBlock

Namespace Prefix: nrci_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 46 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 14 - Segment Information (Tables)
12 Months Ended

Dec. 31, 2017

Notes Tables

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]

201
7

201
6

20
15

(In thousands)

Revenue:

United States
$
112,885
$
104,445
$
97,097

Canada

4,674

4,939

5,246

Total
$
117,559
$
109,384
$
102,343

Long-lived assets:

United States
$
72,562
$
71,192
$
70,624

Canada

2,495

2,367

2,364

Total
$
75,057
$
73,559
$
72,988

Total assets:

United States
$
110,785
$
106,288
$
115,480

Canada

16,531

14,336

12,569

Total
$
127,316
$
120,624
$
128,049

X

- Definition
Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599
+ Details

Name: us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 47 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 1 - Summary of Significant Accounting Policies (Details Textual)
12 Months Ended

Dec. 31, 2017

USD ($)

shares

Dec. 31, 2016

USD ($)

shares

Dec. 31, 2015

USD ($)

shares

Revenue Recognition Subscription Period 1 year

Capitalized Computer Software, Additions $ 3,000,000 $ 2,500,000

Asset Impairment Charges 0 0 $ 0

Impairment of Intangible Assets (Excluding Goodwill) $ 0 0 0

Number of Reportable Segments 1

Goodwill, Impairment Loss $ 0 0 0

Income Tax Credits and Adjustments 4,000 77,000 $ 156,000

Cash Equivalents, at Carrying Value $ 34,500,000 $ 32,700,000

Loss Contingency, New Claims Filed, Number 3

Loss Contingency Accrual $ 0

Percentage of Class B Common Stock Dividend or Other Distribution for Class A Common Stock Dividend or Other Distribution 0.16667%

Accounting Standards Update 2014-09 [Member] | Capitalized Contract Costs [Member]

New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification $ 2,700,000

Common Class A [Member]

Stock Options Excluded from Computation of Earnings Per Share, Amount | shares 156,610 487,639

Common Class A [Member] | Employee Stock Option [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares 104,647 390,300 68,779

Common Class B [Member]

Stock Options Excluded from Computation of Earnings Per Share, Amount | shares 49,262 58,429

Common Class B [Member] | Employee Stock Option [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares 1,858 34,178 1,101

Reclassification from Noncurrent Deferred Income Taxes to Other Noncurrent Liabilities [Member] | December 31, 2016 [Member]

Prior Period Reclassification Adjustment $ 191,000

New Accounting Pronouncement, Early Adoption, Effect [Member] | Accounting Standards Update 2016-02 [Member]

Operating Leases, Future Minimum Payments Due $ 3,000,000

Minimum [Member] | Furniture and Fixtures [Member]

Property, Plant and Equipment, Useful Life 3 years

Minimum [Member] | Computer Equipment [Member]

Property, Plant and Equipment, Useful Life 3 years

Minimum [Member] | Software and Software Development Costs [Member]

Property, Plant and Equipment, Useful Life 1 year

Minimum [Member] | Building and Building Improvements [Member]

Property, Plant and Equipment, Useful Life 7 years

Maximum [Member] | Furniture and Fixtures [Member]

Property, Plant and Equipment, Useful Life 10 years

Maximum [Member] | Computer Equipment [Member]

Property, Plant and Equipment, Useful Life 5 years

Maximum [Member] | Software and Software Development Costs [Member]

Property, Plant and Equipment, Useful Life 5 years

Maximum [Member] | Building and Building Improvements [Member]

Property, Plant and Equipment, Useful Life 40 years

X

- Definition
Represents the amount of any dividend or other distribution, other than share distributions and liquidation rights, payable on each share of class A common stock, expressed as a percentage of any such dividend or other distribution payable on each share of class B common stock.
+ References
No definition available.
+ Details

Name: nrci_PercentageOfClassBCommonStockDividendOrOtherDistributionForClassACommonStockDividendOrOtherDistribution

Namespace Prefix: nrci_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Subscription period for revenue recognition under subscription-based service agreements.
+ References
No definition available.
+ Details

Name: nrci_RevenueRecognitionSubscriptionPeriod

Namespace Prefix: nrci_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Stock options that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because the exercise price exceeds the fair market value.
+ References
No definition available.
+ Details

Name: nrci_StockOptionsExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: nrci_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=68055307&loc=d3e2420-110228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_AssetImpairmentCharges

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Additions made to capitalized computer software costs during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275
+ Details

Name: us-gaap_CapitalizedComputerSoftwareAdditions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
A credit or adjustment for government or taxing authority authorized decrease in taxes owed as a result of meeting certain tax policy conditions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_IncomeTaxCreditsAndAdjustments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of loss contingency liability.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14326-108349
+ Details

Name: us-gaap_LossContingencyAccrualAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The total number of new claims filed pertaining to a loss contingency during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14435-108349
+ Details

Name: us-gaap_LossContingencyNewClaimsFiledNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents the quantification of the effect of adopting the new accounting standard or change in accounting principle expected by the entity to have a significant effect on the entity's financial statements.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.
+ References
No definition available.
+ Details

Name: us-gaap_NumberOfReportableSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of a reclassification adjustment made to prior period financial statement amounts.
+ References
No definition available.
+ Details

Name: us-gaap_PriorPeriodReclassificationAdjustment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CapitalizedContractCostAxis=nrci_CapitalizedContractCostsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_NewAccountingPronouncementEarlyAdoptionAxis=nrci_ReclassificationFromNoncurrentDeferredIncomeTaxesToOtherNoncurrentLiabilitiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreationDateAxis=nrci_December312016Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_NewAccountingPronouncementEarlyAdoptionAxis=us-gaap_NewAccountingPronouncementEarlyAdoptionEffectMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 48 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 1 - Summary of Significant Accounting Policies - Allowance for Doubtful Accounts (Details) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Balance $ 169 $ 173 $ 206

Bad Debt Expense 249 218 111

Write-offs Net of Recoveries 218 222 144

Balance $ 200 $ 169 $ 173

X

- Definition
For an unclassified balance sheet, a valuation allowance for receivables due a company that are expected to be uncollectible.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84173941&loc=d3e5074-111524

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of direct write-downs of accounts receivable charged against the allowance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 310
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68075217&loc=SL9156395-115594

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84173941&loc=d3e5074-111524

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130534-203044

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.5)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=82913847&loc=SL49130543-203045
+ Details

Name: us-gaap_ProvisionForDoubtfulAccounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 49 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 1 - Summary of Significant Accounting Policies - Share-based Compensation Amounts Recognized in Financial Statements (Details) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Non-cash share-based compensation expense $ 1,845 $ 1,929 $ 1,383

Amount of related income tax benefit (2,310) (1,164) (505)

Net (benefit) expense to net income $ (465) $ 765 $ 878

X

- Definition
The amount of expense, net of income tax, recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.
+ References
No definition available.
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The total recognized tax benefit related to compensation cost for equity-based payment arrangements recognized in income during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 50 R36.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 1 - Summary of Significant Accounting Policies - Fair Value of Financial Assets and Liabilities (Details) - Fair Value, Measurements, Recurring [Member] - USD ($)
$ in Thousands

Dec. 31, 2017

Dec. 31, 2016

Assets, fair value $ 34,478 $ 32,650

Money Market Funds [Member]

Assets, fair value 13,971 11,200

Commercial Paper [Member]

Assets, fair value 10,490 21,450

Eurodollar Deposits [Member]

Assets, fair value 10,017

Fair Value, Inputs, Level 1 [Member]

Assets, fair value 13,971 11,200

Fair Value, Inputs, Level 1 [Member] | Money Market Funds [Member]

Assets, fair value 13,971 11,200

Fair Value, Inputs, Level 1 [Member] | Commercial Paper [Member]

Assets, fair value

Fair Value, Inputs, Level 1 [Member] | Eurodollar Deposits [Member]

Assets, fair value

Fair Value, Inputs, Level 2 [Member]

Assets, fair value 20,507 21,450

Fair Value, Inputs, Level 2 [Member] | Money Market Funds [Member]

Assets, fair value

Fair Value, Inputs, Level 2 [Member] | Commercial Paper [Member]

Assets, fair value 10,490 21,450

Fair Value, Inputs, Level 2 [Member] | Eurodollar Deposits [Member]

Assets, fair value 10,017

Fair Value, Inputs, Level 3 [Member]

Assets, fair value

Fair Value, Inputs, Level 3 [Member] | Money Market Funds [Member]

Assets, fair value

Fair Value, Inputs, Level 3 [Member] | Commercial Paper [Member]

Assets, fair value

Fair Value, Inputs, Level 3 [Member] | Eurodollar Deposits [Member]

Assets, fair value

X

- Definition
Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
No definition available.
+ Details

Name: us-gaap_CashAndCashEquivalentsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=nrci_EurodollarDepositsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 51 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 1 - Summary of Significant Accounting Policies - Fair Values of Long-term Debt (Details) - USD ($)
$ in Thousands

Dec. 31, 2017

Dec. 31, 2016

Total carrying amount of long-term debt $ 1,067 $ 3,540

Estimated fair value of long-term debt $ 1,066 $ 3,533

X

- Definition
Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.
+ References
No definition available.
+ Details

Name: us-gaap_LongTermDebtFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 52 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 1 - Summary of Significant Accounting Policies - Net Income Per Share Computation (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Net income $ 22,943 $ 20,518 $ 17,610

Common Class A [Member]

Net income 11,388 10,178 8,759

Allocation of distributed and undistributed income to unvested restricted stock shareholders (88) (88) (76)

Net income attributable to common shareholders $ 11,300 $ 10,090 $ 8,683

Weighted average common shares outstanding - basic (in shares) 20,770 20,713 20,741

Net income per share - basic (in dollars per share) $ 0.54 $ 0.49 $ 0.42

Weighted average effect of dilutive securities – stock options: (in shares) 857 324 240

Denominator for diluted earnings per share – adjusted weighted average shares (in shares) 21,627 21,037 20,981

Net income per share - diluted (in dollars per share) $ 0.52 $ 0.48 $ 0.41

Common Class B [Member]

Net income $ 11,555 $ 10,341 $ 8,851

Allocation of distributed and undistributed income to unvested restricted stock shareholders (87) (88) (77)

Net income attributable to common shareholders $ 11,468 $ 10,253 $ 8,774

Weighted average common shares outstanding - basic (in shares) 3,514 3,505 3,478

Net income per share - basic (in dollars per share) $ 3.26 $ 2.93 $ 2.52

Weighted average effect of dilutive securities – stock options: (in shares) 89 55 44

Denominator for diluted earnings per share – adjusted weighted average shares (in shares) 3,603 3,560 3,522

Net income per share - diluted (in dollars per share) $ 3.18 $ 2.88 $ 2.49

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=96948231&loc=d3e4984-109258

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=96947427&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=96947427&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 28A
-URI http://asc.fasb.org/extlink&oid=96947427&loc=d3e1500-109256
+ Details

Name: us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=96947427&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=96947427&loc=SL5780133-109256
+ Details

Name: us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=96947427&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=96947427&loc=d3e1448-109256
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 53 R39.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 2 - Equity Investments (Details Textual) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Payments to Acquire Investments $ 1,300

PracticingExcellence.com [Member]

Payments to Acquire Investments $ 1,300

Cost Method Investment, Ownership Percentage 15.70%

X

- Definition
The percentage of ownership of common stock or equity participation in the investee accounted for under the cost method of accounting.
+ References
No definition available.
+ Details

Name: nrci_CostMethodInvestmentOwnershipPercentage

Namespace Prefix: nrci_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The cash outflow associated with the purchase of all investments (debt, security, other) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=nrci_PracticingExcellencecomMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 54 R40.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 3 - Divestitures (Details Textual) - USD ($)
1 Months Ended 12 Months Ended

Dec. 21, 2015

Dec. 31, 2016

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Proceeds from Divestiture of Businesses, Net of Cash Divested $ 223,000 $ 1,613,000

Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal $ 223,000 $ 1,102,000

Predictive Analytics [Member]

Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal $ 223,000

Predictive Analytics [Member] | Other Income [Member]

Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal $ 1,100,000

Predictive Analytics [Member] | Disposal Group, Not Discontinued Operations [Member]

Proceeds from Divestiture of Businesses, Net of Cash Divested 1,600,000

Escrow Deposit $ 300,000

X

- Definition
Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68055307&loc=d3e2443-110228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84176398&loc=d3e2941-110230
+ Details

Name: us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.10)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_EscrowDeposit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This element represents the cash inflow during the period from the sale of a component of the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3179-108585
+ Details

Name: us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=nrci_PredictiveAnalyticsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupNotDiscontinuedOperationsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 55 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 4 - Connect (Details Textual) - USD ($)
1 Months Ended 12 Months Ended

Mar. 28, 2016

Mar. 07, 2016

Jul. 31, 2015

Jun. 30, 2013

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Payments to Noncontrolling Interests $ 2,000,000 $ 2,789,000

Connect [Member]

Payments to Noncontrolling Interests $ 2,800,000

Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions 89.00%

Adjustments to Additional Paid-in Capital, Acquisition of Additional Ownership Interests 252,000 $ 2,800,000

Connect [Member] | Illuminate Health, LLC [Member]

Payments to Noncontrolling Interests $ 1,000,000 $ 1,000,000

Ownership Percentage Available to Acquire at Each Recurring Contract Value Target Level 33.33%

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Noncurrent $ 1,700,000

Illuminate Health, LLC [Member]

Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners 11.00%

Connect [Member]

Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage 49.00%

Connect [Member] | NG Customer-Connect, LLC [Member]

Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage 25.00%

Connect [Member] | Illuminate Health, LLC [Member]

Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage 26.00%

X

- Definition
Amount of decrease in additional paid-in capital (APIC) resulting from the acquisition of additional ownership interests in a previously consolidated entity.
+ References
No definition available.
+ Details

Name: nrci_AdjustmentsToAdditionalPaidinCapitalAcquisitionOfAdditionalOwnershipInterests

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Represents the ownership percentage the Company has the option to acquire at each recurring contract value target level.
+ References
No definition available.
+ Details

Name: nrci_OwnershipPercentageAvailableToAcquireAtEachRecurringContractValueTargetLevel

Namespace Prefix: nrci_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount, after allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date, classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472
+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.
+ References
No definition available.
+ Details

Name: us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsToMinorityShareholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions.
+ References
No definition available.
+ Details

Name: us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 5A
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=77990344&loc=SL6759159-111685
+ Details

Name: us-gaap_VariableInterestEntityOwnershipPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=nrci_ConnectMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CounterpartyNameAxis=nrci_IlluminateHealthLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=nrci_IlluminateHealthLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis=nrci_ConnectMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=nrci_NGCustomerConnectLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 56 R42.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 5 - Property and Equipment (Details Textual) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Depreciation, Depletion and Amortization, Nonproduction $ 4,586 $ 4,225 $ 4,109

Including Assets Held under Capital Lease [Member]

Depreciation, Depletion and Amortization, Nonproduction $ 4,000 $ 3,600 $ 3,100

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=nrci_IncludingAssetsHeldUnderCapitalLeaseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 57 R43.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 5 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($)
$ in Thousands

Dec. 31, 2017

Dec. 31, 2016

Property and equipment at cost $ 40,206 $ 37,890

Less accumulated depreciation and amortization 27,847 26,084

Net property and equipment 12,359 11,806

Furniture and Fixtures [Member]

Property and equipment at cost 5,064 4,737

Computer Equipment [Member]

Property and equipment at cost 2,721 2,750

Software and Software Development Costs [Member]

Property and equipment at cost 22,569 20,592

Building and Building Improvements [Member]

Property and equipment at cost 9,386 9,386

Leasehold Improvements [Member]

Property and equipment at cost 41

Land [Member]

Property and equipment at cost $ 425 $ 425

X

- Definition
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.14)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 58 R44.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 5 - Property and Equipment - Schedule of Capital Lease Assets (Details) - USD ($)
$ in Thousands

Dec. 31, 2017

Dec. 31, 2016

Capital leased assets $ 843 $ 769

Less accumulated amortization 684 530

Net assets under capital lease 159 239

Furniture and Fixtures [Member]

Capital leased assets $ 843 $ 769

X

- Definition
Amount before accumulated depreciation of leased physical assets used in the normal conduct of business to produce goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=84164758&loc=d3e45014-112735
+ Details

Name: us-gaap_CapitalLeasedAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The total gross amount less the charge for the use of the long-lived depreciable assets subject to a lease meeting the criteria for capitalization.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737
+ Details

Name: us-gaap_CapitalLeasesBalanceSheetAssetsByMajorClassNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The total charge for the use of long-lived depreciable assets subject to a lease meeting the criteria for capitalization.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=84164758&loc=d3e45014-112735

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 2)
-URI http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697
+ Details

Name: us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 59 R45.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 6 - Goodwill and Intangible Assets (Details Textual) - USD ($)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Amortization of Intangible Assets $ 610,000 $ 654,000 $ 995,000

Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months 662,000

Finite-Lived Intangible Assets, Amortization Expense, Year Two 374,000

Finite-Lived Intangible Assets, Amortization Expense, Year Three 318,000

Finite-Lived Intangible Assets, Amortization Expense, Year Four 180,000

Finite-Lived Intangible Assets, Amortization Expense, Year Five $ 39,000

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 60 R46.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 6 - Goodwill and Intangible Assets - Summary of Goodwill and Intangible Assets (Details) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Goodwill $ 58,021 $ 57,861 $ 57,792

Finite-lived intangible assets, gross 12,279 12,013

Finite-lived intangible assets, accumulated amortization 10,706 10,080

Finite-lived intangible assets, net 1,573 1,933

Total intangible assets other than goodwill 13,470 13,204

Total intangible assets other than goodwill 2,764 3,124

Customer Relationships [Member]

Finite-lived intangible assets, gross 9,347 9,331

Finite-lived intangible assets, accumulated amortization 8,611 8,164

Finite-lived intangible assets, net $ 736 $ 1,167

Customer Relationships [Member] | Minimum [Member]

Finite-lived intangible assets, useful life (Year) 5 years 5 years

Customer Relationships [Member] | Maximum [Member]

Finite-lived intangible assets, useful life (Year) 15 years 15 years

Technology-Based Intangible Assets [Member]

Finite-lived intangible assets, useful life (Year) 7 years 7 years

Finite-lived intangible assets, gross $ 1,360 $ 1,110

Finite-lived intangible assets, accumulated amortization 523 344

Finite-lived intangible assets, net 837 766

Trade Names [Member]

Finite-lived intangible assets, gross 1,572 1,572

Finite-lived intangible assets, accumulated amortization 1,572 $ 1,572

Finite-lived intangible assets, net

Trade Names [Member] | Minimum [Member]

Finite-lived intangible assets, useful life (Year) 5 years 5 years

Trade Names [Member] | Maximum [Member]

Finite-lived intangible assets, useful life (Year) 10 years 10 years

Trade Names 1 [Member]

Indefinite trade name $ 1,191 $ 1,191

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before accumulated amortization of intangible assets, excluding goodwill.
+ References
No definition available.
+ Details

Name: us-gaap_IntangibleAssetsGrossExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph ((a)(1),(b))
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=nrci_TradeNames1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 61 R47.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 6 - Goodwill and Intangible Assets - Summary of Changes in the Carrying Amount of Goodwill (Details) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Balance $ 57,861 $ 57,792

Foreign currency translation 160 69

Balance $ 58,021 $ 57,861

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillForeignCurrencyTranslationGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 62 R48.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 7 - Income Taxes (Details Textual) - USD ($)
12 Months Ended

Dec. 31, 2018

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 35.00%

Provisional Tax Expense (Benefit) for Tax Cuts and Jobs Act $ (1,900,000)

Effective Income Tax Rate Reconciliation, Nondeductible Expense, Depreciation, Amount 0

Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 535,000

Effective Income Tax Rate Reconcilation, Withholding Tax on Repatriation of Foreign Earnings 706,000

Unrecognized Tax Benefits 843,000 662,000 $ 589,000

Unrecognized Tax Benefits, Interest on Income Taxes Accrued 5,000 2,000

Unrecognized Tax Benefits that Would Impact Effective Tax Rate $ 620,000 $ 472,000

Scenario, Forecast [Member]

Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 21.00%

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to withholding tax on repatriation of foreign earnings.
+ References
No definition available.
+ Details

Name: nrci_EffectiveIncomeTaxRateReconcilationWithholdingTaxOnRepatriationOfForeignEarnings

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of tax benefit from the December 22, 2017 Tax Cut and Jobs Act.
+ References
No definition available.
+ Details

Name: nrci_ProvisionalTaxExpenseBenefitForTaxCutsAndJobsAct

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e32123-109318
+ Details

Name: us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible depreciation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319
+ Details

Name: us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of unrecognized tax benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of interest expense accrued for an underpayment of income taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 63 R49.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 7 - Income Taxes - Income Before Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

U.S. Operations $ 32,750 $ 29,848 $ 25,536

Foreign Operations 1,533 1,508 1,824

Income before income taxes $ 34,283 $ 31,356 $ 27,360

X

- Definition
The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 64 R50.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 7 - Income Taxes - Income Tax Expense (Details) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Current $ 10,947 $ 8,930 $ 9,955

Deferred (1,596) 847 (1,232)

Total 9,351 9,777 8,723

Current 387 409 455

Deferred 704 (18) (23)

Total 1,091 391 432

Current 837 634 680

Deferred 61 36 (85)

Total 898 670 595

Total $ 11,340 $ 10,838 $ 9,750

X

- Definition
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319
+ Details

Name: us-gaap_CurrentFederalTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319
+ Details

Name: us-gaap_CurrentForeignTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817
+ Details

Name: us-gaap_CurrentStateAndLocalTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319
+ Details

Name: us-gaap_DeferredFederalIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319
+ Details

Name: us-gaap_DeferredForeignIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319
+ Details

Name: us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)-(b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319
+ Details

Name: us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 65 R51.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 7 - Income Taxes - Income Tax Reconciliation (Details) - USD ($)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Expected federal income taxes $ 11,999,000 $ 10,975,000 $ 9,576,000

Foreign tax rate differential (131,000) (129,000) (139,000)

State income taxes, net of federal benefit and state tax credits 608,000 436,000 391,000

Federal tax credits (130,000) (165,000) (150,000)

Uncertain tax positions 151,000 6,000 93,000

Nondeductible expenses related to proposed recapitalization 504,000

Share based compensation (1,564,000) (441,000)

Compensation limit for covered employees 955,000

Impact of 2017 Tax Act (2,415,000)

Valuation allowance 535,000

Withholding tax on repatriation of foreign earnings 706,000

Other 122,000 156,000 (21,000)

Total $ 11,340,000 $ 10,838,000 $ 9,750,000

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to withholding tax on repatriation of foreign earnings.
+ References
No definition available.
+ Details

Name: nrci_EffectiveIncomeTaxRateReconcilationWithholdingTaxOnRepatriationOfForeignEarnings

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to a proposed recapitalization.
+ References
No definition available.
+ Details

Name: nrci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseProposedRecapitalizationAmount

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible equity-based compensation limits for covered employees.
+ References
No definition available.
+ Details

Name: nrci_IncomeTaxReconciliationCompensationLimitForCoveredEmployees

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for excess tax benefit of share-based compensation.
+ References
No definition available.
+ Details

Name: nrci_IncomeTaxReconciliationDeductionsExcessTaxBenefitOfShareBasedCompensation

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in income taxes accrued due to the Tax Cut and Jobs Act.
+ References
No definition available.
+ Details

Name: nrci_IncomeTaxReconciliationTaxCutAndJobActChanges

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The sum of the differences between total income tax expense or benefit as reported in the Income Statement for the period and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations attributable uncertain tax positions.
+ References
No definition available.
+ Details

Name: nrci_IncomeTaxReconciliationUncertainTaxPositions

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e32123-109318
+ Details

Name: us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319
+ Details

Name: us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319
+ Details

Name: us-gaap_IncomeTaxReconciliationOtherReconcilingItems

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319
+ Details

Name: us-gaap_IncomeTaxReconciliationTaxCredits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 66 R52.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 7 - Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands

Dec. 31, 2017

Dec. 31, 2016

Deferred tax assets:

Allowance for doubtful accounts $ 46 $ 62

Accrued expenses 416 580

Share based compensation 1,457 2,357

Accrued bonuses 113 84

Foreign tax credit from repatriation 535

Other 166 244

Gross deferred tax assets 2,733 3,327

Less Valuation Allowance (535)

Deferred Tax Assets 2,198 3,327

Deferred tax liabilities:

Prepaid expenses 169 270

Property and equipment 856 1,206

Intangible assets 4,497 6,521

Repatriation withholding 706

Deferred tax liabilities 6,228 7,997

Net deferred tax liabilities $ (4,030) $ (4,670)

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences classified as repatriation withholding.
+ References
No definition available.
+ Details

Name: nrci_DeferredTaxLiabilitiesRepatriationWithholding

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(15)(b)(2))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(15)(2))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(26)(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(26)(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredIncomeTaxLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_DeferredTaxAssetsGrossAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b),(c)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=96869850&loc=d3e28680-109314
+ Details

Name: us-gaap_DeferredTaxAssetsOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee bonuses.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=96869850&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=96869850&loc=d3e28680-109314

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=96869850&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=96869850&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e31931-109318

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_DeferredTaxLiabilitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=96869850&loc=d3e28680-109314

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.
+ References
No definition available.
+ Details

Name: us-gaap_DeferredTaxLiabilitiesPrepaidExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=96869850&loc=d3e28680-109314
+ Details

Name: us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 67 R53.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 7 - Income Taxes - Change in Unrecognized Tax Benefits (Details) - USD ($)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Balance of unrecognized tax benefits $ 662,000 $ 589,000

Reductions due to lapse of applicable statute of limitations (148,000)

Additions based on tax positions of prior years 5,000

Additions based on tax positions related to the current year 188,000 216,000

Reductions due to tax positions of prior years (7,000)

Balance of unrecognized tax benefits $ 843,000 $ 662,000

X

- Definition
Amount of unrecognized tax benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (a)(4)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 68 R54.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 8 - Notes Payable (Details Textual) - Revolving Credit Facility [Member]
$ in Thousands
12 Months Ended

Dec. 31, 2017

USD ($)

Line of Credit Facility, Maximum Borrowing Capacity $ 12,000

Long-term Line of Credit 0

Line of Credit Facility, Remaining Borrowing Capacity $ 12,000

One Month LIBOR [Member]

Debt Instrument, Basis Spread on Variable Rate 2.10%

One, Two, or Three Month LIBOR [Member]

Debt Instrument, Basis Spread on Variable Rate 2.10%

X

- Definition
Percentage points added to the reference rate to compute the variable rate on the debt instrument.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentBasisSpreadOnVariableRate1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(16))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_LineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_VariableRateAxis=nrci_OneMonthLiborMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_VariableRateAxis=nrci_OneTwoOrThreeMonthLIBORMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 69 R55.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 8 - Notes Payable - Summary of Notes Payable (Details) - USD ($)
$ in Thousands

Dec. 31, 2017

Dec. 31, 2016

Total notes payable $ 1,067 $ 3,540

Less current portion 1,067 2,683

Note payable, net of current portion 857

Revolving Credit Note [Member]

Total notes payable

Term Note [Member]

Total notes payable $ 1,067 $ 3,540

X

- Definition
Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_DebtInstrumentAxis=nrci_RevolvingCreditNoteMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=nrci_TermNoteMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 70 R56.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 8 - Notes Payable - Summary of Notes Payable (Details) (Parentheticals) - USD ($)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Revolving Credit Note [Member]

Line of Credit Facility, Maximum Borrowing Capacity $ 12,000,000 $ 12,000,000

Term Note [Member]

Note payable, face amount $ 11,800,000 $ 11,800,000

Note payable, fixed interest rate 3.12% 3.12%

Note payable, monthly payment $ 212,468 $ 212,468

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399
+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of the required periodic payments including both interest and principal payments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823
+ Details

Name: us-gaap_DebtInstrumentPeriodicPayment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_DebtInstrumentAxis=nrci_RevolvingCreditNoteMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=nrci_TermNoteMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 71 R57.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 9 - Share-based Compensation (Details Textual) - USD ($)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Proceeds from Stock Options Exercised $ 0 $ 548,000 $ 0

Employee Service Share-based Compensation, Tax Benefit from Exercise of Stock Options 1,100,000 398,000 183,000

Employee Stock Option [Member] | Selling, General and Administrative Expenses [Member]

Allocated Share-based Compensation Expense $ 1,200,000 964,000 828,000

Nonvested [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 5 years

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized $ 806,000

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 2 years 197 days

Nonvested [Member] | Selling, General and Administrative Expenses [Member]

Allocated Share-based Compensation Expense $ 629,000 966,000 $ 555,000

Restricted Stock [Member]

Tax Benefit Realized Restricted Stock Vested $ 1,300,000 $ 161,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 0

The 2001 Equity Incentive Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 0

The 2001 Equity Incentive Plan [Member] | Employee Stock Option [Member] | Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 1 year

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 5 years

The 2001 Equity Incentive Plan [Member] | Employee Stock Option [Member] | Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 5 years

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 10 years

Director Plan 2004 [Member] | Nonqualified Stock Options [Member] | Director [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 1 year

Director Plan 2004 [Member] | Nonqualified Stock Options [Member] | Minimum [Member] | Director [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 3 years

Director Plan 2004 [Member] | Nonqualified Stock Options [Member] | Maximum [Member] | Director [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 10 years

The 2006 Equity Incentive Plan [Member] | Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 5 years

The 2006 Equity Incentive Plan [Member] | Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 10 years

The 2006 Equity Incentive Plan [Member] | Nonvested [Member]

Stock Issued During Period, Shares, Restricted Stock Award, Gross 0

Common Class A [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 299,917 315,620 261,306

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 73,506

Common Class A [Member] | Employee Stock Option [Member]

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized $ 1,200,000

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 2 years 193 days

Common Class A [Member] | The 2001 Equity Incentive Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 1,800,000

Share-based Compensation Arrangement by Share-based Payment Award, Options Grants Cumulative 1,683,309

Common Class A [Member] | Director Plan 2004 [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 3,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 921,000

Share-based Compensation Arrangement by Share-based Payment Award, Options Grants Cumulative 2,079,000

Common Class A [Member] | Director Plan 2004 [Member] | Nonqualified Stock Options [Member] | Director [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Options Granted at Annual Meeting 36,000

Common Class A [Member] | The 2006 Equity Incentive Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 1,800,000

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 865,465

Share-based Compensation Arrangement by Share-based Payment Award, Options Grants Cumulative 934,535

Common Class A [Member] | The 2006 Equity Incentive Plan [Member] | Nonvested [Member]

Stock Issued During Period, Shares, Restricted Stock Award, Gross 20,578 89,416

Share-based Compensation Arrangement by Share-based Payment Award, Nonvested Restricted Stock, Outstanding Number 81,677

Common Class B [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 49,986 52,603 43,551

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12,251

Common Class B [Member] | Employee Stock Option [Member]

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized $ 152,000

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 2 years 208 days

Common Class B [Member] | The 2001 Equity Incentive Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 300,000

Share-based Compensation Arrangement by Share-based Payment Award, Options Grants Cumulative 280,552

Common Class B [Member] | Director Plan 2004 [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 500,000

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 153,500

Share-based Compensation Arrangement by Share-based Payment Award, Options Grants Cumulative 346,500

Common Class B [Member] | Director Plan 2004 [Member] | Nonqualified Stock Options [Member] | Director [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Options Granted at Annual Meeting 6,000

Common Class B [Member] | The 2006 Equity Incentive Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 300,000

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 145,189

Share-based Compensation Arrangement by Share-based Payment Award, Options Grants Cumulative 154,811

Common Class B [Member] | The 2006 Equity Incentive Plan [Member] | Nonvested [Member]

Stock Issued During Period, Shares, Restricted Stock Award, Gross 3,430 14,902

Share-based Compensation Arrangement by Share-based Payment Award, Nonvested Restricted Stock, Outstanding Number 13,611

X

- Definition
Number of nonvested restricted shares outstanding.
+ References
No definition available.
+ Details

Name: nrci_SharebasedCompensationArrangementBySharebasedPaymentAwardNonvestedRestrictedStockOutstandingNumber

Namespace Prefix: nrci_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of share options (or share units) granted at annual meeting.
+ References
No definition available.
+ Details

Name: nrci_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedAtAnnualMeeting

Namespace Prefix: nrci_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Gross number of share options (or share units) granted for plan to date.
+ References
No definition available.
+ Details

Name: nrci_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsCumulative

Namespace Prefix: nrci_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The tax benefit realized from the vesting of restricted stock during the period.
+ References
No definition available.
+ Details

Name: nrci_TaxBenefitRealizedRestrictedStockVested

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Unrecognized cost of unvested share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of tax benefit from exercise of stock options granted under share-based compensation arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=SL79508275-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=SL79508275-113901
+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=nrci_NonvestedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=nrci_The2001EquityIncentivePlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=nrci_DirectorPlan2004Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=nrci_NonqualifiedStockOptionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=nrci_The2006EquityIncentivePlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 72 R58.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 9 - Share-based Compensation - Stock Options Valuation Assumptions (Details)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Common Class A [Member]

Expected dividend yield at date of grant 2.62% 2.99% 2.22%

Expected stock price volatility 32.45% 32.74% 31.97%

Risk-free interest rate 2.18% 1.69% 1.58%

Expected life of options (in years) (Year) 6 years 292 days 6 years 313 days 5 years 178 days

Common Class B [Member]

Expected dividend yield at date of grant 8.06% 7.29% 5.48%

Expected stock price volatility 26.75% 29.41% 31.17%

Risk-free interest rate 2.18% 1.69% 1.60%

Expected life of options (in years) (Year) 6 years 292 days 6 years 313 days 5 years 226 days

X

- Definition
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.D.2)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 73 R59.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 9 - Share-based Compensation - Stock Option Activity Under Equity Incentive Plans and Director Plan (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Common Class A [Member]

Outstanding, number of options (in shares) 1,705,483

Outstanding, weighted average exercise price (in dollars per share) $ 12.31

Granted, number of options (in shares) 299,917 315,620 261,306

Granted, weighted average exercise price (in dollars per share) $ 22.13

Exercised, number of options (in shares) (197,784)

Exercised, weighted average exercise price (in dollars per share) $ 10.55

Exercised, aggregate intrinsic value $ 2,681 $ 459 $ 350

Forfeited, number of options (in shares) (60,982)

Forfeited, weighted average exercise price (in dollars per share) $ 21.35

Outstanding, number of options (in shares) 1,746,634 1,705,483

Outstanding, weighted average exercise price (in dollars per share) $ 13.88 $ 12.31

Outstanding, weighted average remaining contractual term (Year) 5 years 142 days

Outstanding, aggregate intrinsic value $ 40,901

Exercisable, number of options (in shares) 1,274,361

Weighted average exercise price (in dollars per share) $ 12.14

Exercisable, weighted average remaining contractual term (Year) 4 years 116 days

Exercisable, aggregate intrinsic value $ 32,060

Common Class B [Member]

Outstanding, number of options (in shares) 250,493

Outstanding, weighted average exercise price (in dollars per share) $ 29.70

Granted, number of options (in shares) 49,986 52,603 43,551

Granted, weighted average exercise price (in dollars per share) $ 42.90

Exercised, number of options (in shares) (13,600)

Exercised, weighted average exercise price (in dollars per share) $ 27.04

Exercised, aggregate intrinsic value $ 202 $ 632 $ 151

Forfeited, number of options (in shares) (10,163)

Forfeited, weighted average exercise price (in dollars per share) $ 41.53

Outstanding, number of options (in shares) 276,716 250,493

Outstanding, weighted average exercise price (in dollars per share) $ 31.78 $ 29.70

Outstanding, weighted average remaining contractual term (Year) 5 years 189 days

Outstanding, aggregate intrinsic value $ 6,719

Exercisable, number of options (in shares) 198,950

Weighted average exercise price (in dollars per share) $ 29.16

Exercisable, weighted average remaining contractual term (Year) 4 years 160 days

Exercisable, aggregate intrinsic value $ 5,353

X

- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)-(4)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price of options that were either forfeited or expired.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)-(4)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 74 R60.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 9 - Share-based compensation - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Common Class A [Member]

Weighted average grant date fair value of stock options granted (in dollars per share) $ 5.83 $ 3.62 $ 3.49

Exercised, aggregate intrinsic value $ 2,681 $ 459 $ 350

Intrinsic value of stock options vested (in thousands) $ 5,258 $ 1,627 $ 1,351

Common Class B [Member]

Weighted average grant date fair value of stock options granted (in dollars per share) $ 3.66 $ 3.90 $ 5.45

Exercised, aggregate intrinsic value $ 202 $ 632 $ 151

Intrinsic value of stock options vested (in thousands) $ 787 $ 535 $ 415

X

- Definition
Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 75 R61.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 9 - Share-based Compensation - Non-vested Stock (Details)
12 Months Ended

Dec. 31, 2017

$ / shares

shares

Common Class A [Member]

Outstanding (in shares) | shares 174,487

Outstanding (in dollars per share) | $ / shares $ 13.93

Granted (in shares) | shares

Granted (in dollars per share) | $ / shares

Vested (in shares) | shares (73,506)

Vested (in dollars per share) | $ / shares $ 13.99

Forfeited (in shares) | shares (19,314)

Forfeited (in dollars per share) | $ / shares $ 14.27

Outstanding (in shares) | shares 81,677

Outstanding (in dollars per share) | $ / shares $ 13.80

Common Class B [Member]

Outstanding (in shares) | shares 29,081

Outstanding (in dollars per share) | $ / shares $ 37.21

Granted (in shares) | shares

Granted (in dollars per share) | $ / shares

Vested (in shares) | shares (12,251)

Vested (in dollars per share) | $ / shares $ 38.50

Forfeited (in shares) | shares (3,219)

Forfeited (in dollars per share) | $ / shares $ 34.69

Outstanding (in shares) | shares 13,611

Outstanding (in dollars per share) | $ / shares $ 36.65

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(3)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 76 R62.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 10 - Leases (Details Textual) - USD ($)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Operating Leases, Rent Expense, Net $ 869,000 $ 920,000 $ 1,000,000

X

- Definition
Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41499-112717
+ Details

Name: us-gaap_OperatingLeasesRentExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 77 R63.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 10 - Leases - Payments Under Non-cancelable Operating Leases and Capital Leases (Details) - USD ($)
$ in Thousands

Dec. 31, 2017

Dec. 31, 2016

Capital leases, 2018 $ 80

Operating leases, 2018 708

Capital leases, 2019 51

Operating leases, 2019 679

Capital leases, 2020 34

Operating leases, 2020 485

Capital leases, 2021 6

Operating leases, 2021 377

Capital leases, 2022 1

Operating leases, 2022 190

Capital leases, Total minimum lease payments 172

Less: Amount representing interest 14

Present value of minimum lease payments 158

Less: Current maturities 71 $ 82

Capital lease obligations, net of current portion $ 87

X

- Definition
Amount of capital lease obligation due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84164758&loc=d3e45023-112735
+ Details

Name: us-gaap_CapitalLeaseObligationsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84164758&loc=d3e45023-112735

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CapitalLeaseObligationsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of minimum lease payments for capital leases.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737
+ Details

Name: us-gaap_CapitalLeasesFutureMinimumPaymentsDue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of minimum lease payments for capital leases due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737
+ Details

Name: us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of minimum lease payments for capital leases due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737
+ Details

Name: us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of minimum lease payments for capital leases due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737
+ Details

Name: us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of minimum lease payments for capital leases due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737
+ Details

Name: us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of minimum lease payments for capital leases due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737
+ Details

Name: us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount necessary to reduce net minimum lease payments to present value for capital leases.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737
+ Details

Name: us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Present value of minimum lease payments for capital leases net of executory costs, including amounts paid by the lessee to the lessor for insurance, maintenance and taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737
+ Details

Name: us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 78 R64.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 11 - Related Party (Details Textual) - USD ($)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Payments to Acquire Intangible Assets $ 250,000

Ameritas Life Insurance Corp [Member]

Related Party Transaction, Amounts of Transaction 248,000 232,000 227,000

Nebraska Global Investment Company LLC [Member]

Related Party Transaction, Amounts of Transaction 12,500 $ 488,000 $ 440,000

Nebraska Global Investment Company LLC [Member] | Chief Executive Officer [Member]

Officer Ownership Percentage in Vendor 14.00%

Mr. Hays [Member]

Costs and Expenses, Related Party 538,000

PracticingExcellence.com [Member]

Payments to Acquire Intangible Assets 250,000

Revenue from Related Parties $ 633,000 $ 28,000

X

- Definition
The percentage ownership by officer of the company in the company's vendor.
+ References
No definition available.
+ Details

Name: nrci_OfficerOwnershipPercentageInVendor

Namespace Prefix: nrci_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Costs of sales and operating expenses for the period incurred from transactions with related parties.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_CostsAndExpensesRelatedParty

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of transactions with related party during the financial reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864
+ Details

Name: us-gaap_RelatedPartyTransactionAmountsOfTransaction

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(e))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07.1(c))
-URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606610-122999
+ Details

Name: us-gaap_RevenueFromRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nrci_AmeritasLifeInsuranceCorpMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nrci_NebraskaGlobalInvestmentCompanyLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nrci_MrHaysMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nrci_PracticingExcellencecomMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 79 R65.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 12 - Associate Benefits (Details Textual) - USD ($)
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 25.00%

Defined Contribution Plan, Maximum Percentage of Annual Contribution Employee Subject to Match 6.00%

Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage 20.00%

Defined Contribution Plan, Employer Discretionary Contribution Amount $ 350,000 $ 291,000 $ 330,000

X

- Definition
Maximum percentage of employee gross pay, by the terms of the plan, that the employer may apply a percentage match contribution to a defined contribution plan.
+ References
No definition available.
+ Details

Name: nrci_DefinedContributionPlanMaximumPercentageOfAnnualContributionEmployeeSubjectToMatch

Namespace Prefix: nrci_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of discretionary contributions made by an employer to a defined contribution plan.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of employer's matching contributions to a defined contribution plan that vests in a given year.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

XML 80 R66.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 13 - Proposed Recapitalization (Details Textual)
1 Months Ended 12 Months Ended

Dec. 31, 2017

USD ($)

$ / shares

Dec. 31, 2017

USD ($)

Selling and Administrative Expenses [Member]

Recapitalization Costs $ 1,400,000

First National Bank of Omaha [Member] | Term Loan Commitment Letter [Member]

Commitment to Provide Long-term Debt $ 40,000,000 40,000,000

First National Bank of Omaha [Member] | Delayed Draw Term Loan Facility Commitment Letter [Member]

Commitment to Provide Senior Notes 15,000,000 15,000,000

First National Bank of Omaha [Member] | Revolving Credit Facility Commitment Letter [Member]

Commtiment to Provide Line of Credit, Maximum Proposed Borrowing Capacity 15,000,000 $ 15,000,000

Common Class B [Member]

Proposed Cash Payment Per Class B Share $ 19.59

Exchange Value Per Share | $ / shares $ 53.44

X

- Definition
The amount of unfunded long term debt that has been committed to be provided to the Company by certain parties.
+ References
No definition available.
+ Details

Name: nrci_CommitmentToProvideLongtermDebt

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of unfunded senior notes that has been committed to be provided to the Company by certain parties.
+ References
No definition available.
+ Details

Name: nrci_CommitmentToProvideSeniorNotes

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of unfunded line of credit that has been committed to be provided to the Company by certain parties.
+ References
No definition available.
+ Details

Name: nrci_CommtimentToProvideLineOfCreditMaximumProposedBorrowingCapacity

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Represents the value per share of an exchange from class B common stock to class A common stock plus cash under the proposed recapitalization plan.
+ References
No definition available.
+ Details

Name: nrci_ExchangeValuePerShare

Namespace Prefix: nrci_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of cash to be paid for each class B share in the proposed recapitalization.
+ References
No definition available.
+ Details

Name: nrci_ProposedCashPaymentPerClassBShare

Namespace Prefix: nrci_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of recapitalization costs for professional fees associated with restructuring debt and equity mixture that do not qualify for capitalization.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 5.P.4(b)(1))
-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747
+ Details

Name: us-gaap_RecapitalizationCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=nrci_SellingAndAdministrativeExpensesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LineOfCreditFacilityAxis=nrci_FirstNationalBankOfOmahaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=nrci_TermLoanCommitmentLetterMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=nrci_DelayedDrawTermLoanFacilityCommitmentLetterMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=nrci_RevolvingCreditFacilityCommitmentLetterMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 81 R67.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 14 - Segment Information (Details Textual)
12 Months Ended

Dec. 31, 2015

Dec. 31, 2017

Dec. 21, 2015

Number of Operating Segments 6 6 7

Number of Reportable Segments 1

X

- Definition
Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.
+ References
No definition available.
+ Details

Name: us-gaap_NumberOfOperatingSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.
+ References
No definition available.
+ Details

Name: us-gaap_NumberOfReportableSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

XML 82 R68.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 14 - Segment Information - Revenue and Assets by Geographic Area (Details) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Revenues $ 117,559 $ 109,384 $ 102,343

Long-lived assets 75,057 73,559 72,988

Total assets 127,316 120,624 128,049

UNITED STATES

Revenues 112,885 104,445 97,097

Long-lived assets 72,562 71,192 70,624

Total assets 110,785 106,288 115,480

CANADA

Revenues 4,674 4,939 5,246

Long-lived assets 2,495 2,367 2,364

Total assets $ 16,531 $ 14,336 $ 12,569

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(10))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(12))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(15))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(11))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(17))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(16))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_US

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_CA

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

EXCEL 83 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 84 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 85 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 87 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 232 360 1 false 69 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://nrchealth.com/20171231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://nrchealth.com/20171231/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://nrchealth.com/20171231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Income Sheet http://nrchealth.com/20171231/role/statement-consolidated-statements-of-income Consolidated Statements of Income Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Comprehensive Income Sheet http://nrchealth.com/20171231/role/statement-consolidated-statements-of-comprehensive-income Consolidated Statements of Comprehensive Income Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Shareholders' Equity Sheet http://nrchealth.com/20171231/role/statement-consolidated-statements-of-shareholders-equity Consolidated Statements of Shareholders' Equity Statements 6 false false R7.htm 006 - Statement - Consolidated Statements of Shareholders' Equity (Parentheticals) Sheet http://nrchealth.com/20171231/role/statement-consolidated-statements-of-shareholders-equity-parentheticals Consolidated Statements of Shareholders' Equity (Parentheticals) Statements 7 false false R8.htm 007 - Statement - Consolidated Statements of Cash Flows Sheet http://nrchealth.com/20171231/role/statement-consolidated-statements-of-cash-flows Consolidated Statements of Cash Flows Statements 8 false false R9.htm 008 - Statement - Consolidated Statements of Cash Flows (Parentheticals) Sheet http://nrchealth.com/20171231/role/statement-consolidated-statements-of-cash-flows-parentheticals Consolidated Statements of Cash Flows (Parentheticals) Statements 9 false false R10.htm 009 - Disclosure - Note 1 - Summary of Significant Accounting Policies Sheet http://nrchealth.com/20171231/role/statement-note-1-summary-of-significant-accounting-policies Note 1 - Summary of Significant Accounting Policies Notes 10 false false R11.htm 010 - Disclosure - Note 2 - Equity Investments Sheet http://nrchealth.com/20171231/role/statement-note-2-equity-investments Note 2 - Equity Investments Notes 11 false false R12.htm 011 - Disclosure - Note 3 - Divestitures Sheet http://nrchealth.com/20171231/role/statement-note-3-divestitures Note 3 - Divestitures Notes 12 false false R13.htm 012 - Disclosure - Note 4 - Connect Sheet http://nrchealth.com/20171231/role/statement-note-4-connect Note 4 - Connect Notes 13 false false R14.htm 013 - Disclosure - Note 5 - Property and Equipment Sheet http://nrchealth.com/20171231/role/statement-note-5-property-and-equipment Note 5 - Property and Equipment Notes 14 false false R15.htm 014 - Disclosure - Note 6 - Goodwill and Intangible Assets Sheet http://nrchealth.com/20171231/role/statement-note-6-goodwill-and-intangible-assets Note 6 - Goodwill and Intangible Assets Notes 15 false false R16.htm 015 - Disclosure - Note 7 - Income Taxes Sheet http://nrchealth.com/20171231/role/statement-note-7-income-taxes Note 7 - Income Taxes Notes 16 false false R17.htm 016 - Disclosure - Note 8 - Notes Payable Notes http://nrchealth.com/20171231/role/statement-note-8-notes-payable Note 8 - Notes Payable Notes 17 false false R18.htm 017 - Disclosure - Note 9 - Share-based Compensation Sheet http://nrchealth.com/20171231/role/statement-note-9-sharebased-compensation Note 9 - Share-based Compensation Notes 18 false false R19.htm 018 - Disclosure - Note 10 - Leases Sheet http://nrchealth.com/20171231/role/statement-note-10-leases Note 10 - Leases Notes 19 false false R20.htm 019 - Disclosure - Note 11 - Related Party Sheet http://nrchealth.com/20171231/role/statement-note-11-related-party Note 11 - Related Party Notes 20 false false R21.htm 020 - Disclosure - Note 12 - Associate Benefits Sheet http://nrchealth.com/20171231/role/statement-note-12-associate-benefits Note 12 - Associate Benefits Notes 21 false false R22.htm 021 - Disclosure - Note 13 - Proposed Recapitalization Sheet http://nrchealth.com/20171231/role/statement-note-13-proposed-recapitalization Note 13 - Proposed Recapitalization Notes 22 false false R23.htm 022 - Disclosure - Note 14 - Segment Information Sheet http://nrchealth.com/20171231/role/statement-note-14-segment-information Note 14 - Segment Information Notes 23 false false R24.htm 023 - Disclosure - Significant Accounting Policies (Policies) Sheet http://nrchealth.com/20171231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://nrchealth.com/20171231/role/statement-note-1-summary-of-significant-accounting-policies 24 false false R25.htm 024 - Disclosure - Note 1 - Summary of Significant Accounting Policies (Tables) Sheet http://nrchealth.com/20171231/role/statement-note-1-summary-of-significant-accounting-policies-tables Note 1 - Summary of Significant Accounting Policies (Tables) Tables http://nrchealth.com/20171231/role/statement-note-1-summary-of-significant-accounting-policies 25 false false R26.htm 025 - Disclosure - Note 5 - Property and Equipment (Tables) Sheet http://nrchealth.com/20171231/role/statement-note-5-property-and-equipment-tables Note 5 - Property and Equipment (Tables) Tables http://nrchealth.com/20171231/role/statement-note-5-property-and-equipment 26 false false R27.htm 026 - Disclosure - Note 6 - Goodwill and Intangible Assets (Tables) Sheet http://nrchealth.com/20171231/role/statement-note-6-goodwill-and-intangible-assets-tables Note 6 - Goodwill and Intangible Assets (Tables) Tables http://nrchealth.com/20171231/role/statement-note-6-goodwill-and-intangible-assets 27 false false R28.htm 027 - Disclosure - Note 7 - Income Taxes (Tables) Sheet http://nrchealth.com/20171231/role/statement-note-7-income-taxes-tables Note 7 - Income Taxes (Tables) Tables http://nrchealth.com/20171231/role/statement-note-7-income-taxes 28 false false R29.htm 028 - Disclosure - Note 8 - Notes Payable (Tables) Notes http://nrchealth.com/20171231/role/statement-note-8-notes-payable-tables Note 8 - Notes Payable (Tables) Tables http://nrchealth.com/20171231/role/statement-note-8-notes-payable 29 false false R30.htm 029 - Disclosure - Note 9 - Share-based Compensation (Tables) Sheet http://nrchealth.com/20171231/role/statement-note-9-sharebased-compensation-tables Note 9 - Share-based Compensation (Tables) Tables http://nrchealth.com/20171231/role/statement-note-9-sharebased-compensation 30 false false R31.htm 030 - Disclosure - Note 10 - Leases (Tables) Sheet http://nrchealth.com/20171231/role/statement-note-10-leases-tables Note 10 - Leases (Tables) Tables http://nrchealth.com/20171231/role/statement-note-10-leases 31 false false R32.htm 031 - Disclosure - Note 14 - Segment Information (Tables) Sheet http://nrchealth.com/20171231/role/statement-note-14-segment-information-tables Note 14 - Segment Information (Tables) Tables http://nrchealth.com/20171231/role/statement-note-14-segment-information 32 false false R33.htm 032 - Disclosure - Note 1 - Summary of Significant Accounting Policies (Details Textual) Sheet http://nrchealth.com/20171231/role/statement-note-1-summary-of-significant-accounting-policies-details-textual Note 1 - Summary of Significant Accounting Policies (Details Textual) Details http://nrchealth.com/20171231/role/statement-note-1-summary-of-significant-accounting-policies-tables 33 false false R34.htm 033 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Allowance for Doubtful Accounts (Details) Sheet http://nrchealth.com/20171231/role/statement-note-1-summary-of-significant-accounting-policies-allowance-for-doubtful-accounts-details Note 1 - Summary of Significant Accounting Policies - Allowance for Doubtful Accounts (Details) Details 34 false false R35.htm 034 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Share-based Compensation Amounts Recognized in Financial Statements (Details) Sheet http://nrchealth.com/20171231/role/statement-note-1-summary-of-significant-accounting-policies-sharebased-compensation-amounts-recognized-in-financial-statements-details Note 1 - Summary of Significant Accounting Policies - Share-based Compensation Amounts Recognized in Financial Statements (Details) Details 35 false false R36.htm 035 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Fair Value of Financial Assets and Liabilities (Details) Sheet http://nrchealth.com/20171231/role/statement-note-1-summary-of-significant-accounting-policies-fair-value-of-financial-assets-and-liabilities-details Note 1 - Summary of Significant Accounting Policies - Fair Value of Financial Assets and Liabilities (Details) Details 36 false false R37.htm 036 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Fair Values of Long-term Debt (Details) Sheet http://nrchealth.com/20171231/role/statement-note-1-summary-of-significant-accounting-policies-fair-values-of-longterm-debt-details Note 1 - Summary of Significant Accounting Policies - Fair Values of Long-term Debt (Details) Details 37 false false R38.htm 037 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Net Income Per Share Computation (Details) Sheet http://nrchealth.com/20171231/role/statement-note-1-summary-of-significant-accounting-policies-net-income-per-share-computation-details Note 1 - Summary of Significant Accounting Policies - Net Income Per Share Computation (Details) Details 38 false false R39.htm 038 - Disclosure - Note 2 - Equity Investments (Details Textual) Sheet http://nrchealth.com/20171231/role/statement-note-2-equity-investments-details-textual Note 2 - Equity Investments (Details Textual) Details http://nrchealth.com/20171231/role/statement-note-2-equity-investments 39 false false R40.htm 039 - Disclosure - Note 3 - Divestitures (Details Textual) Sheet http://nrchealth.com/20171231/role/statement-note-3-divestitures-details-textual Note 3 - Divestitures (Details Textual) Details http://nrchealth.com/20171231/role/statement-note-3-divestitures 40 false false R41.htm 040 - Disclosure - Note 4 - Connect (Details Textual) Sheet http://nrchealth.com/20171231/role/statement-note-4-connect-details-textual Note 4 - Connect (Details Textual) Details http://nrchealth.com/20171231/role/statement-note-4-connect 41 false false R42.htm 041 - Disclosure - Note 5 - Property and Equipment (Details Textual) Sheet http://nrchealth.com/20171231/role/statement-note-5-property-and-equipment-details-textual Note 5 - Property and Equipment (Details Textual) Details http://nrchealth.com/20171231/role/statement-note-5-property-and-equipment-tables 42 false false R43.htm 042 - Disclosure - Note 5 - Property and Equipment - Summary of Property and Equipment (Details) Sheet http://nrchealth.com/20171231/role/statement-note-5-property-and-equipment-summary-of-property-and-equipment-details Note 5 - Property and Equipment - Summary of Property and Equipment (Details) Details 43 false false R44.htm 043 - Disclosure - Note 5 - Property and Equipment - Schedule of Capital Lease Assets (Details) Sheet http://nrchealth.com/20171231/role/statement-note-5-property-and-equipment-schedule-of-capital-lease-assets-details Note 5 - Property and Equipment - Schedule of Capital Lease Assets (Details) Details 44 false false R45.htm 044 - Disclosure - Note 6 - Goodwill and Intangible Assets (Details Textual) Sheet http://nrchealth.com/20171231/role/statement-note-6-goodwill-and-intangible-assets-details-textual Note 6 - Goodwill and Intangible Assets (Details Textual) Details http://nrchealth.com/20171231/role/statement-note-6-goodwill-and-intangible-assets-tables 45 false false R46.htm 045 - Disclosure - Note 6 - Goodwill and Intangible Assets - Summary of Goodwill and Intangible Assets (Details) Sheet http://nrchealth.com/20171231/role/statement-note-6-goodwill-and-intangible-assets-summary-of-goodwill-and-intangible-assets-details Note 6 - Goodwill and Intangible Assets - Summary of Goodwill and Intangible Assets (Details) Details 46 false false R47.htm 046 - Disclosure - Note 6 - Goodwill and Intangible Assets - Summary of Changes in the Carrying Amount of Goodwill (Details) Sheet http://nrchealth.com/20171231/role/statement-note-6-goodwill-and-intangible-assets-summary-of-changes-in-the-carrying-amount-of-goodwill-details Note 6 - Goodwill and Intangible Assets - Summary of Changes in the Carrying Amount of Goodwill (Details) Details 47 false false R48.htm 047 - Disclosure - Note 7 - Income Taxes (Details Textual) Sheet http://nrchealth.com/20171231/role/statement-note-7-income-taxes-details-textual Note 7 - Income Taxes (Details Textual) Details http://nrchealth.com/20171231/role/statement-note-7-income-taxes-tables 48 false false R49.htm 048 - Disclosure - Note 7 - Income Taxes - Income Before Income Taxes (Details) Sheet http://nrchealth.com/20171231/role/statement-note-7-income-taxes-income-before-income-taxes-details Note 7 - Income Taxes - Income Before Income Taxes (Details) Details 49 false false R50.htm 049 - Disclosure - Note 7 - Income Taxes - Income Tax Expense (Details) Sheet http://nrchealth.com/20171231/role/statement-note-7-income-taxes-income-tax-expense-details Note 7 - Income Taxes - Income Tax Expense (Details) Details 50 false false R51.htm 050 - Disclosure - Note 7 - Income Taxes - Income Tax Reconciliation (Details) Sheet http://nrchealth.com/20171231/role/statement-note-7-income-taxes-income-tax-reconciliation-details Note 7 - Income Taxes - Income Tax Reconciliation (Details) Details 51 false false R52.htm 051 - Disclosure - Note 7 - Income Taxes - Deferred Tax Assets and Liabilities (Details) Sheet http://nrchealth.com/20171231/role/statement-note-7-income-taxes-deferred-tax-assets-and-liabilities-details Note 7 - Income Taxes - Deferred Tax Assets and Liabilities (Details) Details 52 false false R53.htm 052 - Disclosure - Note 7 - Income Taxes - Change in Unrecognized Tax Benefits (Details) Sheet http://nrchealth.com/20171231/role/statement-note-7-income-taxes-change-in-unrecognized-tax-benefits-details Note 7 - Income Taxes - Change in Unrecognized Tax Benefits (Details) Details 53 false false R54.htm 053 - Disclosure - Note 8 - Notes Payable (Details Textual) Notes http://nrchealth.com/20171231/role/statement-note-8-notes-payable-details-textual Note 8 - Notes Payable (Details Textual) Details http://nrchealth.com/20171231/role/statement-note-8-notes-payable-tables 54 false false R55.htm 054 - Disclosure - Note 8 - Notes Payable - Summary of Notes Payable (Details) Notes http://nrchealth.com/20171231/role/statement-note-8-notes-payable-summary-of-notes-payable-details Note 8 - Notes Payable - Summary of Notes Payable (Details) Details 55 false false R56.htm 055 - Disclosure - Note 8 - Notes Payable - Summary of Notes Payable (Details) (Parentheticals) Notes http://nrchealth.com/20171231/role/statement-note-8-notes-payable-summary-of-notes-payable-details-parentheticals Note 8 - Notes Payable - Summary of Notes Payable (Details) (Parentheticals) Details 56 false false R57.htm 056 - Disclosure - Note 9 - Share-based Compensation (Details Textual) Sheet http://nrchealth.com/20171231/role/statement-note-9-sharebased-compensation-details-textual Note 9 - Share-based Compensation (Details Textual) Details http://nrchealth.com/20171231/role/statement-note-9-sharebased-compensation-tables 57 false false R58.htm 057 - Disclosure - Note 9 - Share-based Compensation - Stock Options Valuation Assumptions (Details) Sheet http://nrchealth.com/20171231/role/statement-note-9-sharebased-compensation-stock-options-valuation-assumptions-details Note 9 - Share-based Compensation - Stock Options Valuation Assumptions (Details) Details 58 false false R59.htm 058 - Disclosure - Note 9 - Share-based Compensation - Stock Option Activity Under Equity Incentive Plans and Director Plan (Details) Sheet http://nrchealth.com/20171231/role/statement-note-9-sharebased-compensation-stock-option-activity-under-equity-incentive-plans-and-director-plan-details Note 9 - Share-based Compensation - Stock Option Activity Under Equity Incentive Plans and Director Plan (Details) Details 59 false false R60.htm 059 - Disclosure - Note 9 - Share-based compensation - Stock Option Activity (Details) Sheet http://nrchealth.com/20171231/role/statement-note-9-sharebased-compensation-stock-option-activity-details Note 9 - Share-based compensation - Stock Option Activity (Details) Details 60 false false R61.htm 060 - Disclosure - Note 9 - Share-based Compensation - Non-vested Stock (Details) Sheet http://nrchealth.com/20171231/role/statement-note-9-sharebased-compensation-nonvested-stock-details Note 9 - Share-based Compensation - Non-vested Stock (Details) Details 61 false false R62.htm 061 - Disclosure - Note 10 - Leases (Details Textual) Sheet http://nrchealth.com/20171231/role/statement-note-10-leases-details-textual Note 10 - Leases (Details Textual) Details http://nrchealth.com/20171231/role/statement-note-10-leases-tables 62 false false R63.htm 062 - Disclosure - Note 10 - Leases - Payments Under Non-cancelable Operating Leases and Capital Leases (Details) Sheet http://nrchealth.com/20171231/role/statement-note-10-leases-payments-under-noncancelable-operating-leases-and-capital-leases-details Note 10 - Leases - Payments Under Non-cancelable Operating Leases and Capital Leases (Details) Details 63 false false R64.htm 063 - Disclosure - Note 11 - Related Party (Details Textual) Sheet http://nrchealth.com/20171231/role/statement-note-11-related-party-details-textual Note 11 - Related Party (Details Textual) Details http://nrchealth.com/20171231/role/statement-note-11-related-party 64 false false R65.htm 064 - Disclosure - Note 12 - Associate Benefits (Details Textual) Sheet http://nrchealth.com/20171231/role/statement-note-12-associate-benefits-details-textual Note 12 - Associate Benefits (Details Textual) Details http://nrchealth.com/20171231/role/statement-note-12-associate-benefits 65 false false R66.htm 065 - Disclosure - Note 13 - Proposed Recapitalization (Details Textual) Sheet http://nrchealth.com/20171231/role/statement-note-13-proposed-recapitalization-details-textual Note 13 - Proposed Recapitalization (Details Textual) Details http://nrchealth.com/20171231/role/statement-note-13-proposed-recapitalization 66 false false R67.htm 066 - Disclosure - Note 14 - Segment Information (Details Textual) Sheet http://nrchealth.com/20171231/role/statement-note-14-segment-information-details-textual Note 14 - Segment Information (Details Textual) Details http://nrchealth.com/20171231/role/statement-note-14-segment-information-tables 67 false false R68.htm 067 - Disclosure - Note 14 - Segment Information - Revenue and Assets by Geographic Area (Details) Sheet http://nrchealth.com/20171231/role/statement-note-14-segment-information-revenue-and-assets-by-geographic-area-details Note 14 - Segment Information - Revenue and Assets by Geographic Area (Details) Details 68 false false All Reports Book All Reports nrci-20171231.xml nrci-20171231.xsd nrci-20171231_cal.xml nrci-20171231_def.xml nrci-20171231_lab.xml nrci-20171231_pre.xml http://fasb.org/us-gaap/2017-01-31 http://xbrl.sec.gov/country/2017-01-31 http://xbrl.sec.gov/dei/2014-01-31 true true ZIP 89 0001437749-18-004585-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-18-004585-xbrl.zip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�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end

Document And Entity Information - USD ($)	12 Months Ended
Document And Entity Information - USD ($)	Dec. 31, 2017	Feb. 28, 2018	Jun. 30, 2017
Document Information [Line Items]
Entity Registrant Name	National Research Corporation
Entity Central Index Key	0000070487
Trading Symbol	nrci
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Public Float			$ 458,611,975
Document Type	10-K
Document Period End Date	Dec. 31, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	FY
Amendment Flag	false
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		20,970,575
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		3,540,857

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 34,733	$ 33,021
Trade accounts receivable, less allowance for doubtful accounts of $200 and $169, respectively	13,343	10,864
Unbilled revenue	1,463	1,546
Prepaid expenses	2,310	1,585
Income taxes receivable	375	14
Other current assets	35	35
Total current assets	52,259	47,065
Net property and equipment	12,359	11,806
Intangible assets, net	2,764	3,124
Goodwill	58,021	57,861
Other	1,913	768
Total assets	127,316	120,624
Current liabilities:
Current portion of notes payable	1,067	2,683
Accounts payable	593	765
Accrued wages, bonus and profit sharing	6,597	4,543
Accrued expenses	2,882	3,069
Current portion of capital lease obligations	71	82
Income taxes payable		662
Dividends payable	4,222	4,213
Deferred revenue	16,878	15,497
Total current liabilities	32,310	31,514
Notes payable, net of current portion		857
Deferred income taxes	4,030	4,670
Other long term liabilities	935	777
Total liabilities	37,275	37,818
Shareholders’ equity:
Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued	0	0
Additional paid-in capital	51,025	46,725
Retained earnings	77,574	71,507
Accumulated other comprehensive (loss) income, foreign currency translation adjustment	(1,635)	(2,626)
Treasury stock, at cost; 4,898,527 Class A shares, 784,018 Class B shares in 2017 and 4,765,691 Class A shares, 768,944 Class B shares in 2016	(36,953)	(32,830)
Total shareholders’ equity	90,041	82,806
Total liabilities and shareholders’ equity	127,316	120,624
Common Class A [Member]
Shareholders’ equity:
Common stock, value	26	26
Common Class B [Member]
Shareholders’ equity:
Common stock, value	$ 4	$ 4

Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Allowance for doubtful accounts	$ 200	$ 169
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	2,000,000	2,000,000
Preferred stock, shares issued (in shares)	0	0
Common Class A [Member]
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	60,000,000	60,000,000
Common stock, shares issued (in shares)	25,835,230	25,656,760
Common stock, shares outstanding (in shares)	20,936,703	20,891,069
Treasury stock, shares (in shares)	4,898,527	4,765,691
Common Class B [Member]
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	80,000,000	80,000,000
Common stock, shares issued (in shares)	4,319,256	4,308,875
Common stock, shares outstanding (in shares)	3,535,238	3,539,931
Treasury stock, shares (in shares)	784,018	768,944

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Revenue	$ 117,559	$ 109,384	$ 102,343
Operating expenses:
Direct	49,068	45,577	44,610
Selling, general and administrative	29,686	28,385	27,177
Depreciation and amortization	4,586	4,225	4,109
Total operating expenses	83,340	78,187	75,896
Operating income	34,219	31,197	26,447
Other income (expense):
Interest income	96	47	60
Interest expense	(82)	(190)	(220)
Other, net	50	302	1,073
Total other income	64	159	913
Income before income taxes	34,283	31,356	27,360
Provision for income taxes	11,340	10,838	9,750
Net income	22,943	20,518	17,610
Common Class A [Member]
Other income (expense):
Net income	$ 11,388	$ 10,178	$ 8,759
Basic earnings per share:
Basic earnings per share (in dollars per share)	$ 0.54	$ 0.49	$ 0.42
Diluted earnings per share:
Diluted earnings per share (in dollars per share)	$ 0.52	$ 0.48	$ 0.41
Weighted average shares and share equivalents outstanding
Weighted average shares and share equivalents outstanding, basic (in shares)	20,770	20,713	20,741
Weighted average shares and share equivalents outstanding, diluted (in shares)	21,627	21,037	20,981
Common Class B [Member]
Other income (expense):
Net income	$ 11,555	$ 10,341	$ 8,851
Basic earnings per share:
Basic earnings per share (in dollars per share)	$ 3.26	$ 2.93	$ 2.52
Diluted earnings per share:
Diluted earnings per share (in dollars per share)	$ 3.18	$ 2.88	$ 2.49
Weighted average shares and share equivalents outstanding
Weighted average shares and share equivalents outstanding, basic (in shares)	3,514	3,505	3,478
Weighted average shares and share equivalents outstanding, diluted (in shares)	3,603	3,560	3,522

Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Common Stock [Member] Common Class A [Member]	Common Stock [Member] Common Class B [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Treasury Stock [Member]	Common Class A [Member]	Common Class B [Member]	Total
Balances at Dec. 31, 2014	$ 25	$ 4	$ 44,864	$ 73,686	$ (773)	$ (30,058)			$ 87,748
Purchase of treasury stock						(2,171)			(2,171)
Issuance of shares for the exercise of stock options			406						406
Tax benefit from the exercise of options and restricted stock			240						240
Issuance of restricted common shares, net of forfeitures	1		(1)
Non-cash stock compensation expense			1,383						1,383
Dividends declared				(25,983)					(25,983)
Acquisition of non-controlling interest			(2,789)						(2,789)
Other comprehensive income (loss), foreign currency translation adjustment					(2,222)				(2,222)
Net income				17,610			$ 8,759	$ 8,851	17,610
Balances at Dec. 31, 2015	26	4	44,103	65,313	(2,995)	(32,229)			74,222
Purchase of treasury stock						(601)			(601)
Issuance of shares for the exercise of stock options			945						945
Issuance of restricted common shares, net of forfeitures
Non-cash stock compensation expense			1,929						1,929
Dividends declared				(14,324)					(14,324)
Acquisition of non-controlling interest			(252)						(252)
Other comprehensive income (loss), foreign currency translation adjustment					369				369
Net income				20,518			10,178	10,341	20,518
Balances at Dec. 31, 2016	26	4	46,725	71,507	(2,626)	(32,830)			82,806
Purchase of treasury stock						(4,123)			(4,123)
Issuance of shares for the exercise of stock options			2,455						2,455
Issuance of restricted common shares, net of forfeitures
Non-cash stock compensation expense			1,845						1,845
Dividends declared				(16,876)					(16,876)
Other comprehensive income (loss), foreign currency translation adjustment					991				991
Net income				22,943			$ 11,388	$ 11,555	22,943
Balances at Dec. 31, 2017	$ 26	$ 4	$ 51,025	$ 77,574	$ (1,635)	$ (36,953)			$ 90,041

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities:
Net income	$ 22,943,000	$ 20,518,000	$ 17,610,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	4,586,000	4,225,000	4,109,000
Deferred income taxes	(684,000)	798,000	(1,387,000)
Reserve for uncertain tax positions	181,000	73,000	119,000
Loss on disposal of property and equipment	26,000	22,000
Gain on sale from operating segment		(223,000)	(1,102,000)
Write-off of purchase option			657,000
Tax benefit from exercise of stock options			25,000
Non-cash share-based compensation expense	1,845,000	1,929,000	1,383,000
Change in assets and liabilities, net of effect of acquisition and disposal:
Trade accounts receivable	(2,463,000)	(1,044,000)	(1,777,000)
Unbilled revenue	123,000	(93,000)	(390,000)
Prepaid expenses and other current assets	(565,000)	(535,000)	207,000
Accounts payable	12,000	(15,000)	(224,000)
Accrued expenses, wages, bonus and profit sharing	1,759,000	440,000	755,000
Income taxes receivable and payable	(1,023,000)	105,000	1,504,000
Deferred revenue	1,351,000	643,000	397,000
Net cash provided by operating activities	28,091,000	26,843,000	21,886,000
Cash flows from investing activities:
Purchases of property and equipment	(4,568,000)	(3,973,000)	(2,939,000)
Purchase of equity investment	(1,300,000)
Purchase of intangible content license	(250,000)
Net proceeds from sale of operating segment		223,000	1,613,000
Net cash used in investing activities	(6,118,000)	(3,750,000)	(1,326,000)
Cash flows from financing activities:
Payments on notes payable	(2,473,000)	(2,199,000)	(2,328,000)
Payments on capital lease obligations	(108,000)	(95,000)	(173,000)
Cash paid for non-controlling interest		(2,000,000)	(2,789,000)
Proceeds from exercise of stock options	0	548,000	0
Excess tax benefit from share-based compensation			240,000
Repurchase of shares for payroll tax withholdings related to share-based compensation	(1,668,000)	(204,000)	(92,000)
Purchase of Treasury Stock			(1,673,000)
Payment of dividends on common stock	(16,867,000)	(28,552,000)	(10,054,000)
Net cash used in financing activities	(21,116,000)	(32,502,000)	(16,869,000)
Effect of exchange rate changes on cash	855,000	285,000	(1,588,000)
Net increase (decrease) in cash and cash equivalents	1,712,000	(9,124,000)	2,103,000
Cash and cash equivalents at beginning of period	33,021,000	42,145,000	40,042,000
Cash and cash equivalents at end of period	34,733,000	33,021,000	42,145,000
Supplemental disclosure of cash paid for:
Interest expense, net of $0, $10, and $14 capitalized, respectively	76,000	192,000	207,000
Income taxes	12,827,000	9,963,000	9,377,000
Supplemental disclosure of non-cash investing and financing activities:
Capital lease obligations originated for property and equipment	74,000	109,000	32,000
Stock tendered to the Company for cashless exercise of stock options in connection with equity incentive plans	$ 2,455,000	$ 397,000	$ 406,000

Note 1 - Summary of Significant Accounting Policies (Details Textual)	12 Months Ended
	Dec. 31, 2017 USD ($) shares	Dec. 31, 2016 USD ($) shares	Dec. 31, 2015 USD ($) shares
Revenue Recognition Subscription Period	1 year
Capitalized Computer Software, Additions	$ 3,000,000	$ 2,500,000
Asset Impairment Charges	0	0	$ 0
Impairment of Intangible Assets (Excluding Goodwill)	$ 0	0	0
Number of Reportable Segments	1
Goodwill, Impairment Loss	$ 0	0	0
Income Tax Credits and Adjustments	4,000	77,000	$ 156,000
Cash Equivalents, at Carrying Value	$ 34,500,000	$ 32,700,000
Loss Contingency, New Claims Filed, Number	3
Loss Contingency Accrual	$ 0
Percentage of Class B Common Stock Dividend or Other Distribution for Class A Common Stock Dividend or Other Distribution	0.16667%
Accounting Standards Update 2014-09 [Member] \| Capitalized Contract Costs [Member]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	$ 2,700,000
Common Class A [Member]
Stock Options Excluded from Computation of Earnings Per Share, Amount \| shares		156,610	487,639
Common Class A [Member] \| Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount \| shares	104,647	390,300	68,779
Common Class B [Member]
Stock Options Excluded from Computation of Earnings Per Share, Amount \| shares		49,262	58,429
Common Class B [Member] \| Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount \| shares	1,858	34,178	1,101
Reclassification from Noncurrent Deferred Income Taxes to Other Noncurrent Liabilities [Member] \| December 31, 2016 [Member]
Prior Period Reclassification Adjustment	$ 191,000
New Accounting Pronouncement, Early Adoption, Effect [Member] \| Accounting Standards Update 2016-02 [Member]
Operating Leases, Future Minimum Payments Due	$ 3,000,000
Minimum [Member] \| Furniture and Fixtures [Member]
Property, Plant and Equipment, Useful Life	3 years
Minimum [Member] \| Computer Equipment [Member]
Property, Plant and Equipment, Useful Life	3 years
Minimum [Member] \| Software and Software Development Costs [Member]
Property, Plant and Equipment, Useful Life	1 year
Minimum [Member] \| Building and Building Improvements [Member]
Property, Plant and Equipment, Useful Life	7 years
Maximum [Member] \| Furniture and Fixtures [Member]
Property, Plant and Equipment, Useful Life	10 years
Maximum [Member] \| Computer Equipment [Member]
Property, Plant and Equipment, Useful Life	5 years
Maximum [Member] \| Software and Software Development Costs [Member]
Property, Plant and Equipment, Useful Life	5 years
Maximum [Member] \| Building and Building Improvements [Member]
Property, Plant and Equipment, Useful Life	40 years

Note 1 - Summary of Significant Accounting Policies - Fair Value of Financial Assets and Liabilities (Details) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Assets, fair value	$ 34,478	$ 32,650
Money Market Funds [Member]
Assets, fair value	13,971	11,200
Commercial Paper [Member]
Assets, fair value	10,490	21,450
Eurodollar Deposits [Member]
Assets, fair value	10,017
Fair Value, Inputs, Level 1 [Member]
Assets, fair value	13,971	11,200
Fair Value, Inputs, Level 1 [Member] \| Money Market Funds [Member]
Assets, fair value	13,971	11,200
Fair Value, Inputs, Level 1 [Member] \| Commercial Paper [Member]
Assets, fair value
Fair Value, Inputs, Level 1 [Member] \| Eurodollar Deposits [Member]
Assets, fair value
Fair Value, Inputs, Level 2 [Member]
Assets, fair value	20,507	21,450
Fair Value, Inputs, Level 2 [Member] \| Money Market Funds [Member]
Assets, fair value
Fair Value, Inputs, Level 2 [Member] \| Commercial Paper [Member]
Assets, fair value	10,490	21,450
Fair Value, Inputs, Level 2 [Member] \| Eurodollar Deposits [Member]
Assets, fair value	10,017
Fair Value, Inputs, Level 3 [Member]
Assets, fair value
Fair Value, Inputs, Level 3 [Member] \| Money Market Funds [Member]
Assets, fair value
Fair Value, Inputs, Level 3 [Member] \| Commercial Paper [Member]
Assets, fair value
Fair Value, Inputs, Level 3 [Member] \| Eurodollar Deposits [Member]
Assets, fair value

Note 1 - Summary of Significant Accounting Policies - Fair Values of Long-term Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Total carrying amount of long-term debt	$ 1,067	$ 3,540
Estimated fair value of long-term debt	$ 1,066	$ 3,533

Note 3 - Divestitures (Details Textual) - USD ($)		1 Months Ended	12 Months Ended
Note 3 - Divestitures (Details Textual) - USD ($)	Dec. 21, 2015	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Proceeds from Divestiture of Businesses, Net of Cash Divested				$ 223,000	$ 1,613,000
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal				$ 223,000	$ 1,102,000
Predictive Analytics [Member]
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal		$ 223,000
Predictive Analytics [Member] \| Other Income [Member]
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal	$ 1,100,000
Predictive Analytics [Member] \| Disposal Group, Not Discontinued Operations [Member]
Proceeds from Divestiture of Businesses, Net of Cash Divested	1,600,000
Escrow Deposit	$ 300,000

Note 4 - Connect (Details Textual) - USD ($)			1 Months Ended		12 Months Ended
Note 4 - Connect (Details Textual) - USD ($)	Mar. 28, 2016	Mar. 07, 2016	Jul. 31, 2015	Jun. 30, 2013	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Payments to Noncontrolling Interests						$ 2,000,000	$ 2,789,000
Connect [Member]
Payments to Noncontrolling Interests			$ 2,800,000
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions							89.00%
Adjustments to Additional Paid-in Capital, Acquisition of Additional Ownership Interests						252,000	$ 2,800,000
Connect [Member] \| Illuminate Health, LLC [Member]
Payments to Noncontrolling Interests	$ 1,000,000	$ 1,000,000
Ownership Percentage Available to Acquire at Each Recurring Contract Value Target Level		33.33%
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Noncurrent						$ 1,700,000
Illuminate Health, LLC [Member]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners							11.00%
Connect [Member]
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage				49.00%
Connect [Member] \| NG Customer-Connect, LLC [Member]
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage				25.00%
Connect [Member] \| Illuminate Health, LLC [Member]
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage				26.00%

Note 5 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Property and equipment at cost	$ 40,206	$ 37,890
Less accumulated depreciation and amortization	27,847	26,084
Net property and equipment	12,359	11,806
Furniture and Fixtures [Member]
Property and equipment at cost	5,064	4,737
Computer Equipment [Member]
Property and equipment at cost	2,721	2,750
Software and Software Development Costs [Member]
Property and equipment at cost	22,569	20,592
Building and Building Improvements [Member]
Property and equipment at cost	9,386	9,386
Leasehold Improvements [Member]
Property and equipment at cost	41
Land [Member]
Property and equipment at cost	$ 425	$ 425

Note 5 - Property and Equipment - Schedule of Capital Lease Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Capital leased assets	$ 843	$ 769
Less accumulated amortization	684	530
Net assets under capital lease	159	239
Furniture and Fixtures [Member]
Capital leased assets	$ 843	$ 769

Note 7 - Income Taxes (Details Textual) - USD ($)	12 Months Ended
Note 7 - Income Taxes (Details Textual) - USD ($)	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent		35.00%
Provisional Tax Expense (Benefit) for Tax Cuts and Jobs Act		$ (1,900,000)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Depreciation, Amount		0
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount		535,000
Effective Income Tax Rate Reconcilation, Withholding Tax on Repatriation of Foreign Earnings		706,000
Unrecognized Tax Benefits		843,000	662,000	$ 589,000
Unrecognized Tax Benefits, Interest on Income Taxes Accrued		5,000	2,000
Unrecognized Tax Benefits that Would Impact Effective Tax Rate		$ 620,000	$ 472,000
Scenario, Forecast [Member]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%

Note 7 - Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Deferred tax assets:
Allowance for doubtful accounts	$ 46	$ 62
Accrued expenses	416	580
Share based compensation	1,457	2,357
Accrued bonuses	113	84
Foreign tax credit from repatriation	535
Other	166	244
Gross deferred tax assets	2,733	3,327
Less Valuation Allowance	(535)
Deferred Tax Assets	2,198	3,327
Deferred tax liabilities:
Prepaid expenses	169	270
Property and equipment	856	1,206
Intangible assets	4,497	6,521
Repatriation withholding	706
Deferred tax liabilities	6,228	7,997
Net deferred tax liabilities	$ (4,030)	$ (4,670)

Note 7 - Income Taxes - Change in Unrecognized Tax Benefits (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Balance of unrecognized tax benefits	$ 662,000	$ 589,000
Reductions due to lapse of applicable statute of limitations		(148,000)
Additions based on tax positions of prior years		5,000
Additions based on tax positions related to the current year	188,000	216,000
Reductions due to tax positions of prior years	(7,000)
Balance of unrecognized tax benefits	$ 843,000	$ 662,000

Note 8 - Notes Payable (Details Textual) - Revolving Credit Facility [Member] $ in Thousands	12 Months Ended
	Dec. 31, 2017 USD ($)
Line of Credit Facility, Maximum Borrowing Capacity	$ 12,000
Long-term Line of Credit	0
Line of Credit Facility, Remaining Borrowing Capacity	$ 12,000
One Month LIBOR [Member]
Debt Instrument, Basis Spread on Variable Rate	2.10%
One, Two, or Three Month LIBOR [Member]
Debt Instrument, Basis Spread on Variable Rate	2.10%

Note 8 - Notes Payable - Summary of Notes Payable (Details) (Parentheticals) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Revolving Credit Note [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 12,000,000	$ 12,000,000
Term Note [Member]
Note payable, face amount	$ 11,800,000	$ 11,800,000
Note payable, fixed interest rate	3.12%	3.12%
Note payable, monthly payment	$ 212,468	$ 212,468

Note 9 - Share-based Compensation - Non-vested Stock (Details)	12 Months Ended
	Dec. 31, 2017 $ / shares shares
Common Class A [Member]
Outstanding (in shares) \| shares	174,487
Outstanding (in dollars per share) \| $ / shares	$ 13.93
Granted (in shares) \| shares
Granted (in dollars per share) \| $ / shares
Vested (in shares) \| shares	(73,506)
Vested (in dollars per share) \| $ / shares	$ 13.99
Forfeited (in shares) \| shares	(19,314)
Forfeited (in dollars per share) \| $ / shares	$ 14.27
Outstanding (in shares) \| shares	81,677
Outstanding (in dollars per share) \| $ / shares	$ 13.80
Common Class B [Member]
Outstanding (in shares) \| shares	29,081
Outstanding (in dollars per share) \| $ / shares	$ 37.21
Granted (in shares) \| shares
Granted (in dollars per share) \| $ / shares
Vested (in shares) \| shares	(12,251)
Vested (in dollars per share) \| $ / shares	$ 38.50
Forfeited (in shares) \| shares	(3,219)
Forfeited (in dollars per share) \| $ / shares	$ 34.69
Outstanding (in shares) \| shares	13,611
Outstanding (in dollars per share) \| $ / shares	$ 36.65

Note 10 - Leases (Details Textual) - USD ($)	12 Months Ended
Note 10 - Leases (Details Textual) - USD ($)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Operating Leases, Rent Expense, Net	$ 869,000	$ 920,000	$ 1,000,000

Note 10 - Leases - Payments Under Non-cancelable Operating Leases and Capital Leases (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Capital leases, 2018	$ 80
Operating leases, 2018	708
Capital leases, 2019	51
Operating leases, 2019	679
Capital leases, 2020	34
Operating leases, 2020	485
Capital leases, 2021	6
Operating leases, 2021	377
Capital leases, 2022	1
Operating leases, 2022	190
Capital leases, Total minimum lease payments	172
Less: Amount representing interest	14
Present value of minimum lease payments	158
Less: Current maturities	71	$ 82
Capital lease obligations, net of current portion	$ 87

Note 11 - Related Party (Details Textual) - USD ($)	12 Months Ended
Note 11 - Related Party (Details Textual) - USD ($)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Payments to Acquire Intangible Assets	$ 250,000
Ameritas Life Insurance Corp [Member]
Related Party Transaction, Amounts of Transaction	248,000	232,000	227,000
Nebraska Global Investment Company LLC [Member]
Related Party Transaction, Amounts of Transaction	12,500	$ 488,000	$ 440,000
Nebraska Global Investment Company LLC [Member] \| Chief Executive Officer [Member]
Officer Ownership Percentage in Vendor		14.00%
Mr. Hays [Member]
Costs and Expenses, Related Party	538,000
PracticingExcellence.com [Member]
Payments to Acquire Intangible Assets	250,000
Revenue from Related Parties	$ 633,000	$ 28,000

Note 13 - Proposed Recapitalization (Details Textual)	1 Months Ended	12 Months Ended
Note 13 - Proposed Recapitalization (Details Textual)	Dec. 31, 2017 USD ($) $ / shares	Dec. 31, 2017 USD ($)
Selling and Administrative Expenses [Member]
Recapitalization Costs		$ 1,400,000
First National Bank of Omaha [Member] \| Term Loan Commitment Letter [Member]
Commitment to Provide Long-term Debt	$ 40,000,000	40,000,000
First National Bank of Omaha [Member] \| Delayed Draw Term Loan Facility Commitment Letter [Member]
Commitment to Provide Senior Notes	15,000,000	15,000,000
First National Bank of Omaha [Member] \| Revolving Credit Facility Commitment Letter [Member]
Commtiment to Provide Line of Credit, Maximum Proposed Borrowing Capacity	15,000,000	$ 15,000,000
Common Class B [Member]
Proposed Cash Payment Per Class B Share	$ 19.59
Exchange Value Per Share \| $ / shares	$ 53.44

Note 14 - Segment Information (Details Textual)		12 Months Ended
Note 14 - Segment Information (Details Textual)	Dec. 31, 2015	Dec. 31, 2017	Dec. 21, 2015
Number of Operating Segments	6	6	7
Number of Reportable Segments		1